MENU

 Education

School ¡X Major ¡X Degree Duration

°ª¶¯Âå¾Ç¤j¾Ç ¡X Âå¾Ç¬ã¨s©Ò(²¦) ¡X ³Õ¤h

Doctorate, Graduate Institute of Medical Science, Kaohsiung Medical University

1992/08 ¡X 2000/06

°ª¶¯Âå¾Ç°| ¡X Âå¾Ç¨t(²¦) ¡X ¾Ç¤h

Bachelor, Faculty of Medicine, Kaohsiung Medical University

1982/08 ¡X 1989/06

 Intramural Experience

Office/Department/Institute Position Duration
¨xÁx¯Ø¤º¬ì Division of Hepato/Billiary/ Pancreatic   Visiting Staff   ¡X  
¤º¬ì¾Ç¬ì Department of Internal Medicine Chair Professor 2023/08/01 ¡X 2026/07/31
¤º¬ì¾Ç¬ì Department of Internal Medicine   Professor 2007/08/01 ¡X  
¤º¬ì¾Ç Internal Medicine   Professor 2006/08/01 ¡X 2007/07/31
¤º¬ì¾Ç Internal Medicine   Associate Professor 2003/08/01 ¡X 2006/07/31
¤º¬ì¾Ç Internal Medicine   Assistant Professor 2000/08/01 ¡X 2003/07/31

 Extramural Experience

 

 Discipline

NO Discipline Expertise
1 ¥Íª«Âå¹AÃþ Biology, Medicine and Agriculture Âå¾Ç¤§¥Í¤Æ¤Î¤À¤l¥Íª« Medical Biochemistry and Molecular Biology
2 ¥Íª«Âå¹AÃþ Biology, Medicine and Agriculture ¸z­G¤º¬ì Division of Gastroenterology

 Research & Technology Platform Open to the Outside

 

 Interested Area(s)for Interdisciplinary Research

Âå¾Ç¤§¥Í¤Æ¤Î¤À¤l¥Íª«¡B¤½¦@½Ã¥Í¤ÎÀô¹ÒÂå¾Ç¡B·s³¯¥NÁ¤Τº¤Àªc

Biochemistry and Molecular Biology in Medicine, Public Health, Environmental & Occupational Health, Metabolism and Endocrine

 Area(s) of Expertise & Research

®ø¤Æ¾Ç¡B¤º¬ì¾Ç¡B¶W­µªi¾Ç¡B¥Í¤l¥Íª«¾Ç¡B¬y¦æ¯f¾ÇB«¬¡AC«¬¨xª¢¡A¯×ªÕ©Ê¨xª¢¡A¨xµw¤Æ¡A¨xÀù¡AÂàĶÂå¾Ç

Viral Hepatitis, Hepatitis B, Hepatitis C, Nonalcoholic Steatohepatitis, Hepatocellular Carcinoma, Metabolic Syndrome, HBV, HCV, HDV, NAFLD, NASH, HCC, Translational Research, Non-Coding RNA, Liquid Biopsy

 Publication

NO Publication
1

Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study
Ogawa E, Jun DW, Toyoda H, Hsu YC, Yoon EL, Ahn SB, ¸­©ú­Û, Do S, Trinh HN, Takahashi H, Enomoto M, Kawada N, Yasuda S, ´¿¬F»¨, Kawashima K, Lee HA, Inoue K, Haga H, Do AT, Maeda M, Hoang JH, Cheung R, Ueno Y, Eguchi Y, Furusyo N, §E©ú¶©, Tanaka Y, Nguyen MH* - - 1 - Aliment Pharmacol Ther - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2024 59¨÷(2´Á):239-248­¶
(IF: 7.6, »â°ì±Æ¦W: 20, »â°ì´Á¥Z¼Æ: 277, »â°ì±Æ¦W: 7.22%)

Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study
Ogawa E, Jun DW, Toyoda H, Hsu YC, Yoon EL, Ahn SB, Yeh ML, Do S, Trinh HN, Takahashi H, Enomoto M, Kawada N, Yasuda S, Tseng CH, Kawashima K, Lee HA, Inoue K, Haga H, Do AT, Maeda M, Hoang JH, Cheung R, Ueno Y, Eguchi Y, Furusyo N, Yu ML, Tanaka Y, Nguyen MH* - - 1 - Aliment Pharmacol Ther - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2024;59(2):239-248
(IF: 7.6, Journal Ranking: 20, Number of Journals of this Field: 277, Ranking: 7.22%)

2

Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response.
Park JE, Nguyen VH, ½²¨Ø­Å, Toyoda H, Leong J, Guy JE, ¸­©ú­Û, ¶À³©®p, Yasuda S, Abe H, Hsu YC, Tseng CH, Liu J, Chen YL, Lin PY, Jun DW, Yoshimaru Y, Ogawa E, Ishigami M, Enomoto M, Tamori A, Uojima H, Wang XZ, Xu Q, Takahashi H, Eguchi Y, Inoue K, Huang DQ, Zhao WJ, ²ø¸UÀs, À¹¹Å¨¥, ¶À§Ó´I, Barnett S, Maeda M, Cheung R, Landis C, Tanaka Y, Roberts LR, Schwartz ME, Kumada T, §E©ú¶©, Nguyen MH*. - - 1 - ALIMENTARY PHARMACOLOGY & THERAPEUTICS - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2024 59¨÷(6´Á):742-751­¶
(IF: 7.6, »â°ì±Æ¦W: 20, »â°ì´Á¥Z¼Æ: 277, »â°ì±Æ¦W: 7.22%)

Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response.
Jung Eun Park, Vy H Nguyen, Pei-Chien Tsai, Hidenori Toyoda, Jennifer Leong, Jennifer E Guy, Ming-Lun Yeh, Chung-Feng Huang, Satoshi Yasuda, Hiroshi Abe, Yao-Chun Hsu, Cheng-Hao Tseng, Joanne Liu, Yao-Li Chen, Ping-Yi Lin, Dae Won Jun, Yoko Yoshimaru, Eiichi Ogawa, Masatoshi Ishigami, Masaru Enomoto, Akihiro Tamori, Haruki Uojima, Xiao Zhong Wang, Qiang Xu, Hirokazu Takahashi, Yuichiro Eguchi, Kaori Inoue, Daniel Q Huang, Wen Jing Zhao, Wan-Long Chuang, Chia-Yen Dai, Jee-Fu Huang, Scott Barnett, Mayumi Maeda, Ramsey Cheung, Charles Landis, Yasuhito Tanaka, Lewis R Roberts, Myron E Schwartz, Takashi Kumada, Ming-Lung Yu, Mindie H Nguyen* - - 1 - ALIMENTARY PHARMACOLOGY & THERAPEUTICS - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2024;59(6):742-751
(IF: 7.6, Journal Ranking: 20, Number of Journals of this Field: 277, Ranking: 7.22%)

3

Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B.
¾GÙy¨k, ¶¾·N­õ, ³¯§Ó¦{, ³¢¦æ¹D, §õ¨Ø­Û, §E©ú¶©, ªô«Ûµ{, ªô§»´¼, ²¥@ªN, ³¯°ö­õ, ¼B«T¤H* - - 1 - ALIMENTARY PHARMACOLOGY & THERAPEUTICS - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2024 59¨÷(2´Á):230-238­¶
(IF: 7.6, »â°ì±Æ¦W: 20, »â°ì´Á¥Z¼Æ: 277, »â°ì±Æ¦W: 7.22%)

Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B.
Pin-Nan Cheng, I-Cher Feng, Jyh-Jou Chen, Hsing-Tao Kuo, Pei-Lun Lee, Ming-Lung Yu, Yen-Cheng Chiu, Hung-Chih Chiu, Shih-Chieh Chien, Pei-Jer Chen, Chun-Jen Liu* - - 1 - ALIMENTARY PHARMACOLOGY & THERAPEUTICS - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2024;59(2):230-238
(IF: 7.6, Journal Ranking: 20, Number of Journals of this Field: 277, Ranking: 7.22%)

4

Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program.
§f©ú¿o, ¶À³©®p, ¬x»F§», À¹±Ò©ú, Mo LR, ³¢¦æ¹D, ´¿°êªK, ù²M¦À, ¥Õ©ú©v, ¤ý¶à¤¯, ¶À§Ó´I, ¸­©ú­Û, ³¯«T©µ, ½²©ú¼ý, ¶À°·ºû, §õ¨Ø­Û, ·¨¼W¼z, ¶À©Éµ¾, Chong LW, ³¯°·Åï, ·¨°òÞf, ·¨³ÓµÏ, ¾GÙy¨k, Á°]·½, ­J·ç®x, §d¤å»x, ¾G°·¬ê, ³¯®Û­^, ©P°ê¶¯, ½²ºû­Û, °ª°·¯à, ªL§Ó­¦, ¤ý¹Å»ô, ªL¤j¶®, ªL§Ó³®, Ĭºû¤å, §õ©vº³, ±i¼w¥Í, ¼B«T¤H, À¹¹Å¨¥, °ª¹Å§», ªLº~³Ç, ²ø¸UÀs, ´^¦¨¤¸, ½²±RÞm, ³¯±Ò¯q, §E©ú¶©*; TACR Study Group - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2024 30¨÷(1´Á):64-79­¶
(IF: 8.9, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 12.90%)

Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program.
Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, Chi-Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Kuo-Chih Tseng, Ching-Chu Lo, Ming-Jong Bair, Szu-Jen Wang, Jee-Fu Huang, Ming-Lun Yeh, Chun-Ting Chen, Ming-Chang Tsai, Chien-Wei Huang, Pei-Lun Lee, Tzeng-Hue Yang, Yi-Hsiang Huang, Lee-Won Chong, Chien-Lin Chen, Chi-Chieh Yang, Sheng-Shun Yang, Pin-Nan Cheng, Tsai-Yuan Hsieh, Jui-Ting Hu, Wen-Chih Wu, Chien-Yu Cheng, Guei-Ying Chen, Guo-Xiong Zhou, Wei-Lun Tsai, Chien-Neng Kao, Chih-Lang Lin, Chia-Chi Wang, Ta-Ya Lin, Chih-Lin Lin, Wei-Wen Su, Tzong-Hsi Lee, Te-Sheng Chang, Chun-Jen Liu, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wan-Long Chuang, Cheng-Yuan Peng, Chun-Wei- Tsai, Chi-Yi Chen, Ming-Lung Yu, - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2024;30(1):64-79
(IF: 8.9, Journal Ranking: 12, Number of Journals of this Field: 93, Ranking: 12.90%)

5

Patient-centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in Taiwan.
¶À³©®p, ±i®x»·, ´åµÏªN, ¶À«H¼ý, ¦óÊo­Û, ¸­©ú­Û, ¤ý§Ó¤å, ±ç³Õµ{, ÃQà±¾§, ³\³Õ³ó, ¶ÀÂ@¶h, Á©ú«Û, ªL©yÐA, ´åªQÀM, §d¨ØªÚ, ³¯à±²[, ²¨¯µX, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, ¤ý§@¤¯*, §E©ú¶©* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024 40¨÷(1´Á):86-93­¶
(IF: 3.3, »â°ì±Æ¦W: 81, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 59.56%)

Patient-centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in Taiwan.
Chung-Feng Huang, Tyng-Yuan Jang, Shun-Chieh Yu, Shin-Chung Huang, Shao-Lun Ho, Ming-Lun Yeh, Chih-Wen Wang, Po-Cheng Liang, Yu-Ju Wei, Po-Yao Hsu, Ching-I Huang, Ming-Yen Hsieh, Yi-Hung Lin, Sung-Lin Yu, Pey-Fang Wu, Yu-Han Chen, Shin-Chi Chien, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Tso-Jen Wang, Ming-Lung Yu - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024;40(1):86-93
(IF: 3.3, Journal Ranking: 81, Number of Journals of this Field: 136, Ranking: 59.56%)

6

Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis.
¶À³©®p, ±ç³Õµ{#, ¤ý§Ó¤å, ±i®x»·, ³\³Õ³ó, ½²¨Ø­Å, ÃQà±¾§, ¸­©ú­Û, Á©ú«Û, ªL©yÐA, ¶À¥ü¼e, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, §E©ú¶©* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024 40¨÷(4´Á):374-383­¶
(IF: 3.3, »â°ì±Æ¦W: 81, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 59.56%)

Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis.
Chung-Feng Huang, Po-Cheng Liang, Chih-Wen Wang, Tyng-Yuan Jang, Po-Yao Hsu, Pei-Chien Tsai, Yu-Ju Wei, Ming-Lun Yeh, Ming-Yen Hsieh, Yi-Hung Lin, Chao-Kuan Huang, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024;40(4):374-383
(IF: 3.3, Journal Ranking: 81, Number of Journals of this Field: 136, Ranking: 59.56%)

7

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories.
Polaris Observatory Collaborators ( D Razavi-Shearer*, ²ø¸UÀs,§E©ú¶©) - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2024 80¨÷(2´Á):232-242­¶
(IF: 25.7, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 4.30%)

Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories.
Polaris Observatory Collaborators - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2024;80(2):232-242
(IF: 25.7, Journal Ranking: 4, Number of Journals of this Field: 93, Ranking: 4.30%)

8

The interplay of metabolic dysfunction-associated fatty liver disease and viral hepatitis on liver disease severity: A large community-based study in a viral endemic area.
¶À³©®p,±ç³Õµ{,½²¨Ø­Å,ÃQà±¾§,¶ÀÂ@¶h,¤ý§Ó¤å,±i®x»·,¸­©ú­Û,³\³Õ³ó,ªL©yÐA,À¹¹Å¨¥,²ø¸UÀs,¶À§Ó´I*,§E©ú¶©* - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2024 39¨÷(1´Á):193-201­¶
(IF: 4.1, »â°ì±Æ¦W: 38, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 40.86%)

The interplay of metabolic dysfunction-associated fatty liver disease and viral hepatitis on liver disease severity: A large community-based study in a viral endemic area.
Chung-Feng Huang, Po-Cheng Liang, Pei-Chien Tsai, Yu-Ju Wei, Ching-I Huang, Chih-Wen Wang, Tyng-Yuan Jang, Ming-Lun Yeh, Po-Yao Hsu, Ming-Yen Hsieh, Yi-Hung Lin, Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang*, Ming-Lung Yu* - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2024;39(1):193-201
(IF: 4.1, Journal Ranking: 38, Number of Journals of this Field: 93, Ranking: 40.86%)

9

Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs.
±i®x»·,±ç³Õµ{, Dae Won Jun, Jang Han Jung, Hidenori Toyoda, ¤ý§Ó¤å, Man-Fung Yuen, Ka Shing Cheung, Satoshi Yasuda, Sung Eun Kim, Eileen L Yoon, Jihyun An, Masaru Enomoto, Ritsuzo Kozuka, Makoto Chuma, Akito Nozaki, Toru Ishikawa, Tsunamasa Watanabe, Masanori Atsukawa, Taeang Arai, Korenobu Hayama, Masatoshi Ishigami, Yong Kyun Cho, Eiichi Ogawa, Hyoung Su Kim, Jae-Jun Shim, Haruki Uojima, Soung Won Jeong, Sang Bong Ahn, Koichi Takaguchi, Tomonori Senoh, Maria Buti, Elena Vargas-Accarino, Hiroshi Abe, Hirokazu Takahashi, Kaori Inoue,¶À§Ó´I,²ø¸UÀs, ¸­©ú­Û, À¹¹Å¨¥*, ¶À³©®p*, Mindie H Nguyen,§E©ú¶© - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024 40¨÷(2´Á):188-197­¶
(IF: 3.3, »â°ì±Æ¦W: 81, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 59.56%)

Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs.
Tyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, Jang Han Jung, Hidenori Toyoda, Chih-Wen Wang, Man-Fung Yuen, Ka Shing Cheung, Satoshi Yasuda, Sung Eun Kim, Eileen L Yoon, Jihyun An, Masaru Enomoto, Ritsuzo Kozuka, Makoto Chuma, Akito Nozaki, Toru Ishikawa, Tsunamasa Watanabe, Masanori Atsukawa, Taeang Arai, Korenobu Hayama, Masatoshi Ishigami, Yong Kyun Cho, Eiichi Ogawa, Hyoung Su Kim, Jae-Jun Shim, Haruki Uojima, Soung Won Jeong, Sang Bong Ahn, Koichi Takaguchi, Tomonori Senoh, Maria Buti, Elena Vargas-Accarino, Hiroshi Abe, Hirokazu Takahashi, Kaori Inoue, Jee-Fu Huang, Wan-Long Chuang, Ming-Lun Yeh, Chia-Yen Dai*, Chung-Feng Huang*, Mindie H Nguyen, Ming-Lung Yu - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024;40(2):188-197
(IF: 3.3, Journal Ranking: 81, Number of Journals of this Field: 136, Ranking: 59.56%)

10

Hepatitis C virus micro-elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide.
À¹±Ò©ú,§E©ú¶©* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024 40¨÷(2´Á):112-118­¶
(IF: 3.3, »â°ì±Æ¦W: 81, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 59.56%)

Hepatitis C virus micro-elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide.
Chi-Ming Tai, Ming-Lung Yu* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024;40(2):112-118
(IF: 3.3, Journal Ranking: 81, Number of Journals of this Field: 136, Ranking: 59.56%)

11

¯×ªÕ¨xªºÄY­«µ{«×»Pµo¥Í°ª¦åÀ£¿}§¿¯fªº­·ÀI§e°ª«×¬ÛÃö¡G¾îÂ_»PÁa¦V¥@¥N¬ã¨s
Chin-I Shih, §d«a¹F#, Á©s°a, ·¨¥¿ºÖ, ³¯ÃÀ¯§, Wei-Lun Tsai, Wen-Chi Chen, ±ç³Õµ{, ÃQà±¾§, ½²¨Ø­Å, ³\³Õ³ó, Á©ú«Û, ªL©yÐA, ±i®x»·, ¤ý§Ó¤å, ¸­©ú­Û, ¶À³©®p, ¶À§Ó´I, À¹¹Å¨¥, ¦ó±Ò¥\, ²ø¸UÀs, §E©ú¶©* - - 1 - Hepatology International - HEPATOLOGY INTERNATIONAL 2024 18¨÷(1´Á):138-154­¶
(IF: 6.6, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 22.58%)

Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study
Chin-I Shih, Kuan-Ta Wu#, Meng-Hsuan Hsieh, Jeng-Fu Yang, Yi-Yu Chen, Wei-Lun Tsai, Wen-Chi Chen, Po-Cheng Liang, Yu-Ju Wei, Pei-Chien Tsai, Po-Yao Hsu, Ming-Yen Hsieh, Yi-Hung Lin, Tyng-Yuan Jang, Chih-Wen Wang, Ming-Lun Yeh, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Chi-Kung Ho, Wan-Long Chuang, Ming-Lung Yu* - - 1 - Hepatology International - HEPATOLOGY INTERNATIONAL 2024;18(1):138-154
(IF: 6.6, Journal Ranking: 21, Number of Journals of this Field: 93, Ranking: 22.58%)

12

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
Younossi ZM*, AlQahtani SA,,¡K, §E©ú¶©, ...; Global NASH Council.(¦@56¦ìµ¥) - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2024 80¨÷(3´Á):419-430­¶
(IF: 25.7, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 4.30%)

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
Younossi ZM*, AlQahtani SA, ,¡K, Yu ML, ...; Global NASH Council.(¦@56¦ìµ¥) - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2024;80(3):419-430
(IF: 25.7, Journal Ranking: 4, Number of Journals of this Field: 93, Ranking: 4.30%)

13

Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases.
¾GÙy¨k, ³¯¤åÁé, «J¹Å®ï, ªL§Ó»·, ±i©ú¹a, ¤ý¹Å»ô, ±iÞ³´@, ¤ý´Â¥Ã, ªL«T«Û, ¬x±R¯P, ´^¦¨¤¸, §E©ú¶©, »¯®x¿³, ¶À§Ó´I, ¶À©Éµ¾, ³¯±Ò¯q, Chiang CE, ªLº~³Ç, §õ¶MùÚ, ªL©v¾Ë, °ª¹Å§», ¤ý©v¹D, ¼BªÃ«Û, §d«Û¶²*, ¼B«T¤H*. - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2024 30¨÷(1´Á):16-36­¶
(IF: 8.9, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 12.90%)

Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases.
Pin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, Chih-Lin Lin, Ming-Ling Chang, Chia-Chi Wang, Wei-Ting Chang, Chao-Yung Wang, Chun-Yen Lin, Chung-Lieh Hung, Cheng-Yuan Peng, Ming-Lung Yu, Ting-Hsing Chao, Jee-Fu Huang, Yi-Hsiang Huang, Chi-Yi Chen, Chern-En Chiang, Han-Chieh Lin, Yi-Heng Li, Tsung-Hsien Lin, Jia-Horng Kao, Tzung-Dau Wang, Ping-Yen Liu, Yen-Wen Wu, Chun-Jen Liu - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2024;30(1):16-36
(IF: 8.9, Journal Ranking: 12, Number of Journals of this Field: 93, Ranking: 12.90%)

14

Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma.
Huang DQ, Hoang JK, Kamal R, ½²¨Ø­Å, Toyoda H, ¸­©ú­Û, Yasuda S, Leong J, Maeda M, ¶À³©®p, Won Jun D, Ishigami M, Tanaka Y, Uojima H, Ogawa E, Abe H, Hsu YC, Tseng CH, Alsudaney M, Yang JD, Yoshimaru Y, Suzuki T, Liu JK, Landis C, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, Schwartz M, Dan YY, Esquivel C, Bonham A, §E©ú¶©, Nguyen MH*. - - 1 - JOURNAL OF CLINICAL ONCOLOGY : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY - JOURNAL OF CLINICAL ONCOLOGY 2024 42¨÷(7´Á):790-799­¶
(IF: 45.4, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 241, »â°ì±Æ¦W: 2.90%)

Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma.
Daniel Q Huang, Joseph K Hoang, Rubayet Kamal, Pei-Chien Tsai, Hidenori Toyoda, Ming-Lun Yeh, Satoshi Yasuda, Jennifer Leong, Mayumi Maeda, Chung-Feng Huang, Dae Won Jun, Masatoshi Ishigami, Yasuhito Tanaka, Haruki Uojima, Eiichi Ogawa, Hiroshi Abe, Yao-Chun Hsu, Cheng-Hao Tseng, Manaf Alsudaney, Ju Dong Yang, Yoko Yoshimaru, Takanori Suzuki, Joanne K Liu, Charles Landis, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Myron Schwartz, Yock Young Dan, Carlos Esquivel, Andrew Bonham, Ming-Lung Yu, Mindie H Nguyen - - 1 - JOURNAL OF CLINICAL ONCOLOGY : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY - JOURNAL OF CLINICAL ONCOLOGY 2024;42(7):790-799
(IF: 45.4, Journal Ranking: 7, Number of Journals of this Field: 241, Ranking: 2.90%)

15

An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan.
§E©ú¶©, À¹±Ò©ú, ¦È联·ç, ³¢¦æ¹D, ¶À³©®p, ´¿°êªK, ù²M¦À, ¥Õ©ú©¾, ¤ý¶à¤¯, ¶À§Ó´I, ¸­©ú­Û, ³¯­x§Ê, ½²©ú¼ý, ¶À°·ºû, §õ¨Ø­Û, ·¨¼W¼z, ¶À©Éµ¾, ±iÄR¤å, ³¯°·Åï, ·¨°òÞf, ¬x»F§», ·¨³ÓµÏ, ¾GÙy¨k, Á°]·½, ­J·ç®x, §d¤å»x, ¾G®Ê¦t, ³¯®Û­^, ©P°ê¶¯, ½²ºû­Û, °ª°·¯à, ªL§Ó­¦, ¤ý¹Å»ô, ªL¤j¶®, ªL§Ó³®, Ĭºû¤å, §õ©vº³, ±i¼w¥Í, ¼B«T¤H, À¹¹Å¨¥, ³¯±Ò¯q, °ª¹Å§», ªLº~³Ç, ²ø¸UÀs*, ´^¦¨¤¸* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2024 18¨÷(2´Á):461-475­¶
(IF: 6.6, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 22.58%)

An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan.
Ming-Lung Yu, Chi-Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Chung-Feng Huang, Kuo-Chih Tseng, Ching-Chu Lo, Ming-Jong Bair, Szu-Jen Wang, Jee-Fu Huang, Ming-Lun Yeh, Chun-Ting Chen, Ming-Chang Tsai, Chien-Wei Huang, Pei-Lun Lee, Tzeng-Hue Yang, Yi-Hsiang Huang, Lee-Won Chong, Chien-Lin Chen, Chi-Chieh Yang, Chao-Hung Hung, Sheng-Shun Yang, Pin-Nan Cheng, Tsai-Yuan Hsieh, Jui-Ting Hu, Wen-Chih Wu, Chien-Yu Cheng, Guei-Ying Chen, Guo-Xiong Zhou, Wei-Lun Tsai, Chien-Neng Kao, Chih-Lang Lin, Chia-Chi Wang, Ta-Ya Lin, Chih-Lin Lin, Wei-Wen Su, Tzong-Hsi Lee, Te-Sheng Chang, Chun-Jen Liu, Chia-Yen Dai, Chi-Yi Chen, Jia-Horng Kao, Han-Chieh Lin, Wan-Long Chuang*, Cheng-Yuan Peng* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2024;18(2):461-475
(IF: 6.6, Journal Ranking: 21, Number of Journals of this Field: 93, Ranking: 22.58%)

16

Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease.
±i®x»·,¦ó¬ö¼ý,±ç³Õµ{,§dªv¹F,ÃQà±¾§,½²¨Ø­Å,³\³Õ³ó,Á©ú«Û,ªL©yÐA,Á©s°a,¤ý§Ó¤å,·¨¥¿ºÖ,¸­©ú­Û,¶À³©®p,²ø¸UÀs,¶À§Ó´I,¾G¶®¤Ã,À¹¹Å¨¥,³¯«O¤¤*§E©ú¶©* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024 40¨÷(3´Á):304-314­¶
(IF: 3.3, »â°ì±Æ¦W: 81, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 59.56%)

Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease.
Tyng-Yuan Jang, Chi-Chang Ho, Po-Cheng Liang, Chih-Da Wu, Yu-Ju Wei, Pei-Chien Tsai, Po-Yao Hsu, Ming-Yen Hsieh, Yi-Hung Lin, Meng-Hsuan Hsieh, Chih-Wen Wang, Jeng-Fu Yang, Ming-Lun Yeh, Chung-Feng Huang, Wan-Long Chuang, Jee-Fu Huang, Ya-Yun Cheng, Chia-Yen Dai, Pau-Chung Chen*, Ming-Lung Yu* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024;40(3):304-314
(IF: 3.3, Journal Ranking: 81, Number of Journals of this Field: 136, Ranking: 59.56%)

17

HCV »¤¾Éªº¨x²Ó­MÀùªº¤À¤l©MÁ{§É¤èªkªº¨t²Î¾ã¦X
Ciniso Sylvester Shabangu, Ĭª³¨q, §õ¨Î¶§, §E©ú¶©, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, ¤ý­zºö* - - 1 - Journal of Translational Medicine - JOURNAL OF TRANSLATIONAL MEDICINE 2024 1¨÷(22´Á):268­¶
(IF: 7.4, »â°ì±Æ¦W: 29, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 21.32%)

Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma
Ciniso Sylvester Shabangu, Wen‑Hsiu Su, Chia‑Yang Li, Ming‑Lung Yu, Chia‑Yen Dai, Jee‑Fu Huang, Wan‑Long Chuang and Shu‑Chi Wang* - - 1 - Journal of Translational Medicine - JOURNAL OF TRANSLATIONAL MEDICINE 2024;1(22):268
(IF: 7.4, Journal Ranking: 29, Number of Journals of this Field: 136, Ranking: 21.32%)

18

Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study.
Angela Chau, ¸­©ú­Û, ½²¨Ø­Å, Daniel Q Huang, Sung Eun Kim, Huy Trinh, Eileen L Yoon, Hyunwoo Oh, Jae Yoon Jeong, Sang Bong Ahn, Jihyun An, Cheng-Hao Tseng, Yao-Chun Hsu, Soung Won Jeong, Yong Kyun Cho, Jae-Jun Shim, Hyoung Su Kim, Takanori Ito, Sebastin Marciano, Keigo Kawashima, Takanori Suzuki, Tsunamasa Watanabe, Akito Nozaki, Toru Ishikawa, Kaori Inoue, Yuichiro Eguchi, Haruki Uojima, Hiroshi Abe, Hirokazu Takahashi, Makoto Chuma, Masatoshi Ishigami, Joseph K Hoang, Mayumi Maeda, ¶À³©®p, Adrian Gadano,À¹¹Å¨¥, ¶À§Ó´I, Yasuhito Tanaka, ²ø¸UÀs, Seng Gee Lim, Ramsey Cheung, §E©ú¶©, Dae-Won Jun, Mindie H Nguyen* - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2024 22¨÷(3´Á):572-580.e5­¶
(IF: 12.6, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 8.60%)

Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study.
Angela Chau, Ming-Lun Yeh, Pei-Chien Tsai, Daniel Q Huang, Sung Eun Kim, Huy Trinh, Eileen L Yoon, Hyunwoo Oh, Jae Yoon Jeong, Sang Bong Ahn, Jihyun An, Cheng-Hao Tseng, Yao-Chun Hsu, Soung Won Jeong, Yong Kyun Cho, Jae-Jun Shim, Hyoung Su Kim, Takanori Ito, Sebastián Marciano, Keigo Kawashima, Takanori Suzuki, Tsunamasa Watanabe, Akito Nozaki, Toru Ishikawa, Kaori Inoue, Yuichiro Eguchi, Haruki Uojima, Hiroshi Abe, Hirokazu Takahashi, Makoto Chuma, Masatoshi Ishigami, Joseph K Hoang, Mayumi Maeda, Chung-Feng Huang, Adrian Gadano, Chia-Yen Dai, Jee-Fu Huang, Yasuhito Tanaka, Wan-Long Chuang, Seng Gee Lim, Ramsey Cheung, Ming-Lung Yu, Dae-Won Jun, Mindie H Nguyen - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2024;22(3):572-580.e5
(IF: 12.6, Journal Ranking: 8, Number of Journals of this Field: 93, Ranking: 8.60%)

19

Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation.
Kim DS*, Yoon YI, Kim BK, Choudhury A, Kulkarni A, Park JY, Kim J, Sinn DH, Joo DJ, Choi Y, Lee JH, Choi HJ, Yoon KT, Yim SY, Park CS, Kim DG, Lee HW, Choi WM, Chon YE, Kang WH, Rhu J, Lee JG, Cho Y, Sung PS, Lee HA, Kim JH, Bae SH, Yang JM, Suh KS, Al Mahtab M, Tan SS, Abbas Z, Shresta A, Alam S, Arora A, Kumar A, Rathi P, Bhavani R, Panackel C, Lee KC, Li J, §E©ú¶©, George J, Tanwandee T, Hsieh SY, Yong CC, Rela M, Lin HC, Omata M, Sarin SK; for Asian Pacific Association for Study of Liver (APASL) - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2024 18¨÷(2´Á):299-383­¶
(IF: 6.6, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 22.58%)

Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation.
Dong-Sik Kim, Young-In Yoon, Beom Kyung Kim, Ashok Choudhury, Anand Kulkarni, Jun Yong Park, Jongman Kim, Dong Hyun Sinn, Dong Jin Joo, YoungRok Choi, Jeong-Hoon Lee, Ho Joong Choi, Ki Tae Yoon, Sun Young Yim, Cheon-Soo Park, Deok-Gie Kim, Hae Won Lee, Won-Mook Choi, Young Eun Chon, Woo-Hyoung Kang, Jinsoo Rhu, Jae Geun Lee, Yuri Cho, Pil Soo Sung, Han Ah Lee, Ji Hoon Kim, Si Hyun Bae, Jin Mo Yang, Kyung-Suk Suh, Mamun Al Mahtab, Soek Siam Tan, Zaigham Abbas, Ananta Shresta, Shahinul Alam, Anil Arora, Ashish Kumar, Pravin Rathi, Ruveena Bhavani, Charles Panackel, Kuei Chuan Lee, Jun Li, Ming-Lung Yu, Jacob George, Tawesak Tanwandee, Sen-Yung Hsieh, Chee Chien Yong, Mohamed Rela, H C Lin, Masao Omata, Shiv Kumar Sarin, - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2024;18(2):299-383
(IF: 6.6, Journal Ranking: 21, Number of Journals of this Field: 93, Ranking: 22.58%)

20

Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature.
Lonardo A*, Bril F, Caldwell SH, Eslam M, Fan JG, Gish RG, Gronbaek H, Sanal MG, Stefan N, Suzuki A, Targher G, Tilg H, §E©ú¶©, Zheng MH, George J - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2024 80¨÷(5´Á):e192-e194­¶
(IF: 25.7, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 4.30%)

Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature.
Amedeo Lonardo, Fernando Bril, Stephen H Caldwell, Mohammed Eslam, Jian-Gao Fan, Robert G Gish, Henning Gronbaek, Madhusudana Girija Sanal, Norbert Stefan, Ayako Suzuki, Giovanni Targher, Herbert Tilg, Ming-Lung Yu, Ming-Hua Zheng, Jacob George - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2024;80(5):e192-e194
(IF: 25.7, Journal Ranking: 4, Number of Journals of this Field: 93, Ranking: 4.30%)

21

Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer.
¾GÙy¨k,§E©ú¶©* - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2024 30¨÷(2´Á):144-146­¶
(IF: 8.9, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 12.90%)

Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer.
Pin-Nan Cheng, Ming-Lung Yu - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2024;30(2):144-146
(IF: 8.9, Journal Ranking: 12, Number of Journals of this Field: 93, Ranking: 12.90%)

22

Correspondence on Letter regarding "Toward hepatitis C virus elimination using artificial intelligence".
§f©ú¿o,§E©ú¶©* - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2024 30¨÷(2´Á):274-275­¶
(IF: 8.9, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 12.90%)

Correspondence on Letter regarding "Toward hepatitis C virus elimination using artificial intelligence".
Ming-Ying Lu, Ming-Lung Yu* - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2024;30(2):274-275
(IF: 8.9, Journal Ranking: 12, Number of Journals of this Field: 93, Ranking: 12.90%)

23

Third vaccine boosters and anti-S-IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma.
¤ý§Ó¤å,¶À³©®p,±i®x»·,§E©ú¶©,±ç³Õµ{,ÃQà±¾§,³\³Õ³ó,¶ÀÂ@¶h,Á©ú«Û,ªL©yÐA,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶© - - 1 - Kaohsiung Journal of Medical Sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024 0¨÷(0´Á):0­¶
(IF: 3.3, »â°ì±Æ¦W: 81, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 59.56%)

Third vaccine boosters and anti-S-IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma.
Chih-Wen Wang,Chung-Feng Huang,Tyng-Yuan Jang,Ming-Lun Yeh,Po-Cheng Liang,Yu-Ju Wei,Po-Yao Hsu,Ching-I Huang,Ming-Yen Hsieh,Yi-Hung Lin,Jee-Fu Huang,Chia-Yen Dai,Wan-Long Chuang,Ming-Lung Yu - - 1 - Kaohsiung Journal of Medical Sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024;0(0):0
(IF: 3.3, Journal Ranking: 81, Number of Journals of this Field: 136, Ranking: 59.56%)

24

Comparative evaluation of pediatric fatty liver disease criteria: MASLD, ESPGHAN, NASPGHAN, and NAFLD - identifying the optimal pediatric label.
¤ý§Ó¤å,¶À¬fµ×*,À¹¹Å¨¥*,¶À§Ó´I,§E©ú¶© - - 1 - Journal of Hepatology - JOURNAL OF HEPATOLOGY 2024 80¨÷(4´Á):e157-e159­¶
(IF: 25.7, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 4.30%)

Comparative evaluation of pediatric fatty liver disease criteria: MASLD, ESPGHAN, NASPGHAN, and NAFLD - identifying the optimal pediatric label.
Chih-Wen Wang,Po-Chin Huang,Chia-Yen Dai*,Jee-Fu Huang,Ming-Lung Yu - - 1 - Journal of Hepatology - JOURNAL OF HEPATOLOGY 2024;80(4):e157-e159
(IF: 25.7, Journal Ranking: 4, Number of Journals of this Field: 93, Ranking: 4.30%)

25

Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
½²¨Ø­Å, ³¢¦æ¹D#, ¬x»F§», ´¿°êªK, ¿à¾Ç¬w, ´^¦¨¤¸, Jing-Houng Wang, Jyh-Jou Chen, §õ¨Ø­Û, ²ºa«n, ·¨°òÞf, ùÀAªe, °ª¹Å§», ¼B«T¤H, ¼B®¶÷~, Sheng-Lei Yan, ¥Õ©ú©¾, ªL«T«Û, Ĭºû¤å, Cheng-Hsin Chu, Chih-Jen Chen, ¸³¤ô¸q, À¹±Ò©ú, ªL§Ó¤å, ù²M¦À, ¾GÙy¨k, ªô«Ûµ{, ¤ý¹Å»ô, ¾GÀAµ¾, ½²ºû­Û, ªLº~³Ç, ¶À©Éµ¾, ¸­©ú­Û, ¶À³©®p, Á©s°a, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, ³¯±Ò¯q*, §E©ú¶©*, T-COACH Study Group - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2023 78¨÷(2´Á):281-292­¶
(IF: 30.083, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 5.38%)

Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
Pei-Chien Tsai, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi-Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Ming-Lun Yeh, Chung-Feng Huang, Meng-Hsuan Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chung, Chi-Yi Chen, Ming-Lung Yu, - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2023;78(2):281-292
(IF: 30.083, Journal Ranking: 5, Number of Journals of this Field: 93, Ranking: 5.38%)

26

Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradication.
§f©ú¿o, ¼B¤jºû, ±ç³Õµ{, ¶ÀÂ@¶h, ½²©ö¬À, ½²¨Ø­Å, ¬_¦ö¥Á, Wen-Hsuan Wang, ªL·q´¼, ³¯«a¦t, ¤ý­zºö, ÃQà±¾§, ³\³Õ³ó, ±i®x»·, Á©ú«Û, ¤ý§Ó¤å, ¸­©ú­Û, ªL¤l³ó, ¶À³©®p, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2023 13¨÷(1´Á):190-203­¶
(IF: 5.942, »â°ì±Æ¦W: 71, »â°ì´Á¥Z¼Æ: 245, »â°ì±Æ¦W: 28.98%)

Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradication.
Ming-Ying Lu, Ta-Wei Liu, Po-Cheng Liang, Ching-I Huang, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Wen-Hsuan Wang, Ching-Chih Lin, Kuan-Yu Chen, Shu-Chi Wang, Yu-Ju Wei, Po-Yao Hsu, Tyng-Yuan Jang, Ming-Yen Hsieh, Chih-Wen Wang, Ming-Lun Yeh, Zu-Yau Lin, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2023;13(1):190-203
(IF: 5.942, Journal Ranking: 71, Number of Journals of this Field: 245, Ranking: 28.98%)

27

TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes.
§E©ú¶©, ¤ýªv¤¸, §õ¬üæ¢, ¼Ú¥°¼Ý, ¾GÙy¨k, §ù«ä¼w, ¶À§Ó´I, ³¯ºaºÖ, ­JÚz½÷, Chih-Cheng Hsu, °ª¹Å§», ³¯«Ø¤¯, ªLº~³Ç*, ¶À«Ø¹ç* - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2023 122¨÷(3´Á):202-220­¶
(IF: 3.871, »â°ì±Æ¦W: 61, »â°ì´Á¥Z¼Æ: 172, »â°ì±Æ¦W: 35.47%)

TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes.
Ming-Lung Yu, Chih-Yuan Wang, Mei-Hsuan Lee, Horng-Yih Ou, Pin-Nan Cheng, Shih-Te Tu, Jee-Fu Huang, Jung-Fu Chen, Tsung-Hui Hu, Chih-Cheng Hsu, Jia-Horng Kao, Chien-Jen Chen, Han-Chieh Lin, Chien-Ning Huang - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2023;122(3):202-220
(IF: 3.871, Journal Ranking: 61, Number of Journals of this Field: 172, Ranking: 35.47%)

28

Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
Zobair M Younossi, §E©ú¶©, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El-Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart K Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Aijaz Ahmed, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani - - 1 - JOURNAL OF VIRAL HEPATITIS - JOURNAL OF VIRAL HEPATITIS 2023 30¨÷(4´Á):335-344­¶
(IF: 3.517, »â°ì±Æ¦W: 56, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 60.22%)

Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El-Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart K Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Aijaz Ahmed, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani - - 1 - JOURNAL OF VIRAL HEPATITIS - JOURNAL OF VIRAL HEPATITIS 2023;30(4):335-344
(IF: 3.517, Journal Ranking: 56, Number of Journals of this Field: 93, Ranking: 60.22%)

29

Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma.
Yu-Han Huang, Chi Chan, Hye-Won Lee, Claire Huang, Yen-Ju Chen, Po-Chun Liu, ¿c³Ó¨k, ²ø¸UÀs, ¶À§Ó´I, §E©ú¶©, Jill Koshiol, §õ¬üæ¢* - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2023 21¨÷(4´Á):960-969.e1­¶
(IF: 13.576, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 7.53%)

Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma.
Yu-Han Huang, Chi Chan, Hye-Won Lee, Claire Huang, Yen-Ju Chen, Po-Chun Liu, Sheng-Nan Lu, Wan-Long Chuang, Jee-Fu Huang, Ming-Lung Yu, Jill Koshiol, Mei-Hsuan Lee - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2023;21(4):960-969.e1
(IF: 13.576, Journal Ranking: 7, Number of Journals of this Field: 93, Ranking: 7.53%)

30

Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients.
Takanori Ito, Vy H Nguyen, Taku Tanaka, Huiyul Park, ¸­©ú­Û, Miwa Kawanaka, Taeang Arai, Masanori Atsukawa, Eileen L Yoon, ½²¨Ø­Å, Hidenori Toyoda, ¶À§Ó´I, Linda Henry, Dae Won Jun, §E©ú¶©, Masatoshi Ishigami*, Mindie H Nguyen*, Ramsey C Cheung* - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2023 21¨÷(4´Á):1013-1022.e6­¶
(IF: 13.576, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 7.53%)

Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients.
Takanori Ito, Vy H Nguyen, Taku Tanaka, Huiyul Park, Ming-Lun Yeh, Miwa Kawanaka, Taeang Arai, Masanori Atsukawa, Eileen L Yoon, Pei-Chien Tsai, Hidenori Toyoda, Jee-Fu Huang, Linda Henry, Dae Won Jun, Ming-Lung Yu, Masatoshi Ishigami, Mindie H Nguyen, Ramsey C Cheung - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2023;21(4):1013-1022.e6
(IF: 13.576, Journal Ranking: 7, Number of Journals of this Field: 93, Ranking: 7.53%)

31

Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma.
Saleh A Alqahtani*, Wah-Kheong Chan, §E©ú¶© - - 1 - CLINICS IN LIVER DISEASE - CLINICS IN LIVER DISEASE 2023 27¨÷(2´Á):211-223­¶
(IF: 6.265, »â°ì±Æ¦W: 27, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 29.03%)

Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma.
Saleh A Alqahtani, Wah-Kheong Chan, Ming-Lung Yu - - 1 - CLINICS IN LIVER DISEASE - CLINICS IN LIVER DISEASE 2023;27(2):211-223
(IF: 6.265, Journal Ranking: 27, Number of Journals of this Field: 93, Ranking: 29.03%)

32

Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region.
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, §E©ú¶©, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, §õÄ˸Î, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2023 29¨÷(2´Á):277-292­¶
(IF: 8.337, »â°ì±Æ¦W: 19, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 20.43%)

Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region.
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2023;29(2):277-292
(IF: 8.337, Journal Ranking: 19, Number of Journals of this Field: 93, Ranking: 20.43%)

33

¥Î©ó§Ö³tÀË´ú SARS-CoV-2 ªº¨ã¦³ NIR µo®g¶tÜgÄq¯Ç¦Ì½Æ¦X§÷®ÆªºÂ²«K¥B¤£´¡¹qªºªí­±µ¥Â÷¤lÅé¦@®¶¥Íª«¶Ç·P¾¹
ung-Chien Chen, Meng-Chi Li, Kai-Ren Chen, Yu-Jui Cheng, Xun-Ying Wu, Sih-An Chen, Meng-Jey Youh, Chien-Cheng Kuo, Yu-Xen Lin, ªLªé§°, ¤ý¯]»ñ, ¶À³©¾W, ªL©|»ö, ¤ý¤å§», ³¯«Û¦°, §E©ú¶©, Arunee Thitithanyanont, ¤ý¸t¦|*, Ĭ²ú­s* - - 1 - ANALYTICAL CHEMISTRY - ANALYTICAL CHEMISTRY 2023 95¨÷(18´Á):7186-7194­¶
(IF: 8.008, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 87, »â°ì±Æ¦W: 8.05%)

Facile and Unplugged Surface Plasmon Resonance Biosensor with NIR-Emitting Perovskite Nanocomposites for Fast Detection of SARS-CoV-2.
Lung-Chien Chen, Meng-Chi Li, Kai-Ren Chen, Yu-Jui Cheng, Xun-Ying Wu, Sih-An Chen, Meng-Jey Youh, Chien-Cheng Kuo, Yu-Xen Lin, Chih-Yen Lin, Chu-Feng Wang, Chung-Feng Huang, Shang-Yi Lin, Wen-Hung Wang, Yen-Hsu Chen, Ming-Lung Yu, Arunee Thitithanyanont, Sheng-Fan Wang, Li-Chen Su - - 1 - ANALYTICAL CHEMISTRY - ANALYTICAL CHEMISTRY 2023;95(18):7186-7194
(IF: 8.008, Journal Ranking: 7, Number of Journals of this Field: 87, Ranking: 8.05%)

34

Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort.
¶À³©®p,±i®x»·,§dªÃ¾±,³¢¬ü®S,¸­©ú­Û,¤ý§Ó¤å,±ç³Õµ{,ÃQà±¾§,³\³Õ³ó,¶ÀÂ@¶h,Á©ú«Û,ªL©yÓT,¿½´f¾ì,,³\´Ü¤ì,¶À¤d·O,§õ¹m¤¸,³¯«Û¦°,³¯±¬ªN,ªL©ø¼w, ¤ý­zºö,¤ý¸t¦|,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©* - - 1 - VIROLOGY JOURNAL - VIROLOGY JOURNAL 2023 20¨÷(1´Á):112­¶
(IF: 4.8, »â°ì±Æ¦W: 14, »â°ì´Á¥Z¼Æ: 36, »â°ì±Æ¦W: 38.89%)

Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort.
Chung-Feng Huang, Tyng-Yuan Jang, Ping-Hsun Wu, Mei-Chuan Kuo, Ming-Lun Yeh, Chih-Wen Wang, Po-Cheng Liang, Yu-Ju Wei, Po-Yao Hsu, Ching-I Huang, Ming-Yen Hsieh, Yi-Hung Lin, Hui-Hua Hsiao, Chin-Mu Hsu, Chien-Tzu Huang, Chun-Yuan Lee, Yen-Hsu Chen, Tun-Chieh Chen, Kun-Der Lin, Shuo-Hung Wang, Sheng-Fan Wang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu - - 1 - VIROLOGY JOURNAL - VIROLOGY JOURNAL 2023;20(1):112
(IF: 4.8, Journal Ranking: 14, Number of Journals of this Field: 36, Ranking: 38.89%)

35

Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry
±i¼w¥Í,¶À³©®p,³¢¦æ¹D,ù²M¦À,¶À°·ºû,±iÄR¤å,¾GÙy¨k,¸­©ú­Û,´^¦¨¤¸,¾G°·¬ê,¶À§Ó´I,¥Õ©ú©¾,ªL§Ó­¦,·¨°òÞf,¤ý¶à¤¯,Á°]·½,§õ©vº³,§õ¨Ø­Û,§d¤å»x,ªL§Ó³®,Ĭºû¤å,·¨³ÓµÏ,¤ý¹Å»ô,­J·ç®x,¦È联·ç,³¯­x§Ê,¶À©Éµ¾,±i§g·Ó,¶À¹Å¥Í,³¯®Û­^,°ª°·¯à,À¹±Ò©ú,¼B«T¤H,§õ¬üæ¢,,½²¨Ø­Å,À¹¹Å¨¥,°ª¹Å§»,ªLº~³Ç,²ø¸UÀs,³¯±Ò¯q,´¿°êªK,¬x»F§»*,§E©ú¶©* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2023 17¨÷(3´Á):550-561­¶
(IF: 6.6, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 22.58%)

Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry
Chang TS, Huang CF, Kuo HT, Lo CC, Huang CW, Chong LW, Cheng PN, Yeh ML, Peng CY, Cheng CY, Huang JF, Bair MJ, Lin CL, Yang CC, Wang SJ, Hsieh TY, Lee TH, Lee PL, Wu WC, Lin CL, Su WW, Yang SS, Wang CC, Hu JT, Mo LR, Chen CT, Huang YH, Chang CC, Huang CS, Chen GY, Kao CN, Tai CM, Liu CJ, Lee MH, Tsai PC, Dai CY, Kao JH, Lin HC, Chuang WL, Chen CY, Tseng KC, Hung CH*, Yu ML* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2023;17(3):550-561
(IF: 6.6, Journal Ranking: 21, Number of Journals of this Field: 93, Ranking: 22.58%)

36

High-Resolution Genomic Profiling of Liver Cancer Links Etiology With Mutation and Epigenetic Signatures
Perez S, Lavi-Itzkovitz A, Gidoni M, Domovitz T, Dabour R, Khurana I, Davidovich A, Tobar A, Livoff A, Solomonov E, Maman Y, El-Osta A, ½²©ö¬À, §E©ú¶©, Stemmer SM, Haviv I*, Yaari G*, Gal-Tanamy M* - - 1 - Cell Mol Gastroenterol Hepatol - CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY 2023 16¨÷(1´Á):63-81­¶
(IF: 7.2, »â°ì±Æ¦W: 19, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 20.43%)

High-Resolution Genomic Profiling of Liver Cancer Links Etiology With Mutation and Epigenetic Signatures
Perez S, Lavi-Itzkovitz A, Gidoni M, Domovitz T, Dabour R, Khurana I, Davidovich A, Tobar A, Livoff A, Solomonov E, Maman Y, El-Osta A, Tsai Y, Yu ML, Stemmer SM, Haviv I*, Yaari G*, Gal-Tanamy M* - - 1 - Cell Mol Gastroenterol Hepatol - CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY 2023;16(1):63-81
(IF: 7.2, Journal Ranking: 19, Number of Journals of this Field: 93, Ranking: 20.43%)

37

Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Razavi HA*, Buti M, Terrault NA, Zeuzem S, Yurdaydin C, Tanaka J, Aghemo A, Akarca US, Al Masri NM, Alalwan AM, Aleman S, Alghamdi AS, Alghamdi S, Al-Hamoudi WK, Aljumah AA, Altraif IH, Asselah T, Ben-Ari Z, Berg T, Biondi MJ, Blach S, Braga WSM, Brandão-Mello CE, Brunetto MR, Cabezas J, Cheinquer H, Chen PJ, Cheon ME, ²ø¸UÀs, Coffin CS, Coppola N, Craxi A, Crespo J, De Ledinghen V, Duberg AS, Etzion O, Ferraz MLG, ... ¶À§Ó´I, .... §E©ú¶©, Zuckerman E; Polaris Observatory. - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2023 79¨÷(2´Á):576-580­¶
(IF: 25.7, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 4.30%)

Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Razavi HA*, Buti M, Terrault NA, Zeuzem S, Yurdaydin C, Tanaka J, Aghemo A, Akarca US, Al Masri NM, Alalwan AM, Aleman S, Alghamdi AS, Alghamdi S, Al-Hamoudi WK, Aljumah AA, Altraif IH, Asselah T, Ben-Ari Z, Berg T, Biondi MJ, Blach S, Braga WSM, Brandão-Mello CE, Brunetto MR, Cabezas J, Cheinquer H, Chen PJ, Cheon ME, Chuang WL, Coffin CS, Coppola N, Craxi A, Crespo J, De Ledinghen V, Duberg AS, Etzion O, Ferraz MLG, ... Huang JF, .... Yu ML, Zuckerman E; Polaris Observatory. - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2023;79(2):576-580
(IF: 25.7, Journal Ranking: 4, Number of Journals of this Field: 93, Ranking: 4.30%)

38

A People-centered Decentralized Outreach Model Toward HCV Micro-elimination in hyperendemic areas: COMPACT Study in SARS Co-V2 pandemic.
¶ÀÂ@¶h,±ç³Õµ{,ÃQà±¾§,½²¨Ø­Å,³\³Õ³ó,Á©s°a,¼B¤jºû,ªL©yÐA,Á©ú«Û,±i®x»·,¤ý§Ó¤å,·¨®¶ºÖ,¸­©ú­Û,¶À³©®p,À¹¹Å¨¥,²ø¸UÀs,¶À§Ó´I*,§E©ú¶©* - - 1 - J Microbiol Immunol Infect. - MICROBIOLOGY 2023 29¨÷(56(3)´Á):586-97­¶
(IF: 1.5, »â°ì±Æ¦W: 124, »â°ì´Á¥Z¼Æ: 135, »â°ì±Æ¦W: 91.85%)

A People-centered Decentralized Outreach Model Toward HCV Micro-elimination in hyperendemic areas: COMPACT Study in SARS Co-V2 pandemic.
Huang CI, Liang PC, Wei YJ, Tsai PC, Hsu PY, Hsieh MY, Liu TW, Lin YH, Hsieh MH, Jang TY, Wang CW, Yang JF, Yeh ML, Huang CF, Dai CY, Chuang WL, Huang JF*, Yu ML* - - 1 - J Microbiol Immunol Infect. - MICROBIOLOGY 2023;29(56(3)):586-97
(IF: 1.5, Journal Ranking: 124, Number of Journals of this Field: 135, Ranking: 91.85%)

39

Asia-Pacific association for study of liver guidelines on management of ascites in liver disease
Virendra Singh*, Arka De, Rohit Mehtani, Paolo Angeli, Rakhi Maiwall, Sanjaya Satapathy, Ashwini K Singal, Anoop Saraya, B C Sharma, C E Eapen, P N Rao, Akash Shukla, Shalimar, Narendra S Choudhary, Diana Alcantara-Payawal, Vinod Arora, Guru Aithal, Anand Kulkarni, Akash Roy, Ananta Shrestha, Mamun Al Mahtab, Madunil A Niriella, Tan Soek Siam, Chun-Qing Zhang, Lee Guan Huei, §E©ú¶©, Stuart K Roberts, ´^¦¨¤¸, Tao Chen, Jacob George, Vincent Wong, Yusuf Yilmaz, Sombat Treeprasertsuk, Juferdy Kurniawan, Seung Up Kim, Zobair M Younossi, Shiv Kumar Sarin. - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2023 17¨÷(4´Á):792-826­¶
(IF: 6.6, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 22.58%)

Asia-Pacific association for study of liver guidelines on management of ascites in liver disease
Virendra Singh*, Arka De, Rohit Mehtani, Paolo Angeli, Rakhi Maiwall, Sanjaya Satapathy, Ashwini K Singal, Anoop Saraya, B C Sharma, C E Eapen, P N Rao, Akash Shukla, Shalimar, Narendra S Choudhary, Diana Alcantara-Payawal, Vinod Arora, Guru Aithal, Anand Kulkarni, Akash Roy, Ananta Shrestha, Mamun Al Mahtab, Madunil A Niriella, Tan Soek Siam, Chun-Qing Zhang, Lee Guan Huei, Ming-Lung Yu, Stuart K Roberts , Cheng-Yuan Peng, Tao Chen, Jacob George, Vincent Wong, Yusuf Yilmaz, Sombat Treeprasertsuk , Juferdy Kurniawan , Seung Up Kim, Zobair M Younossi , Shiv Kumar Sarin. - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2023;17(4):792-826
(IF: 6.6, Journal Ranking: 21, Number of Journals of this Field: 93, Ranking: 22.58%)

40

¥xÆW°¾»·¦a°ÏC«¬¨xª¢·L®Ú°£
ù²M¦À, Wei-Yi Lei, Ying-Che Huang, Jow-Jyh Hwang, Chen-Yu Lo, Chien-Hung Lin, Hsu-Sheng Cheng, Yee-Tam Liao, ±ç³Õµ{, Meng-Jau Chiou, ¥Õ©ú©v*,À¹¹Å¨¥*,§E©ú¶© - - 1 - JOURNAL OF MICROBIOLOGY, IMMUNOLOGY, AND INFECTION - JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION 2023 56¨÷(4´Á):680-687­¶
(IF: 7.4, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 96, »â°ì±Æ¦W: 16.67%)

Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan - A multi-center collaborative care model.
Ching-Chu Lo, Wei-Yi Lei, Ying-Che Huang, Jow-Jyh Hwang, Chen-Yu Lo, Chien-Hung Lin, Hsu-Sheng Cheng, Yee-Tam Liao, Po-Cheng Liang, Meng-Jau Chiou, Ming-Jong Bair*, Chia-Yen Dai*, Ming-Lung Yu - - 1 - JOURNAL OF MICROBIOLOGY, IMMUNOLOGY, AND INFECTION - JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION 2023;56(4):680-687
(IF: 7.4, Journal Ranking: 16, Number of Journals of this Field: 96, Ranking: 16.67%)

41

Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease
¶À§Ó´I,½²¨Ø­Å,¸­©ú­Û,¶À³©®p,¶ÀÂ@¶h,§õ¬üæ¢,³\³Õ³ó,¤ý§Ó¤å,ÃQà±¾§,ªL©yÐA,Á©s°a,·¨¥¿ºÖ,Á©ú«Û,±i®x»·,¥Õ©ú©¾,ªL¤l³ó,À¹¹Å¨¥,§E©ú¶©*,²ø¸UÀs* - - 1 - JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY - JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY 2023 11¨÷(5´Á):1061-1068­¶
(IF: 3.6, »â°ì±Æ¦W: 43, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 46.24%)

Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease
Jee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, Mei-Hsuan Lee, Po-Yau Hsu, Chih-Wen Wang, Yu-Ju Wei, Po-Cheng Liang, Yi-Hung Lin, Meng-Hsuan Hsieh, Jeng-Fu Yang, Ming-Yen Hsieh, Tyng-Yuan Jang, Ming-Jong Bair, Zu-Yau Lin, Chia-Yen Dai, Ming-Lung Yu* and Wan-Long Chuang* - - 1 - JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY - JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY 2023;11(5):1061-1068
(IF: 3.6, Journal Ranking: 43, Number of Journals of this Field: 93, Ranking: 46.24%)

42

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
Huiyul Park, Eileen L Yoon, Takanori Ito, Ae Jung Jo, Mimi Kim, Jonghyun Lee, Hye-Lin Kim, Taeang Arai, Masanori Atsukawa, Miwa Kawanaka, Hidenori Toyoda, Masatoshi Ishigami, §E©ú¶©, Dae Won Jun*, Mindie H Nguyen* - - 1 - JAMA NETWORK OPEN - JAMA NETWORK OPEN 2023 6¨÷(8´Á):e2329568­¶
(IF: 13.8, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 167, »â°ì±Æ¦W: 8.98%)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
Huiyul Park, Eileen L Yoon, Takanori Ito, Ae Jung Jo, Mimi Kim, Jonghyun Lee, Hye-Lin Kim, Taeang Arai, Masanori Atsukawa, Miwa Kawanaka, Hidenori Toyoda, Masatoshi Ishigami, Ming-Lung Yu, Dae Won Jun*, Mindie H Nguyen* - - 1 - JAMA NETWORK OPEN - JAMA NETWORK OPEN 2023;6(8):e2329568
(IF: 13.8, Journal Ranking: 15, Number of Journals of this Field: 167, Ranking: 8.98%)

43

Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort study
¶À³©®p, À¹¹Å¨¥#, ¤ý§Ó¤å, ±ç³Õµ{, ÃQà±¾§, ½²¨Ø­Å, ±i®x»·, ³\³Õ³ó, §õ¨Î»T, ¶s¸t¤å,¶À«T¸R, ¸­©ú­Û, ¶ÀÂ@¶h, Á©ú«Û, ªL©yÐA, ³¯«ä¹Å, ªô©É¤å, ¶À§Ó´I, ±i­õ»Ê*, ¶À©|§Ó, ²ø¸UÀs, §E©ú¶©*, the FORMOSA-LIKE investigators - - 1 - CLINICAL KIDNEY JOURNAL - CLINICAL KIDNEY JOURNAL 2023 16¨÷(12´Á):2429¡V2436­¶
(IF: 4.6, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 19.32%)

Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort study
Chung-Feng Huang, Chia-Yen Dai#, Chih-Wen Wang, Po-Cheng Liang, Yu-Ju Wei, Pei-Chien Tsai, Tyng-Yuan Jang, Po-Yao Hsu, Jia-Jung Lee, Sheng-Wen Niu, Jiun-Chi Huang, Ming-Lun Yeh, Ching-I Huang, Ming-Yen Hsieh, Yi-Hung Lin, Szu-Chia Chen, Yi-Wen Chiu, Jee-Fu Huang, Jer-Ming Chang*, Shang-Jyh Hwang, Wan-Long Chuang, Ming-Lung Yu*, the FORMOSA-LIKE investigators - - 1 - CLINICAL KIDNEY JOURNAL - CLINICAL KIDNEY JOURNAL 2023;16(12):2429¡V2436
(IF: 4.6, Journal Ranking: 17, Number of Journals of this Field: 88, Ranking: 19.32%)

44

Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies.
¶À¤d·O, §õµ×µÓ, ³¯«º§u, ¼B¯q©÷, ¨ô¤hûß, §ù¬F¾±, §E©ú¶©, ¶À³©®p, ¤ý¸t¦|, ¿½´f¾ì* - - 1 - JOURNAL OF CLINICAL MEDICINE - JOURNAL OF CLINICAL MEDICINE 2023 12¨÷(17´Á):5647­¶
(IF: 3.9, »â°ì±Æ¦W: 58, »â°ì´Á¥Z¼Æ: 167, »â°ì±Æ¦W: 34.73%)

Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies.
Chien-Tzu Huang, Ching-Ping Lee, Tzu-Yin Chen, Yi-Chang Liu, Shih-Feng Cho, Jeng-Shiun Du, Ming-Lung Yu, Chung-Feng Huang, Sheng-Fan Wang, Hui-Hua Hsiao - - 1 - JOURNAL OF CLINICAL MEDICINE - JOURNAL OF CLINICAL MEDICINE 2023;12(17):5647
(IF: 3.9, Journal Ranking: 58, Number of Journals of this Field: 167, Ranking: 34.73%)

45

Sharing Lessons Learned to Build Effective Hepatitis Elimination Programs
§E©ú¶©*, John W Ward - - 1 - JOURNAL OF INFECTIOUS DISEASES - JOURNAL OF INFECTIOUS DISEASES 2023 228¨÷(Supplement´Á):S145-S147­¶
(IF: 6.4, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 135, »â°ì±Æ¦W: 17.78%)

Sharing Lessons Learned to Build Effective Hepatitis Elimination Programs
Ming-Lung Yu*, John W Ward - - 1 - JOURNAL OF INFECTIOUS DISEASES - JOURNAL OF INFECTIOUS DISEASES 2023;228(Supplement):S145-S147
(IF: 6.4, Journal Ranking: 24, Number of Journals of this Field: 135, Ranking: 17.78%)

46

Strategies for Removal of Barriers to Hepatitis C Elimination in Sub-Saharan Africa
Justine Umutesi*, §E©ú¶©, Olufunmilayo Lesi, John W. Ward, and Janvier Serumondo - - 1 - JOURNAL OF INFECTIOUS DISEASES - JOURNAL OF INFECTIOUS DISEASES 2023 228¨÷(Supplement´Á):S221-S225­¶
(IF: 6.4, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 135, »â°ì±Æ¦W: 17.78%)

Strategies for Removal of Barriers to Hepatitis C Elimination in Sub-Saharan Africa
Justine Umutesi*, Ming-Lung Yu, Olufunmilayo Lesi, John W. Ward, and Janvier Serumondo - - 1 - JOURNAL OF INFECTIOUS DISEASES - JOURNAL OF INFECTIOUS DISEASES 2023;228(Supplement):S221-S225
(IF: 6.4, Journal Ranking: 24, Number of Journals of this Field: 135, Ranking: 17.78%)

47

HCV Microelimination for High-risk Special Populations
¶À³©®p,³¯«a¦{,¬x°·²M,§E©ú¶©* - - 1 - JOURNAL OF INFECTIOUS DISEASES - JOURNAL OF INFECTIOUS DISEASES 2023 228¨÷(Supplement´Á):S168-S179­¶
(IF: 6.4, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 135, »â°ì±Æ¦W: 17.78%)

HCV Microelimination for High-risk Special Populations
Chung-Feng Huang¡BGuan-Jhou Chen¡BChien-Ching Hung¡BMing-Lung Yu* - - 1 - JOURNAL OF INFECTIOUS DISEASES - JOURNAL OF INFECTIOUS DISEASES 2023;228(Supplement):S168-S179
(IF: 6.4, Journal Ranking: 24, Number of Journals of this Field: 135, Ranking: 17.78%)

48

Dose consideration of lenvatinib anti-cancer effect on hepatocellular carcinoma and the potential benefit of colchicine combined therapy
ªL¤l³ó*, ¸­©ú­Û, ±ç³Õµ{, ³\³Õ³ó, ¶À³©®p, ¶À§Ó´I, À¹¹Å¨¥, §E©ú¶©, ²ø¸UÀs - - 1 - Cancers (Basel) - CANCERS 2023 15¨÷(20´Á):5097­¶
(IF: 5.2, »â°ì±Æ¦W: 72, »â°ì´Á¥Z¼Æ: 241, »â°ì±Æ¦W: 29.88%)

Dose consideration of lenvatinib anti-cancer effect on hepatocellular carcinoma and the potential benefit of colchicine combined therapy
Zu-Yau Lin,*, Ming-Lun Yeh, Po-Cheng Liang, Po-Yao Hsu, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang - - 1 - Cancers (Basel) - CANCERS 2023;15(20):5097
(IF: 5.2, Journal Ranking: 72, Number of Journals of this Field: 241, Ranking: 29.88%)

49

Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study
Wong YJ, Tran S, ¶À³©®p, Hsu YC, Preda C, Toyoda H, Liu J, Jun DW, Landis C, Huang DQ, Gila A, Negoita L, Yasuda S, Tseng CH, Tsai PC, Uojima H, Nozaki A, Chuma M, Atsukawa M, Ishigami M, Itokawa N, Iio E, Lam CP, Watanabe T, Asai A, Yokohama K, Abe H, Enomoto M, Kawada N, Tamori A, Lee DH, Jun MJ, Do S, Vo DKH, Liu L, Li J, Ji F, Wang W, Li Y, Wang X, Guo F, Xu Q, Jing L, Ye Q, Pan H, Zhang J, Wen X, Wang Q, Ren H, Cai D, Shang J, Liu J, Lu C, Zang W, Li J, Niu J, Zhang M, Wu C, Huang R, Maeda M, Nakanishi A, ¸­©ú­Û, ²ø¸UÀs, ¶À§Ó´I, À¹¹Å¨¥, Ishikawa T, Takaguchi K, Senoh T, Trinh HN, Takahashi H, Eguchi Y, Quek SXZ, Haga H, Ogawa E, Wong G, Buti M, Fukunishi S, Ueno Y, Yuen MF, Tanaka Y, Lim SG, Cheung R, §E©ú¶©, Nguyen MH* - - 1 - Hepatol Int - HEPATOLOGY INTERNATIONAL 2023 17¨÷(5´Á):1150-1161­¶
(IF: 6.6, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 22.58%)

Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study
Wong YJ, Tran S, Huang CF, Hsu YC, Preda C, Toyoda H, Liu J, Jun DW, Landis C, Huang DQ, Gila A, Negoita L, Yasuda S, Tseng CH, Tsai PC, Uojima H, Nozaki A, Chuma M, Atsukawa M, Ishigami M, Itokawa N, Iio E, Lam CP, Watanabe T, Asai A, Yokohama K, Abe H, Enomoto M, Kawada N, Tamori A, Lee DH, Jun MJ, Do S, Vo DKH, Liu L, Li J, Ji F, Wang W, Li Y, Wang X, Guo F, Xu Q, Jing L, Ye Q, Pan H, Zhang J, Wen X, Wang Q, Ren H, Cai D, Shang J, Liu J, Lu C, Zang W, Li J, Niu J, Zhang M, Wu C, Huang R, Maeda M, Nakanishi A, Yeh ML, Chuang WL, Huang JF, Dai C, Ishikawa T, Takaguchi K, Senoh T, Trinh HN, Takahashi H, Eguchi Y, Quek SXZ, Haga H, Ogawa E, Wong G, Buti M, Fukunishi S, Ueno Y, Yuen MF, Tanaka Y, Lim SG, Cheung R, Yu ML, Nguyen MH* - - 1 - Hepatol Int - HEPATOLOGY INTERNATIONAL 2023;17(5):1150-1161
(IF: 6.6, Journal Ranking: 21, Number of Journals of this Field: 93, Ranking: 22.58%)

50

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
¸­©ú­Û,§E©ú¶©* - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2023 29¨÷(4´Á):969-972­¶
(IF: 8.9, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 12.90%)

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
Yeh ML, Yu ML*. - - 1 - CLINICAL AND MOLECULAR HEPATOLOGY - CLINICAL AND MOLECULAR HEPATOLOGY 2023;29(4):969-972
(IF: 8.9, Journal Ranking: 12, Number of Journals of this Field: 93, Ranking: 12.90%)

51

Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic
À¹±Ò©ú,¥Õ©ú©¾,³¯¤lµq,´¿¬F»¨,³¯§Ó«°,ªLÂE*,§E©ú¶©* - - 1 - VIRUSES-BASEL - VIRUSES-BASEL 2023 15¨÷(4´Á):827­¶
(IF: 4.7, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 36, »â°ì±Æ¦W: 41.67%)

Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic
Tai CM, Bair MJ, Chen TH, Tseng CH, Chen CC, Lam H, Yu ML*# - - 1 - VIRUSES-BASEL - VIRUSES-BASEL 2023;15(4):827
(IF: 4.7, Journal Ranking: 15, Number of Journals of this Field: 36, Ranking: 41.67%)

52

Treatment effectiveness and side effects of patients with hepatitis C in the prisons of Southern Taiwan: a real-life retrospective analysis
Tsai YC, §E©ú¶©, Ko CY, Hsin YH, Tsai QZ, ¶À°·ºû* - - 1 - BMJ Open - BMJ OPEN 2023 13¨÷(6´Á):e070490­¶
(IF: 2.9, »â°ì±Æ¦W: 77, »â°ì´Á¥Z¼Æ: 167, »â°ì±Æ¦W: 46.11%)

Treatment effectiveness and side effects of patients with hepatitis C in the prisons of Southern Taiwan: a real-life retrospective analysis
Tsai YC, Yu ML, Ko CY, Hsin YH, Tsai QZ, Huang CW* - - 1 - BMJ Open - BMJ OPEN 2023;13(6):e070490
(IF: 2.9, Journal Ranking: 77, Number of Journals of this Field: 167, Ranking: 46.11%)

53

A global research priority agenda to advance public health responses to fatty liver disease.
Lazarus JV*, Mark HE#, Allen AM#, Arab JP#, Carrieri P#, Noureddin M#, Alazawi W, Alkhouri N, Alqahtani SA, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Hagström H, Huang TT, Wajcman DI, Kautz A, Kopka CJ, Krag A, Miller V, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Tsochatzis EA, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg JM*, Wong VW*, Younossi ZM*; Healthy Livers, Healthy Lives Collaborators (Yu ML) - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2023 79¨÷(3´Á):618-634­¶
(IF: 25.7, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 4.30%)

A global research priority agenda to advance public health responses to fatty liver disease.
Lazarus JV*, Mark HE#, Allen AM#, Arab JP#, Carrieri P#, Noureddin M#, Alazawi W, Alkhouri N, Alqahtani SA, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Hagström H, Huang TT, Wajcman DI, Kautz A, Kopka CJ, Krag A, Miller V, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Tsochatzis EA, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg JM*, Wong VW*, Younossi ZM*; Healthy Livers, Healthy Lives Collaborators (Yu ML) - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2023;79(3):618-634
(IF: 25.7, Journal Ranking: 4, Number of Journals of this Field: 93, Ranking: 4.30%)

54

Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.
Huang DQ, Tran A, ¸­©ú­Û, Yasuda S, ½²¨Ø­Å, ¶À³©®p, À¹¹Å¨¥, Ogawa E, Ishigami M, Ito T, Kozuka R, Enomoto M, Suzuki T, Yoshimaru Y, Preda CM, Marin RI, Sandra I, Tran S, Quek SX, Khine HHTW, Itokawa N, Atsukawa M, Uojima H, Watanabe T, Takahashi H, Inoue K, Maeda M, Hoang JK, Trinh L, Barnett S, Cheung R, Lim SG, Trinh HN, ²ø¸UÀs, Tanaka Y, Toyoda H, §E©ú¶©, Nguyen MH*. - - 1 - HEPATOLOGY (BALTIMORE, MD.) - HEPATOLOGY 2023 78¨÷(5´Á):1558-1568­¶
(IF: 13.5, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 7.53%)

Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.
Daniel Q Huang, Andrew Tran, Ming-Lun Yeh, Satoshi Yasuda, Pei-Chien Tsai, Chung-Feng Huang, Chia Yen Dai, Eiichi Ogawa, Masatoshi Ishigami, Takanori Ito, Ritsuzo Kozuka, Masaru Enomoto, Takanori Suzuki, Yoko Yoshimaru, Carmen M Preda, Raluca I Marin, Irina Sandra, Sally Tran, Sabrina X Z Quek, Htet Htet Toe Wai Khine, Norio Itokawa, Masanori Atsukawa, Haruki Uojima, Tsunamasa Watanabe, Hirokazu Takahashi, Kaori Inoue, Mayumi Maeda, Joseph K Hoang, Lindsey Trinh, Scott Barnett, Ramsey Cheung, Seng Gee Lim, Huy N Trinh, Wan-Long Chuang, Yasuhito Tanaka, Hidenori Toyoda, Ming-Lung Yu, Mindie H Nguyen - - 1 - HEPATOLOGY (BALTIMORE, MD.) - HEPATOLOGY 2023;78(5):1558-1568
(IF: 13.5, Journal Ranking: 7, Number of Journals of this Field: 93, Ranking: 7.53%)

55

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.
Polaris Observatory Collaborators (²ø¸UÀs,§E©ú¶©,Devin Razavi-Shearer*) - - 1 - THE LANCET. GASTROENTEROLOGY & HEPATOLOGY - LANCET GASTROENTEROLOGY & HEPATOLOGY 2023 8¨÷(10´Á):879-907­¶
(IF: 35.7, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 2.15%)

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.
Polaris Observatory Collaborators - - 1 - THE LANCET. GASTROENTEROLOGY & HEPATOLOGY - LANCET GASTROENTEROLOGY & HEPATOLOGY 2023;8(10):879-907
(IF: 35.7, Journal Ranking: 2, Number of Journals of this Field: 93, Ranking: 2.15%)

56

Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinoma.
§õ«a»ö, ±ç³Õµ{, ³\³Õ³ó, ±i®x»·, ÃQà±¾§, ¶ÀÂ@¶h, Á©ú«Û, ªL©yÓT, ¸­©ú­Û*, ¶À³©®p, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©. - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2023 39¨÷(11´Á):1145-1154­¶
(IF: 3.3, »â°ì±Æ¦W: 81, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 59.56%)

Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinoma.
Kuan-I Lee, Po-Cheng Liang, Po-Yau Hsu, Tyng-Yuan Jang, Yu-Ju Wei, Ching-I Huang, Ming-Yen Hsieh, Zu-Yau Lin, Ming-Lun Yeh, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2023;39(11):1145-1154
(IF: 3.3, Journal Ranking: 81, Number of Journals of this Field: 136, Ranking: 59.56%)

57

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH*; IMbrave050 investigators(¶À§Ó´I,§E©ú¶©) - - 1 - LANCET (LONDON, ENGLAND) - LANCET GASTROENTEROLOGY & HEPATOLOGY 2023 402¨÷(10415´Á):1835-1847­¶
(IF: 35.7, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 2.15%)

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Shukui Qin, Minshan Chen, Ann-Lii Cheng, Ahmed O Kaseb, Masatoshi Kudo, Han Chu Lee, Adam C Yopp, Jian Zhou, Lu Wang, Xiaoyu Wen, Jeong Heo, Won Young Tak, Shinichiro Nakamura, Kazushi Numata, Thomas Uguen, David Hsiehchen, Edward Cha, Stephen P Hack, Qinshu Lian, Ning Ma, Jessica H Spahn, Yulei Wang, Chun Wu, Pierce K H Chow, - - 1 - LANCET (LONDON, ENGLAND) - LANCET GASTROENTEROLOGY & HEPATOLOGY 2023;402(10415):1835-1847
(IF: 35.7, Journal Ranking: 2, Number of Journals of this Field: 93, Ranking: 2.15%)

58

Rapid and sensitive LAMP/CRISPR-powered diagnostics to detect different hepatitis C virus genotypes using an ITO-based EG-FET biosensing platform
Hsin-Ying Ho, Wei-Sin Kao, Piyush Deval, À¹¹Å¨¥, ³¯«Û¦°,§E©ú¶©, Che-Hsin Lin,§EÆF¬À - - 1 - Sensors and Actuators B: Chemical - SENSORS AND ACTUATORS B-CHEMICAL 2023 394¨÷(11´Á):134278­¶
(IF: 8.4, »â°ì±Æ¦W: 1, »â°ì´Á¥Z¼Æ: 63, »â°ì±Æ¦W: 1.59%)

Rapid and sensitive LAMP/CRISPR-powered diagnostics to detect different hepatitis C virus genotypes using an ITO-based EG-FET biosensing platform
Hsin-Ying Ho a 1, Wei-Sin Kao b 1, Piyush Deval a, Chia-Yen Dai c d, Yen-Hsu Chen c d e, Ming-Lung Yu c d e f, Che-Hsin Lin b, Ling-Shan Yu - - 1 - Sensors and Actuators B: Chemical - SENSORS AND ACTUATORS B-CHEMICAL 2023;394(11):134278
(IF: 8.4, Journal Ranking: 1, Number of Journals of this Field: 63, Ranking: 1.59%)

59

¹w´ú¨xµw¤Æªù¯ß®ê¶ë: ¤@¨Ç°ÝÃD
À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©* - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2022 76¨÷(1´Á):224-225­¶
(IF: 30.083, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 5.38%)

Predicting portal thrombosis in cirrhosis: Some issues.
Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu* - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2022;76(1):224-225
(IF: 30.083, Journal Ranking: 5, Number of Journals of this Field: 93, Ranking: 5.38%)

60

ºC©ÊC«¬¨xª¢µÇ¥\¯à¤£¥þ¤§DAAªvÀø: eGFR²Ä¥|»P¤­¯Å·s¸ê°T
À¹¹Å¨¥,¶À§Ó´I,²ø¸UÀs,§E©ú¶©*. - - 1 - Clinical gastroenterology and hepatology - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2022 20¨÷(1´Á):246-247­¶
(IF: 11.382, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 8.70%)

DAA Therapy in Hepatitis C in Patients With Chronic Kidney Disease: New Information for GFR Category G4 and G5.
Chia-Yen Dai,Jee-Fu Huang,Wan-Long Chuang,Ming-Lung Yu* - - 1 - Clinical gastroenterology and hepatology - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2022;20(1):246-247
(IF: 11.382, Journal Ranking: 8, Number of Journals of this Field: 92, Ranking: 8.70%)

61

Advancing the global public health agenda for NAFLD: a consensus statement.
Lazarus JV*, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, Cortez-Pinto H, Crespo J, Cusi K, Dirac MA, Francque S, George J, Hagström H, Huang TT, Ismail MH, Kautz A, Sarin SK, Loomba R, Miller V, Newsome PN, Ninburg M, Ocama P, Ratziu V, Rinella M, Romero D, Romero-Gómez M, Schattenberg JM, Tsochatzis EA, Valenti L, Wong VW, Yilmaz Y, Younossi ZM, Zelber-Sagi S; §E©ú¶©, NAFLD Consensus Consortium - - 1 - NATURE REVIEWS. GASTROENTEROLOGY & HEPATOLOGY - NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY 2022 19¨÷(1´Á):60-78­¶
(IF: 46.802, »â°ì±Æ¦W: 1, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 1.09%)

Advancing the global public health agenda for NAFLD: a consensus statement.
Lazarus JV*, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, Cortez-Pinto H, Crespo J, Cusi K, Dirac MA, Francque S, George J, Hagström H, Huang TT, Ismail MH, Kautz A, Sarin SK, Loomba R, Miller V, Newsome PN, Ninburg M, Ocama P, Ratziu V, Rinella M, Romero D, Romero-Gómez M, Schattenberg JM, Tsochatzis EA, Valenti L, Wong VW, Yilmaz Y, Younossi ZM, Zelber-Sagi S; NAFLD Consensus Consortium - - 1 - NATURE REVIEWS. GASTROENTEROLOGY & HEPATOLOGY - NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY 2022;19(1):60-78
(IF: 46.802, Journal Ranking: 1, Number of Journals of this Field: 92, Ranking: 1.09%)

62

Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study).
¶À§Ó´I,Á©ú«Û,ÃQà±¾§,¬x¤¯¦t,¶À¬¯­},¶ÀÂ@¶h,¸­©ú­Û,¶À³©®p,±i®x»·,³\³Õ³ó,±ç³Õµ{,À¹¹Å¨¥,ªL¤l³ó,§E©ú¶©*,²ø¸UÀs* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2022 16¨÷(1´Á):59-67­¶
(IF: 9.046, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 17.20%)

Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study).
Jee-Fu Huang, Ming-Yen Hsieh, Yu-Ju Wei, Jen-Yu Hung, Hsuan-Ti Huang, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Tyng-Yuan Jang, Po-Yao Hsu, Po-Cheng Liang, Chia-Yen Dai, Zu-Yau Lin, Ming-Lung Yu, Wan-Long Chuang - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2022;16(1):59-67
(IF: 9.046, Journal Ranking: 16, Number of Journals of this Field: 93, Ranking: 17.20%)

63

EASL ¹ï¨xÀù¨t²Î©ÊªvÀøªº¥ß³õ:«i©¹ª½«e
À¹¹Å¨¥,¸­©ú­Û,§E©ú¶©* - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2022 76¨÷(2´Á):478-480­¶
(IF: 25.083, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 2.17%)

An EASL position paper for systemic treatment of hepatocellular carcinoma: Go forward courageously.
Chia-Yen Dai, Ming-Lun Yeh, Ming-Lung Yu* - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2022;76(2):478-480
(IF: 25.083, Journal Ranking: 2, Number of Journals of this Field: 92, Ranking: 2.17%)

64

Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.
³¯­x§Ê,§f©ú¿o,Á©s°a,½²¨Ø­Å,Á°]·½,¸­©ú­Û,¶ÀÂ@¶h,½²©ö¬À,¬_¦ö¥Á,ªL·q´¼,³¯«a¦t,ÃQà±¾§,³\³Õ³ó,®}¦¨¹©,±i®x»·,¼B¤jºû,±ç³Õµ{,Á©ú«Û,ªL¤l³ó,¶À³©®p,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,¬I¦t¶©,§E©ú¶©* - - 1 - WORLD JOURNAL OF GASTROENTEROLOGY - WORLD JOURNAL OF GASTROENTEROLOGY 2022 28¨÷(2´Á):263-274­¶
(IF: 5.374, »â°ì±Æ¦W: 31, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 33.33%)

Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.
Chun-Ting Chen, Ming-Ying Lu, Meng-Hsuan Hsieh, Pei-Chien Tsai, Tsai-Yuan Hsieh, Ming-Lun Yeh, Ching-I Huang, Yi-Shan Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Yu-Lueng Shih, Ming-Lung Yu - - 1 - WORLD JOURNAL OF GASTROENTEROLOGY - WORLD JOURNAL OF GASTROENTEROLOGY 2022;28(2):263-274
(IF: 5.374, Journal Ranking: 31, Number of Journals of this Field: 93, Ranking: 33.33%)

65

­­¶qªº¯Á©Ô«D¥§¹ï§ÜÀù§@¥Î¹ï¨ã¦³°ª NANOG ªº°ò¥»¨xÀù²Ó­Mªº°ö¾i
ªL¤l³ó*,¸­©ú­Û,¶ÀÂ@¶h,³¯«H¦¨,¶À³©®p,¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©,²ø¸UÀs - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022 38¨÷(2´Á):157-164­¶
(IF: 2.744, »â°ì±Æ¦W: 93, »â°ì´Á¥Z¼Æ: 140, »â°ì±Æ¦W: 66.43%)

Limited sorafenib anticancer effects on primary cultured hepatocellular carcinoma cells with high NANOG expression
Zu-Yau Lin,Ming-Lun Yeh,Ching-I Huang,Shinn-Cherng Chen,Chung-Feng Huang,Jee-Fu Huang,Chia-Yen Dai,Ming-Lung Yu,Wan-Long Chuang - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022;38(2):157-164
(IF: 2.744, Journal Ranking: 93, Number of Journals of this Field: 140, Ranking: 66.43%)

66

Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication.
§f©ú¿o,¸­©ú­Û,¶ÀÂ@¶h,¤ý­zºö,½²©ö¬À,½²¨Ø­Å,¬_¦ö¥Á,ªL·q´¼,³¯«a¦t,ÃQà±¾§,³\³Õ³ó,®}¦¨¹©,±i®x»·,¼B¤jºû,±ç³Õµ{,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,¶À³©®p,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©* - - 1 - WORLD JOURNAL OF GASTROENTEROLOGY - WORLD JOURNAL OF GASTROENTEROLOGY 2022 28¨÷(1´Á):140-153­¶
(IF: 5.742, »â°ì±Æ¦W: 28, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 30.43%)

Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication.
Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, Shu-Chi Wang, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu - - 1 - WORLD JOURNAL OF GASTROENTEROLOGY - WORLD JOURNAL OF GASTROENTEROLOGY 2022;28(1):140-153
(IF: 5.742, Journal Ranking: 28, Number of Journals of this Field: 92, Ranking: 30.43%)

67

Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study.
Lung-Yi Mak, Joseph Hoang, Dae Won Jun, Chien-Hung Chen, ´^¦¨¤¸, ¸­©ú­Û, Sung Eun Kim, Daniel Q Huang, Jae Yoon Jeong, Eileen Yoon, Hyunwoo Oh, ½²¨Ø­Å, ¶À³©®p, Sang Bong Ahn, Huy Trinh, Qing Xie, Grace L H Wong, Masaru Enomoto, Jae-Jun Shim, Dong-Hyun Lee, Li Liu, Ritsuzo Kozuka, Yong Kyun Cho, Soung Won Jeong, Hyoung Su Kim, Lindsey Trinh, Allen Dao, Rui Huang, Rex Wan-Hin Hui, Vivien Tsui, Sabrina Quek, Htet Htet Toe Wai Khine, Eiichi Ogawa, À¹¹Å¨¥, ¶À§Ó´I, Ramsey Cheung, Chao Wu, ²ø¸UÀs, Seng Gee Lim, §E©ú¶©, Man-Fung Yuen, Mindie H Nguyen* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2022 16¨÷(1´Á):48-58­¶
(IF: 9.029, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 17.20%)

Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study.
Lung-Yi Mak, Joseph Hoang, Dae Won Jun, Chien-Hung Chen, Cheng-Yuan Peng, Ming-Lun Yeh, Sung Eun Kim, Daniel Q Huang, Jae Yoon Jeong, Eileen Yoon, Hyunwoo Oh, Pei-Chien Tsai, Chung-Feng Huang, Sang Bong Ahn, Huy Trinh, Qing Xie, Grace L H Wong, Masaru Enomoto, Jae-Jun Shim, Dong-Hyun Lee, Li Liu, Ritsuzo Kozuka, Yong Kyun Cho, Soung Won Jeong, Hyoung Su Kim, Lindsey Trinh, Allen Dao, Rui Huang, Rex Wan-Hin Hui, Vivien Tsui, Sabrina Quek, Htet Htet Toe Wai Khine, Eiichi Ogawa, Chia Yen Dai, Jee Fu Huang, Ramsey Cheung, Chao Wu, Wan-Long Chuang, Seng Gee Lim, Ming-Lung Yu, Man-Fung Yuen, Mindie H Nguyen - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2022;16(1):48-58
(IF: 9.029, Journal Ranking: 16, Number of Journals of this Field: 93, Ranking: 17.20%)

68

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan.
¾GÙy¨k, ¦ÈÁp·ç, ³¯­x§Ê, ³¯±Ò¯q, ¶À³©®p, ³¢¦æ¹D, ù²M¦À, ´¿°êªK, ¶À©Éµ¾, À¹±Ò©ú, ´^¦¨¤¸, ¥Õ©ú©¾, ³¯«Ø§», ¸­©ú­Û, Chih-Lang Lin, ªL«T«Û, §õ¨Ø­Û, Lee-Won Chong, ¬x»F§», ±i¼w¥Í, ¶À§Ó´I, ·¨°òÞf, Jui-Ting Hu, ªL§Ó¤å, ¤ý¹Å»ô, Ĭºû¤å, Á°]·½, ªL§Ó³®, ½²ºû­Û, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Kwok-Hsiung Chou, Chien-Neng Kao, ½²¨Ø­Å, ¼B®¶÷~, §õ¬üæ¢, Chien-Yu Cheng, Ming-Chang Tsai, ¼B«T¤H, À¹¹Å¨¥, ªLº~³Ç*, °ª¹Å§», ²ø¸UÀs, §E©ú¶©*, TACR investigators - - 1 - INFECTIOUS DISEASES AND THERAPY - INFECTIOUS DISEASES AND THERAPY 2022 11¨÷(1´Á):485-500­¶
(IF: 6.119, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 94, »â°ì±Æ¦W: 27.66%)

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan.
Pin-Nan Cheng, Lein-Ray Mo, Chun-Ting Chen, Chi-Yi Chen, Chung-Feng Huang, Hsing-Tao Kuo, Ching-Chu Lo, Kuo-Chih Tseng, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Chien-Hung Chen, Ming-Lun Yeh, Chih-Lang Lin, Chun-Yen Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Te Sheng Chang, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Kwok-Hsiung Chou, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chien-Yu Cheng, Ming-Chang Tsai, Chun-Jen Liu, Chia-Yen Dai, Han-Chieh Lin, Jia-Horng Kao, Wan-Long Chuang, Ming-Lung Yu, TACR investigators - - 1 - INFECTIOUS DISEASES AND THERAPY - INFECTIOUS DISEASES AND THERAPY 2022;11(1):485-500
(IF: 6.119, Journal Ranking: 26, Number of Journals of this Field: 94, Ranking: 27.66%)

69

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients.
±i®x»·,¶À³©®p,¸­©ú­Û,¶ÀÂ@¶h*,À¹¹Å¨¥,½²¨Ø­Å,³\³Õ³ó,ÃQà±¾§,«J¤D¤¯,±ç³Õµ{,ªL©yÐA, ¤ý§Ó¤å, Á©ú«Û, ªL¤l³ó, ¶À§Ó´I*, §E©ú¶©, ²ø¸UÀs - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022 38¨÷(3´Á):261-267­¶
(IF: 2.996, »â°ì±Æ¦W: 97, »â°ì´Á¥Z¼Æ: 139, »â°ì±Æ¦W: 69.78%)

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients.
Tyng-Yuan Jang, Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, Chia-Yen Dai, Pei-Chien Tsai, Po-Yau Hsu, Yi-Ju Wei, Nai-Jen Hou, Po-Cheng Liang, Yi-Hung Lin, Chih-Wen Wang, Ming-Yen Hsieh, Zu-Yau Lin, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022;38(3):261-267
(IF: 2.996, Journal Ranking: 97, Number of Journals of this Field: 139, Ranking: 69.78%)

70

Limited sorafenib anticancer effects on primary cultured hepatocellular carcinoma cells with high NANOG expression.
ªL¤l³ó*,¸­©ú­Û,¶ÀÂ@¶h,³¯«H¦¨,¶À³©®p,¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©,²ø¸UÀs - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022 38¨÷(2´Á):157-164­¶
(IF: 2.996, »â°ì±Æ¦W: 97, »â°ì´Á¥Z¼Æ: 139, »â°ì±Æ¦W: 69.78%)

Limited sorafenib anticancer effects on primary cultured hepatocellular carcinoma cells with high NANOG expression.
Zu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022;38(2):157-164
(IF: 2.996, Journal Ranking: 97, Number of Journals of this Field: 139, Ranking: 69.78%)

71

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
³\³Õ³ó,¾G¦Û³Ó#,²ø¥@©÷,±i¤åÀé,±ç³Õµ{,®}¦¨¹©,ÃQà±¾§,±i®x»·,¸­©ú­Û,¶ÀÂ@¶h,ªL©yÐA,¤ý§Ó¤å,Á©ú«Û,«J¤D¤¯,Á©s°a,½²©ö¬À,¬_¦ö¥Á,ªL·q´¼,³¯«a¦t,À¹¹Å¨¥,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,²ø¸UÀs,¶À³©®p*,§E©ú¶©* - - 1 - CANCER MEDICINE - CANCER MEDICINE 2022 11¨÷(1´Á):104-116­¶
(IF: 4.711, »â°ì±Æ¦W: 106, »â°ì´Á¥Z¼Æ: 245, »â°ì±Æ¦W: 43.27%)

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
Po-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, Wen-Tsan Chang, Po-Cheng Liang, Cheng-Ting Hsu, Yu-Ju Wei, Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, Yi-Hung Lin, Chih-Wen Wang, Ming-Yen Hsieh, Nai-Jen Hou, Meng-Hsuan Hsieh, Yi-Shan Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Wan-Long Chuang, Chung-Feng Huang, Ming-Lung Yu - - 1 - CANCER MEDICINE - CANCER MEDICINE 2022;11(1):104-116
(IF: 4.711, Journal Ranking: 106, Number of Journals of this Field: 245, Ranking: 43.27%)

72

Itemization difference of patient-reported outcome in patients with chronic liver disease.
ªL©ú¾e,À¹¹Å¨¥,¶À³©®p,¸­©ú­Û,Yi-Chan Liu,³\³Õ³ó,ÃQà±¾§,§õ¨Ø­Û*,¶ÀÂ@¶h,±ç³Õµ{,Á©ú«Û,Á©s°a,±i®x»·,ªL¤l³ó,¶À§Ó´I*,§E©ú¶©,²ø¸UÀs - - 1 - PLOS ONE - PLOS ONE 2022 17¨÷(2´Á):e0264348­¶
(IF: 3.752, »â°ì±Æ¦W: 29, »â°ì´Á¥Z¼Æ: 73, »â°ì±Æ¦W: 39.73%)

Itemization difference of patient-reported outcome in patients with chronic liver disease.
Ming-Chieh Lin, Chia-Yen Dai, Chung-Feng Huang, Ming-Lun Yeh, Yi-Chan Liu, Po-Yao Hsu, Yu-Ju Wei, Pei-Lun Lee, Ching-I Huang, Po-Cheng Liang, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Tyng-Yuan Jang, Zu-Yau Lin, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang - - 1 - PLOS ONE - PLOS ONE 2022;17(2):e0264348
(IF: 3.752, Journal Ranking: 29, Number of Journals of this Field: 73, Ranking: 39.73%)

73

Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals.
³¯«Û§¡, ±i¼w¥Í, ³¯«Ø§», ¾GÙy¨k, ù²M¦À, ¦ÈÁp·ç, ³¯­x§Ê, ¶À³©®p, ³¢¦æ¹D, ¶À©Éµ¾, À¹±Ò©ú, ´^¦¨¤¸, ¥Õ©ú©¾, ¸­©ú­Û, ªL§Ó­¦, ªL«T«Û, §õ¨Ø­Û, Lee-Won Chong, ¬x»F§», ¶À§Ó´I, ·¨°òÞf, ­J·ç®x, ªL§Ó¤å, ¤ý¹Å»ô, Ĭºû¤å, Á°]·½, ªL§Ó³®, ½²ºû­Û, Tzong-Hsi Lee, ³¯®Û­^, ¤ý¶à¤¯, ±i§g·Ó, ·¨³ÓµÏ, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, ½²¨Ø­Å, ¼B®¶÷~, §õ¬üæ¢, À¹¹Å¨¥, °ª¹Å§», ²ø¸UÀs, ªLº~³Ç, ³¯±Ò¯q, ´¿°êªK*, §E©ú¶©*, On Behalf Of TACR Investigators - - 1 - VIRUSES-BASEL - VIRUSES-BASEL 2022 14¨÷(2´Á):333­¶
(IF: 5.818, »â°ì±Æ¦W: 14, »â°ì´Á¥Z¼Æ: 37, »â°ì±Æ¦W: 37.84%)

Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals.
Yen-Chun Chen, Te-Sheng Chang, Chien-Hung Chen, Pin-Nan Cheng, Ching-Chu Lo, Lein-Ray Mo, Chun-Ting Chen, Chung-Feng Huang, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Ming-Lun Yeh, Chih-Lang Lin, Chun-Yen Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chia-Yen Dai, Jia-Horng Kao, Wan-Long Chuang, Han-Chieh Lin, Chi-Yi Chen, Kuo-Chih Tseng, Ming-Lung Yu, On Behalf Of Tacr Investigators - - 1 - VIRUSES-BASEL - VIRUSES-BASEL 2022;14(2):333
(IF: 5.818, Journal Ranking: 14, Number of Journals of this Field: 37, Ranking: 37.84%)

74

Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.
Jiyoon Park, An K Le, Tai-Chung Tseng, ¸­©ú­Û, Dae Won Jun, Huy Trinh, Grace L H Wong, Chien-Hung Chen, ´^¦¨¤¸, Sung Eun Kim, Hyunwoo Oh, Min-Sun Kwak, Ka Shing Cheung, Hidenori Toyoda, ³\Ä£µ¤, Jae Yoon Jeong, Eileen L Yoon, Teerapat Ungtrakul, Jian Zhang, Qing Xie, Sang Bong Ahn, Masaru Enomoto, Jae-Jun Shim, Chris Cunningham, Soung Won Jeong, Yong Kyun Cho, Eiichi Ogawa, Rui Huang, Dong-Hyun Lee, Hirokazu Takahashi, ½²¨Ø­Å, ¶À³©®p, À¹¹Å¨¥, Cheng-Hao Tseng, Satoshi Yasuda, Ritsuzo Kozuka, Jiayi Li, Christopher Wong, Clifford C Wong, Changqing Zhao, Joseph Hoang, Yuichiro Eguchi, Chao Wu, Yasuhito Tanaka, Ed Gane, Tawesak Tanwandee, Ramsey Cheung, Man-Fung Yuen, Hyo-Suk Lee, §E©ú¶©, °ª¹Å§», ·¨Ãh³ü, Mindie H Nguyen* - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2022 20¨÷(4´Á):874-885.e4­¶
(IF: 13.576, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 7.53%)

Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.
Jiyoon Park, An K Le, Tai-Chung Tseng, Ming-Lun Yeh, Dae Won Jun, Huy Trinh, Grace L H Wong, Chien-Hung Chen, Cheng-Yuan Peng, Sung Eun Kim, Hyunwoo Oh, Min-Sun Kwak, Ka Shing Cheung, Hidenori Toyoda, Yao-Chun Hsu, Jae Yoon Jeong, Eileen L Yoon, Teerapat Ungtrakul, Jian Zhang, Qing Xie, Sang Bong Ahn, Masaru Enomoto, Jae-Jun Shim, Chris Cunningham, Soung Won Jeong, Yong Kyun Cho, Eiichi Ogawa, Rui Huang, Dong-Hyun Lee, Hirokazu Takahashi, Pei-Chien Tsai, Chung-Feng Huang, Chia-Yen Dai, Cheng-Hao Tseng, Satoshi Yasuda, Ritsuzo Kozuka, Jiayi Li, Christopher Wong, Clifford C Wong, Changqing Zhao, Joseph Hoang, Yuichiro Eguchi, Chao Wu, Yasuhito Tanaka, Ed Gane, Tawesak Tanwandee, Ramsey Cheung, Man-Fung Yuen, Hyo-Suk Lee, Ming-Lung Yu, Jia-Horng Kao, Hwai-I Yang, Mindie H Nguyen* - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2022;20(4):874-885.e4
(IF: 13.576, Journal Ranking: 7, Number of Journals of this Field: 93, Ranking: 7.53%)

75

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Victor Sapena,Marco Enea,Ferran Torres,Ciro Celsa,Jose Rios,Giacomo Emanuele Maria Rizzo,Pierre Nahon,Zoe Mario,Ryosuke Tateishi,Tatsuya Minami,Angelo ,Amit G Singal,Caitlin Murphy,Mohamed Kohla,,Luisa Cavalletto,Liliana Lc Chemello,Stanislas Pol,Javier Crespo,Jose Luis Calleja,Rosanna Villani,Gaetano Serviddio,Alberto Zanetto,Sarah Shalaby,Francesco Paolo Russo,Rob Bielen,§E©ú¶© - - 1 - Gut - GUT 2022 71¨÷(3´Á):593-604­¶
(IF: 23.059, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 3.26%)

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Victor Sapena,Marco Enea,Ferran Torres,Ciro Celsa,Jose Rios,Giacomo Emanuele Maria Rizzo,Pierre Nahon,Zoe Mario,Ryosuke Tateishi,Tatsuya Minami,Angelo Sangiovanni,Xavier Forns,Hidenori Toyoda,Stefano Brillanti,Fabio Conti,Elisabetta Degasperi,Ming-Lung Yu,Pei-Chien Tsai,Kevin Jean,Mohamed El Kassas,Hend Ibrahim Shousha,Ashraf Omar,Claudio Zavaglia,Hiroko Nagata,Mina Nakagawa,Yasuhiro Asahina,Amit G Singal,Caitlin Murphy,Mohamed Kohla,Chiara Masetti,Jean-Franois Dufour,Nicolas Merchante,Luisa Cavalletto,Liliana Lc Chemello,Stanislas Pol,Javier Crespo,Jose Luis Calleja,Rosanna Villani,Gaetano Serviddio,Alberto Zanetto,Sarah Shalaby,Francesco Paolo Russo,Rob Bielen,Franco Trevisani,Calogero Camm,Jordi Bruix,Giuseppe Cabibbo,Maria Reig - - 1 - Gut - GUT 2022;71(3):593-604
(IF: 23.059, Journal Ranking: 3, Number of Journals of this Field: 92, Ranking: 3.26%)

76

On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
¶À³©®p,±i®x»·#,Dae Won Jun, Sang Bong Ahn, Jihyun An, Masaru Enomoto, Hirokazu Takahashi, Eiichi Ogawa, Eileen Yoon, Soung Won Jeong, Jae-Jun Shim, Jae Yoon Jeong, Sung Eun Kim, Hyunwoo Oh, Hyoung Su Kim, Yong Kyun Cho, Ritsuzo Kozuka, Kaori Inoue, Ka Shing Cheung, Lung Yi Mak, ¶À§Ó´I,À¹¹Å¨¥, Man-Fung Yuen, Mindie H Nguyen, §E©ú¶©* - - 1 - LIVER INTERNATIONAL : OFFICIAL JOURNAL OF THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF THE LIVER - LIVER INTERNATIONAL 2022 42¨÷(1´Á):59-68­¶
(IF: 5.828, »â°ì±Æ¦W: 25, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 27.17%)

On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
Chung-Feng Huang, Tyng-Yuan Jang, Dae Won Jun, Sang Bong Ahn, Jihyun An, Masaru Enomoto, Hirokazu Takahashi, Eiichi Ogawa, Eileen Yoon, Soung Won Jeong, Jae-Jun Shim, Jae Yoon Jeong, Sung Eun Kim, Hyunwoo Oh, Hyoung Su Kim, Yong Kyun Cho, Ritsuzo Kozuka, Kaori Inoue, Ka Shing Cheung, Lung Yi Mak, Jee-Fu Huang, Chia-Yen Dai, Man-Fung Yuen, Mindie H Nguyen, Ming-Lung Yu* - - 1 - LIVER INTERNATIONAL : OFFICIAL JOURNAL OF THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF THE LIVER - LIVER INTERNATIONAL 2022;42(1):59-68
(IF: 5.828, Journal Ranking: 25, Number of Journals of this Field: 92, Ranking: 27.17%)

77

The compound annual growth rate of the fibrosis-4 index in chronic hepatitis B patients
¼B¤jºû,¶À³©®p,½²¨Ø­Å,¸­©ú­Û,±i®x»·,¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©,²ø¸UÀs* - - 1 - Kaohsiung J Med - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022 38¨÷(7´Á):686-693­¶
(IF: 2.996, »â°ì±Æ¦W: 97, »â°ì´Á¥Z¼Æ: 139, »â°ì±Æ¦W: 69.78%)

The compound annual growth rate of the fibrosis-4 index in chronic hepatitis B patients
Ta-Wei Liu,Chung-Feng Huang,Pei-Chien Tsai,Ming-Lun Yeh,Tyng-Yuan Jang,Jee-Fu Huang,Chia-Yen Dai,Ming-Lung Yu,Wan-Long Chuang - - 1 - Kaohsiung J Med - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022;38(7):686-693
(IF: 2.996, Journal Ranking: 97, Number of Journals of this Field: 139, Ranking: 69.78%)

78

Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C Patients.
½²©ö¬À, ¶ÀÂ@¶h, ½²¨Ø­Å, ¸­©ú­Û, ¶À³©®p, Á©s°a, ¼B¤jºû, ªL©yÐA, ±ç³Õµ{, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, ²ø¸UÀs, À¹¹Å¨¥, §E©ú¶©* - - 1 - CANCERS - CANCERS 2022 14¨÷(8´Á):2023­¶
(IF: 6.575, »â°ì±Æ¦W: 60, »â°ì´Á¥Z¼Æ: 245, »â°ì±Æ¦W: 24.49%)

Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C Patients.
Yi-Shan Tsai, Ching-I Huang, Pei-Chien Tsai, Ming-Lun Yeh, Chung-Feng Huang, Meng-Hsuan Hsieh, Ta-Wei Liu, Yi-Hung Lin, Po-Cheng Liang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Wan-Long Chuang, Chia-Yen Dai, Ming-Lung Yu - - 1 - CANCERS - CANCERS 2022;14(8):2023
(IF: 6.575, Journal Ranking: 60, Number of Journals of this Field: 245, Ranking: 24.49%)

79

Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR).
¶À³©®p, ´¿°êªK, ¾GÙy¨k, ¬x»F§», ù²M¦À, ´^¦¨¤¸, ¥Õ©ú©¾, ¸­©ú­Û, ³¯«Ø§», §õ¨Ø­Û, ªL«T«Û, ³¢¦æ¹D, ³¯­x§Ê, ·¨°òÞf, ¶À§Ó´I, À¹±Ò©ú, Jui-Ting Hu, Chih-Lang Lin, Wei-Wen Su, ½²ºû­Û, ¶À©Éµ¾, Chien-Yu Cheng, ªL§Ó³®, ¤ý¹Å»ô, ·¨µÏ³Ó, ¦ÈÁp·ç, ³¯®Û­^, Chun-Chao Chang, ¤ý¶à¤¯, Chia-Sheng Huang, Á°]·½, ªL§Ó¤å, Tzong-Hsi Lee, Lee-Won Chong, Chien-Wei Huang, Shiuh-Nan Chang 35, Ming-Chang Tsai, ®}¤h­õ, °ª¹Å§», ¼B«T¤H, ¼B®¶÷~, ªLº~³Ç, §õ¬üæ¢, ½²¨Ø­Å, À¹¹Å¨¥, ²ø¸UÀs, ³¯±Ò¯q, §E©ú¶©* - - 1 - Clin Gastroenterol Hepatol - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2022 20¨÷(5´Á):1151-1162.e6­¶
(IF: 11.382, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 8.70%)

Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR).
Chung-Feng Huang, Kuo-Chih Tseng, Pin-Nan Cheng, Chao-Hung Hung, Ching-Chu Lo, Cheng-Yuan Peng, Ming-Jong Bair, Ming-Lun Yeh, Chien-Hung Chen, Pei-Lun Lee, Chun-Yen Lin, Hsing-Tao Kuo, Chun-Ting Chen, Chi-Chieh Yang, Jee-Fu Huang, Chi-Ming Tai, Jui-Ting Hu, Chih-Lang Lin, Wei-Wen Su, Wei-Lun Tsai, Yi-Hsiang Huang, Chien-Yu Cheng, Chih-Lin Lin, Chia-Chi Wang, Sheng-Shun Yang, Lein-Ray Mo, Guei-Ying Chen, Chun-Chao Chang, Szu-Jen Wang, Chia-Sheng Huang, Tsai-Yuan Hsieh, Chih-Wen Lin, Tzong-Hsi Lee, Lee-Won Chong, Chien-Wei Huang, Shiuh-Nan Chang, Ming-Chang Tsai, Shih-Jer Hsu, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Han-Chieh Lin, Mei-Hsuan Lee, Pei-Chien Tsai, Chia-Yen Dai, Wan-Long Chuang, Chi-Yi Chen, Ming-Lung Yu - - 1 - Clin Gastroenterol Hepatol - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2022;20(5):1151-1162.e6
(IF: 11.382, Journal Ranking: 8, Number of Journals of this Field: 92, Ranking: 8.70%)

80

Are immune-checkpoint inhibitors immunosuppressive to hepatitis B virus?
Lau G*, §E©ú¶©, Wong G, Thompson A - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2022 16¨÷(2´Á):482-483­¶
(IF: 6.047, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 26.09%)

Are immune-checkpoint inhibitors immunosuppressive to hepatitis B virus?
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2022;16(2):482-483
(IF: 6.047, Journal Ranking: 24, Number of Journals of this Field: 92, Ranking: 26.09%)

81

A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease.
Younossi ZM, Ong JP, Takahashi H, Yilmaz Y, Eguc Hi Y, El Kassas M, Buti M, Diago M, Zheng MH, Fan JG, §E©ú¶©, Wai-Sun Wong V, Alswat K, Chan WK, Mendez-Sanchez N, Burra P, Bugianesi E, Duseja AK, George J, Papatheodoridis GV, Saeed H, Castera L, Arrese M, Kugelmas M, Romero-Gomez M, Alqahtani S, Ziayee M, Lam B, Younossi I, Racila A, Henry L, Stepanova M; Global Nonalcoholic Steatohepatitis Council - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2022 20¨÷(6´Á):e1456-e1468­¶
(IF: 13.576, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 7.53%)

A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease.
Zobair M Younossi, Janus P Ong, Hirokazu Takahashi, Yusuf Yilmaz, Yuichiro Eguc Hi, Mohamed El Kassas, Maria Buti, Moisés Diago, Ming-Hua Zheng, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Khalid Alswat, Wah-Kheong Chan, Nahum Mendez-Sanchez, Patrizia Burra, Elisabetta Bugianesi, Ajay K Duseja, Jacob George, George V Papatheodoridis, Hamid Saeed, Laurent Castera, Marco Arrese, Marcelo Kugelmas, Manuel Romero-Gomez, Saleh Alqahtani, Mariam Ziayee, Brian Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova, - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2022;20(6):e1456-e1468
(IF: 13.576, Journal Ranking: 7, Number of Journals of this Field: 93, Ranking: 7.53%)

82

C«¬¨xª¢¯f±wªvÀø«á«ùÄò§N¾®³J¥Õ¦å¯g»PÅÖºû¤Æ¬ÛÃö
Batbold Batsaikhan, ¶ÀÂ@¶h,¸­©ú­Û,¶À³©¾W,ªL©yÓT,±ç³Õµ{, Á©ú«Û,ªL©yÀR,¶À§Ó´I, ²ø¸UÀs, §õ´º´Ü,§E©ú¶©,³¢¦æ¹D,À¹¹Å¨¥* - - 1 - PLOS ONE - PLOS ONE 2022 17¨÷(5´Á):e0268180­¶
(IF: 3.752, »â°ì±Æ¦W: 29, »â°ì´Á¥Z¼Æ: 73, »â°ì±Æ¦W: 39.73%)

Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients.
Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Yi-Hung Lin, Po-Cheng Liang, Ming-Yen Hsieh, Yi-Ching Lin, Jee-Fu Huang, Wan-Long Chuang, Jin-Ching Lee, Ming-Lung Yu, Hsing-Tao Kuo, Chia-Yen Dai* - - 1 - PLOS ONE - PLOS ONE 2022;17(5):e0268180
(IF: 3.752, Journal Ranking: 29, Number of Journals of this Field: 73, Ranking: 39.73%)

83

Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide.
¸­©ú­Û, ±ç³Õµ{, Sam Trinh, ¶ÀÂ@¶h, ¶À³©®p, Á©ú«Û, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, Mindie H Nguyen*, §E©ú¶©* - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2022 121¨÷(7´Á):1273-1282­¶
(IF: 3.871, »â°ì±Æ¦W: 61, »â°ì´Á¥Z¼Æ: 172, »â°ì±Æ¦W: 35.47%)

Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide.
Ming-Lun Yeh, Po-Cheng Liang, Sam Trinh, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Mindie H Nguyen, Ming-Lung Yu - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2022;121(7):1273-1282
(IF: 3.871, Journal Ranking: 61, Number of Journals of this Field: 172, Ranking: 35.47%)

84

Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations.
Hsin-Yun Sun, Chieh Chiang, Sung-Hsi Huang, Wen-Jin Guo, Yu-Chung Chuang, Yi-Chia Huang, Chia-Jui Yang, Li-Hsin Su, Yi-Ting Chen, Yea-Wen Chen, Fu-Chiang Hsu, Shu-Yuan Ho, Wen-Chun Liu, Yi-Ching Su, Sui-Yuan Chang, Chin-Fu Hsiao, ¬x°·²M, §E©ú¶©* - - 1 - MICROBIOLOGY SPECTRUM - MICROBIOLOGY SPECTRUM 2022 10¨÷(3´Á):e0243721­¶
(IF: 9.043, »â°ì±Æ¦W: 20, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 14.71%)

Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations.
Hsin-Yun Sun, Chieh Chiang, Sung-Hsi Huang, Wen-Jin Guo, Yu-Chung Chuang, Yi-Chia Huang, Chia-Jui Yang, Li-Hsin Su, Yi-Ting Chen, Yea-Wen Chen, Fu-Chiang Hsu, Shu-Yuan Ho, Wen-Chun Liu, Yi-Ching Su, Sui-Yuan Chang, Chin-Fu Hsiao, Chien-Ching Hung, Ming-Lung Yu - - 1 - MICROBIOLOGY SPECTRUM - MICROBIOLOGY SPECTRUM 2022;10(3):e0243721
(IF: 9.043, Journal Ranking: 20, Number of Journals of this Field: 136, Ranking: 14.71%)

85

Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations.
Hsin-Yun Sun, Wang-Da Liu, Chih-Wen Wang, Yu-Ju Wei, Kuan-Yin Lin, Yu-Shan Huang, Li-Hsin Su, Yi-Ting Chen, Wen-Chun Liu, Yi-Chin Su, Yea-Wen Chen, Yu-Chung Chuang, Po-Liang Lu, ¬x°·²M, §E©ú¶©* - - 1 - MICROBIOLOGY SPECTRUM - MICROBIOLOGY SPECTRUM 2022 10¨÷(3´Á):e0034522­¶
(IF: 9.043, »â°ì±Æ¦W: 20, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 14.71%)

Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations.
Hsin-Yun Sun, Wang-Da Liu, Chih-Wen Wang, Yu-Ju Wei, Kuan-Yin Lin, Yu-Shan Huang, Li-Hsin Su, Yi-Ting Chen, Wen-Chun Liu, Yi-Chin Su, Yea-Wen Chen, Yu-Chung Chuang, Po-Liang Lu, Chien-Ching Hung, Ming-Lung Yu - - 1 - MICROBIOLOGY SPECTRUM - MICROBIOLOGY SPECTRUM 2022;10(3):e0034522
(IF: 9.043, Journal Ranking: 20, Number of Journals of this Field: 136, Ranking: 14.71%)

86

Liver stiffness, fatty liver disease and atrial fibrillation in the Rotterdam study: some issues
½²ºû¤¤,§E©ú¶©,À¹¹Å¨¥* - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2022 S0168-8278¨÷(22´Á):02925-7­¶
(IF: 30.083, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 5.38%)

Liver stiffness, fatty liver disease and atrial fibrillation in the Rotterdam study: some issues
Wei-Chung Tsai, Ming-Lung Yu, Chia-Yen Dai* - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2022;S0168-8278(22):02925-7
(IF: 30.083, Journal Ranking: 5, Number of Journals of this Field: 93, Ranking: 5.38%)

87

Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.
ù²M¦À, ¶À³©®p, ¾GÙy¨k, ´¿°êªK, ³¯±Ò¯q, ³¢¦æ¹D, ¶À©Éµ¾, À¹±Ò©ú, ´^¦¨¤¸, ¥Õ©ú©¾, ³¯«Ø§», ¸­©ú­Û, Chih-Lang Lin, ªL«T«Û, §õ¨Ø­Û, Lee-Won Chong, ¬x»F§», ±i¼w¥Í, ¶À§Ó´I, ·¨°òÞf, Jui-Ting Hu, ªL§Ó¤å, ³¯­x§Ê, ¤ý¹Å»ô, Ĭºû¤å, Á°]·½, ªL§Ó³®, ½²ºû­Û, Tzong-Hsi Lee, ³¯®Û­^, ¤ý¶à¤¯, Chun-Chao Chang, ¦ÈÁp·ç, ·¨³ÓµÏ, §d¤å»x, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, ½²¨Ø­Å, ¼B®¶÷~, §õ¬üæ¢, ¼B«T¤H, À¹¹Å¨¥, ²ø¸UÀs, ªLº~³Ç, °ª¹Å§»*, §E©ú¶©*, TACR investigators - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION = TAIWAN YI ZHI - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2022 121¨÷(8´Á):1567-1578­¶
(IF: 3.871, »â°ì±Æ¦W: 61, »â°ì´Á¥Z¼Æ: 172, »â°ì±Æ¦W: 35.47%)

Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.
Ching-Chu Lo, Chung-Feng Huang, Pin-Nan Cheng, Kuo-Chih Tseng, Chi-Yi Chen, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Chien-Hung Chen, Ming-Lun Yeh, Chih-Lang Lin, Chun-Yen Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Te Sheng Chang, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chun-Ting Chen, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Lein-Ray Mo, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chun-Jen Liu, Chia-Yen Dai, Wan-Long Chuang, Han-Chieh Lin, Jia-Horng Kao, Ming-Lung Yu, TACR investigators - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION = TAIWAN YI ZHI - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2022;121(8):1567-1578
(IF: 3.871, Journal Ranking: 61, Number of Journals of this Field: 172, Ranking: 35.47%)

88

¥xÆW®È¦æªÌ¦æ«e·Ç³Æ»P·Ó·|·NÄ@¬ÛÃö¦]¤l:¤@¨ÇºÃ¼{
À¹¹Å¨¥,§E©ú¶©,²ø¥°¼Ý,¦ó±Ò¥\,¤ý»FÄÖ* - - 1 - TRAVEL MEDICINE AND INFECTIOUS DISEASE - TRAVEL MEDICINE AND INFECTIOUS DISEASE 2022 49¨÷(-´Á):102422­¶
(IF: 20.441, »â°ì±Æ¦W: 9, »â°ì´Á¥Z¼Æ: 210, »â°ì±Æ¦W: 4.29%)

Pretravel preparation and factors associated with willingness to seek pretravel consultation among Taiwanese travelers: Some concerns.
Chia-Yen Dai, Ming-Lung Yu, Hung-Yi Chuang, Chi-Kung Ho, Chao-Ling Wang - - 1 - TRAVEL MEDICINE AND INFECTIOUS DISEASE - TRAVEL MEDICINE AND INFECTIOUS DISEASE 2022;49(-):102422
(IF: 20.441, Journal Ranking: 9, Number of Journals of this Field: 210, Ranking: 4.29%)

89

Association of depression and parasympathetic activation with glycemic control in type 2 diabetes mellitus.
ªL©ø¼w, ±iÄ×ÄÉ, ¥î¬M¾§, ®}Þ³À¢, ³¢¬L§», ½²©¾ºa, §E©ú¶©, Ĭ¤åºÓ*, ªL©y¬ü* - - 1 - JOURNAL OF DIABETES AND ITS COMPLICATIONS - JOURNAL OF DIABETES AND ITS COMPLICATIONS 2022 36¨÷(8´Á):108264­¶
(IF: 3.219, »â°ì±Æ¦W: 102, »â°ì´Á¥Z¼Æ: 146, »â°ì±Æ¦W: 69.86%)

Association of depression and parasympathetic activation with glycemic control in type 2 diabetes mellitus.
Kun-Der Lin, Li-Hsin Chang, Ying-Ru Wu, Wei-Hao Hsu, Chao-Hung Kuo, Jong-Rung Tsai, Ming-Lung Yu, Wen-So Su, I-Mei Lin - - 1 - JOURNAL OF DIABETES AND ITS COMPLICATIONS - JOURNAL OF DIABETES AND ITS COMPLICATIONS 2022;36(8):108264
(IF: 3.219, Journal Ranking: 102, Number of Journals of this Field: 146, Ranking: 69.86%)

90

Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021.
±i®x»·, ¤ýÁ~´f, ¶À³©®p, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, ³¢¬F¿Ù*, §E©ú¶©* - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION = TAIWAN YI ZHI - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2022 121¨÷(9´Á):1767-1772­¶
(IF: 3.871, »â°ì±Æ¦W: 61, »â°ì´Á¥Z¼Æ: 172, »â°ì±Æ¦W: 35.47%)

Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021.
Tyng-Yuan Jang, Hsin-Hui Wang, Chung-Feng Huang, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Cheng-Yu Kuo*, Ming-Lung Yu* - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION = TAIWAN YI ZHI - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2022;121(9):1767-1772
(IF: 3.871, Journal Ranking: 61, Number of Journals of this Field: 172, Ranking: 35.47%)

91

Low disease awareness as a contributing factor to the high prevalence of hepatitis C infection in Tzukuan, a hyperendemic area of southern Taiwan.
½²¨Ø­Å, À¹¹Å¨¥, ¶ÀÂ@¶h, ¸­©ú­Û, ¶À³©®p, Á©s°a, ·¨¥¿ºÖ, ³\³Õ³ó, ±ç³Õµ{, ªL©yÐA, ±i®x»·, Á©ú«Û, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, §E©ú¶©*, ²ø¸UÀs*, ±i¤å¦t - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022 38¨÷(7´Á):694-702­¶
(IF: 2.996, »â°ì±Æ¦W: 97, »â°ì´Á¥Z¼Æ: 139, »â°ì±Æ¦W: 69.78%)

Low disease awareness as a contributing factor to the high prevalence of hepatitis C infection in Tzukuan, a hyperendemic area of southern Taiwan.
Pei-Chien Tsai, Chia-Yen Dai, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Meng-Hsuan Hsieh, Jeng-Fu Yang, Po-Yao Hsu, Po-Cheng Liang, Yi-Hung Lin, Tyng-Yuan Jang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Chern Chen, Jee-Fu Huang, Ming-Lung Yu*, Wan-Long Chuang*, Wen-Yu Chang - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022;38(7):694-702
(IF: 2.996, Journal Ranking: 97, Number of Journals of this Field: 139, Ranking: 69.78%)

92

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study.
M Simonelli*, E Garralda, F Eskens, M Gil-Martin, C-J Yen, R Obermannova, Y Chao, S Lonardi, B Melichar, V Moreno, §E©ú¶©, A Bongiovanni, E Calvo, S Rottey, J-P Machiels, A Gonzalez-Martin, L Paz-Ares, C-L Chang, W Mason, C-C Lin, D A Reardon, M Vieito, A Santoro, R Meng, G Abbadessa, F Menas, H Lee, Q Liu, C Combeau, N Ternes, S Ziti-Ljajic, C Massard - - 1 - ESMO OPEN - ESMO OPEN 2022 7¨÷(5´Á):100562­¶
(IF: 6.883, »â°ì±Æ¦W: 57, »â°ì´Á¥Z¼Æ: 245, »â°ì±Æ¦W: 23.27%)

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study.
M Simonelli*, E Garralda, F Eskens, M Gil-Martin, C-J Yen, R Obermannova, Y Chao, S Lonardi, B Melichar, V Moreno, M-L Yu, A Bongiovanni, E Calvo, S Rottey, J-P Machiels, A Gonzalez-Martin, L Paz-Ares, C-L Chang, W Mason, C-C Lin, D A Reardon, M Vieito, A Santoro, R Meng, G Abbadessa, F Menas, H Lee, Q Liu, C Combeau, N Ternes, S Ziti-Ljajic, C Massard - - 1 - ESMO OPEN - ESMO OPEN 2022;7(5):100562
(IF: 6.883, Journal Ranking: 57, Number of Journals of this Field: 245, Ranking: 23.27%)

93

Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes.
±i®x»·,ªL©yÐA,±ç³Õµ{,¸­©ú­Û,¶ÀÂ@¶h,¼B¤jºû,ÃQà±¾§,³\³Õ³ó,·¨¥¿ºÖ,«J¤D¤¯,¤ý§Ó¤å,Á©ú«Û,ªL¤l³ó,¶À³©®p*,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©* - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022 38¨÷(9´Á):897-906­¶
(IF: 2.996, »â°ì±Æ¦W: 97, »â°ì´Á¥Z¼Æ: 139, »â°ì±Æ¦W: 69.78%)

Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes.
Tyng-Yuan Jang, Yi-Hung Lin, Po-Cheng Liang, Ming-Lun Yeh, Ching-I Huang, Ta-Wei Liu, Yu-Ju Wei, Po-Yao Hsu, Jeng-Fu Yang, Nai-Jen Hou, Chih-Wen Wang, Ming-Yen Hsieh, Zu-Yau Lin, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022;38(9):897-906
(IF: 2.996, Journal Ranking: 97, Number of Journals of this Field: 139, Ranking: 69.78%)

94

Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.
Zobair M Younossi*, Yusuf Yilmaz, §E©ú¶©, Vincent Wai-Sun Wong, Marlen Castellanos Fernandez, Vasily A Isakov, Ajay K Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, George V Papatheodoridis, Wah Kheong Chan, Khalid Alswat, Hamid S Saeed, Ashwani K Singal, Manuel Romero-Gomez, Stuart C Gordon, Stuart K Roberts, Mohamed El Kassas, Marcelo Kugelmas, Janus P Ong, Saleh Alqahtani, Mariam Ziayee, Brian Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova, Global NASH Council - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2022 20¨÷(10´Á):2296-2306.e6­¶
(IF: 13.576, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 7.53%)

Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.
Zobair M Younossi*, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Castellanos Fernandez, Vasily A Isakov, Ajay K Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, George V Papatheodoridis, Wah Kheong Chan, Khalid Alswat, Hamid S Saeed, Ashwani K Singal, Manuel Romero-Gomez, Stuart C Gordon, Stuart K Roberts, Mohamed El Kassas, Marcelo Kugelmas, Janus P Ong, Saleh Alqahtani, Mariam Ziayee, Brian Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova, - - 1 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2022;20(10):2296-2306.e6
(IF: 13.576, Journal Ranking: 7, Number of Journals of this Field: 93, Ranking: 7.53%)

95

Advantage of clinical colchicine concentration to promote sorafenib or regorafenib anti-cancer effects on hepatocellular carcinoma.
ªL¤l³ó*,¸­©ú­Û,¶ÀÂ@¶h,±ç³Õµ{,³\³Õ³ó,³¯«H¦¨,¶À³©¾W,¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©,²ø¸UÀs - - 1 - BIOMEDICINE & PHARMACOTHERAPY - BIOMEDICINE & PHARMACOTHERAPY 2022 153¨÷(2022´Á):113540­¶
(IF: 7.419, »â°ì±Æ¦W: 30, »â°ì´Á¥Z¼Æ: 139, »â°ì±Æ¦W: 21.58%)

Advantage of clinical colchicine concentration to promote sorafenib or regorafenib anti-cancer effects on hepatocellular carcinoma.
Zu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Po-Yao Hsu, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang - - 1 - BIOMEDICINE & PHARMACOTHERAPY - BIOMEDICINE & PHARMACOTHERAPY 2022;153(2022):113540
(IF: 7.419, Journal Ranking: 30, Number of Journals of this Field: 139, Ranking: 21.58%)

96

Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
Zobair M Younossi*, §E©ú¶©, Mohamed El-Kassas, Gamal Esmat, Marlen I Castellanos Fernández, Maria Buti, Georgios Papatheodoridis, Yusuf Yilmaz, Vasily Isakov, Ajay Duseja, Nahum Méndez-Sánchez, Saeed Hamid, Stuart C Gordon, Manuel Romero-Gómez, Wah-Kheong Chan, Janus P Ong, Issah Younossi, Brain Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova, Global NASH Council™ - - 1 - JOURNAL OF VIRAL HEPATITIS - JOURNAL OF VIRAL HEPATITIS 2022 29¨÷(11´Á):1015-1025­¶
(IF: 3.517, »â°ì±Æ¦W: 56, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 60.22%)

Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
Zobair M Younossi, Ming-Lung Yu, Mohamed El-Kassas, Gamal Esmat, Marlen I Castellanos Fernández, Maria Buti, Georgios Papatheodoridis, Yusuf Yilmaz, Vasily Isakov, Ajay Duseja, Nahum Méndez-Sánchez, Saeed Hamid, Stuart C Gordon, Manuel Romero-Gómez, Wah-Kheong Chan, Janus P Ong, Issah Younossi, Brain Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova, - - 1 - JOURNAL OF VIRAL HEPATITIS - JOURNAL OF VIRAL HEPATITIS 2022;29(11):1015-1025
(IF: 3.517, Journal Ranking: 56, Number of Journals of this Field: 93, Ranking: 60.22%)

97

glecaprevir/pibrentasvir ¹ïHCV·P¬V¤§ÃÄÅ}±wªÌ¦³°ªÀø®Ä:¤@¨Ç°ÝÃD
À¹¹Å¨¥,¶À³©®p,¶À§Ó´I,²ø¸UÀs,§E©ú¶©* - - 1 - THE JOURNAL OF INFECTION - JOURNAL OF INFECTION 2022 85¨÷(4´Á):e94-e95­¶
(IF: 38.637, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 94, »â°ì±Æ¦W: 4.26%)

High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use: Some issues.
Chia-Yen Dai, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu* - - 1 - THE JOURNAL OF INFECTION - JOURNAL OF INFECTION 2022;85(4):e94-e95
(IF: 38.637, Journal Ranking: 4, Number of Journals of this Field: 94, Ranking: 4.26%)

98

´`ÀômiR-125b°ò¦­È¥i¹w´úB¨x¯f±w±µ¨ü§Ü¯f¬r¤fªAÃĪvÀø«á¤§°ªFIB-4­È
§d«T¼Ý,½²©ö¬À#,Chia-Chen Li,¸­©ú­Û,¶ÀÂ@¶h,¶À³©®p,³\®a¹ç,Á©s°a,³¯¤S¹Å,¼B¤jºû,ªL©yÐA,±ç³Õµ{,ªL¤l³ó,²ø¸UÀs,§E©ú¶©,À¹¹Å¨¥* - - 1 - BIOMEDICINES - BIOMEDICINES 2022 10¨÷(11´Á):2824­¶
(IF: 4.757, »â°ì±Æ¦W: 86, »â°ì´Á¥Z¼Æ: 279, »â°ì±Æ¦W: 30.82%)

Baseline Circulating miR-125b Levels Predict a High FIB-4 Index Score in Chronic Hepatitis B Patients after Nucleos(t)ide Analog Treatment
Jyun-Yi Wu, Yi-Shan Tsai, Chia-Chen Li, Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Jia-Ning Hsu, Meng-Hsuan Hsieh, Yo-Chia Chen, Ta-Wei Liu, Yi-Hung Lin, Po-Cheng Liang, Zu-Yau Lin, Wan-Long Chuang, Ming-Lung Yu, Chia-Yen Dai - - 1 - BIOMEDICINES - BIOMEDICINES 2022;10(11):2824
(IF: 4.757, Journal Ranking: 86, Number of Journals of this Field: 279, Ranking: 30.82%)

99

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
George Lau*, §E©ú¶©*, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin-Lin Hou, Teerha Piratvisuth, Ji-Dong Jia, Masashi Mizokami, Gregory Cheng, Guo-Feng Chen, Zhen-Wen Liu, Oidov Baatarkhuu, Ann Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok, Jer-Ming Chang, Saeed Hamid, A Kadir Dokmeci, Rino A Gani, Diana A Payawal, Pierce Chow, Joong-Won Park, Simone I Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tawesak Tanwandee, Shiv Kumar Sarin, Masao Omata - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2022 16¨÷(2´Á):486-487­¶
(IF: 9.029, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 17.20%)

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
George Lau*, Ming-Lung Yu*, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin-Lin Hou, Teerha Piratvisuth, Ji-Dong Jia, Masashi Mizokami, Gregory Cheng, Guo-Feng Chen, Zhen-Wen Liu, Oidov Baatarkhuu, Ann Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok, Jer-Ming Chang, Saeed Hamid, A Kadir Dokmeci, Rino A Gani, Diana A Payawal, Pierce Chow, Joong-Won Park, Simone I Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tawesak Tanwandee, Shiv Kumar Sarin, Masao Omata - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2022;16(2):486-487
(IF: 9.029, Journal Ranking: 16, Number of Journals of this Field: 93, Ranking: 17.20%)

100

Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease(§t§E©ú¶©). - - 1 - THE LANCET. GASTROENTEROLOGY & HEPATOLOGY - LANCET GASTROENTEROLOGY & HEPATOLOGY 2022 7¨÷(5´Á):388-390­¶
(IF: 45.042, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 2.15%)

Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. - - 1 - THE LANCET. GASTROENTEROLOGY & HEPATOLOGY - LANCET GASTROENTEROLOGY & HEPATOLOGY 2022;7(5):388-390
(IF: 45.042, Journal Ranking: 2, Number of Journals of this Field: 93, Ranking: 2.15%)

101

Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus-Related Cirrhosis.
Ming-Chao Tsai, Sien-Sing Yang, Chih-Che Lin, Wen-Lun Wang, Yao-Chun Hsu, Yaw-Sen Chen, Jui-Ting Hu, James Yu Lin, §E©ú¶©, Chih-Wen Lin* - - 1 - JAMA NETWORK OPEN - JAMA NETWORK OPEN 2022 5¨÷(7´Á):e2223511­¶
(IF: 13.353, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 172, »â°ì±Æ¦W: 8.72%)

Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus-Related Cirrhosis.
Ming-Chao Tsai, Sien-Sing Yang, Chih-Che Lin, Wen-Lun Wang, Yao-Chun Hsu, Yaw-Sen Chen, Jui-Ting Hu, James Yu Lin, Ming-Lung Yu, Chih-Wen Lin* - - 1 - JAMA NETWORK OPEN - JAMA NETWORK OPEN 2022;5(7):e2223511
(IF: 13.353, Journal Ranking: 15, Number of Journals of this Field: 172, Ranking: 8.72%)

102

Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study.
Hung-Wei Wang, Pei-Chein Tsai, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Ron-Nan Chien, Chun-Yen Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©*, Cheng-Yuan Peng* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2022 12¨÷(7´Á):3164-3174­¶
(IF: 5.942, »â°ì±Æ¦W: 71, »â°ì´Á¥Z¼Æ: 245, »â°ì±Æ¦W: 28.98%)

Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study.
Hung-Wei Wang, Pei-Chein Tsai, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Ron-Nan Chien, Chun-Yen Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu*, Cheng-Yuan Peng* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2022;12(7):3164-3174
(IF: 5.942, Journal Ranking: 71, Number of Journals of this Field: 245, Ranking: 28.98%)

103

Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic.
Chi-Ming Tai, Chun-Kai Huang, Te-Chang Changchien, Po-Chun Lin, Deng-Wu Wang, Ting-Ting Chang, Hsue-Wei Chan, Tzu-Haw Chen, Cheng-Hao Tseng, Chih-Cheng Chen, Chia-Ta Tsai, Yu-Ting Sie, Yung-Chieh Yen*, §E©ú¶© - - 1 - VIRUSES - VIRUSES-BASEL 2022 14¨÷(8´Á):1637.­¶
(IF: 5.818, »â°ì±Æ¦W: 14, »â°ì´Á¥Z¼Æ: 37, »â°ì±Æ¦W: 37.84%)

Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic.
Chi-Ming Tai, Chun-Kai Huang, Te-Chang Changchien, Po-Chun Lin, Deng-Wu Wang, Ting-Ting Chang, Hsue-Wei Chan, Tzu-Haw Chen, Cheng-Hao Tseng, Chih-Cheng Chen, Chia-Ta Tsai, Yu-Ting Sie, Yung-Chieh Yen*, Ming-Lung Yu - - 1 - VIRUSES - VIRUSES-BASEL 2022;14(8):1637.
(IF: 5.818, Journal Ranking: 14, Number of Journals of this Field: 37, Ranking: 37.84%)

104

HBV Reactivation After Bariatric Surgery for HBV-Infected Obese Patients.
Chi-Ming Tai, Hung-Pin Tu, Jau-Chung Hwang, ¸­©ú­Û, ¶À³©®p, §E©ú¶©* - - 1 - OBESITY SURGERY - OBESITY SURGERY 2022 32¨÷(10´Á):3332-3339­¶
(IF: 3.479, »â°ì±Æ¦W: 57, »â°ì´Á¥Z¼Æ: 211, »â°ì±Æ¦W: 27.01%)

HBV Reactivation After Bariatric Surgery for HBV-Infected Obese Patients.
Chi-Ming Tai, Hung-Pin Tu, Jau-Chung Hwang, Ming-Lun Yeh, Chung-Feng Huang, Ming-Lung Yu* - - 1 - OBESITY SURGERY - OBESITY SURGERY 2022;32(10):3332-3339
(IF: 3.479, Journal Ranking: 57, Number of Journals of this Field: 211, Ranking: 27.01%)

105

NPRL2 down-regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression.
Ya-Chin Wang, Ming-Chao Tsai, Yaw-Sen Chen, Pei-Min Hsieh, Chao-Ming Hung, Hung-Yu Lin, Yao-Chun Hsu, Jen-Hao Yeh, Pojen Hsiao, Yu-Cheih Su, Ching-Hou Ma, Chih-Yuan Lee, Chih-Che Lin, Chih-Wen Shu, Yu-Chan Li, Mei-Hsing Tsai, James Yu Lin, Wei-Hao Peng, §E©ú¶©, Chih-Wen Lin* - - 1 - HEPATOLOGY COMMUNICATIONS - HEPATOLOGY COMMUNICATIONS 2022 6¨÷(12´Á):3563-3577­¶
(IF: 5.701, »â°ì±Æ¦W: 30, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 32.26%)

NPRL2 down-regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression.
Ya-Chin Wang, Ming-Chao Tsai, Yaw-Sen Chen, Pei-Min Hsieh, Chao-Ming Hung, Hung-Yu Lin, Yao-Chun Hsu, Jen-Hao Yeh, Pojen Hsiao, Yu-Cheih Su, Ching-Hou Ma, Chih-Yuan Lee, Chih-Che Lin, Chih-Wen Shu, Yu-Chan Li, Mei-Hsing Tsai, James Yu Lin, Wei-Hao Peng, Ming-Lung Yu, Chih-Wen Lin* - - 1 - HEPATOLOGY COMMUNICATIONS - HEPATOLOGY COMMUNICATIONS 2022;6(12):3563-3577
(IF: 5.701, Journal Ranking: 30, Number of Journals of this Field: 93, Ranking: 32.26%)

106

Simulation of Long-term Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
¶À§Ó´I*, §E©ú¶©, ²ø¸UÀs - - 1 - JAMA NETWORK OPEN - JAMA NETWORK OPEN 2022 5¨÷(9´Á):e2230436­¶
(IF: 13.353, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 172, »â°ì±Æ¦W: 8.72%)

Simulation of Long-term Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
Jee-Fu Huang*, Ming-Lung Yu, Wan-Long Chuang - - 1 - JAMA NETWORK OPEN - JAMA NETWORK OPEN 2022;5(9):e2230436
(IF: 13.353, Journal Ranking: 15, Number of Journals of this Field: 172, Ranking: 8.72%)

107

Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort.
Yao-Chun Hsu, Dae Won Jun, Cheng-Yuan Peng, ¸­©ú­Û, Huy Trinh, Grace Lai-Hung Wong, Sung Eun Kim, Chien-Hung Chen, Hyunwoo Oh, Chia-Hsin Lin, Lindsey Trinh, Vincent Wai-Sun Wong, Eilleen Yoon, Sang Bong Ahn, Daniel Huang, Yong Kyun Cho, Jae Yoon Jeong, Soung Won Jeong, Hyoung Su Kim, Qing Xie, Li Liu, Mar Riveiro-Barciela, ½²¨Ø­Å, Elena Vargas Accarino, Hidenori Toyoda, Masaru Enomoto, Carmen Preda, Sebastián Marciano, Joseph Hoang, ¶À³©®p, Ritsuzo Kozuka, Satoshi Yasuda, Doina Istratescu, Dong-Hyun Lee, Jia-Ying Su, Yen-Tsung Huang, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, Man-Fung Yuen, Adrian Gadano, Ramsey Cheung, Seng Gee Lim, Maria Buti, §E©ú¶©, Mindie H Nguyen* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2022 16¨÷(6´Á):1297-1307­¶
(IF: 9.029, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 17.20%)

Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort.
Yao-Chun Hsu, Dae Won Jun, Cheng-Yuan Peng, Ming-Lun Yeh, Huy Trinh, Grace Lai-Hung Wong, Sung Eun Kim, Chien-Hung Chen, Hyunwoo Oh, Chia-Hsin Lin, Lindsey Trinh, Vincent Wai-Sun Wong, Eilleen Yoon, Sang Bong Ahn, Daniel Huang, Yong Kyun Cho, Jae Yoon Jeong, Soung Won Jeong, Hyoung Su Kim, Qing Xie, Li Liu, Mar Riveiro-Barciela, Pei-Chien Tsai, Elena Vargas Accarino, Hidenori Toyoda, Masaru Enomoto, Carmen Preda, Sebastián Marciano, Joseph Hoang, Chung-Feng Huang, Ritsuzo Kozuka, Satoshi Yasuda, Doina Istratescu, Dong-Hyun Lee, Jia-Ying Su, Yen-Tsung Huang, Jee Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Man-Fung Yuen, Adrian Gadano, Ramsey Cheung, Seng Gee Lim, Maria Buti, Ming-Lung Yu, Mindie H Nguyen* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2022;16(6):1297-1307
(IF: 9.029, Journal Ranking: 16, Number of Journals of this Field: 93, Ranking: 17.20%)

108

Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma.
³\³Õ³ó,±ç³Õµ{,±i¤åÀé,§f©ú¿o,¤ýüQÞ±,²ø¥@©÷,ÃQà±¾§,±i®x»·,¸­©ú­Û,¶ÀÂ@¶h,ªL©yÓT,¤ý§Ó¤å,Á©ú«Û,«J¤D¤¯,Á©s°a,½²©ö¬À,¬_¦ö¥Á,ªL·q´¼,³¯«a¦t,À¹¹Å¨¥,ªL¤l³ó,³¯«H¦¨,²ø¸UÀs,¶À³©®p,¶À§Ó´I*,§E©ú¶©* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2022 12¨÷(12´Á):5576-5588­¶
(IF: 5.942, »â°ì±Æ¦W: 71, »â°ì´Á¥Z¼Æ: 245, »â°ì±Æ¦W: 28.98%)

Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma.
Po-Yao Hsu, Po-Cheng Liang, Wen-Tsan Chang, Ming-Ying Lu, Wen-Hsuan Wang, Shih-Chang Chuang, Yu-Ju Wei, Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, Yi-Hung Lin, Chih-Wen Wang, Ming-Yen Hsieh, Nai-Jen Hou, Meng-Hsuan Hsieh, Yi-Shan Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang, Chung-Feng Huang, Jee-Fu Huang, Ming-Lung Yu - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2022;12(12):5576-5588
(IF: 5.942, Journal Ranking: 71, Number of Journals of this Field: 245, Ranking: 28.98%)

109

The case for simplifying and using absolute targets for viral hepatitis elimination goals.
PolarisObservatoryCollaborators,²ø¸UÀs,§E©ú¶© - - 1 - Journal of viral hepatitis - JOURNAL OF VIRAL HEPATITIS 2021 28¨÷(1´Á):12-19­¶
(IF: 3.728, »â°ì±Æ¦W: 41, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 44.57%)

The case for simplifying and using absolute targets for viral hepatitis elimination goals.
PolarisObservatoryCollaborators - - 1 - Journal of viral hepatitis - JOURNAL OF VIRAL HEPATITIS 2021;28(1):12-19
(IF: 3.728, Journal Ranking: 41, Number of Journals of this Field: 92, Ranking: 44.57%)

110

Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B.
LeAK,YangHI,¸­©ú­Û,JinM,TrinhHN,HenryL,LiuA,ZhangJQ,LiJ,WongC,WongC,CheungR,§E©ú¶©,NguyenMH*. - - 1 - The Journal of infectious diseases - JOURNAL OF INFECTIOUS DISEASES 2021 223¨÷(1´Á):139-146­¶
(IF: 5.226, »â°ì±Æ¦W: 18, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 19.57%)

Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B.
An K Le,Hwai-I Yang,Ming-Lun Yeh,Mingjuan Jin,Huy N Trinh,Linda Henry,Anne Liu,Jian Q Zhang,Jiayi Li,Christopher Wong,Clifford Wong,Ramsey Cheung,Ming-Lung Yu,Mindie H Nguyen - - 1 - The Journal of infectious diseases - JOURNAL OF INFECTIOUS DISEASES 2021;223(1):139-146
(IF: 5.226, Journal Ranking: 18, Number of Journals of this Field: 92, Ranking: 19.57%)

111

EASL C«¬¨xª¢ªvÀø³Ì²×«Øij: ¤@¨Ç¦Ò¶q
À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©* - - 1 - Journal of hepatology - JOURNAL OF HEPATOLOGY 2021 74¨÷(2´Á):473-4­¶
(IF: 25.083, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 2.17%)

EASL recommendations on treatment of hepatitis C: Final update of the series - Some issues.
Chia-Yen Dai,Wan-Long Chuang,Ming-Lung Yu - - 1 - Journal of hepatology - JOURNAL OF HEPATOLOGY 2021;74(2):473-4
(IF: 25.083, Journal Ranking: 2, Number of Journals of this Field: 92, Ranking: 2.17%)

112

Scaling up the in-hospital hepatitis C virus care cascade in Taiwan.
¶À³©®p,§d¨ØªÚ,¸­©ú­Û,¶ÀÂ@¶h,±ç³Õµ{,®}¦¨¹©,³\³Õ³ó,¼B­i§u,¶À­^¬w,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©* - - 1 - Clinical and molecular hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2021 27¨÷(1´Á):136-143­¶
(IF: 6.074, »â°ì±Æ¦W: 23, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 25.00%)

Scaling up the in-hospital hepatitis C virus care cascade in Taiwan.
Chung-Feng Huang,Pey-Fang Wu,Ming-Lun Yeh,Ching-I Huang,Po-Cheng Liang,Cheng-Ting Hsu,Po-Yao Hsu,Hung-Yin Liu,Ying-Chou Huang,Zu-Yau Lin,Shinn-Cherng Chen,Jee-Fu Huang,Chia-Yen Dai,Wan-Long Chuang,Ming-Lung Yu* - - 1 - Clinical and molecular hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2021;27(1):136-143
(IF: 6.074, Journal Ranking: 23, Number of Journals of this Field: 92, Ranking: 25.00%)

113

Elbasvir and grazoprevir for the treatment of hepatitis C.
¤ý¶à¤¯,¶À³©®p,§E©ú¶©* - - 1 - Expert review of anti-infective therapy - EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2021 19¨÷(9´Á):1071-1081­¶
(IF: 5.091, »â°ì±Æ¦W: 19, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 20.65%)

Elbasvir and grazoprevir for the treatment of hepatitis C.
Szu-Jen Wang,Chung-Feng Huang,Ming-Lung Yu* - - 1 - Expert review of anti-infective therapy - EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2021;19(9):1071-1081
(IF: 5.091, Journal Ranking: 19, Number of Journals of this Field: 92, Ranking: 20.65%)

114

The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan.
¶À­^¬w,¶À³©®p,¼B²Qªâ,¼B­i§u,¸­©ú­Û,¶ÀÂ@¶h,Á©s°a,À¹¹Å¨¥,³¯«H¦¨,§E©ú¶©,²ø¸UÀs,¶À§Ó´I* - - 1 - PloS one - PLOS ONE 2021 16¨÷(1´Á):e0246376­¶
(IF: 3.24, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 73, »â°ì±Æ¦W: 35.62%)

The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan.
Ying-Chou Huang,Chung-Feng Huang,Shu-Fen Liu,Hung-Yin Liu,Ming-Lun Yeh,Ching-I Huang,Meng-Hsuan Hsieh,Chia-Yen Dai,Shinn-Chern Chen,Ming-Lung Yu,Wan-Long Chuang,Jee-Fu Huang - - 1 - PloS one - PLOS ONE 2021;16(1):e0246376
(IF: 3.24, Journal Ranking: 26, Number of Journals of this Field: 73, Ranking: 35.62%)

115

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis.
³\³Õ³ó,ÃQà±¾§,§õ¨Î»T,¶s¸t¤å,¶À«T¸R,®}¦¨¹©,±i®x»·,¸­©ú­Û,¶ÀÂ@¶h,±ç³Õµ{,ªL©yÐA,Á©ú«Û,Á©s°a,³¯«ä¹Å,À¹¹Å¨¥,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,±i­õ»Ê,¶À©|§Ó,²ø¸UÀs,¶À³©®p,ªô©É¤å*,§E©ú¶©* - - 1 - Clinical and molecular hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2021 27¨÷(1´Á):186-196­¶
(IF: 6.074, »â°ì±Æ¦W: 23, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 25.00%)

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis.
Po-Yao Hsu,Yu-Ju Wei,Jia-Jung Lee,Sheng-Wen Niu,Jiun-Chi Huang,Cheng-Ting Hsu,Tyng-Yuan Jang,Ming-Lun Yeh,Ching-I Huang,Po-Cheng Liang,Yi-Hung Lin,Ming-Yen Hsieh,Meng-Hsuan Hsieh,Szu-Chia Chen,Chia-Yen Dai,Zu-Yau Lin,Shinn-Cherng Chen,Jee-Fu Huang,Jer-Ming Chang,Shang-Jyh Hwang,Wan-Long Chuang,Chung-Feng Huang,Yi-Wen Chiu,Ming-Lung Yu - - 1 - Clinical and molecular hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2021;27(1):186-196
(IF: 6.074, Journal Ranking: 23, Number of Journals of this Field: 92, Ranking: 25.00%)

116

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.
ªL¸àÙy,±ç³Õµ{,¶ÀÂ@¶h,¸­©ú­Û,³\³Õ³ó,®}¦¨¹©,ÃQà±¾§,¼B¤jºû,Á©ú«Û,«J¤D¤¯,±i®x»·,ªL©yÐA,¤ý§Ó¤å,ªL¤l³ó,³¯«H¦¨,¶À³©®p*,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶© - - 1 - PloS one - PLOS ONE 2021 16¨÷(2´Á):e0245479­¶
(IF: 3.24, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 73, »â°ì±Æ¦W: 35.62%)

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.
Chuan-Pin Lin,Po-Cheng Liang,Ching-I Huang,Ming-Lun Yeh,Po-Yao Hsu,Cheng-Ting Hsu,Yu-Ju Wei,Ta-Wei Liu,Ming-Yen Hsieh,Nai-Jen Hou,Tyng-Yuang Jang,Yi-Hung Lin,Chih-Wen Wang,Zu-Yau Lin,Shinn-Cherng Chen,Chung-Feng Huang*,Jee-Fu Huang,Chia-Yen Dai,Wan-Long Chuang,Ming-Lung Yu - - 1 - PloS one - PLOS ONE 2021;16(2):e0245479
(IF: 3.24, Journal Ranking: 26, Number of Journals of this Field: 73, Ranking: 35.62%)

117

Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study.
§E©ú¶©,½²ºû­Û,¦¶±Ò¤¯,°ª¹Å§»*. - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2021 37¨÷(3´Á):245-252.­¶
(IF: 2.744, »â°ì±Æ¦W: 93, »â°ì´Á¥Z¼Æ: 140, »â°ì±Æ¦W: 66.43%)

Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study.
Ming-Lung Yu,Wei-Lun Tsai,Chi-Jen Chu,Jia-Horng Kao - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2021;37(3):245-252.
(IF: 2.744, Journal Ranking: 93, Number of Journals of this Field: 140, Ranking: 66.43%)

118

Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020.
§E©ú¶©,²ø¸UÀs* - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2021 37¨÷(1´Á):7-11­¶
(IF: 2.744, »â°ì±Æ¦W: 93, »â°ì´Á¥Z¼Æ: 140, »â°ì±Æ¦W: 66.43%)

Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020.
Ming-Lung Yu,Wan-Long Chuang* - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2021;37(1):7-11
(IF: 2.744, Journal Ranking: 93, Number of Journals of this Field: 140, Ranking: 66.43%)

119

Potential of novel colchicine dosage schedule for the palliative treatment of advanced hepatocellular carcinoma.
ªL¤l³ó*,¸­©ú­Û,¶ÀÂ@¶h,³¯«H¦¨,¶À³©®p,¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©,²ø¸UÀs - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2021 37¨÷(7´Á):616-623­¶
(IF: 2.744, »â°ì±Æ¦W: 93, »â°ì´Á¥Z¼Æ: 140, »â°ì±Æ¦W: 66.43%)

Potential of novel colchicine dosage schedule for the palliative treatment of advanced hepatocellular carcinoma
Zu-Yau Lin,Ming-Lun Yeh,Ching-I Huang,Shinn-Cherng Chen,Chung-Feng Huang,Jee-Fu Huang,Chia-Yen Dai,Ming-Lung Yu,Wan-Long Chuang - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2021;37(7):616-623
(IF: 2.744, Journal Ranking: 93, Number of Journals of this Field: 140, Ranking: 66.43%)

120

Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan.
½²¨Ø­Å,黄Â@¶h,¸­©ú­Û,黄³©®p,Á©s°a,·¨¥¿ºÖ,³\³Õ³ó,±ç³Õµ{,ªL©yÐA,±i®x»·,Á©ú彦,À¹¹Å¨¥,ªL¤l³ó,³¯«H¦¨,黄§Ó´I*,§E©ú¶©,²ø¸UÀs,±i¤å¦t, - - 1 - BMJ open - BMJ OPEN 2021 11¨÷(3´Á):e042861­¶
(IF: 2.692, »â°ì±Æ¦W: 64, »â°ì´Á¥Z¼Æ: 169, »â°ì±Æ¦W: 37.87%)

Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan.
Pei-Chien Tsai,Ching-I Huang,Ming-Lun Yeh,Chung-Feng Huang,Meng-Hsuan Hsieh,Jeng-Fu Yang,Po-Yao Hsu,Po-Cheng Liang,Yi-Hung Lin,Tyng Yuan Jang,Ming-Yen Hsieh,Chia-Yen Dai,Zu-Yau Lin,Shinn-Chern Chen,Jee-Fu Huang,Ming-Lung Yu,Wan-Long Chuang,Wen-Yu Chang - - 1 - BMJ open - BMJ OPEN 2021;11(3):e042861
(IF: 2.692, Journal Ranking: 64, Number of Journals of this Field: 169, Ranking: 37.87%)

121

Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma.
ChenVL,¸­©ú­Û,YangJD,LeongJ,HuangDQ,ToyodaH,ChenYL,GuyJ,MaedaM,½²¨Ø­Å,¶À³©®p,YasudaS,LeAK,DangH,GiamaNH,AliHA,ZhangN,WangX,JunDW,TsengCH,HsuYC,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,ZhuQ,DanYY,SchwartzM,RobertsLR,§E©ú¶©,NguyenMH*. - - 1 - HEPATOLOGY COMMUNICATIONS - HEPATOLOGY COMMUNICATIONS 2021 5¨÷(1´Á):122-132­¶
(IF: 5.073, »â°ì±Æ¦W: 32, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 34.78%)

Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma.
Vincent L Chen,Ming-Lun Yeh,Ju Dong Yang,Jennifer Leong,Daniel Q Huang,Hidenori Toyoda,Yao-Li Chen,Jennifer Guy,Mayumi Maeda,Pei-Chien Tsai,Chung-Feng Huang,Satoshi Yasuda,An K Le,Hansen Dang,Nasra H Giama,Hamdi A Ali,Ning Zhang,Xiaozhong Wang,Dae Won Jun,Cheng-Hao Tseng,Yao-Chun Hsu,Jee-Fu Huang,Chia-Yen Dai,Wan-Long Chuang,Qiang Zhu,Yock Young Dan,Myron Schwartz,Lewis R Roberts,Ming-Lung Yu,Mindie H Nguyen - - 1 - HEPATOLOGY COMMUNICATIONS - HEPATOLOGY COMMUNICATIONS 2021;5(1):122-132
(IF: 5.073, Journal Ranking: 32, Number of Journals of this Field: 92, Ranking: 34.78%)

122

Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group.
ÃQà±¾§,³\³Õ³ó,§õ¨Î»T,¶s¸t¤å,¶À«T´Ñ,®}¦¨¹©,±i®x»·,¸­©ú­Û,¶ÀÂ@¶h,±ç³Õµ{,ªL©yÐA,Á©ú«Û,Á©s°a,³¯«ä¹Å,À¹¹Å¨¥,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,±i­õ»Ê,¶À©|§Ó,²ø¸UÀs,¶À³©®p,ªô©É¤å*,§E©ú¶©*. - - 1 - Journal of viral hepatitis - JOURNAL OF VIRAL HEPATITIS 2021 28¨÷(5´Á):719-727­¶
(IF: 3.728, »â°ì±Æ¦W: 41, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 44.57%)

Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group.
Yu-Ju Wei,Po-Yao Hsu,Jia-Jung Lee,Sheng-Wen Niu,Jiun-Chi Huang,Cheng-Ting Hsu,Tyng-Yuan Jang,Ming-Lun Yeh,Ching-I Huang,Po-Cheng Liang,Yi-Hung Lin,Ming-Yen Hsieh,Meng-Hsuan Hsieh,Szu-Chia Chen,Chia-Yen Dai,Zu-Yau Lin,Shinn-Cherng Chen,Jee-Fu Huang,Jer-Ming Chang,Shang-Jyh Hwang,Wan-Long Chuang,Chung-Feng Huang,Yi-Wen Chiu,Ming-Lung Yu - - 1 - Journal of viral hepatitis - JOURNAL OF VIRAL HEPATITIS 2021;28(5):719-727
(IF: 3.728, Journal Ranking: 41, Number of Journals of this Field: 92, Ranking: 44.57%)

123

Reply to "Tacrolimus concentrations were not affected by glecaprevir/pibrentasvir treatment for hepatitis C virus infection in an adult living donor liver transplant recipient with uremia".
§E©ú¶©*,°ª¹Å§». - - 1 - Journal of the Formosan Medical Association = Taiwan yi zhi - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2021 120¨÷(6´Á):1410-1411.­¶
(IF: 3.282, »â°ì±Æ¦W: 53, »â°ì´Á¥Z¼Æ: 169, »â°ì±Æ¦W: 31.36%)

Reply to "Tacrolimus concentrations were not affected by glecaprevir/pibrentasvir treatment for hepatitis C virus infection in an adult living donor liver transplant recipient with uremia".
Ming-Lung Yu,Jia-Horng Kao - - 1 - Journal of the Formosan Medical Association = Taiwan yi zhi - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2021;120(6):1410-1411.
(IF: 3.282, Journal Ranking: 53, Number of Journals of this Field: 169, Ranking: 31.36%)

124

Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients.
LiuM,TsengTC,JunDW,¸­©ú­Û,TrinhH,WongGLH,ChenCH,PengCY,KimSE,OhH,KwakMS,CheungM,ToyodaH,HsuYC,JeongJY,YoonEL,UngtrakulT,ZhangJ,XieQ,AhnSB,EnomotoM,ShimJJ,CunninghamC,JeongSW,ChoYK,OgawaE,HuangR,LeeDH,TakahashiH,½²¨Ø­Å,¶À³©®p,À¹¹Å¨¥,TsengCH,YasudaS,KozukaR,LiJ,WongC,WongCC,ZhaoC,HoangJ,EguchiY,WuC,TanakaY,GaneE,TanwandeeT,CheungR,YuenMF,LeeHS,§E©ú¶©,KaoJH,YangHI,NguyenMH*. - - 1 - Hepatology international - HEPATOLOGY INTERNATIONAL 2021 15¨÷(1´Á):71-81­¶
(IF: 5.102, »â°ì±Æ¦W: 20, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 22.73%)

Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients.
Matt Liu,Tai-Chung Tseng,Dae Won Jun,Ming-Lun Yeh,Huy Trinh,Grace L H Wong,Chien-Hung Chen,Cheng-Yuan Peng,Sung Eun Kim,Hyunwoo Oh,Min-Sun Kwak,Michael Cheung,Hidenori Toyoda,Yao-Chun Hsu,Jae Yoon Jeong,Eileen L Yoon,Teerapat Ungtrakul,Jian Zhang,Qing Xie,Sang Bong Ahn,Masaru Enomoto,Jae-Jun Shim,Chris Cunningham,Soung Won Jeong,Yong Kyun Cho,Eiichi Ogawa,Rui Huang,Dong-Hyun Lee,Hirokazu Takahashi,Pei-Chien Tsai,Chung-Feng Huang,Chia-Yen Dai,Cheng-Hao Tseng,Satoshi Yasuda,Ritsuzo Kozuka,Jiayi Li,Christopher Wong,Clifford C Wong,Changqing Zhao,Joseph Hoang,Yuichiro Eguchi,Chao Wu,Yasuhito Tanaka,Ed Gane,Tawesak Tanwandee,Ramsey Cheung,Man-Fung Yuen,Hyo-Suk Lee,Ming-Lung Yu,Jia-Horng Kao,Hwai-I Yang,Mindie H Nguyen - - 1 - Hepatology international - HEPATOLOGY INTERNATIONAL 2021;15(1):71-81
(IF: 5.102, Journal Ranking: 20, Number of Journals of this Field: 88, Ranking: 22.73%)

125

Genotype distribution, clinical characteristics, and racial differences observed in chronic hepatitis C patients in Pingtung, Taiwan.
±i®x»·,±ç³Õµ{,¼B¤jºû,ÃQà±¾§,¸­©ú­Û,®}¦¨¹©,³\³Õ³ó,ªL©yÐA,Á©s°a,¶ÀÂ@¶h,¶À³©®p,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,À¹¹Å¨¥*,§E©ú¶©,²ø¸UÀs. - - 1 - Journal of the Chinese Medical Association : JCMA - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2021 84¨÷(3´Á):255-260­¶
(IF: 2.743, »â°ì±Æ¦W: 62, »â°ì´Á¥Z¼Æ: 169, »â°ì±Æ¦W: 36.69%)

Genotype distribution, clinical characteristics, and racial differences observed in chronic hepatitis C patients in Pingtung, Taiwan.
Tyng-Yuan Jang,Po-Cheng Liang,Ta-Wei Liu,Yu-Ju Wei,Ming-Lun Yeh,Cheng-Ting Hsu,Po-Yao Hsu,Yi-Hung Lin,Meng-Hsuan Hsieh,Ching-I Huang,Chung-Feng Huang,Zu-Yau Lin,Shinn-Cherng Chen,Jee-Fu Huang,Chia-Yen Dai,Ming-Lung Yu,Wan-Long Chuang - - 1 - Journal of the Chinese Medical Association : JCMA - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2021;84(3):255-260
(IF: 2.743, Journal Ranking: 62, Number of Journals of this Field: 169, Ranking: 36.69%)

126

Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C).
§E©ú¶©*,¶À³©®p#,ÃQà±¾§#,ªL¤å¤@,ªL©yÐA,³\³Õ³ó,®}¦¨¹©,¼B¤jºû,LeeJJ,NiuSW,HuangJC,HungTS,¸­©ú­Û,¶ÀÂ@¶h,±ç³Õµ{,Á©ú«Û,³¯«H¦¨,¶À§Ó´I,ChangJM,ChiuYW,À¹¹Å¨¥,¶À©|§Ó,²ø¸UÀs*,FORMOSA-LIKEinvestigators. - - 1 - Gut - GUT 2021 70¨÷(12´Á):2349-2358­¶
(IF: 23.059, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 3.26%)

Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C).
Ming-Lung Yu,Chung-Feng Huang,Yu-Ju Wei,Wen-Yi Lin,Yi-Hung Lin,Po-Yao Hsu,Cheng-Ting Hsu,Ta Wei Liu,Jia-Jung Lee,Sheng-Wen Niu,Jiun-Chi Huang,Tzu-Sui Hung,Ming-Lun Yeh,Ching-I Huang,Po-Cheng Liang,Ming-Yen Hsieh,Szu-Chia Chen,Jee-Fu Huang,Jer-Ming Chang,Yi-Wen Chiu,Chia-Yen Dai,Shang-Jyh Hwang,Wan-Long Chuang, - - 1 - Gut - GUT 2021;70(12):2349-2358
(IF: 23.059, Journal Ranking: 3, Number of Journals of this Field: 92, Ranking: 3.26%)

127

Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment.
¾G¦Û³Ó,±ç³Õµ{,¶À³©®p,¸­©ú­Û,¶ÀÂ@¶h,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,À¹¹Å¨¥*,HsiehPH*,²ø¸UÀs,§E©ú¶© - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2021 37¨÷(4´Á):334-345.­¶
(IF: 2.744, »â°ì±Æ¦W: 93, »â°ì´Á¥Z¼Æ: 140, »â°ì±Æ¦W: 66.43%)

Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment.
Tzu-Sheng Cheng,Po-Cheng Liang,Chung-Feng Huang,Ming-Lun Yeh,Ching-I Huang,Zu-Yau Lin,Shinn-Cherng Chen,Jee-Fu Huang,Chia-Yen Dai,Ping-Hsin Hsieh,Wan-Long Chuang,Ming-Lung Yu - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2021;37(4):334-345.
(IF: 2.744, Journal Ranking: 93, Number of Journals of this Field: 140, Ranking: 66.43%)

128

Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
±i®x»·,ÃQà±¾§,¸­©ú­Û,¼B²Qªâ,®}¦¨¹©,³\³Õ³ó,¼B¤jºû,ªL©yÐA,±ç³Õµ{,Á©s°a,¬_¦ö¥Á,½²©ö¬À,³¯«a¦t,ªL·q´¼,½²¨Ø­Å,¤ý­zºö,¶ÀÂ@¶h,ªL¤l³ó,³¯«H¦¨,²ø¸UÀs,¶À§Ó´I,À¹¹Å¨¥,¶À³©®p,§E©ú¶©*. - - 1 - Journal of the Formosan Medical Association = Taiwan yi zhi - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2021 120¨÷(1 Pt 2´Á):303-310­¶
(IF: 3.282, »â°ì±Æ¦W: 53, »â°ì´Á¥Z¼Æ: 169, »â°ì±Æ¦W: 31.36%)

Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
Tyng-Yuan Jang,Yu-Ju Wei,Ming-Lun Yeh,Shu-Fen Liu,Cheng-Ting Hsu,Po-Yao Hsu,Ta-Wei Liu,Yi-Hung Lin,Po-Cheng Liang,Meng-Hsuan Hsieh,Yu-Min Ko,Yi-Shan Tsai,Kuan-Yu Chen,Ching-Chih Lin,Pei-Chien Tsai,Shu-Chi Wang,Ching-I Huang,Zu-Yau Lin,Shinn-Cherng Chen,Wan-Long Chuang,Jee-Fu Huang,Chia-Yen Dai,Chung-Feng Huang*,Ming-Lung Yu* - - 1 - Journal of the Formosan Medical Association = Taiwan yi zhi - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2021;120(1 Pt 2):303-310
(IF: 3.282, Journal Ranking: 53, Number of Journals of this Field: 169, Ranking: 31.36%)

129

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).
DanielJKlionsky*(§t§E©ú¶©) - - 1 - Autophagy - AUTOPHAGY 2021 17¨÷(1´Á):1-382­¶
(IF: 9.77, »â°ì±Æ¦W: 22, »â°ì´Á¥Z¼Æ: 195, »â°ì±Æ¦W: 11.28%)

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).
Daniel J Klionsky*,Amal Kamal Abdel-Aziz,Sara Abdelfatah,Mahmoud Abdellatif,Asghar Abdoli,Steffen Abel - - 1 - Autophagy - AUTOPHAGY 2021;17(1):1-382
(IF: 9.77, Journal Ranking: 22, Number of Journals of this Field: 195, Ranking: 11.28%)

130

Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
³¯±Ò¯q,¶À³©®p#,¾GÙy¨k,´¿°êªK,ù²M¦À,³¢¦æ¹D,¶À©Éµ¾,À¹±Ò©ú,´^¦¨¤¸,¥Õ©ú©¾,³¯«Ø§»,¸­©ú­Û,ªL§Ó­¦,ªL«T«Û,§õ¨Ø­Û,Lee-WonChong,¬x»F§»,¶À§Ó´I,·¨°òÞf,Jui-TingHu,ªL§Ó¤å,³¯­x§Ê,¤ý¹Å»ô,Ĭºû¤å,Á°]·½,ªL§Ó³®,½²ºû­Û,§õ©vº³,³¯®Û­^,¤ý¶à¤¯,±i§g·Ó,¦È联·ç,·¨³ÓµÏ,§d¤å»x,¶À¹Å¥Í,©P°ê¶¯,Chien-NengKao,½²¨Ø­Å,¼B®¶÷~,§õ¬üæ¢,¼B«T¤H,À¹¹Å¨¥,°ª¹Å§»,²ø¸UÀs,ªLº~³Ç*,§E©ú¶©* - - 1 - Liver international : official journal of the International Association for the Study of the Liver - LIVER INTERNATIONAL 2021 41¨÷(6´Á):1265-1277­¶
(IF: 5.828, »â°ì±Æ¦W: 25, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 27.17%)

Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
Chi-Yi Chen,Chung-Feng Huang#,Pin-Nan Cheng,Kuo-Chih Tseng,Ching-Chu Lo,Hsing-Tao Kuo,Yi-Hsiang Huang,Chi-Ming Tai,Cheng-Yuan Peng,Ming-Jong Bair,Chien-Hung Chen,Ming-Lun Yeh,Chih-Lang Lin,Chun-Yen Lin,Pei-Lun Lee,Lee-Won Chong,Chao-Hung Hung,Jee-Fu Huang,Chi-Chieh Yang,Jui-Ting Hu,Chih-Wen Lin,Chun-Ting Chen,Chia-Chi Wang,Wei-Wen Su,Tsai-Yuan Hsieh,Chih-Lin Lin,Wei-Lun Tsai,Tzong-Hsi Lee,Guei-Ying Chen,Szu-Jen Wang,Chun-Chao Chang,Lein-Ray Mo,Sheng-Shun Yang,Wen-Chih Wu,Chia-Sheng Huang,Chou-Kwok Hsiung,Chien-Neng Kao,Pei-Chien Tsai,Chen-Hua Liu,Mei-Hsuan Lee,Chun-Jen Liu,Chia-Yen Dai,Jia-Horng Kao,Wan-Long Chuang,Han-Chieh Lin*,Ming-Lung Yu* - - 1 - Liver international : official journal of the International Association for the Study of the Liver - LIVER INTERNATIONAL 2021;41(6):1265-1277
(IF: 5.828, Journal Ranking: 25, Number of Journals of this Field: 92, Ranking: 27.17%)

131

Association between fatty liver and cirrhosis, hepatocellular carcinoma, and HBsAg seroclearance in chronic hepatitis B.
LiJ,YangHI,¸­©ú­Û,LeMH,LeAK,YeoYH,À¹¹Å¨¥,BarnettS,ZhangJQ,¶À§Ó´I,TrinhHN,WongC,WongC,HoangJK,CheungR,§E©ú¶©,NguyenMH*. - - 1 - The Journal of infectious diseases - JOURNAL OF INFECTIOUS DISEASES 2021 739¨÷(739´Á):739­¶
(IF: 5.226, »â°ì±Æ¦W: 18, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 19.57%)

Association between fatty liver and cirrhosis, hepatocellular carcinoma, and HBsAg seroclearance in chronic hepatitis B.
Jie Li,Hwai-I Yang,Ming-Lun Yeh,Michael H Le,An K Le,Yee Hui Yeo,Chia-Yen Dai,Scott Barnett,Jian Q Zhang,Jee-Fu Huang,Huy N Trinh,Christopher Wong,Clifford Wong,Joseph K Hoang,Ramsey Cheung,Ming-Lung Yu,Mindie H Nguyen - - 1 - The Journal of infectious diseases - JOURNAL OF INFECTIOUS DISEASES 2021;739(739):739
(IF: 5.226, Journal Ranking: 18, Number of Journals of this Field: 92, Ranking: 19.57%)

132

Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma
ªL·q´¼,¼B¤jºû,¸­©ú­Û,½²©ö¬À,½²¨Ø­Å,¶À³©®p,¶À§Ó´I,²ø¸UÀs,À¹¹Å¨¥*,§E©ú¶©*. - - 1 - Clinical and molecular hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2021 27¨÷(2´Á):313-328.­¶
(IF: 6.074, »â°ì±Æ¦W: 23, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 25.00%)

Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma
Ching-Chih Lin,Ta-Wei Liu,Ming-Lun Yeh,Yi-Shan Tsai,Pei-Chien Tsai,Chung-Feng Huang,Jee-Fu Huang,Wan-Long Chuang,Chia-Yen Dai,Ming-Lung Yu - - 1 - Clinical and molecular hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2021;27(2):313-328.
(IF: 6.074, Journal Ranking: 23, Number of Journals of this Field: 92, Ranking: 25.00%)

133

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection.
¼B­i§u,ªL©yÐA#,ªLÎr¯ø,½²¨Ø­Å,¼B²Qªâ,¶À­^¬w,½²¨Î§g,¶ÀÂ@¶h,¸­©ú­Û,±ç³Õµ{,ªL¤l³ó,À¹¹Å¨¥,¶À§Ó´I,²ø¸UÀs,¶À³©®p*,§E©ú¶© - - 2 - PloS one - PLOS ONE 2021 16¨÷(7´Á):e0254028­¶
(IF: 3.24, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 73, »â°ì±Æ¦W: 35.62%)

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection.
Hung-Yin Liu,Yi-Hung Lin,Pei-Ju Lin,Pei-Chien Tsai,Shu-Fen Liu,Ying-Chou Huang,Jia-Jiun Tsai,Ching-I Huang,Ming-Lun Yeh,Po-Cheng Liang,Zu-Yau Lin,Chia-Yen Dai,Jee-Fu Huang,Wan-Long Chuang,Chung-Feng Huang,Ming-Lung Yu - - 2 - PloS one - PLOS ONE 2021;16(7):e0254028
(IF: 3.24, Journal Ranking: 26, Number of Journals of this Field: 73, Ranking: 35.62%)

134

¦bºC©ÊC«¬¨xª¢¥B±µ¨ü§Ü¯f¬rªvÀø±wªÌ¨ä¿©±w¥½´ÁµÇ¯fÅÜ¥B±µ¨ü¥B±µ¨ü¦å²G³zªRªÌ¤§ªø´Á¦MÀI¦]¯À
Á©s°a,Ming-JongBair,½²¨Ø­Å,Kuo-ChihTseng,Ching-ChuLo,Chi-YiChen,Hsing-TaoKuo,Chao-HungHung,Hsueh-ChouLai,Cheng-YuanPeng,Jing-HoungWang,Jyh-JouChen,Pei-LunLee,Rong-NanChien,Chi-ChiehYang13,Gin-HoLo1,Jia-HorngKao,Chun-JenLiu,Chen-HuaLiuSheng-LeiYan,Chun-YenLin,Wei-WenSu,Cheng-HsinChu,Chih-JenChen,Shui-YiTung,Chi‐MingTai1,Chih-WenLin1,Pin-NanCheng,Yen-ChengChiu,Chia-ChiWang,Jin-ShiungCheng,Wei-LunTsai,Han-ChiehLin,Yi-HsiangHuang,¸­©ú­Û,¶À³©®p,¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©*,²ø¸UÀs* - - 1 - J Gastroenterol Hepatol . - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2021 36¨÷(8´Á):2247-2254­¶
(IF: 4.029, »â°ì±Æ¦W: 45, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 48.91%)

Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan
Meng-Hsuan Hsieh,Ming-Jong Bair,Pei-Chien Tsai, Kuo-Chih Tseng, Ching-Chu Lo, Chi-Yi Chen, Hsing-Tao Kuo, Chao-Hung Hung, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang13, Gin-Ho Lo1, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu Sheng-Lei Yan, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi‐Ming Tai1, Chih-Wen Lin1, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Ming-Lun Yeh Chung-Feng Huang, Jee-Fu Huang ,Chia-Yen Dai, Ming-Lung Yu*, Wan-Long Chuang* - - 1 - J Gastroenterol Hepatol . - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2021;36(8):2247-2254
(IF: 4.029, Journal Ranking: 45, Number of Journals of this Field: 92, Ranking: 48.91%)

135

Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan.
Ming-Ying Lu,Chun-Ting Chen,Yu-Lueng Shih,½²¨Ø­Å,Á©s°a,¶À³©®p,¸­©ú­Û,¶ÀÂ@¶h,¤ý­zºö,½²©ö¬À,¬_¦ö¥Á,ªL·q´¼,³¯«a¦t,ÃQà±¾§,³\³Õ³ó,®}¦¨¹©,±i®x»·,¼B¤jºû,±ç³Õµ{,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©*,±i¤å¦t - - 1 - Scientific reports - SCIENTIFIC REPORTS 2021 11¨÷(1´Á):8554­¶
(IF: 4.379, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 73, »â°ì±Æ¦W: 23.29%)

Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan.
Ming-Ying Lu,Chun-Ting Chen,Yu-Lueng Shih,Pei-Chien Tsai,Meng-Hsuan Hsieh,Chung-Feng Huang,Ming-Lun Yeh,Ching-I Huang,Shu-Chi Wang,Yi-Shan Tsai,Yu-Min Ko,Ching-Chih Lin,Kuan-Yu Chen,Yu-Ju Wei,Po-Yao Hsu,Cheng-Ting Hsu,Tyng-Yuan Jang,Ta-Wei Liu,Po-Cheng Liang,Ming-Yen Hsieh,Zu-Yau Lin,Shinn-Cherng Chen,Jee-Fu Huang,Chia-Yen Dai,Wan-Long Chuang,Ming-Lung Yu,Wen-Yu Chang - - 1 - Scientific reports - SCIENTIFIC REPORTS 2021;11(1):8554
(IF: 4.379, Journal Ranking: 17, Number of Journals of this Field: 73, Ranking: 23.29%)

136

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
SapenaV,EneaM,TorresF,CelsaC,RiosJ,§E©ú¶© - - 1 - Gut - GUT 2021 71¨÷(3´Á):593-604.­¶
(IF: 23.059, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 3.26%)

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Victor Sapena,Marco Enea,Ferran Torres,Ciro Celsa,Jose Rios,Giacomo Emanuele Maria Rizzo,Pierre Nahon,Zoe Mario,Ryosuke Tateishi,Tatsuya Minami,Angelo Sangiovanni,Xavier Forns,Hidenori Toyoda,Stefano Brillanti,Fabio Conti,Elisabetta Degasperi,Ming-Lung Yu,Pei-Chien Tsai,Kevin Jean,Mohamed El Kassas,Hend Ibrahim Shousha,Ashraf Omar,Claudio Zavaglia,Hiroko Nagata,Mina Nakagawa,Yasuhiro Asahina,Amit G Singal,Caitlin Murphy,Mohamed Kohla,Chiara Masetti,Jean-Franois Dufour,Nicolas Merchante,Luisa Cavalletto,Liliana Lc Chemello,Stanislas Pol,Javier Crespo,Jose Luis Calleja,Rosanna Villani,Gaetano Serviddio,Alberto Zanetto,Sarah Shalaby,Francesco Paolo Russo,Rob Bielen,Franco Trevisani,Calogero Camm,Jordi Bruix,Giuseppe Cabibbo,Maria Reig - - 1 - Gut - GUT 2021;71(3):593-604.
(IF: 23.059, Journal Ranking: 3, Number of Journals of this Field: 92, Ranking: 3.26%)

137

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
±i®x»·,ÃQà±¾§,¼B¤jºû,¸­©ú­Û,¼B²Qªâ,®}¦¨¹©,³\³Õ³ó,ªL©yÐA,±ç³Õµ{,Á©s°a,¬_¦ö¥Á,½²©ö¬À,³¯«a¦t,ªL·q´¼,½²¨Ø­Å,¤ý­zºö,¶ÀÂ@¶h,ªL¤l³ó,³¯«H¦¨,²ø¸UÀs,¶À§Ó´I,À¹¹Å¨¥,¶À³©®p*,§E©ú¶©*. - - 1 - Scientific reports - SCIENTIFIC REPORTS 2021 11¨÷(1´Á):8184­¶
(IF: 4.379, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 73, »â°ì±Æ¦W: 23.29%)

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
Tyng-Yuan Jang,Yu-Ju Wei,Ta-Wei Liu,Ming-Lun Yeh,Shu-Fen Liu,Cheng-Ting Hsu,Po-Yao Hsu,Yi-Hung Lin,Po-Cheng Liang,Meng-Hsuan Hsieh,Yu-Min Ko,Yi-Shan Tsai,Kuan-Yu Chen,Ching-Chih Lin,Pei-Chien Tsai,Shu-Chi Wang,Ching-I Huang,Zu-Yau Lin,Shinn-Cherng Chen,Wan-Long Chuang,Jee-Fu Huang,Chia-Yen Dai,Chung-Feng Huang,Ming-Lung Yu - - 1 - Scientific reports - SCIENTIFIC REPORTS 2021;11(1):8184
(IF: 4.379, Journal Ranking: 17, Number of Journals of this Field: 73, Ranking: 23.29%)

138

Incidences and Determinants of Functional Cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
HsuYC,¸­©ú­Û,WongGL,³¯«Ø§»,´^¦¨¤¸,ButiM,EnomotoM,XieQ,TrinhH,PredaC,LiuL,CheungKS,YeoYH,HoangJ,¶À³©®p,Riveiro-BarcielaM,KozukaR,IstratescuD,½²¨Ø­Å,AccarinoEV,LeeDH,WuJL,¶À§Ó´I,À¹¹Å¨¥,CheungR,²ø¸UÀs,YuenMF,WongVW,§E©ú¶©,NguyenMH*. - - 1 - The Journal of infectious diseases - JOURNAL OF INFECTIOUS DISEASES 2021 224¨÷(11´Á):1890-1899­¶
(IF: 5.226, »â°ì±Æ¦W: 18, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 19.57%)

Incidences and Determinants of Functional Cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
Yao-Chun Hsu,Ming-Lun Yeh,Grace Lai-Hung Wong,Chien-Hung Chen,Cheng-Yuan Peng,Maria Buti,Masaru Enomoto,Qing Xie,Huy Trinh,Carmen Preda,Li Liu,Ka-Shing Cheung,Yee Hui Yeo,Joseph Hoang,Chung-Feng Huang,Mar Riveiro-Barciela,Ritsuzo Kozuka,Doina Istratescu,Pei-Chien Tsai,Elena Vargas Accarino,Dong-Hyun Lee,Jia-Ling Wu,Jee Fu Huang,Chia-Yen Dai,Ramsey Cheung,Wan-Long Chuang,Man-Fung Yuen,Vincent Wai-Sun Wong,Ming-Lung Yu,Mindie H Nguyen - - 1 - The Journal of infectious diseases - JOURNAL OF INFECTIOUS DISEASES 2021;224(11):1890-1899
(IF: 5.226, Journal Ranking: 18, Number of Journals of this Field: 92, Ranking: 19.57%)

139

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR.
¸­©ú­Û,±ç³Õµ{,½²¨Ø­Å,¤ý­zºö, Jennifer Leong, Eiichi Ogawa, Dae Won Jun,´¿¬F»¨, Charles Landis, Yasuhito Tanaka,¶À³©®p, Jun Hayashi,³\Ä£®m,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs, Mindie H Nguyen*,§E©ú¶©* - - 1 - CANCERS - CANCERS 2021 13¨÷(14´Á):3455­¶
(IF: 6.639, »â°ì±Æ¦W: 51, »â°ì´Á¥Z¼Æ: 242, »â°ì±Æ¦W: 21.07%)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR.
Ming-Lun Yeh, Po-Cheng Liang, Pei-Chien Tsai, Shu-Chi Wang, Jennifer Leong, Eiichi Ogawa, Dae Won Jun, Cheng-Hao Tseng, Charles Landis, Yasuhito Tanaka, Chung-Feng Huang, Jun Hayashi, Yao-Chun Hsu, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Mindie H Nguyen*, Ming-Lung Yu* - - 1 - CANCERS - CANCERS 2021;13(14):3455
(IF: 6.639, Journal Ranking: 51, Number of Journals of this Field: 242, Ranking: 21.07%)

140

C«¬¨xª¢¯f¬r·P¬V»PµÇ¥\¯à¤§ÃöÁp©Ê
Gantumur G, Batsaikhan B,¶ÀÂ@¶h,¸­©ú­Û,¶À³©¾W,ªL©yÐA,ªL«º§g,±ç³Õµ{,¼B¤jºû,§õ¨Î»T,ªL©yÀR,ªL©É¬Â,¶À§Ó´I,²ø¸UÀs,§E©ú¶©,§ùÂE»«*,À¹¹Å¨¥* - - 1 - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION : JCMA - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2021 84¨÷(8´Á):757-765­¶
(IF: 2.743, »â°ì±Æ¦W: 62, »â°ì´Á¥Z¼Æ: 169, »â°ì±Æ¦W: 36.69%)

The association between hepatitis C virus infection and renal function.
Gantsetseg Gantumur, Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Yi-Hung Lin, Tzu-Chun Lin, Po-Cheng Liang, Ta-Wei Liu, Jia-Jung Lee, Yi-Ching Lin, I-Ling Lin, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu, Hung-Pin Tu*, Chia-Yen Dai* - - 1 - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION : JCMA - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2021;84(8):757-765
(IF: 2.743, Journal Ranking: 62, Number of Journals of this Field: 169, Ranking: 36.69%)

141

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
George Lau*, §E©ú¶©*, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin-Lin Hou, Teerha Piratvisuth, Ji-Dong Jia, Masashi Mizokami, Gregory Cheng, Guo-Feng Chen, Zhen-Wen Liu, Oidov Baatarkhuu, ¾G¦w²z, Woon Leung Ng, Patrick Lau, Tony Mok, ±i­õ»Ê, Saeed Hamid, A Kadir Dokmeci, Rino A Gani, Diana A Payawal, Pierce Chow, Joong-Won Park, Simone I Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tanwandee Tawesak, Shiv Kumar Sarin, Masao Omata - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2021 2021¨÷(1´Á):1-18­¶
(IF: 6.047, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 28.26%)

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy.
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin-Lin Hou, Teerha Piratvisuth, Ji-Dong Jia, Masashi Mizokami, Gregory Cheng, Guo-Feng Chen, Zhen-Wen Liu, Oidov Baatarkhuu, Ann Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok, Jer-Ming Chang, Saeed Hamid, A Kadir Dokmeci, Rino A Gani, Diana A Payawal, Pierce Chow, Joong-Won Park, Simone I Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tanwandee Tawesak, Shiv Kumar Sarin, Masao Omata - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2021;2021(1):1-18
(IF: 6.047, Journal Ranking: 26, Number of Journals of this Field: 92, Ranking: 28.26%)

142

Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C.
Hsu SJ,§E©ú¶©,Su CW,Peng CY,Chien RN,Lin HH,Lo GH,Su WW,Kuo HT,Hsu CW,Yang SS,Yang SS,Tseng KC,Qin A,Huang YW,²ø¸UÀs*. - - 1 - Journal of the Formosan Medical Association = Taiwan yi zhi - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2021 120¨÷(3´Á):956-964.­¶
(IF: 3.282, »â°ì±Æ¦W: 53, »â°ì´Á¥Z¼Æ: 169, »â°ì±Æ¦W: 31.36%)

Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C
Shih-Jer Hsu,Ming-Lung Yu,Chien-Wei Su,Cheng-Yuan Peng,Rong-Nan Chien,Hsien-Hong Lin,Gin-Ho Lo,Wei-Wen Su,Hsing-Tao Kuo,Chao-Wei Hsu,Sien-Sing Yang,Sheng-Shun Yang,Kuan-Chiao Tseng,Albert Qin,Yi-Wen Huang,Wan-Long Chuang* - - 1 - Journal of the Formosan Medical Association = Taiwan yi zhi - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2021;120(3):956-964.
(IF: 3.282, Journal Ranking: 53, Number of Journals of this Field: 169, Ranking: 31.36%)

143

Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma.
ªL§Ó¤å, Yaw-Sen Chen, Gin-Ho Lo, Tsung-Chin Wu, Jen-Hao Yeh, ¸­©ú­Û, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, Lewis Roberts, Dae Won Jun, Hidenori Toyoda, Satoshi Yasuda, Mindie H Nguyen, §E©ú¶©* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2021 15¨÷(4´Á):946-956­¶
(IF: 6.047, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 26.09%)

Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma.
Chih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, Tsung-Chin Wu, Jen-Hao Yeh, Ming-Lun Yeh, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Lewis Roberts, Dae Won Jun, Hidenori Toyoda, Satoshi Yasuda, Mindie H Nguyen, Ming-Lung Yu - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2021;15(4):946-956
(IF: 6.047, Journal Ranking: 24, Number of Journals of this Field: 92, Ranking: 26.09%)

144

Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis.
³\³Õ³ó,ÃQà±¾§,±ç³Õµ{,§õ¨Î»T,¯Ã¸t¤å,¶À«T¸R,®}¦¨¹©,±i®x»·,¶ÀÂ@¶h,ªL©yÐA,Á©ú«Û,Á©s°a,³¯«ä¹Å,À¹¹Å¨¥,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,±i­õ»Ê,¸­©ú­Û*,¶À³©®p,ªô©É¤å,¶À©|§Ó,²ø¸UÀs,§E©ú¶© - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2021 36¨÷(8´Á):2261-2269­¶
(IF: 4.029, »â°ì±Æ¦W: 45, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 48.91%)

Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis.
Po-Yao Hsu, Yu-Ju Wei, Po-Cheng Liang, Jia-Jung Lee, Sheng-Wen Niu, Jiun-Chi Huang, Cheng-Ting Hsu, Tyng-Yuan Jang, Ching-I Huang, Yi-Hung Lin, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Szu-Chia Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Jer-Ming Chang, Ming-Lun Yeh, Chung-Feng Huang, Yi-Wen Chiu, Shang-Jyh Hwang, Wan-Long Chuang, Ming-Lung Yu - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2021;36(8):2261-2269
(IF: 4.029, Journal Ranking: 45, Number of Journals of this Field: 92, Ranking: 48.91%)

145

Real-world experience of serial serum levels of GS-331007 in chronic hepatitis C hemodialysis patients during and after sofosbuvir/velpatasvir therapy.
¶À³©®p,ÃQà±¾§,§d¨|¿A,ªô©É¤å,§E©ú¶©* - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2021 75¨÷(4´Á):1006-1007­¶
(IF: 25.083, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 2.17%)

Real-world experience of serial serum levels of GS-331007 in chronic hepatitis C hemodialysis patients during and after sofosbuvir/velpatasvir therapy.
Chung-Feng Huang, Yu-Ju Wei, Yu-Tse Wu, Yi-Wen Chiu, Ming-Lung Yu* - - 1 - JOURNAL OF HEPATOLOGY - JOURNAL OF HEPATOLOGY 2021;75(4):1006-1007
(IF: 25.083, Journal Ranking: 2, Number of Journals of this Field: 92, Ranking: 2.17%)

146

Seroreversion of hepatitis B surface antigen among subjects with resolved hepatitis B virus infection: A community-based cohort study
¸­©ú­Û,±ç³Õµ{,¶ÀÂ@¶h,Á©s°a,ªL©yÐA,±i®x»·,ÃQà±¾§,³\³Õ³ó,®}¦¨¹©,¤ý§Ó¤å,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,¶À³©®p,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©* - - 1 - J Gastroenterol Hepatol . - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2021 36¨÷(11´Á):3239-3246.­¶
(IF: 4.029, »â°ì±Æ¦W: 45, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 48.91%)

Seroreversion of hepatitis B surface antigen among subjects with resolved hepatitis B virus infection: A community-based cohort study
Ming-Lun Yeh, Po-Cheng Liang, Ching-I Huang, Meng-Hsuan Hsieh, Yi-Hung Lin, Tyng-Yuan Jang, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Chih-Wen Wang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu* - - 1 - J Gastroenterol Hepatol . - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2021;36(11):3239-3246.
(IF: 4.029, Journal Ranking: 45, Number of Journals of this Field: 92, Ranking: 48.91%)

147

¥xÆW¦a°Ï¤B«¬¨xª¢¯f¬r°ò¦]«¬ªº¬y¦æ²v©M¦å²M¾ÇÃöÁp
Keva Joseph, Ciniso Sylvester Shabangu#, ±i®x»·, ¶À³©®p, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, §E©ú¶©, ¤ý­zºö* - - 1 - Pathogens - PATHOGENS 2021 10¨÷(10´Á):1227­¶
(IF: 4.531, »â°ì±Æ¦W: 58, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 42.65%)

The Prevalence and Serological Association of Hepatitis D Virus Genotypes in Taiwan
Keva Joseph, Ciniso Sylvester Shabangu#, Tyng-Yuan Jang, Chung-Feng Huang, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu, Shu-Chi Wang* - - 1 - Pathogens - PATHOGENS 2021;10(10):1227
(IF: 4.531, Journal Ranking: 58, Number of Journals of this Field: 136, Ranking: 42.65%)

148

Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).
Wei-Fan Hsu, ½²¨Ø­Å, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Ron-Nan Chien, Chun-Yen Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©*, Cheng-Yuan Peng* - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2021 36¨÷(10´Á):2884-2892­¶
(IF: 4.029, »â°ì±Æ¦W: 45, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 48.91%)

Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).
Wei-Fan Hsu, Pei-Chein Tsai, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Ron-Nan Chien, Chun-Yen Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu*, Cheng-Yuan Peng* - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2021;36(10):2884-2892
(IF: 4.029, Journal Ranking: 45, Number of Journals of this Field: 92, Ranking: 48.91%)

149

Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
¸­©ú­Û, ¬x»F§», ´¿°êªK, ¿à¾Ç¬w, ³¯±Ò¯q, ³¢¦æ¹D, ¤ý´º¥°, ³¯§Ó¦{, §õ¯\ºú, ²ºa«n, ·¨°òÞf, ùÀAªe, À¹±Ò©ú, ªL§Ó¤å, °ª¹Å§», ¼B®¶÷~, ÃC¸t¯P, ¥Õ©ú©¾, ªL«T«Û, Ĭºû¤å, ¦¶¥¿¤ß, ³¯§Ó¤¯, ¸³¤ô¸q, ù²M¦À, ¾GÙy¨k, ªô«Ûµ{, ¤ý¹Å»ô, ¾GÀAµ¾, ½²ºû­Û, ªLº~³Ç, ¶À©Éµ¾, ¶À³©®p, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, ½²¨Ø­Å, ´^¦¨¤¸, ¼B«T¤H*, §E©ú¶©* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2021 15¨÷(5´Á):1109-1121­¶
(IF: 6.047, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 26.09%)

Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
Ming-Lun Yeh, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Chi-Yi Chen, Hsing-Tao Kuo, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Pei-Chien Tsai, Cheng-Yuan Peng, Chun-Jen Liu, Ming-Lung Yu - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2021;15(5):1109-1121
(IF: 6.047, Journal Ranking: 24, Number of Journals of this Field: 92, Ranking: 26.09%)

150

¤þ«¬¨xª¢¯f¬r¦b¨x²Ó­M¤¤ªº«ùÄò·P¬V³q¹L«Pª¢©Ê¥Õ²Ó­M¤¶¯À8ªºªí¹F«P¶i¨x²Ó­MÀùªº¶i®i
Ciniso Sylvester Shabangu, Phumelele Yvonne Sipheph, §õ¨Î¶§, ¾Gºû¤¤, §f©ú¿o, ¶À³©¾W, ¸­©ú­Û, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, ªL¤l³ó, §E©ú¶©, ¤ý­zºö* - - 1 - Biomedicines - BIOMEDICINES 2021 9¨÷(10´Á):1446­¶
(IF: 4.757, »â°ì±Æ¦W: 86, »â°ì´Á¥Z¼Æ: 279, »â°ì±Æ¦W: 30.82%)

The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 Expression
Ciniso Sylvester Shabangu, Phumelele Yvonne Siphepho, Chia-Yang Li, Wei-Chung Cheng, Ming-Ying Lu, Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Zu-Yau Lin, Ming-Lung Yu, Shu-Chi Wang* - - 1 - Biomedicines - BIOMEDICINES 2021;9(10):1446
(IF: 4.757, Journal Ranking: 86, Number of Journals of this Field: 279, Ranking: 30.82%)

151

¯×ªÕÅܩʹïºC©Ê¤þ«¬¨xª¢¶i®i©M ¹ï§Ü¯f¬rªvÀøªº¤ÏÀ³
Phumelele Yvonne Siphepho, ¼BÏÔ§Ê, Ciniso Sylvester Shabangu, ¶À§Ó´I, ¶À³©¾W, ¸­©ú­Û, §E©ú¶©, ¤ý­zºö* - - 1 - Biomedicines - BIOMEDICINES 2021 9¨÷(10´Á):1491­¶
(IF: 4.757, »â°ì±Æ¦W: 86, »â°ì´Á¥Z¼Æ: 279, »â°ì±Æ¦W: 30.82%)

The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments
Phumelele Yvonne Siphepho, Yi-Ting Liu, Ciniso Sylvester Shabangu , Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Ming-Lung Yu, Shu-Chi Wang* - - 1 - Biomedicines - BIOMEDICINES 2021;9(10):1491
(IF: 4.757, Journal Ranking: 86, Number of Journals of this Field: 279, Ranking: 30.82%)

152

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection.
½²­§´Ù,¼B¯q©÷,·¨ÀR©y,²ø­õ©ú,¬_¨È­Û,¸­©vÅý,°ª¨|«C,§ù¬F¾±,¤ý¼z´¹,¨ô¤hûß,³\´Ü¤ì,§d¨ØªÚ,¶ÀÂ@¶h,¶À³©®p,§E©ú¶©,À¹¹Å¨¥,¿½´f¾ì* - - 1 - JOURNAL OF PERSONALIZED MEDICINE - JOURNAL OF PERSONALIZED MEDICINE 2021 11¨÷(9´Á):844­¶
(IF: 4.945, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 108, »â°ì±Æ¦W: 13.89%)

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection.
Yu-Fen Tsai, Yi-Chang Liu, Ching-I Yang, Tzer-Ming Chuang, Ya-Lun Ke, Tsung-Jang Yeh, Yuh-Ching Gau, Jeng-Shiun Du, Hui-Ching Wang, Shih-Feng Cho, Chin-Mu Hsu, Pey-Fang Wu, Ching-I Huang, Chung-Feng Huang, Ming-Lung Yu, Chia-Yen Dai, Hui-Hua Hsiao* - - 1 - JOURNAL OF PERSONALIZED MEDICINE - JOURNAL OF PERSONALIZED MEDICINE 2021;11(9):844
(IF: 4.945, Journal Ranking: 15, Number of Journals of this Field: 108, Ranking: 13.89%)

153

First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients.
¶À§Ó´I, À¹¹Å¨¥, ¶À³©®p, ½²¨Ø­Å, ¸­©ú­Û, ³\³Õ³ó, ¶À¨qªâ, ¥Õ©ú©¾, «J¤D¤¯, ¶ÀÂ@¶h, ±ç³Õµ{, ªL©yÐA, ¤ý§Ó¤å, Á©ú«Û, ³¯«H¦¨, ªL¤l³ó, §E©ú¶©*, ²ø¸UÀs* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2021 15¨÷(5´Á):1136-1147­¶
(IF: 6.047, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 26.09%)

First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients.
Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, Pei-Chien Tsai, Ming-Lun Yeh, Po-Yau Hsu, Shiu-Feng Huang, Ming-Jong Bair, Nai-Jen Hou, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Chih-Wen Wang, Ming-Yen Hsieh, Shinn-Chern Chen, Zu-Yau Lin, Ming-Lung Yu, Wan-Long Chuang - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2021;15(5):1136-1147
(IF: 6.047, Journal Ranking: 24, Number of Journals of this Field: 92, Ranking: 26.09%)

154

Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan.
ChengPN,ChenCY, §E©ú¶©,LinCC,LinCY,PengCY,TsengKC,LoCC,TsengIH,LiuCJ*. - - 1 - Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi - JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION 2021 S1684-1182¨÷(20´Á):30118-3­¶
(IF: 3.493, »â°ì±Æ¦W: 33, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 35.48%)

Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan.
Pin-Nan Cheng,Chi-Yi Chen,Ming-Lung Yu,Chun-Che Lin,Chun-Yen Lin,Cheng-Yuan Peng,Kuo-Chih Tseng,Ching-Chu Lo,I-Hao Tseng,Chun-Jen Liu - - 1 - Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi - JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION 2021;S1684-1182(20):30118-3
(IF: 3.493, Journal Ranking: 33, Number of Journals of this Field: 93, Ranking: 35.48%)

155

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan.
Chun-Ming Hong, You-Yu Lin, Chun-Jen Liu, Ya-Yun Lai, Shiou-Hwei Yeh, Hung-Chih Yang, Jia-Horng Kao, Shih-Jer Hsu, Yi-Hsiang Huang, Sheng-Shun Yang, Hsing-Tao Kuo, Pin-Nan Cheng, §E©ú¶©*, Pei-Jer Chen - - 1 - VIRUSES - VIRUSES-BASEL 2021 13¨÷(11´Á):2294­¶
(IF: 5.048, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 36, »â°ì±Æ¦W: 27.78%)

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan.
Chun-Ming Hong, You-Yu Lin, Chun-Jen Liu, Ya-Yun Lai, Shiou-Hwei Yeh, Hung-Chih Yang, Jia-Horng Kao, Shih-Jer Hsu, Yi-Hsiang Huang, Sheng-Shun Yang, Hsing-Tao Kuo, Pin-Nan Cheng, Ming-Lung Yu, Pei-Jer Chen - - 1 - VIRUSES - VIRUSES-BASEL 2021;13(11):2294
(IF: 5.048, Journal Ranking: 10, Number of Journals of this Field: 36, Ranking: 27.78%)

156

Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.
¶À³©®p#,³¢¦æ¹D#,±i¼w¥Í,ù²M¦À,¬x»F§»,¶À°·ºû,Lee-Won Chong,¾GÙy¨k,¸­©ú­Û,´^¦¨¤¸,³¯«Ø¦t,¶À§Ó´I,¥Õ©ú©¾,ªL§Ó­¦,·¨°òÞf,¤ý¶à¤¯,Á°]·½,§õ©vº³,§õ¨Ø­Û,§d¤å»x,ªL§Ó³®,Ĭºû¤å,·¨³ÓµÏ,¤ý¹Å»ô,­J·ç®x,¦È联·ç,³¯­x§Ê,¶À©Éµ¾,±i§g·Ó,Chia-Sheng Huang,³¯®Û­^,°ª°·¯à,À¹±Ò©ú,¼B«T¤H,§õ¬üæ¢,½²¨Ø­Å,À¹¹Å¨¥,°ª¹Å§»,ªLº~³Ç,²ø¸UÀs,³¯±Ò¯q,´¿°êªK*,§E©ú¶©* - - 1 - SCIENTIFIC REPORTS - SCIENTIFIC REPORTS 2021 11¨÷(1´Á):23473­¶
(IF: 4.379, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 73, »â°ì±Æ¦W: 23.29%)

Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.
Chung-Feng Huang, Hsing-Tao Kuo, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chien-Wei Huang, Lee-Won Chong, Pin-Nan Cheng, Ming-Lun Yeh, Cheng-Yuan Peng, Chien-Yu Cheng, Jee-Fu Huang, Ming-Jong Bair, Chih-Lang Lin, Chi-Chieh Yang, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzong-Hsi Lee, Pei-Lun Lee, Wen-Chih Wu, Chih-Lin Lin, Wei-Wen Su, Sheng-Shun Yang, Chia-Chi Wang, Jui-Ting Hu, Lein-Ray Mo, Chun-Ting Chen, Yi-Hsiang Huang, Chun-Chao Chang, Chia-Sheng Huang, Guei-Ying Chen, Chien-Neng Kao, Chi-Ming Tai, Chun-Jen Liu, Mei-Hsuan Lee, Pei-Chien Tsai, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wang-Long Chuang, Chi-Yi Chen, Kuo-Chih Tseng, Ming-Lung Yu - - 1 - SCIENTIFIC REPORTS - SCIENTIFIC REPORTS 2021;11(1):23473
(IF: 4.379, Journal Ranking: 17, Number of Journals of this Field: 73, Ranking: 23.29%)

157

Exosome-derived differentiation antagonizing non-protein coding RNA with risk of hepatitis C virus-related hepatocellular carcinoma recurrence.
¤ý­zºö, §õ¨Î¶§, ±i¤åÀé, ¾Gºû¤¤, ÃC¹Å§», Ò\¤å·ì, ªL¤l³ó, ªL·q´¼, ¸­©ú­Û, ¶À³©¾W, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, ³¯³ó§Q*, §E©ú¶©* - - 1 - Liver international - LIVER INTERNATIONAL 2021 41¨÷(5´Á):956-968­¶
(IF: 8.754, »â°ì±Æ¦W: 18, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 19.35%)

Exosome-derived differentiation antagonizing non-protein coding RNA with risk of hepatitis C virus-related hepatocellular carcinoma recurrence.
Shu-Chi Wang, Chia-Yang Li, Wen-Tsan Chang, Wei-Chung Cheng , Chia-Hung Yen, Wen-Yu Tu, Zu-Yau Lin, Ching-Chih Lin, Ming-Lun Yeh, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Yao-Li Chen*, Ming-Lung Yu* - - 1 - Liver international - LIVER INTERNATIONAL 2021;41(5):956-968
(IF: 8.754, Journal Ranking: 18, Number of Journals of this Field: 93, Ranking: 19.35%)

158

Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines.
Teng W, Chang TT, Yang HI, Peng CY, Su CW, Su TH, Hu TH, §E©ú¶©, Yang HC, Wu JC*. - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2021 15¨÷(6´Á):1421-1430­¶
(IF: 6.047, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 26.09%)

Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines.
Wei Teng, Ting-Tsung Chang, Hwai-I Yang, Cheng-Yuan Peng, Chien-Wei Su, Tung-Hung Su, Tsung-Hui Hu, Ming-Lung Yu, Hung-Chih Yang, Jaw-Ching Wu - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2021;15(6):1421-1430
(IF: 6.047, Journal Ranking: 24, Number of Journals of this Field: 92, Ranking: 26.09%)

159

¸û°ªªº«D°sºë©Ê¨x¯f¯×ÅÖºû¤Æ¤À¼Æ©M¸û®tªºµÇµ·²y¹LÂo²v¦³Ãö
Á©s°a,§d«a¹F,³¯ÃÀ¦ö,·¨¥¿ºÖ,ªL¤å¤@,±i¹ç®a,ªL¹Å¯q,¶À¥ü¼e,¤ý»FÄÖ,ªL²Q­ë,³\¥É®Û,½²©ö¬À,²ø¸UÀs,§E©ú¶©*,À¹¹Å¨¥* - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2020 119¨÷(1´Á):496-503­¶
(IF: 3.008, »â°ì±Æ¦W: 42, »â°ì´Á¥Z¼Æ: 165, »â°ì±Æ¦W: 25.45%)

Higher NAFLD fibrosis score is associated with impaired eGFR
Meng-Hsuan Hsieh,Kuan-Ta Wu,Yi-Yu Chen, Jeng-Fu Yang, Wen-Yi Lin, Ning-Chia Chang ,Chia-Yi Lin ,Chao-Kuan Huang ,Chao-Ling Wang ,Shu-Ching Lin ,Yu-Kuei Hsu, Yi-Shan Tsai ,Wan-Long Chuang, Ming-Lung Yu, Chia-Yen Dai* - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2020;119(1):496-503
(IF: 3.008, Journal Ranking: 42, Number of Journals of this Field: 165, Ranking: 25.45%)

160

¹p¤Ú«ÂÆF¼W¶iºC©ÊC«¬¨xª¢±wªÌ±µ¨üdaclatasvir¤Îasunaprevir¤p¤À¤l§Ü¯f¬rÃĪ«¦­´Á¯f¬r°Ê¤O¾Ç
¶À³©®p,¸­©ú­Û,¶ÀÂ@¶h,±ç³Õµ{,ªL©yÐA,Á©ú«Û,³¯«a¦t,¬_¦ö¥Á,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©* - - 1 - J Gastroenterol Hepatol - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2020 35¨÷(1´Á):151-156­¶
(IF: 3.437, »â°ì±Æ¦W: 42, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 47.73%)

Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir
Huang CF,Yeh ML,Huang CI,Liang PC,Lin YH,Hsieh MY,Chen KY,Ko YM,Lin ZY,Chen SC,Huang JF,Dai CY,Chuang WL,Yu ML* - - 1 - J Gastroenterol Hepatol - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2020;35(1):151-156
(IF: 3.437, Journal Ranking: 42, Number of Journals of this Field: 88, Ranking: 47.73%)

161

Daclatasvir¦X¨ÖasunaprevirªvÀøºC©ÊC«¬¨xª¢¯f¬r°ò¦]«¬1b·P¬V¬~µÇ±wªÌ
¶À³©®p,§E©ú¶©* - - 1 - Kidney International - KIDNEY INTERNATIONAL 2020 97¨÷(3´Á):615-615­¶
(IF: 8.945, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 85, »â°ì±Æ¦W: 7.06%)

Daclatasvir plus asunaprevir in the treatment of uremic patients with chronic hepatitis C genotype 1b infection
Chung-Feng Huang, Ming-Lung Yu* - - 1 - Kidney International - KIDNEY INTERNATIONAL 2020;97(3):615-615
(IF: 8.945, Journal Ranking: 6, Number of Journals of this Field: 85, Ranking: 7.06%)

162

Patient-centered outreach treatment toward micro-elimination of hepatitis C virus infection in hemodialysis patients.
¶À³©®p,ªô©É¤å,§E©ú¶©* - - 1 - KIDNEY INTERNATIONAL - KIDNEY INTERNATIONAL 2020 97¨÷(2´Á):421­¶
(IF: 8.945, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 85, »â°ì±Æ¦W: 7.06%)

Patient-centered outreach treatment toward micro-elimination of hepatitis C virus infection in hemodialysis patients.
Chung-Feng Huang , Yi-Wen Chiu , Ming-Lung Yu* - - 1 - KIDNEY INTERNATIONAL - KIDNEY INTERNATIONAL 2020;97(2):421
(IF: 8.945, Journal Ranking: 6, Number of Journals of this Field: 85, Ranking: 7.06%)

163

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
Yao-Chun Hsu, Grace Lai-Hung Wong, Chien-Hung Chen, Cheng-Yuan Peng, ¸­©ú­Û, Ka-Shing Cheung, Hidenori Toyoda, ¶À³©®p, Huy Trinh, Qing Xie, Masaru Enomoto, Li Liu, Satoshi Yasuda, Yasuhito Tanaka, Ritsuzo Kozuka, ½²¨Ø­Å, Yen-Tsung Huang, Christopher Wong, Rui Huang, ±i®x»·, Joseph Hoang, Hwai-I Yang, Jiayi Li, Dong-Hyun Lee, Hirokazu Takahashi, Jian Q. Zhang, Eiichi Ogawa, Changqing Zhao, Chenghai Liu, Norihiro Furusyo, Yuichiro Eguchi, Clifford Wong, Chao Wu, Takashi Kumada, Man-Fung Yuen, §E©ú¶©, Mindie H. Nguyen*. - - 1 - AMERICAN JOURNAL OF GASTROENTEROLOGY - AMERICAN JOURNAL OF GASTROENTEROLOGY 2020 115¨÷(2´Á):271-280­¶
(IF: 10.864, »â°ì±Æ¦W: 9, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 9.78%)

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
Yao-Chun Hsu, Grace Lai-Hung Wong, Chien-Hung Chen, Cheng-Yuan Peng, Ming-Lun Yeh, Ka-Shing Cheung, Hidenori Toyoda, Chung-Feng Huang, Huy Trinh, Qing Xie, Masaru Enomoto, Li Liu, Satoshi Yasuda, Yasuhito Tanaka, Ritsuzo Kozuka, Pei-Chien Tsai, Yen-Tsung Huang, Christopher Wong, Rui Huang, Tyng-Yuan Jang, Joseph Hoang, Hwai-I Yang, Jiayi Li, Dong-Hyun Lee, Hirokazu Takahashi, Jian Q. Zhang, Eiichi Ogawa, Changqing Zhao, Chenghai Liu, Norihiro Furusyo, Yuichiro Eguchi, Clifford Wong, Chao Wu, Takashi Kumada, Man-Fung Yuen, Ming-Lung Yu, Mindie H. Nguyen*. - - 1 - AMERICAN JOURNAL OF GASTROENTEROLOGY - AMERICAN JOURNAL OF GASTROENTEROLOGY 2020;115(2):271-280
(IF: 10.864, Journal Ranking: 9, Number of Journals of this Field: 92, Ranking: 9.78%)

164

Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy
Hwai-I Yang , ¸­©ú­Û , Grace L Wong , Cheng-Yuan Peng , Chien-Hung Chen , Huy N Trinh , Ka-Shing Cheung , Qing Xie , Tung-Hung Su , Ritsuzo Kozuka , Dong-Hyun Lee , Eiichi Ogawa , Changqing Zhao , Hui-Bin Ning , Rui Huang , Jiayi Li , Jian Q Zhang , Tatsuya Ide , Huichun Xing , Shinji Iwane , Hirokazu Takahashi , Christopher Wong , Clifford Wong , Chia-Hsin Lin , Joseph Hoang , An Le , Linda Henry , Hidenori Toyoda , Yoshiyuki Ueno , Edward J Gane , Yuichiro Eguchi , Masayuki Kurosaki , Chao Wu , Chenghai Liu , Jia Shang , Norihiro Furusyo , Masaru Enomoto , Jia-Horng Kao , Man-Fung Yuen , §E©ú¶©, Mindie H Nguyen* - - 1 - JOURNAL OF INFECTIOUS DISEASES - JOURNAL OF INFECTIOUS DISEASES 2020 221¨÷(3´Á):389-399­¶
(IF: 5.022, »â°ì±Æ¦W: 11, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 11.96%)

Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy
Hwai-I Yang , Ming-Lun Yeh , Grace L Wong , Cheng-Yuan Peng , Chien-Hung Chen , Huy N Trinh , Ka-Shing Cheung , Qing Xie , Tung-Hung Su , Ritsuzo Kozuka , Dong-Hyun Lee , Eiichi Ogawa , Changqing Zhao , Hui-Bin Ning , Rui Huang , Jiayi Li , Jian Q Zhang , Tatsuya Ide , Huichun Xing , Shinji Iwane , Hirokazu Takahashi , Christopher Wong , Clifford Wong , Chia-Hsin Lin , Joseph Hoang , An Le , Linda Henry , Hidenori Toyoda , Yoshiyuki Ueno , Edward J Gane , Yuichiro Eguchi , Masayuki Kurosaki , Chao Wu , Chenghai Liu , Jia Shang , Norihiro Furusyo , Masaru Enomoto , Jia-Horng Kao , Man-Fung Yuen , Ming-Lung Yu , Mindie H Nguyen - - 1 - JOURNAL OF INFECTIOUS DISEASES - JOURNAL OF INFECTIOUS DISEASES 2020;221(3):389-399
(IF: 5.022, Journal Ranking: 11, Number of Journals of this Field: 92, Ranking: 11.96%)

165

Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
³\³Õ³ó,®}¦¨¹©,¸­©ú­Û,¶À³©®p,¶ÀÂ@¶h,±ç³Õµ{,ªL©yÐA,Á©ú«Û,ÃQà±¾§,Á©s°a,À¹¹Å¨¥,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I*,§E©ú¶©,²ø¸UÀs - - 1 - digestive diseases and sciences - DIGESTIVE DISEASES AND SCIENCES 2020 65¨÷(7´Á):2120-2129­¶
(IF: 2.751, »â°ì±Æ¦W: 57, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 64.77%)

Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
Hsu Po-Yao,Hsu Cheng-Ting,Yeh Ming-Lun,Huang Chung-Feng,Huang Ching-I,Liang Po-Cheng,Lin Yi-Hung,Hsieh Ming-Yen,Wei Yu-Ju,Hsieh Meng-Hsuan,Dai Chia-Yen,Lin Zu-Yau,Chen Shinn-Cherng,Huang Jee-Fu*,Yu Ming-Lung,Chuang Wan-Long - - 1 - digestive diseases and sciences - DIGESTIVE DISEASES AND SCIENCES 2020;65(7):2120-2129
(IF: 2.751, Journal Ranking: 57, Number of Journals of this Field: 88, Ranking: 64.77%)

166

Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication
Ogawa E, Toyoda H, Iio E, Jun DW, ¶À³©®p, Enomoto M, Hsu YC, Haga H, Iwane S, Wong G, Lee DH, Tada T, Liu CH, ²ø¸UÀs, Hayashi J, Cheung R, Yasuda S, Tseng CH, Takahashi H, Tran S, Yeo YH, Henry L, Barnett SD, Nomura H, Nakamuta M, À¹¹Å¨¥, ¶À§Ó´I, Yang HI, Lee MH, Jung Jun M, Kao JH, Eguchi Y, Ueno Y, Tamori A, Furusyo N,§E©ú¶©, Tanaka Y, Nguyen MH; REAL-C Investigators, Ahn SB, Azuma K, Dohmen K, Yoon Jeong J, Jung JH, Kajiwara E, Kato M, Kawano A, Koyanagi T, Ooho A, Park SH, Satoh T, Shimoda S, Song DS, Takahashi K, ¸­©ú­Û, Yoon EL - - 1 - Clinical Infectious Diseases - CLINICAL INFECTIOUS DISEASES 2020 71¨÷(11´Á):2840-2848­¶
(IF: 8.313, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 3.26%)

Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication
Ogawa E, Toyoda H, Iio E, Jun DW, Huang CF, Enomoto M, Hsu YC, Haga H, Iwane S, Wong G, Lee DH, Tada T, Liu CH, Chuang WL, Hayashi J, Cheung R, Yasuda S, Tseng CH, Takahashi H, Tran S, Yeo YH, Henry L, Barnett SD, Nomura H, Nakamuta M, Dai CY, Huang JF, Yang HI, Lee MH, Jung Jun M, Kao JH, Eguchi Y, Ueno Y, Tamori A, Furusyo N, Yu ML, Tanaka Y, Nguyen MH*; REAL-C Investigators, Ahn SB, Azuma K, Dohmen K, Yoon Jeong J, Jung JH, Kajiwara E, Kato M, Kawano A, Koyanagi T, Ooho A, Park SH, Satoh T, Shimoda S, Song DS, Takahashi K, Yeh ML, Yoon EL - - 1 - Clinical Infectious Diseases - CLINICAL INFECTIOUS DISEASES 2020;71(11):2840-2848
(IF: 8.313, Journal Ranking: 3, Number of Journals of this Field: 92, Ranking: 3.26%)

167

Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis.
Wei-Fan Hsu, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chun-Yen Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, ½²¨Ø­Å, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©*, Cheng-Yuan Peng* - - 1 - Scientific Reports - SCIENTIFIC REPORTS 2020 10¨÷(1´Á):5372­¶
(IF: 4.011, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 69, »â°ì±Æ¦W: 21.74%)

Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis.
Wei-Fan Hsu, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chun-Yen Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Pei-Chien Tsai, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu*, Cheng-Yuan Peng* - - 1 - Scientific Reports - SCIENTIFIC REPORTS 2020;10(1):5372
(IF: 4.011, Journal Ranking: 15, Number of Journals of this Field: 69, Ranking: 21.74%)

168

Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapy
±i®x»·,ÃQà±¾§,®}¦¨¹©,³\³Õ³ó,¼B¤jºû,ªL©yÓT,±ç³Õµ{,Á©ú«Û,¬_¦ö¥Á,½²©ö¬À,³¯«a¦t,ªL·q´¼,½²¨Ø­Å,²ø¸UÀs,¤ý­zºö,¶ÀÂ@¶h,¸­©ú­Û,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,À¹¹Å¨¥,¶À³©¾W*,§E©ú¶© - - 1 - J Gastroenterol Hepatol - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2020 35¨÷(11´Á):1886-1892­¶
(IF: 3.632, »â°ì±Æ¦W: 30, »â°ì´Á¥Z¼Æ: 84, »â°ì±Æ¦W: 35.71%)

Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapy
Tyng-Yuan Jang,Yu-Ju Wei,Cheng-Ting Hsu,Po-Yao Hsu,Ta-Wei Liu,,Yi-Hung Lin,Po-Cheng Liang,Meng-Hsuan Hsieh,Yu-Min Ko,Yi-Shan Tsai,Kuan-Yu Chen,Ching-Chih Lin,Pei-Chien Tsai,Shu-Chi Wang,Ching-I Huang,Ming-Lun Yeh,Zu-Yau Lin,Shinn-Cherng Chen,Wan-Long Chuang,Jee-Fu Huang,Chia-Yen Dai,Chung-Feng Huang*,and Ming-Lung Yu - - 1 - J Gastroenterol Hepatol - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2020;35(11):1886-1892
(IF: 3.632, Journal Ranking: 30, Number of Journals of this Field: 84, Ranking: 35.71%)

169

ÀR¯ß»P«DÀR¯ß¬rÅ}±µ¨ü¬ü¨F¥VªvÀø±wªÌ·P¬VC«¬¨xª¢ªº­·ÀI
¤ý§Ó¤å,²ø¥°¼Ý,Chiang, Hung-Che,Huang, Po-Chin,§E©ú¶©,À¹¹Å¨¥* - - 1 - Journal of the Chinese Medical Association - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2020 83¨÷(5´Á):454-460­¶
(IF: 1.894, »â°ì±Æ¦W: 67, »â°ì´Á¥Z¼Æ: 160, »â°ì±Æ¦W: 41.88%)

Risk of hepatitis C virus infection in injecting and noninjecting drug users receiving opioid substitution therapy
Wang, Chih-Wen; Chuang, Hung-Yi; Chiang, Hung-Che; Huang, Po-Chin; Yu, Ming-Lung; Dai, Chia-Yen - - 1 - Journal of the Chinese Medical Association - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2020;83(5):454-460
(IF: 1.894, Journal Ranking: 67, Number of Journals of this Field: 160, Ranking: 41.88%)

170

2020 Taiwan Consensus Statement on the Management of Hepatitis C: Part (I) General Population.
§E©ú¶©*, Chen PJ, À¹¹Å¨¥, Hu TH, ¶À³©®p, Huang YH, Hung CH, Lin CY, Liu CH, Liu CJ, Peng CY, Ling HC, Kao JH, ²ø¸UÀs* - - 1 - J Formos Med Assoc. - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2020 119¨÷(6´Á):1019-1040­¶
(IF: 2.844, »â°ì±Æ¦W: 35, »â°ì´Á¥Z¼Æ: 160, »â°ì±Æ¦W: 21.88%)

2020 Taiwan Consensus Statement on the Management of Hepatitis C: Part (I) General Population.
Yu ML*, Chen PJ, Dai CY, Hu TH, Huang CF, Huang YH, Hung CH, Lin CY, Liu CH, Liu CJ, Peng CY, Ling HC, Kao JH, Chuang WL. - - 1 - J Formos Med Assoc. - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2020;119(6):1019-1040
(IF: 2.844, Journal Ranking: 35, Number of Journals of this Field: 160, Ranking: 21.88%)

171

2020 Taiwan Consensus Statement on the Management of Hepatitis C: Part (II) Special Populations.
§E©ú¶©*, Chen PJ, À¹¹Å¨¥, Hu TH, ¶À³©®p, Huang YH, Hung CH, Lin CY, Liu CH, Liu CJ, Peng CY, Ling HC, Kao JH, ²ø¸UÀs - - 1 - J Formos Med Assoc. - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2020 S0929-6646¨÷(20´Á):30122-4­¶
(IF: 2.844, »â°ì±Æ¦W: 35, »â°ì´Á¥Z¼Æ: 160, »â°ì±Æ¦W: 21.88%)

2020 Taiwan Consensus Statement on the Management of Hepatitis C: Part (II) Special Populations.
Yu ML*, Chen PJ, Dai CY, Hu TH, Huang CF, Huang YH, Hung CH, Lin CY, Liu CH, Liu CJ, Peng CY, Ling HC, Kao JH, Chuang WL. - - 1 - J Formos Med Assoc. - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2020;S0929-6646(20):30122-4
(IF: 2.844, Journal Ranking: 35, Number of Journals of this Field: 160, Ranking: 21.88%)

172

Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy.
Tseng TC, Peng CY, Hsu YC, Su TH, Wang CC, Liu CJ, Yang HC, Yang WT, Lin CH, §E©ú¶©, Lai HC, Tanaka Y, Nguyen MH, Liu CH, Chen PJ, Chen DS, Kao JH* - - 1 - Liver Cancer. - LIVER CANCER 2020 9¨÷(2´Á):207-220­¶
(IF: 5.944, »â°ì±Æ¦W: 35, »â°ì´Á¥Z¼Æ: 230, »â°ì±Æ¦W: 15.22%)

Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy.
Tseng TC, Peng CY, Hsu YC, Su TH, Wang CC, Liu CJ, Yang HC, Yang WT, Lin CH, Yu ML, Lai HC, Tanaka Y, Nguyen MH, Liu CH, Chen PJ, Chen DS, Kao JH*. - - 1 - Liver Cancer. - LIVER CANCER 2020;9(2):207-220
(IF: 5.944, Journal Ranking: 35, Number of Journals of this Field: 230, Ranking: 15.22%)

173

²GÅé¥ÍÀ˶EÂ_¯f¬r©Ê¨xª¢¡A¯×ªÕ¨x¯f©M°sºë©Ê¨x¯f
¨¯¤¯ºÓ, ¶À§Ó´I#, ¿½´f¾ì, §E©ú¶©, ²ø¸UÀs, ¤ý­zºö* - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020 21¨÷(10´Á):3732­¶
(IF: 5.923, »â°ì±Æ¦W: 67, »â°ì´Á¥Z¼Æ: 298, »â°ì±Æ¦W: 22.48%)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
Ciniso Sylvester Shabangu, Jee-Fu Huang#, Hui-Hua Hsiao, Ming-Lung Yu, Wan-Long Chuang, Shu-Chi Wang* - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020;21(10):3732
(IF: 5.923, Journal Ranking: 67, Number of Journals of this Field: 298, Ranking: 22.48%)

174

Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis.
¶À§Ó´I,½²¨Ø­Å,¸­©ú­Û,¶À³©®p,¶ÀÂ@¶h,Á©ú«Û,À¹¹Å¨¥,·¨¥¿ºÖ,³¯«H¦¨,§E©ú¶©*,²ø¸UÀs*, ±i¤å¦t - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2020 119¨÷(1´Á):89-96­¶
(IF: 3.008, »â°ì±Æ¦W: 42, »â°ì´Á¥Z¼Æ: 165, »â°ì±Æ¦W: 25.45%)

Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis.
Jee-Fu Huang,Pei-Chien Tsai,Ming-Lun Yeh,Chung-Feng Huang,Ching-I. Huang,Meng-Hsuan Hsieh, Chia-Yen Dai,Jeng-Fu Yang,Shinn-Chern Chen,Ming-Lung Yu,*,Wan-Long Chuang*, Wen-Yu Chang - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2020;119(1):89-96
(IF: 3.008, Journal Ranking: 42, Number of Journals of this Field: 165, Ranking: 25.45%)

175

Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West.
Hansen Dang, Yee Hui Yeo, Satoshi Yasuda, ¶À³©®p, Etsuko Iio, Charles Landis, Dae Won Jun, Masaru Enomoto, Eiichi Ogawa, ½²¨Ø­Å, An Le, Matthew Liu, Mayumi Maeda, Brian Nguyen, Nathan Ramrakhiani, Linda Henry, Ramsey Cheung, Akihiro Tamori, Takashi Kumada, Yasuhito Tanaka, §E©ú¶©, Hidenori Toyoda*, Mindie H. Nguyen*. - - 1 - Hepatology - HEPATOLOGY 2020 71¨÷(6´Á):1910-1922­¶
(IF: 14.971, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 84, »â°ì±Æ¦W: 5.95%)

Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West.
Hansen Dang, Yee Hui Yeo, Satoshi Yasuda, Chung-Feng Huang, Etsuko Iio, Charles Landis, Dae Won Jun, Masaru Enomoto, Eiichi Ogawa, Pei-Chien Tsai, An Le, Matthew Liu, Mayumi Maeda, Brian Nguyen, Nathan Ramrakhiani, Linda Henry, Ramsey Cheung, Akihiro Tamori, Takashi Kumada, Yasuhito Tanaka, Ming-Lung Yu, Hidenori Toyoda*, Mindie H. Nguyen*. - - 1 - Hepatology - HEPATOLOGY 2020;71(6):1910-1922
(IF: 14.971, Journal Ranking: 5, Number of Journals of this Field: 84, Ranking: 5.95%)

176

Hepatitis B-related Outcomes Following Direct-Acting Antiviral Therapy in Taiwanese Patients With Chronic HBV/HCV Co-Infection.
¸­©ú­Û, ¶À³©®p, ¶ÀÂ@¶h, Holmes JA, Á©s°a, ½²©ö¬À, ±ç³Õµ{, ½²¨Ø­Å, Á©ú«Û, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, Chung RT, §E©ú¶©*. - - 1 - J Hepatol . - JOURNAL OF HEPATOLOGY 2020 73¨÷(1´Á):62-71­¶
(IF: 20.582, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 2.27%)

Hepatitis B-related Outcomes Following Direct-Acting Antiviral Therapy in Taiwanese Patients With Chronic HBV/HCV Co-Infection.
Yeh ML, Huang CF, Huang CI, Holmes JA, Hsieh MH, Tsai YS, Liang PC, Tsai PC, Hsieh MY, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Chung RT, Yu ML*. - - 1 - J Hepatol . - JOURNAL OF HEPATOLOGY 2020;73(1):62-71
(IF: 20.582, Journal Ranking: 2, Number of Journals of this Field: 88, Ranking: 2.27%)

177

Letter to the editors: Successful eradication of HCV by short-course DAAs in HCV-Positive donor to HCV-Negative recipient during Haplo-HSCT
°ª¨|«C,¿½´f¾ì*,¶À§Ó´I,§E©ú¶© - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2020 S0929-6646¨÷(20´Á):30239-4­¶
(IF: 2.844, »â°ì±Æ¦W: 35, »â°ì´Á¥Z¼Æ: 160, »â°ì±Æ¦W: 21.88%)

Letter to the editors: Successful eradication of HCV by short-course DAAs in HCV-Positive donor to HCV-Negative recipient during Haplo-HSCT
Yuh-Ching Gau, Hui-Hua Hsiao, Jee-Fu Huang, Ming-Lung Yu - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2020;S0929-6646(20):30239-4
(IF: 2.844, Journal Ranking: 35, Number of Journals of this Field: 160, Ranking: 21.88%)

178

Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan.
ªLªé§°, ¤ý¤å§», ¼Ú»p¼Ö, ´¿·CÙy, ¿c¬f¼Ù, ³¯«Û¦°, §E©ú¶©, ¤ý¸t¦|* - - 1 - International journal of infectious diseases - INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 2020 97¨÷(-´Á):240-244­¶
(IF: 3.623, »â°ì±Æ¦W: 45, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 48.91%)

Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan.
Chih-Yen Lin, Wen-Hung Wang, Aspiro Nayim Urbina, Sung-Pin Tseng, Po-Liang Lu, Yen-Hsu Chen, Ming-Lung Yu, Seng-Fan Wang* - - 1 - International journal of infectious diseases - INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 2020;97(-):240-244
(IF: 3.623, Journal Ranking: 45, Number of Journals of this Field: 92, Ranking: 48.91%)

179

Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement.
Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan WK, Gane E, Ong-Go AK, Lim SG, Ahn SH,§E©ú¶©, Piratvisuth T, Chan HL*; Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic. - - 1 - Lancet Gastroenterol Hepatol. - LANCET GASTROENTEROLOGY & HEPATOLOGY 2020 5¨÷(8´Á):776-787­¶
(IF: 14.789, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 5.68%)

Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement.
Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan WK, Gane E, Ong-Go AK, Lim SG, Ahn SH, Yu ML, Piratvisuth T, Chan HL*; Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic. - - 1 - Lancet Gastroenterol Hepatol. - LANCET GASTROENTEROLOGY & HEPATOLOGY 2020;5(8):776-787
(IF: 14.789, Journal Ranking: 5, Number of Journals of this Field: 88, Ranking: 5.68%)

180

Reply to "DAA and HBV/HCV co-infection: Glimmer of light and a few shades of grey"
¸­©ú­Û,§E©ú¶©*. - - 1 - J Hepatol. - JOURNAL OF HEPATOLOGY 2020 73¨÷(2´Á):462­¶
(IF: 20.582, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 2.27%)

Reply to "DAA and HBV/HCV co-infection: Glimmer of light and a few shades of grey"
Yeh ML, Yu ML*. - - 1 - J Hepatol. - JOURNAL OF HEPATOLOGY 2020;73(2):462
(IF: 20.582, Journal Ranking: 2, Number of Journals of this Field: 88, Ranking: 2.27%)

181

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy.
¶À³©®p,§E©ú¶©*. - - 1 - Clinical and molecular hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2020 26¨÷(3´Á):251-260­¶
(IF: 3.987, »â°ì±Æ¦W: 31, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 35.23%)

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy.
Chung-Feng Huang,Ming-Lung Yu*. - - 1 - Clinical and molecular hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2020;26(3):251-260
(IF: 3.987, Journal Ranking: 31, Number of Journals of this Field: 88, Ranking: 35.23%)

182

Primary culture of aspiration residual specimens improves the diagnostic accuracy between hepatocellular carcinoma and benign nodules.
ªL¤l³ó*,¤ý´º¥°,¸­©ú­Û,¶ÀÂ@¶h,¬ö¼s©ú,ÃC¼Ý»¨,³¯«H¦¨,¶À³©®p,¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©,²ø¸UÀs - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2020 36¨÷(6´Á):460-466­¶
(IF: 1.737, »â°ì±Æ¦W: 107, »â°ì´Á¥Z¼Æ: 138, »â°ì±Æ¦W: 77.54%)

Primary culture of aspiration residual specimens improves the diagnostic accuracy between hepatocellular carcinoma and benign nodules.
Zu-Yau Lin,Jing-Houng Wang,Ming-Lun Yeh,Ching-I Huang,Kwong-Ming Kee,Yi-Hao Yen,Shinn-Cherng Chen,Chung-Feng Huang,Jee-Fu Huang,Chia-Yen Dai,Ming-Lung Yu,Wan-Long Chuang - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2020;36(6):460-466
(IF: 1.737, Journal Ranking: 107, Number of Journals of this Field: 138, Ranking: 77.54%)

183

µn­²¼ö¯f¬r»PC«¬¨xª¢¯f¬r¶¡¤§¥æ¤¬¤zÂZ
±ç³Õµ{,³¯«a¦t,¶À±R»¨,±i¬ì,¿c¬f¼Ù,¸­©ú­Û,¶À³©®p,¶ÀÂ@¶h,Á©s°a,À¹¹Å¨¥,ªL¤l³ó,³¯«H¦¨,²ø¸UÀs,³¯«Û¦°*,¶À§Ó´I*,§E©ú¶©* - - 1 - Open Forum Infectious Diseases - OPEN FORUM INFECTIOUS DISEASES 2020 7¨÷(8´Á):ofaa272­¶
(IF: 3.656, »â°ì±Æ¦W: 28, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 30.11%)

Viral interference between dengue virus and hepatitis C virus infections
Po-Cheng Liang, Kuan-Yu Chen, Chung-Hao Huang, Ko Chang, Po-Liang Lu, Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, Meng-Hsuan Hsieh, Chia-Yen Dai, Zu-Yau Lin, Shinn-Chern Chen, Wan-Long Chuang, Yen-Hsu Chen*, Jee-Fu Huang*, Ming-Lung Yu* - - 1 - Open Forum Infectious Diseases - OPEN FORUM INFECTIOUS DISEASES 2020;7(8):ofaa272
(IF: 3.656, Journal Ranking: 28, Number of Journals of this Field: 93, Ranking: 30.11%)

184

Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
¶À³©®p,Hsueh-Chou Lai,Chi-Yi Chen,Kuo-Chih Tseng,Hsing-Tao Kuo,Chao-Hung Hung,Jing-Houng Wang,Jyh-Jou Chen,Pei-Lun Lee,Rong-Nan Chien,Chi-Chieh Yang,Gin-Ho Lo,Chi-Ming Tai,Chih-Wen Lin,Jia-Horng Kao,Chun-Jen Liu,Chen-Hua Liu,Sheng-Lei Yan,Ming-Jong Bair,Chun-Yen Lin,Wei-Wen Su,Cheng-Hsin Chu,Chih-Jen Chen,Shui-Yi Tung,Ching-Chu Lo,Pin-Nan Cheng,Yen-Cheng Chiu,Chia-Chi Wang,Jin-Shiung Cheng,Wei-Lun Tsai,Han-Chieh Lin,Yi-Hsiang Huang,¸­©ú­Û,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,½²¨Ø­Å,Cheng-Yuan Peng*,§E©ú¶©* - - 1 - The American journal of gastroenterology - AMERICAN JOURNAL OF GASTROENTEROLOGY 2020 115¨÷(8´Á):1226-1235­¶
(IF: 10.171, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 7.95%)

Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
Chung-Feng Huang,Hsueh-Chou Lai,Chi-Yi Chen,Kuo-Chih Tseng,Hsing-Tao Kuo,Chao-Hung Hung,Jing-Houng Wang,Jyh-Jou Chen,Pei-Lun Lee,Rong-Nan Chien,Chi-Chieh Yang,Gin-Ho Lo,Chi-Ming Tai,Chih-Wen Lin,Jia-Horng Kao,Chun-Jen Liu,Chen-Hua Liu,Sheng-Lei Yan,Ming-Jong Bair,Chun-Yen Lin,Wei-Wen Su,Cheng-Hsin Chu,Chih-Jen Chen,Shui-Yi Tung,Ching-Chu Lo,Pin-Nan Cheng,Yen-Cheng Chiu,Chia-Chi Wang,Jin-Shiung Cheng,Wei-Lun Tsai,Han-Chieh Lin,Yi-Hsiang Huang,Ming-Lun Yeh,Jee-Fu Huang,Chia-Yen Dai,Wan-Long Chuang,Pei-Chien Tsai,Cheng-Yuan Peng,Ming-Lung Yu* - - 1 - The American journal of gastroenterology - AMERICAN JOURNAL OF GASTROENTEROLOGY 2020;115(8):1226-1235
(IF: 10.171, Journal Ranking: 7, Number of Journals of this Field: 88, Ranking: 7.95%)

185

2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report.
Philip Kam-Tao Li,Sunita Bavanandan,Rosmawati Mohamed,Cheuk-Chun Szeto,Vincent Wai-Sun Wong,Kai-Ming Chow,Yock-Young Dan,Chiu-Ching Huang,Ching-Lung Lai,Tawesak Tanwandee,Boon Wee Teo,Grace Lai-Hung Wong,Eng-Kiong Yeoh,Kunitoshi Iseki,Chi-Bon Leung,Hyeong Cheon Park,Talerngsak Kanjanabuch,Wanhong Lu,James Fung,Jidong Jia,Eiichiro Kanda,Man-Ching Law,Hong Liu,Ching-Kong Loo,Siu-Ka Mak,Sing-Leung Lui,Hon-Lok Tang,Angela Yee-Moon Wang,§E©ú¶©,Michael Cheung,Michel Jadoul - - 1 - Kidney international reports - KIDNEY INTERNATIONAL REPORTS 2020 5¨÷(8´Á):1129-1138­¶
(IF: 3.374, »â°ì±Æ¦W: 20, »â°ì´Á¥Z¼Æ: 85, »â°ì±Æ¦W: 23.53%)

2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report.
Philip Kam-Tao Li,Sunita Bavanandan,Rosmawati Mohamed,Cheuk-Chun Szeto,Vincent Wai-Sun Wong,Kai-Ming Chow,Yock-Young Dan,Chiu-Ching Huang,Ching-Lung Lai,Tawesak Tanwandee,Boon Wee Teo,Grace Lai-Hung Wong,Eng-Kiong Yeoh,Kunitoshi Iseki,Chi-Bon Leung,Hyeong Cheon Park,Talerngsak Kanjanabuch,Wanhong Lu,James Fung,Jidong Jia,Eiichiro Kanda,Man-Ching Law,Hong Liu,Ching-Kong Loo,Siu-Ka Mak,Sing-Leung Lui,Hon-Lok Tang,Angela Yee-Moon Wang,Ming-Lung Yu,Michael Cheung,Michel Jadoul - - 1 - Kidney international reports - KIDNEY INTERNATIONAL REPORTS 2020;5(8):1129-1138
(IF: 3.374, Journal Ranking: 20, Number of Journals of this Field: 85, Ranking: 23.53%)

186

Familial clusters of the 2019 novel coronavirus diseases in Taiwan.
À¹¹Å¨¥,§E©ú¶©,ÄÁ¨|§Ó*,¦ó±Ò¥\* - - 1 - Travel medicine and infectious disease - TRAVEL MEDICINE AND INFECTIOUS DISEASE 2020 36¨÷(36´Á):101813­¶
(IF: 4.589, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 18.28%)

Familial clusters of the 2019 novel coronavirus diseases in Taiwan.
Chia-Yen Dai,Ming-Lung Yu,Yuh-Jyh Jong,Chi-Kung Ho - - 1 - Travel medicine and infectious disease - TRAVEL MEDICINE AND INFECTIOUS DISEASE 2020;36(36):101813
(IF: 4.589, Journal Ranking: 17, Number of Journals of this Field: 93, Ranking: 18.28%)

187

Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment.
ªL¤l³ó,Jing-Houng Wang,¸­©ú­Û,¶ÀÂ@¶h,Kwong-Ming Kee, Yi-Hao Yen,³¯«H¦¨,¶À³©®p,¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©,²ø¸UÀs - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2020 36¨÷(9´Á):750-756­¶
(IF: 1.737, »â°ì±Æ¦W: 107, »â°ì´Á¥Z¼Æ: 138, »â°ì±Æ¦W: 77.54%)

Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment.
Zu-Yau Lin,Jing-Houng Wang,Ming-Lun Yeh,Ching-I Huang,Kwong-Ming Kee,Yi-Hao Yen,Shinn-Cherng Chen,Chung-Feng Huang,Jee-Fu Huang,Chia-Yen Dai,Ming-Lung Yu,Wan-Long Chuang - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2020;36(9):750-756
(IF: 1.737, Journal Ranking: 107, Number of Journals of this Field: 138, Ranking: 77.54%)

188

Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment.
DesmondYH Yap,KevinSH Liu,Yu-Chun Hsu,GraceLH Wong,Ming-Chang Tsai,Chien-Hung Chen,Ching-Sheng Hsu,YeeTak Hui,Michael KK Li,Chen-Hua Liu,Yee-Man Kan,§E©ú¶©,Man-Fung Yuen* - - 1 - Clinical and molecular hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2020 26¨÷(4´Á):554-561­¶
(IF: 3.987, »â°ì±Æ¦W: 31, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 35.23%)

Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment.
Desmond Y H Yap,Kevin S H Liu,Yu-Chun Hsu,Grace L H Wong,Ming-Chang Tsai,Chien-Hung Chen,Ching-Sheng Hsu,Yee Tak Hui,Michael K K Li,Chen-Hua Liu,Yee-Man Kan,Ming-Lung Yu,Man-Fung Yuen* - - 1 - Clinical and molecular hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2020;26(4):554-561
(IF: 3.987, Journal Ranking: 31, Number of Journals of this Field: 88, Ranking: 35.23%)

189

Àù¯g¯f¤H±µ¨ü ¤Æ¾ÇªvÀø®ÉºC©Êc«¬¨xª¢­««×«æ©Êµo§@:¤@¨Ç°ÝÃD
À¹¹Å¨¥,¶À§Ó´I,²ø¸UÀs,§E©ú¶©* - - 1 - Journal of viral hepatitis - JOURNAL OF VIRAL HEPATITIS 2020 27¨÷(12´Á):1508­¶
(IF: 3.561, »â°ì±Æ¦W: 31, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 33.33%)

Severe acute exacerbation of HCV infection in cancer patients who undergo chemotherapy: some issues.
Chia-Yen Dai,Jee-Fu Huang,Wan-Long Chuang,Ming-Lung Yu - - 1 - Journal of viral hepatitis - JOURNAL OF VIRAL HEPATITIS 2020;27(12):1508
(IF: 3.561, Journal Ranking: 31, Number of Journals of this Field: 93, Ranking: 33.33%)

190

´`Àôlet-7±Ú¸~½F§í¨î¸s»E»PºC©ÊC«¬¨xª¢Á{§Éªí¼xÃöÁp©Ê
½²©ö¬À,¸­©ú­Û,½²¨Ø­Å,¶ÀÂ@¶h,¶À³©¾W,Á©s°a,¼B¤jºû,ªL©yÐA,±ç³Õµ{,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,²ø¸UÀs,À¹¹Å¨¥*,§E©ú¶©* - - 1 - International journal of molecular sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020 21¨÷(14´Á):4945­¶
(IF: 4.556, »â°ì±Æ¦W: 74, »â°ì´Á¥Z¼Æ: 297, »â°ì±Æ¦W: 24.92%)

Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C.
Yi-Shan Tsai,Ming-Lun Yeh,Pei-Chien Tsai,Ching-I Huang,Chung-Feng Huang,Meng-Hsuan Hsieh,Ta-Wei Liu,Yi-Hung Lin,Po-Cheng Liang,Zu-Yau Lin,Shinn-Cherng Chen,Jee-Fu Huang,Wan-Long Chuang,Chia-Yen Dai,Ming-Lung Yu - - 1 - International journal of molecular sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020;21(14):4945
(IF: 4.556, Journal Ranking: 74, Number of Journals of this Field: 297, Ranking: 24.92%)

191

Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication.
¶À³©®p*,À¹¹Å¨¥,¸­©ú­Û,¶ÀÂ@¶h,Hsiang-ChunLee,Wen-TerLai,±ç³Õµ{,ªL©yÐA,Á©ú«Û,«J¤D¤¯,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,²ø¸UÀs,§E©ú¶© - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2020 36¨÷(11´Á):920-928­¶
(IF: 1.737, »â°ì±Æ¦W: 107, »â°ì´Á¥Z¼Æ: 138, »â°ì±Æ¦W: 77.54%)

Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication.
Chung-Feng Huang*,Chia-Yen Dai,Ming-Lun Yeh,Ching-I Huang,Hsiang-Chun Lee,Wen-Ter Lai,Po-Cheng Liang,Yi-Hung Lin,Ming-Yen Hsieh,Nai-Jen Hou,Zu-Yau Lin,Shinn-Cherng Chen,Jee-Fu Huang,Wan-Long Chuang,Ming-Lung Yu - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2020;36(11):920-928
(IF: 1.737, Journal Ranking: 107, Number of Journals of this Field: 138, Ranking: 77.54%)

192

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C.
§õ¨Î»T,ÃQà±¾§,ªL©ú«Û,¶s¸t¤å,³\³Õ³ó,¶À«T¸R,±i®x»·,¸­©ú­Û,¶ÀÂ@¶h,±ç³Õµ{,ªL©yÐA,Á©ú«Û,Á©s°a,³¯«ä¹Å,À¹¹Å¨¥,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,±i­õ»Ê,¶À©|§Ó,¶À³©®p,ªô©É¤å*,²ø¸UÀs*,§E©ú¶© - - 1 - PloS one - PLOS ONE 2020 15¨÷(11´Á):e0242601­¶
(IF: 2.74, »â°ì±Æ¦W: 27, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 38.03%)

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C.
Jia-Jung Lee,Yu-Ju Wei,Ming-Yen Lin,Sheng-Wen Niu,Po-Yao Hsu,Jiun-Chi Huang,Tyng-Yuan Jang,Ming-Lun Yeh,Ching-I Huang,Po-Cheng Liang,Yi-Hung Lin,Ming-Yen Hsieh,Meng-Hsuan Hsieh,Szu-Chia Chen,Chia-Yen Dai,Zu-Yau Lin,Shinn-Cherng Chen,Jee-Fu Huang,Jer-Ming Chang,Shang-Jyh Hwang,Chung-Feng Huang,Yi-Wen Chiu,Wan-Long Chuang,Ming-Lung Yu - - 1 - PloS one - PLOS ONE 2020;15(11):e0242601
(IF: 2.74, Journal Ranking: 27, Number of Journals of this Field: 71, Ranking: 38.03%)

193

ºC©ÊC«¬¨xª¢±wªÌ¦¨¥\ªº§Ü¯f¬rÀøªk¥i­°§Cºë¯«¤Àµõ¯gµo¯f¡G¤@­Ó¥þ°ê©Ê¯u¹êÀô¹Ò»OÆW¤H¥@¥N¡]T-COACH¡^
½²¨Ø­Å,Chi-YiChen,Hsing-TaoKuo,Chao-HungHung,Kuo-ChihTseng,Hsueh-ChouLai,Cheng-YuanPeng,Jing-HoungWang,Jyh-JouChen,Pei-LunLee,Rong-NanChien,Chi-ChiehYang,Gin-HoLo,Jia-HorngKao,Chun-JenLiu,Chen-HuaLiu,Sheng-LeiYan,Ming-JongBair,Chun-YenLin,Wei-WenSu,Cheng-HsinChu,Chih-JenChen,Shui-YiTung,Chi‐MingTai,Chih-WenLin,Ching-ChuLo,Pin-NanCheng,Yen-ChengChiu,Chia-ChiWang,Jin-ShiungCheng,Wei-LunTsai,Han-ChiehLin,Yi-HsiangHuang,¸­©ú­Û,¶À³©®p,Á©s°a,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,¬_¥©«W#,§E©ú¶©# - - 1 - Open Forum Infectious Diseases - OPEN FORUM INFECTIOUS DISEASES 2020 10¨÷(7´Á):ofaa397­¶
(IF: 3.656, »â°ì±Æ¦W: 28, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 30.11%)

Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis C patients : a nation-wide real-world Taiwanese cohort (T-COACH)
Pei-Chien Tsai, Chi-Yi Chen, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi‐Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Ming-Lun Yeh, Chung-Feng Huang, Meng-Hsuan Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chung, Chiao-Li Khale Ke*, Ming-Lung Yu1* - - 1 - Open Forum Infectious Diseases - OPEN FORUM INFECTIOUS DISEASES 2020;10(7):ofaa397
(IF: 3.656, Journal Ranking: 28, Number of Journals of this Field: 93, Ranking: 30.11%)

194

Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index.
¼B¤jºû,¶À³©®p,¸­©ú­Û,½²¨Ø­Å,±i®x»·,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©* - - 1 - BMJ open gastroenterology - BMJ OPEN 2020 7¨÷(1´Á):e000543­¶
(IF: 2.496, »â°ì±Æ¦W: 52, »â°ì´Á¥Z¼Æ: 165, »â°ì±Æ¦W: 31.52%)

Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index.
Ta-Wei Liu,Chung-Feng Huang,Ming-Lun Yeh,Pei-Chien Tsai,Tyng-Yuan Jang,Jee-Fu Huang,Chia-Yen Dai,Wan-Long Chuang,Ming-Lung Yu - - 1 - BMJ open gastroenterology - BMJ OPEN 2020;7(1):e000543
(IF: 2.496, Journal Ranking: 52, Number of Journals of this Field: 165, Ranking: 31.52%)

195

Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter.
¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©*,²ø¸UÀs - - 1 - Hepatology (Baltimore, Md.) - HEPATOLOGY 2020 72¨÷(2´Á):781­¶
(IF: 14.679, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 6.82%)

Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter.
Jee-Fu Huang,Chia-Yen Dai,Ming-Lung Yu*,Wan-Long Chuang - - 1 - Hepatology (Baltimore, Md.) - HEPATOLOGY 2020;72(2):781
(IF: 14.679, Journal Ranking: 6, Number of Journals of this Field: 88, Ranking: 6.82%)

196

Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents.
±i®x»·,¶ÀÂ@¶h,¸­©ú­Û,±ç³Õµ{,½²¨Ø­Å,ªL©yÐA,Á©ú«Û,«J¤D¤¯,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,À¹¹Å¨¥,¶À³©®p*,²ø¸UÀs,§E©ú¶©* - - 1 - Journal of gastroenterology and hepatology - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2020 35¨÷(3´Á):473-481­¶
(IF: 3.437, »â°ì±Æ¦W: 42, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 47.73%)

Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents.
Tyng-Yuan Jang,Ching-I Huang,Ming-Lun Yeh,Po-Cheng Liang,Pei-Chien Tsai,Yi-Hung Lin,Ming-Yen Hsieh,Nai-Jen Hou,Zu-Yau Lin,Shinn-Cherng Chen,Jee-Fu Huang,Chia-Yen Dai,Chung-Feng Huang*,Wan-Long Chuang,Ming-Lung Yu* - - 1 - Journal of gastroenterology and hepatology - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2020;35(3):473-481
(IF: 3.437, Journal Ranking: 42, Number of Journals of this Field: 88, Ranking: 47.73%)

197

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy.
¸­©ú­Û,KuoHT,¶ÀÂ@¶h,¶À³©®p,Á©ú«Û,±ç³Õµ{,ªL©yÐA,Á©s°a,ªL¤l³ó,³¯«H¦¨,À¹¹Å¨¥,¶À§Ó´I,§E©ú¶©*,²ø¸UÀs - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2020 37¨÷(2´Á):145-153.­¶
(IF: 1.737, »â°ì±Æ¦W: 107, »â°ì´Á¥Z¼Æ: 138, »â°ì±Æ¦W: 77.54%)

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy.
Ming-Lun Yeh,Hsing-Tao Kuo,Ching-I Huang,Chung-Feng Huang,Ming-Yen Hsieh,Po-Cheng Liang,I-Hung Lin,Meng-Hsuan Hsieh,Zu-Yau Lin,Shinn-Chern Chen,Chia-Yen Dai,Jee-Fu Huang,Ming-Lung Yu,Wan-Long Chuang - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2020;37(2):145-153.
(IF: 1.737, Journal Ranking: 107, Number of Journals of this Field: 138, Ranking: 77.54%)

198

Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B.
HuangYW,HsuCW,LuSN,§E©ú¶©,SuCW,SuWW,ChienRN,HsuCS,HsuSJ,LaiHC,QinA,TsengKC,ChenPJ*. - - 1 - Hepatology international - HEPATOLOGY INTERNATIONAL 2020 14¨÷(6´Á):997-1008.­¶
(IF: 5.102, »â°ì±Æ¦W: 20, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 22.73%)

Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B.
Yi-Wen Huang,Chao-Wei Hsu,Sheng-Nan Lu,Ming-Lung Yu,Chien-Wei Su,Wei-Wen Su,Rong-Nan Chien,Ching-Sheng Hsu,Shih-Jer Hsu,Hsueh-Chou Lai,Albert Qin,Kuan-Chiao Tseng,Pei-Jer Chen - - 1 - Hepatology international - HEPATOLOGY INTERNATIONAL 2020;14(6):997-1008.
(IF: 5.102, Journal Ranking: 20, Number of Journals of this Field: 88, Ranking: 22.73%)

199

Corrigendum to "Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan" [Int J Infect Dis 97 (2020) 240-244].
LinCY,WangWH,UrbinaAN,TsengSP,LuPL,ChenYH,§E©ú¶©,WangSF*. - - 1 - Int J Infect Dis. - INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 2020 98¨÷(0´Á):440­¶
(IF: 3.202, »â°ì±Æ¦W: 38, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 40.86%)

Corrigendum to "Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan" [Int J Infect Dis 97 (2020) 240-244].
Chih-Yen Lin,Wen-Hung Wang,Aspiro Nayim Urbina,Sung-Pin Tseng,Po-Liang Lu,Yen-Hsu Chen,Ming-Lung Yu,Sheng-Fan Wang - - 1 - Int J Infect Dis. - INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 2020;98(0):440
(IF: 3.202, Journal Ranking: 38, Number of Journals of this Field: 93, Ranking: 40.86%)

200

Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients.
YeoYH,TsengTC,HosakaT,CunninghamC,FungJYY,HoHJ,KwakMS,TrinhHN,UngtrakulT,§E©ú¶©,KobayashiM,LeAK,HenryL,LiJ,ZhangJ,SriprayoonT,JeongD,TanwandeeT,GaneE,CheungRC,WuCY,LokAS,LeeHS,SuzukiF,YuenMF,KaoJH,YangHI,NguyenMH*. - - 1 - Clinical and translational gastroenterology - CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 2020 11¨÷(9´Á):e00196­¶
(IF: 3.968, »â°ì±Æ¦W: 32, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 36.36%)

Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients.
Yee Hui Yeo,Tai-Chung Tseng,Tetsuya Hosaka,Chris Cunningham,James Yan Yue Fung,Hsiu J Ho,Min-Sun Kwak,Huy N Trinh,Teerapat Ungtrakul,Ming-Lung Yu,Mariko Kobayashi,An K Le,Linda Henry,Jiayi Li,Jian Zhang,Tassanee Sriprayoon,Donghak Jeong,Tawesak Tanwandee,Ed Gane,Ramsey C Cheung,Chun-Ying Wu,Anna S Lok,Hyo-Suk Lee,Fumitaka Suzuki,Man-Fung Yuen,Jia-Horng Kao,Hwai-I Yang,Mindie H Nguyen - - 1 - Clinical and translational gastroenterology - CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 2020;11(9):e00196
(IF: 3.968, Journal Ranking: 32, Number of Journals of this Field: 88, Ranking: 36.36%)

201

Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa.
¸­©ú­Û,¶À§Ó´I,§E©ú¶©,²ø¸UÀs* - - 1 - Expert review of gastroenterology & hepatology - EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 2020 15¨÷(4´Á):427-435.­¶
(IF: 3.514, »â°ì±Æ¦W: 41, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 46.59%)

Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa.
Ming-Lun Yeh,Jee-Fu Huang,Ming-Lung Yu,Wan-Long Chuang* - - 1 - Expert review of gastroenterology & hepatology - EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 2020;15(4):427-435.
(IF: 3.514, Journal Ranking: 41, Number of Journals of this Field: 88, Ranking: 46.59%)

202

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort.
TanakaY,OgawaE,¶À³©®p,ToyodaH,JunDW,TsengCH,HsuYC,EnomotoM,TakahashiH,FurusyoN,¸­©ú­Û,IioE,YasudaS,LamCP,LeeDH,HagaH,YoonEL,AhnSB,WongG,NakamutaM,NomuraH,½²¨Ø­Å,JungJH,SongDS,DangH,MaedaM,HenryL,CheungR,YuenMF,UenoY,EguchiY,TamoriA,§E©ú¶©,HayashiJ,NguyenMH*;REAL-CInvestigators. - - 1 - Hepatology international - HEPATOLOGY INTERNATIONAL 2020 14¨÷(6´Á):1023-1033­¶
(IF: 5.102, »â°ì±Æ¦W: 20, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 22.73%)

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort.
Yasuhito Tanaka,Eiichi Ogawa,Chung-Feng Huang,Hidenori Toyoda,Dae Won Jun,Cheng-Hao Tseng,Yao-Chun Hsu,Masaru Enomoto,Hirokazu Takahashi,Norihiro Furusyo,Ming-Lun Yeh,Etsuko Iio,Satoshi Yasuda,Carla Pui-Mei Lam,Dong Hyun Lee,Hiroaki Haga,Eileen L Yoon,Sang Bong Ahn,Grace Wong,Makoto Nakamuta,Hideyuki Nomura,Pei-Chien Tsai,Jang Han Jung,Do Seon Song,Hansen Dang,Mayumi Maeda,Linda Henry,Ramsey Cheung,Man-Fung Yuen,Yoshiyuki Ueno,Yuichiro Eguchi,Akihiro Tamori,Ming-Lung Yu,Jun Hayashi,Mindie H Nguyen, - - 1 - Hepatology international - HEPATOLOGY INTERNATIONAL 2020;14(6):1023-1033
(IF: 5.102, Journal Ranking: 20, Number of Journals of this Field: 88, Ranking: 22.73%)

203

Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.
¶À³©®p, ¤ý­zºö, ¸­©ú­Û, ¶ÀÂ@¶h, ½²¨Ø­Å, ªL¤l³ó, ³¯«H¦¨, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, Chen A, §E©ú¶©* - - 1 - Journal of Gastroenterology and Hepatology - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2019 34¨÷(1´Á):249-255­¶
(IF: 3.632, »â°ì±Æ¦W: 30, »â°ì´Á¥Z¼Æ: 84, »â°ì±Æ¦W: 35.71%)

Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.
Huang CF, Wang SC, Yeh ML, Huang CI, Tsai PC, Lin ZY, Chen SC, Dai CY, Huang JF, Chuang WL, Chen A, Yu ML* - - 1 - Journal of Gastroenterology and Hepatology - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2019;34(1):249-255
(IF: 3.632, Journal Ranking: 30, Number of Journals of this Field: 84, Ranking: 35.71%)

204

Association between urinary thiodiglycolic acid level and hepatic function or fibrosis index in school-aged children living near a petrochemical complex.
¤ý§Ó¤å,¹ù³Í«Â,¸âªøÅv,§E©ú¶©,²ø¥°¼Ý,¦¿§»­õ,¶À¬fµ×* - - 1 - Environmental Pollution - ENVIRONMENTAL POLLUTION 2019 244¨÷(244´Á):648-656­¶
(IF: 5.714, »â°ì±Æ¦W: 25, »â°ì´Á¥Z¼Æ: 251, »â°ì±Æ¦W: 9.96%)

Association between urinary thiodiglycolic acid level and hepatic function or fibrosis index in school-aged children living near a petrochemical complex.
Wang CW,Liao KW,Chan CC,Yu ML,Chuang HY,Chiang HC,Huang PC - - 1 - Environmental Pollution - ENVIRONMENTAL POLLUTION 2019;244(244):648-656
(IF: 5.714, Journal Ranking: 25, Number of Journals of this Field: 251, Ranking: 9.96%)

205

Fulminant Emphysematous Pancreatic Pseudocyst: Infected with Normal Skin Flora.
¤ý§Ó¤å,À¹¹Å¨¥,²ø­õ©ú,¶À³©®p,¸­©ú­Û,¶ÀÂ@¶h,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,§E©ú¶©*,²ø¸UÀs. - - 1 - AMERICAN JOURNAL OF MEDICINE - AMERICAN JOURNAL OF MEDICINE 2019 132¨÷(2´Á):E41-E42­¶
(IF: 4.529, »â°ì±Æ¦W: 23, »â°ì´Á¥Z¼Æ: 165, »â°ì±Æ¦W: 13.94%)

Fulminant Emphysematous Pancreatic Pseudocyst: Infected with Normal Skin Flora.
Wang CW, Dai CY, Chuang TM, Huang CF, Yeh ML, Huang CI, Lin ZY, Chen SC, Huang JF, Yu ML, Chuang WL - - 1 - AMERICAN JOURNAL OF MEDICINE - AMERICAN JOURNAL OF MEDICINE 2019;132(2):E41-E42
(IF: 4.529, Journal Ranking: 23, Number of Journals of this Field: 165, Ranking: 13.94%)

206

Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus-infected patients
Batsaikhan B,Gantumur G,¶ÀÂ@¶h,¸­©ú­Û,¶À³©®p,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,§E©ú¶©,²ø¸UÀs,§õ´º´Ü,À¹¹Å¨¥* - - 1 - Journal of the Chinese Medical Association - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2019 82¨÷(2´Á):99-104­¶
(IF: 1.894, »â°ì±Æ¦W: 67, »â°ì´Á¥Z¼Æ: 160, »â°ì±Æ¦W: 41.88%)

Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus-infected patients.
Batsaikhan B, Gantumur G, Huang CI, Yeh ML, Huang CF, Lin ZY, Chen SC, Huang JF, Yu ML, Chuang WL, Lee JC, Dai CY* - - 1 - Journal of the Chinese Medical Association - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2019;82(2):99-104
(IF: 1.894, Journal Ranking: 67, Number of Journals of this Field: 160, Ranking: 41.88%)

207

Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia
Zobair M. Younossi*,Linda Henry,Janus P. Ong,Atsushi Tanaka,Yuichiro Eguchi,Masashi Mizokami,Young‐Suk Lim,Yock Young Dan,§E©ú¶©,Maria Stepanova - - 1 - ALIMENTARY PHARMACOLOGY & THERAPEUTICS - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2019 49¨÷(6´Á):644-653­¶
(IF: 7.731, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 267, »â°ì±Æ¦W: 3.75%)

Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia
Zobair M. Younossi*,Linda Henry,Janus P. Ong,Atsushi Tanaka,Yuichiro Eguchi,Masashi Mizokami,Young‐Suk Lim,Yock Young Dan,Ming‐Lung Yu,Maria Stepanova - - 1 - ALIMENTARY PHARMACOLOGY & THERAPEUTICS - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2019;49(6):644-653
(IF: 7.731, Journal Ranking: 10, Number of Journals of this Field: 267, Ranking: 3.75%)

208

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
¶À³©®p,§E©ú¶©* - - 1 - Clinical and Molecular Hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2019 25¨÷(2´Á):168-171­¶
(IF: 3.987, »â°ì±Æ¦W: 31, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 35.23%)

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Huang CF,Yu ML - - 1 - Clinical and Molecular Hepatology - CLINICAL AND MOLECULAR HEPATOLOGY 2019;25(2):168-171
(IF: 3.987, Journal Ranking: 31, Number of Journals of this Field: 88, Ranking: 35.23%)

209

Genome-wide DNA hypermethylation and homocysteine increase a risk for myopia
Hsi E,Wang YS,Huang CW,§E©ú¶©,Juo SH*,Liang CL - - 1 - INTERNATIONAL JOURNAL OF OPHTHALMOLOGY - INTERNATIONAL JOURNAL OF OPHTHALMOLOGY 2019 12¨÷(1´Á):38-45­¶
(IF: 1.189, »â°ì±Æ¦W: 51, »â°ì´Á¥Z¼Æ: 60, »â°ì±Æ¦W: 85.00%)

Genome-wide DNA hypermethylation and homocysteine increase a risk for myopia
Hsi E,Wang YS,Huang CW,Yu ML,Juo SH*,Liang CL - - 1 - INTERNATIONAL JOURNAL OF OPHTHALMOLOGY - INTERNATIONAL JOURNAL OF OPHTHALMOLOGY 2019;12(1):38-45
(IF: 1.189, Journal Ranking: 51, Number of Journals of this Field: 60, Ranking: 85.00%)

210

APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment
Kanda T, Lau GKK, Wei L, Moriyama M, §E©ú¶©, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DHG, Kao JH, Yokosuka O, Sarin SK, Omata M* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2019 13¨÷(2´Á):103-109­¶
(IF: 5.49, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 84, »â°ì±Æ¦W: 20.24%)

APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment
Kanda T, Lau GKK, Wei L, Moriyama M, Yu ML, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DHG, Kao JH, Yokosuka O, Sarin SK, Omata M* - - 1 - HEPATOLOGY INTERNATIONAL - HEPATOLOGY INTERNATIONAL 2019;13(2):103-109
(IF: 5.49, Journal Ranking: 17, Number of Journals of this Field: 84, Ranking: 20.24%)

211

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions.
§E©ú¶©*, Hung CH, Huang YH, Peng CY, Lin CY, Cheng PN, Chien RN, Hsu SJ, Liu CH, ¶À³©®p, Su CW, ¶À§Ó´I, Liu CJ, Kao JH, ²ø¸UÀs*, Chen PJ, Chen DS - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2019 18¨÷(2´Á):556-564­¶
(IF: 2.844, »â°ì±Æ¦W: 35, »â°ì´Á¥Z¼Æ: 160, »â°ì±Æ¦W: 21.88%)

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions.
Yu ML*, Hung CH, Huang YH, Peng CY, Lin CY, Cheng PN, Chien RN, Hsu SJ, Liu CH, Huang CF, Su CW, Huang JF, Liu CJ, Kao JH, Chuang WL, Chen PJ, Chen DS - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2019;18(2):556-564
(IF: 2.844, Journal Ranking: 35, Number of Journals of this Field: 160, Ranking: 21.88%)

212

¦å²MÀËÅ餤C«¬¨x¯f¬rRNAÀx¦s¦b4¢Jí©w©Ê´ú¸Õ
¶À­^¬w,¼B²Qªâ,¼B­i§u,¶À³©®p,¸­©ú­Û,À¹¹Å¨¥,½²¨Ø­Å,³¯«H¦¨,§E©ú¶©,²ø¸UÀs,¶À§Ó´I* - - 9 - Advances in digestive medicine - 2019 1¨÷(1´Á):1-4­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

The acceptability of serum sample storage for hepatitis C viral load analysis in chronic hepatitis C patients
Ying-Chou Huang, Shu-Fen Liu, Hung-Yin Liu, Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Pei-Chien Tsai, Shinn-Cherng Chen, Ming-Lung Yu, Wan-Long Chuang, Jee-Fu Huang* - - 9 - Advances in digestive medicine - 2019;1(1):1-4
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

213

A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6.
Liu X, Duan X, Holmes JA, Li W, Lee SH, Tu Z, Cai D, Li S, Wang H, Huang Y, Zhao Y,§E©ú¶©, Xu Z, Chen L, Hong J, Lin W, Chung RT - - 1 - HEPATOLOGY - HEPATOLOGY 2019 69¨÷(3´Á):1004-19­¶
(IF: 14.971, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 84, »â°ì±Æ¦W: 5.95%)

A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6.
Liu X, Duan X, Holmes JA, Li W, Lee SH, Tu Z, Cai D, Li S, Wang H, Huang Y, Zhao Y, Yu ML, Xu Z, Chen L, Hong J, Lin W, Chung RT - - 1 - HEPATOLOGY - HEPATOLOGY 2019;69(3):1004-19
(IF: 14.971, Journal Ranking: 5, Number of Journals of this Field: 84, Ranking: 5.95%)

214

ºC©ÊC«¬¨xª¢¦X¨Ö¨xÀù±wªÌ±µ¨ü¤p¤À¤l§Ü¯f¬rÃĪ«ªvÀø¬O§_¦³¦Pµ¥Àø®Ä-¤@«e¤©Ê¬ã¨s
¶À³©®p,¸­©ú­Û,¶ÀÂ@¶h,±ç³Õµ{,ªL©yÐA,Á©ú«Û,ÃQà±¾§,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©* - - 1 - BMJ Open - BMJ OPEN 2019 9¨÷(5´Á):e026703­¶
(IF: 2.376, »â°ì±Æ¦W: 50, »â°ì´Á¥Z¼Æ: 160, »â°ì±Æ¦W: 31.25%)

Equal treatment efficacy of direct-acting antivirals in chronic hepatitis C patients with hepatocellular carcinoma? A prospective cohort study
Chung-Feng Huang,Ming-Lun Yeh,Ching-I Huang, Po-Cheng Liang,Yi-Hung Lin, Ming-Yen Hsieh,Yu-Ju Wei,Zu-Yau Lin,Shinn-Cherng Chen,Jee-Fu Huang,Chia-Yen Dai,Wan-Long Chuang,Ming-Lung Yu* - - 1 - BMJ Open - BMJ OPEN 2019;9(5):e026703
(IF: 2.376, Journal Ranking: 50, Number of Journals of this Field: 160, Ranking: 31.25%)

215

Pretreatment Hepatitis B Viral Load Predicts Long-Term Hepatitis B Response After Anti-Hepatitis C Therapy in Hepatitis B/C Dual-Infected Patients.
¸­©ú­Û,¶ÀÂ@¶h,¶À³©®p,Á©s°a,¼B¤jºû,ªL©yÐA,±ç³Õµ{,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I, ³¢¬fÅï,À¹¹Å¨¥*,§E©ú¶©,²ø¸UÀs - - 1 - The Journal of Infectious Diseases - JOURNAL OF INFECTIOUS DISEASES 2019 219¨÷(8´Á):1224-1233­¶
(IF: 5.045, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 89, »â°ì±Æ¦W: 11.24%)

Pretreatment Hepatitis B Viral Load Predicts Long-Term Hepatitis B Response After Anti-Hepatitis C Therapy in Hepatitis B/C Dual-Infected Patients.
Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Meng-Hsuan Hsieh, Ta-Wei Liu, Yi-Hung Lin, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Po-Lin Kuo, Chia-Yen Dai*, Ming-Lung Yu, Wan-Long Chuang - - 1 - The Journal of Infectious Diseases - JOURNAL OF INFECTIOUS DISEASES 2019;219(8):1224-1233
(IF: 5.045, Journal Ranking: 10, Number of Journals of this Field: 89, Ranking: 11.24%)

216

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
Shira Perez, Antony Kaspi, Tom Domovitz, Ateret Davidovich, Anat LaviItzkovitz, Tomer Meirson, Jacinta Alison Holmes, À¹¹Å¨¥, ¶À³©®p, Raymond T. Chung, Assy Nimer, Assam El-Osta, Gur Yaari,Salomon M. Stemmer, §E©ú¶©*, Izhak Haviv*, Meital Gal-Tanamy* - - 1 - PLoS Genetics - PLOS GENETICS 2019 19¨÷(15´Á):e1008181­¶
(IF: 5.224, »â°ì±Æ¦W: 23, »â°ì´Á¥Z¼Æ: 174, »â°ì±Æ¦W: 13.22%)

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
Shira Perez1,, Antony Kaspi, Tom Domovitz, Ateret Davidovich, Anat LaviItzkovitz, Tomer Meirson, Jacinta Alison Holmes, Chia-Yen Dai, ChungFeng Huang, Raymond T. Chung, Assy Nimer, Assam El-Osta, Gur Yaari,Salomon M. Stemmer, Ming-Lung Yu*, Izhak Haviv*, Meital Gal-Tanamy* - - 1 - PLoS Genetics - PLOS GENETICS 2019;19(15):e1008181
(IF: 5.224, Journal Ranking: 23, Number of Journals of this Field: 174, Ranking: 13.22%)

217

¤¤³¡¥Û¤Æ°Ïªþªñ¾Çµ£²¸¥N¤G¤A»Ä¼ÉÅS»P¯×ªÕ¨x­·ÀI¬ÛÃö©Ê¬ã¨s
¤ý§Ó¤å,²ø¥°¼Ý,¹ù³Í«Â,§E©ú¶©,À¹¹Å¨¥,±i°û´@,½²¬F¾Ë,¦¿§»­õ,¶À¬fµ×* - - 1 - ENVIRONMENT INTERNATIONAL - ENVIRONMENT INTERNATIONAL 2019 131¨÷(-´Á):104978­¶
(IF: 7.943, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 251, »â°ì±Æ¦W: 3.19%)

Urinary Thiodiglycolic Acid is Associated with Increased Risk of Non-Alcoholic Fatty Liver Disease in Children Living near a Petrochemical Complex
Chih-Wen Wang, Hung-Yi Chuang, Kai-Wei Liao, Ming-Lung Yu, Chia-Yen Dai, Wan-Ting Chang, Cheng-Hsan Tsai, Hung-Che Chiang, Po-Chin Huang* - - 1 - ENVIRONMENT INTERNATIONAL - ENVIRONMENT INTERNATIONAL 2019;131(-):104978
(IF: 7.943, Journal Ranking: 8, Number of Journals of this Field: 251, Ranking: 3.19%)

218

Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C.
Batsaikhan B,§f©ú¿o,¸­©ú­Û,¶ÀÂ@¶h,¶À³©®p,ªL¤l³ó,³¯«H¦¨,¶À§Ó´I, ÁªêY, ²ø¸UÀs,§õ´º´Ü,§E©ú¶©,À¹¹Å¨¥* - - 1 - Journal of the Chinese Medical Association - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2019 82¨÷(4´Á):277-281­¶
(IF: 2.17, »â°ì±Æ¦W: 63, »â°ì´Á¥Z¼Æ: 165, »â°ì±Æ¦W: 38.18%)

Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C.
Batsaikhan B, Lu MY, Yeh ML, Huang CI, Huang CF, Lin ZY, Chen SC, Huang JF, Hsieh PH, Chuang WL, Lee JC, Yu ML, Dai CY* - - 1 - Journal of the Chinese Medical Association - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2019;82(4):277-281
(IF: 2.17, Journal Ranking: 63, Number of Journals of this Field: 165, Ranking: 38.18%)

219

Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection.
Hsu CC, Hsieh PM, Chen YS, Lo GH, Lin HY, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, Chen YL, §E©ú¶©, Lin CW - - 1 - Cancer Med - CANCER MEDICINE 2019 8¨÷(7´Á):3453-3463­¶
(IF: 3.357, »â°ì±Æ¦W: 98, »â°ì´Á¥Z¼Æ: 230, »â°ì±Æ¦W: 42.61%)

Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection.
Hsu CC, Hsieh PM, Chen YS, Lo GH, Lin HY, Dai CY, Huang JF, Chuang WL, Chen YL, Yu ML, Lin CW - - 1 - Cancer Med - CANCER MEDICINE 2019;8(7):3453-3463
(IF: 3.357, Journal Ranking: 98, Number of Journals of this Field: 230, Ranking: 42.61%)

220

Integrated care for methadone maintenance patients with hepatitis C virus infection
À¹±Ò©ú,Yung‐Chieh Yen,Ming‐Jong Bair,Cheng‐Hao Tseng,Ting‐Ting Chang,¶À³©®p,¸­©ú­Û,À¹¹Å¨¥,²ø¸UÀs, §E©ú¶©,¶À§Ó´I* - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2019 35¨÷(8´Á):501-507­¶
(IF: 1.291, »â°ì±Æ¦W: 114, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 83.82%)

Integrated care for methadone maintenance patients with hepatitis C virus infection
Chi‐Ming Tai,Yung‐Chieh Yen,Ming‐Jong Bair,Cheng‐Hao Tseng,Ting‐Ting Chang,Chung‐Feng Huang,Ming‐Lun Yeh,Chia‐Yen Dai,Wan‐Long Chuang, Ming‐Lung Yu,Jee‐Fu Huang* - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2019;35(8):501-507
(IF: 1.291, Journal Ranking: 114, Number of Journals of this Field: 136, Ranking: 83.82%)

221

An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naïve chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE)
¶À³©®p, Chao-Hung Hung, Pin-Nan Cheng, Ming-Jong Bair, Yi-Hsiang Huang, Jia-Horng Kao, Shih-Jer Hsu, Pei-Lun Lee, Jyh-Jou Chen, Rong-Nan Chien, Cheng-Yuan Peng, Chun-Yen Lin, Tsai-Yuan Hsieh, Chun-Han Cheng, À¹¹Å¨¥,¶À§Ó´I, ²ø¸UÀs,§E©ú¶©* - - 1 - JOURNAL OF INFECTIOUS DISEASES - JOURNAL OF INFECTIOUS DISEASES 2019 220¨÷(4´Á):557-566­¶
(IF: 5.045, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 89, »â°ì±Æ¦W: 11.24%)

An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naïve chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE)
Huang CF, Hung CH, Cheng PN, Bair MJ, Huang YH, Kao JH, Hsu SJ, Lee PL, Chen JJ, Chien RN, Peng CY, Lin CY, Hsieh TY, Cheng CH, Dai CY, Huang JF, Chuang WL, Yu ML* - - 1 - JOURNAL OF INFECTIOUS DISEASES - JOURNAL OF INFECTIOUS DISEASES 2019;220(4):557-566
(IF: 5.045, Journal Ranking: 10, Number of Journals of this Field: 89, Ranking: 11.24%)

222

Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection.
Tomi Jun,Yao-Chun Hsu,Shintaro Ogawa,Yen-Tsung Huang,¸­©ú­Û,Cheng-Hao Tseng, ¶À³©®p,À¹±Ò©ú,À¹¹Å¨¥,¶À§Ó´I,²ø¸UÀs,§E©ú¶©,Yasuhito Tanaka,and Mindie H. Nguyen* - - 1 - HEPATOLOGY COMMUNICATIONS - HEPATOLOGY COMMUNICATIONS 2019 8¨÷(3(4)´Á):493-503­¶
(IF: 5.701, »â°ì±Æ¦W: 30, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 32.26%)

Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection.
Tomi Jun,Yao-Chun Hsu,Shintaro Ogawa,Yen-Tsung Huang, Ming-Lun Yeh,Cheng-Hao Tseng,Chung-Feng Huang,Chi-Ming Tai,Chia-Yen Dai,Jee-Fu Huang,Wan-Long Chuang,Ming-Lung Yu,Yasuhito Tanaka,Mindie H. Nguyen* - - 1 - HEPATOLOGY COMMUNICATIONS - HEPATOLOGY COMMUNICATIONS 2019;8(3(4)):493-503
(IF: 5.701, Journal Ranking: 30, Number of Journals of this Field: 93, Ranking: 32.26%)

223

C«¬¨xª¢¤p¤À¤l§Ü¯fÃĪ«ªvÀø¯u¹ê¥@¬É¦¨®Ä:REAL-C¨È¬wÁp·ù
¶À³©®p,²ø¸UÀs,¶À§Ó´I,§E©ú¶©,À¹¹Å¨¥,¸­©ú­Û - - 1 - Hepatology International - HEPATOLOGY INTERNATIONAL 2019 13¨÷(5´Á):587-598­¶
(IF: 5.49, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 84, »â°ì±Æ¦W: 20.24%)

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium
Hsu YC,LiuCH,Tseng CH,Tai CM, Lo GH,Lee MH,Yang HI,Kao JH,Iio E,Jun DW,Ogawa E,Toyoda H,Haga H,Iwane S,Enomoto M,Lee DH,Wong G,Tada T,Cheung R,Hayashi J,Yasuda S, Tran S,Kam L,Henry L,Jeong JY,Nomura H,Park SH,Nakamuta M,Tamori A,Eguchi Y,Ueno Y,Furusyo N,Tanaka Y,Nguyen MH* - - 1 - Hepatology International - HEPATOLOGY INTERNATIONAL 2019;13(5):587-598
(IF: 5.49, Journal Ranking: 17, Number of Journals of this Field: 84, Ranking: 20.24%)

224

Pharmacokinetics and pharmacodynamics of pegylated interferon for the treatment of hepatitis B.
¸­©ú­Û,¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©,²ø¸UÀs* - - 1 - Expert Opinion on Drug Metabolism & Toxicology - EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY 2019 15¨÷(10´Á):779-785­¶
(IF: 3.487, »â°ì±Æ¦W: 74, »â°ì´Á¥Z¼Æ: 267, »â°ì±Æ¦W: 27.72%)

Pharmacokinetics and pharmacodynamics of pegylated interferon for the treatment of hepatitis B.
Yeh ML, Huang JF, Dai CY, Yu ML, Chuang WL*. - - 1 - Expert Opinion on Drug Metabolism & Toxicology - EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY 2019;15(10):779-785
(IF: 3.487, Journal Ranking: 74, Number of Journals of this Field: 267, Ranking: 27.72%)

225

Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients
¸­©ú­Û, ¶À³©®p, ¶ÀÂ@¶h, À¹¹Å¨¥, ªL©yÐA, ±ç³Õµ{, Á©s°a, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I*, ³¯§Ó¦{*, §E©ú¶©, ²ø¸UÀs - - 1 - PLoS One - PLoS One 2019 14¨÷(8´Á):e0220663­¶
(IF: 2.776, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 69, »â°ì±Æ¦W: 34.78%)

Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients
Yeh ML, Huang CF, Huang CI, Dai CY, Lin IH, Liang PC, Hsieh MH, Lin ZY, Chen SC, Huang JF*, Chen JJ*, Yu ML, Chuang WL. - - 1 - PLoS One - PLoS One 2019;14(8):e0220663
(IF: 2.776, Journal Ranking: 24, Number of Journals of this Field: 69, Ranking: 34.78%)

226

APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation.
Kanda T, Lau GKK, Wei L, Moriyama M, §E©ú¶©, ²ø¸UÀs, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Kadir Dokmeci A, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DHG, °ª¹Å§», Ooka Y, Yokosuka O, Sarin SK, Omata M*. - - 1 - Hepatology International - HEPATOLOGY INTERNATIONAL 2019 13¨÷(6´Á):649-661­¶
(IF: 5.49, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 84, »â°ì±Æ¦W: 20.24%)

APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation.
Kanda T, Lau GKK, Wei L, Moriyama M, Yu ML, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC11, Hamid SS, Kadir Dokmeci A, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DHG, Kao JH, Ooka Y, Yokosuka O, Sarin SK, Omata M*. - - 1 - Hepatology International - HEPATOLOGY INTERNATIONAL 2019;13(6):649-661
(IF: 5.49, Journal Ranking: 17, Number of Journals of this Field: 84, Ranking: 20.24%)

227

Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study.
Liu CH, §E©ú¶©, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH*. - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2019 118¨÷(6´Á):1014-1023­¶
(IF: 2.844, »â°ì±Æ¦W: 35, »â°ì´Á¥Z¼Æ: 160, »â°ì±Æ¦W: 21.88%)

Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study.
Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH*. - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2019;118(6):1014-1023
(IF: 2.844, Journal Ranking: 35, Number of Journals of this Field: 160, Ranking: 21.88%)

228

The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment
¸­©ú­Û,¶À³©®p,¶ÀÂ@¶h,Á©ú«Û,«J¤D¤¯,ªL©yÐA,±ç³Õµ{,½²©ö¬À,Á©s°a,ªL¤l³ó,³¯«H¦¨,À¹¹Å¨¥,¶À§Ó´I,§E©ú¶©*,²ø¸UÀs - - 1 - Kaohsiung J Med Sci - 2019 35¨÷(10´Á):624-632­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment
Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, Ming-Yen Hsieh, Nei-Jen Hou, I-Hung Lin, Po-Cheng Liang, Yi-Shan Tsai, Meng-Hsuan Hsieh, Zu-Yau Lin , Shinn-Chern Chen, Chia-Yen Dai, Jee-Fu Huang, Ming-Lung Yu*, Wan-Long Chuang - - 1 - Kaohsiung J Med Sci - 2019;35(10):624-632
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

229

Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsies.
ªL¤j¶®,¸­©ú­Û,¶À³©®p,¶ÀÂ@¶h,À¹¹Å¨¥,Á©s°a,³¯«H¦¨,¶À§Ó´I*,§E©ú¶©,²ø¸UÀs - - 1 - EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY - EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 2019 31¨÷(2´Á):224-229­¶
(IF: 2.251, »â°ì±Æ¦W: 68, »â°ì´Á¥Z¼Æ: 88, »â°ì±Æ¦W: 77.27%)

Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsies.
Lin TY, Yeh ML, Huang CF, Huang CI, Dai CY, Hsieh MH, Chen SC, Huang JF*, Yu ML, Chuang WL - - 1 - EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY - EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 2019;31(2):224-229
(IF: 2.251, Journal Ranking: 68, Number of Journals of this Field: 88, Ranking: 77.27%)

230

The acceptability of serum sample storage for hepatitis C viral load analysis in chronic hepatitis C patients
Ying-Chou Huang, Shu-Fen Liu, Hung-Yin Liu, ¶À³©®p, ¸­©ú­Û, À¹¹Å¨¥, ½²¨Ø­Å, Shinn-Cherng Chen, §E©ú¶©, ²ø¸UÀs, ¶À§Ó´I - - 1 - Advances in Digestive Medicine - JOURNAL OF ULTRASOUND IN MEDICINE 2019 2019¨÷(0´Á):0­¶
(IF: 2.3, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 31, »â°ì±Æ¦W: 48.39%)

The acceptability of serum sample storage for hepatitis C viral load analysis in chronic hepatitis C patients.
Ying-Chou Huang, Shu-Fen Liu, Hung-Yin Liu, Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Pei-Chien Tsai, Shinn-Cherng Chen, Ming-Lung Yu, Wan-Long Chuang, Jee-Fu Huang - - 1 - Advances in Digestive Medicine - JOURNAL OF ULTRASOUND IN MEDICINE 2019;2019(0):0
(IF: 2.3, Journal Ranking: 15, Number of Journals of this Field: 31, Ranking: 48.39%)

231

¤¤³¡¥Û¤Æ°Ïªþªñ¾Çµ£²¸¥N¤G¤A»Ä¼ÉÅS»P¯×ªÕ¨x­·ÀI¬ÛÃö©Ê¬ã¨s 
¤ý§Ó¤å,²ø¥°¼Ý,¹ù³Í«Â,§E©ú¶©,À¹¹Å¨¥,±i°û´@,½²¬F¾Ë,¦¿§»­õ,¶À¬fµ×*  - - 1 - ENVIRONMENT INTERNATIONAL - ENVIRONMENT INTERNATIONAL 2019 131¨÷(0´Á):104978­¶
(IF: 11.8, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 274, »â°ì±Æ¦W: 6.20%)

Urinary thiodiglycolic acid is associated with increased risk of non-alcoholic fatty liver disease in children living near a petrochemical complex.
Chih-Wen Wang, Hung-Yi Chuang, Kai-Wei Liao, Ming-Lung Yu, Chia-Yen Dai, Wan-Ting Chang, Cheng-Hsan Tsai, Hung-Che Chiang, Po-Chin Huang - - 1 - ENVIRONMENT INTERNATIONAL - ENVIRONMENT INTERNATIONAL 2019;131(0):104978
(IF: 11.8, Journal Ranking: 17, Number of Journals of this Field: 274, Ranking: 6.20%)

232

Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort.
¼B¤jºû, ½²¨Ø­Å, ¶ÀÂ@¶h, ½²©ö¬À, ¤ý­zºö, ¬_¦ö¥Á, ªL·q´¼, ³¯«a¦t, ±ç³Õµ{, ªL©yÐA, Á©ú«Û, «J¤D¤¯, ¶À³©®p, ¸­©ú­Û, ªL¤l³ó, ³¯«H¦¨, À¹¹Å¨¥, ²ø¸UÀs, ¶À§Ó´I, §E©ú¶©* - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018 117¨÷(1´Á):54-62­¶
(IF: 2.452, »â°ì±Æ¦W: 42, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 27.10%)

Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort.
Liu TW, Tsai PC, Huang CI, Tsai YS, Wang SC, Ko YM, Lin CC, Chen KY, Liang PC, Lin YH, Hsieh MY, Hou NJ, Huang CF, Yeh ML, Lin ZY, Chen SC, Dai CY, Chuang WL, Huang JF, Yu ML* - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018;117(1):54-62
(IF: 2.452, Journal Ranking: 42, Number of Journals of this Field: 155, Ranking: 27.10%)

233

Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection.
À¹¹Å¨¥, ªL·q·~, ½²¨Ø­Å, ªL«Ì¨^, ¸­©ú­Û, ¶À³©®p, ±i¤åÀé, ¶À§Ó´I, §E©ú¶©, ³¯³ó«W* - - 1 - Journal of the Chinese Medical Association - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2018 81¨÷(2´Á):155-163­¶
(IF: 1.66, »â°ì±Æ¦W: 72, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 46.45%)

Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection.
Dai CY, Lin CY, Tsai PC, Lin PY, Yeh ML, Huang CF, Chang WT, Huang JF, Yu ML, Chen YL* - - 1 - Journal of the Chinese Medical Association - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2018;81(2):155-163
(IF: 1.66, Journal Ranking: 72, Number of Journals of this Field: 155, Ranking: 46.45%)

234

Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C
¸­©ú­Û, ¶ÀÂ@¶h, ¶À³©®p, Á©s°a, Á©ú«Û, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, ³¢¬fÅï, ³¢¦æ¹D*, À¹¹Å¨¥*, §E©ú¶©, ²ø¸UÀs - - 1 - Oncotarget - Oncotarget 2018 9¨÷(15´Á):pp:12240-12249­¶
(IF: 5.168, »â°ì±Æ¦W: 44, »â°ì´Á¥Z¼Æ: 217, »â°ì±Æ¦W: 20.28%)

Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C
Yeh ML, Huang CI, Huang CF, Hsieh MH, Hsieh MY, Lin ZY, Chen SC, Huang JF, Kuo PL, Kuo HT*, Dai CY*, Yu ML, Chuang WL - - 1 - Oncotarget - Oncotarget 2018;9(15):pp:12240-12249
(IF: 5.168, Journal Ranking: 44, Number of Journals of this Field: 217, Ranking: 20.28%)

235

Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes.
¶ÀÂ@¶h, ¶À³©®p, ¸­©ú­Û, ªL©yÐA, ±ç³Õµ{, ¼B°ÓÁô, Á©s°a, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, ²ø¸UÀs, À¹¹Å¨¥*, §E©ú¶©* - - 1 - Medicine (Baltimore) - MEDICINE 2018 97¨÷(10´Á):e9782­¶
(IF: 2.028, »â°ì±Æ¦W: 56, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 36.13%)

Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes.
Huang CI, Huang CF, Yeh ML, Lin YH, Liang PC, Liu SV, Hsieh MH, Lin ZY, Chen SC, Huang JF, Chuang WL, Dai CY*, Yu ML*. - - 1 - Medicine (Baltimore) - MEDICINE 2018;97(10):e9782
(IF: 2.028, Journal Ranking: 56, Number of Journals of this Field: 155, Ranking: 36.13%)

236

The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C.
±ç³Õµ{, ªL¨Ø½@, ¶ÀÂ@¶h, ¶À³©®p, ¸­©ú­Û, ´¿¨|ª@, ³\Ú{©y, Á©ú«Û, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, ªô¥@ªY*, §E©ú¶©* - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018 117¨÷(1´Á):14-23­¶
(IF: 2.452, »â°ì±Æ¦W: 42, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 27.10%)

The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C.
Liang PC, Lin PC, Huang CI, Huang CF, Yeh ML, Zeng YS, Hsu WY, Hsieh MY, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Chiou SS*, Yu ML* - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018;117(1):14-23
(IF: 2.452, Journal Ranking: 42, Number of Journals of this Field: 155, Ranking: 27.10%)

237

The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infection.
À¹¹Å¨¥, ½²©ö¬À(¦@¦P²Ä¤@), ©Pª³ª³, ¼B¤jºû, ¶À³©®p, ¤ý­zºö, ½²¨Ø­Å, ¸­©ú­Û, Á©ú«Û, ¶ÀÂ@¶h, ¼B°ÓÁô, ¶À§Ó´I, ²ø¸UÀs, §E©ú¶©* - - 1 - Oncotarget - Oncotarget 2018 9¨÷(13´Á):11291-11302­¶
(IF: 5.168, »â°ì±Æ¦W: 44, »â°ì´Á¥Z¼Æ: 217, »â°ì±Æ¦W: 20.28%)

The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infection.
Dai CY, Tsai YS, Chou WW, Liu T, Huang CF, Wang SC, Tsai PC, Yeh ML, Hsieh MY, Huang CI, Vanson Liu SY, Huang JF, Chuang WL, Yu ML* - - 1 - Oncotarget - Oncotarget 2018;9(13):11291-11302
(IF: 5.168, Journal Ranking: 44, Number of Journals of this Field: 217, Ranking: 20.28%)

238

Poor adherence to hepatocellular carcinoma surveillance: a systematic review and meta-analysis of a complex issue.
Zhao C, Jin M, Le RH, Le MH, Chen VL, Jin M, Wong GL, Wong VW, Lim YS, ²ø¸UÀs, §E©ú¶©, Nguyen MH* - - 1 - Liver International - LIVER INTERNATIONAL 2018 38¨÷(3´Á):503-514­¶
(IF: 4.5, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 80, »â°ì±Æ¦W: 20.00%)

Poor adherence to hepatocellular carcinoma surveillance: a systematic review and meta-analysis of a complex issue.
Zhao C, Jin M, Le RH, Le MH, Chen VL, Jin M, Wong GL, Wong VW, Lim YS, Chuang WL, Yu ML, Nguyen MH* - - 1 - Liver International - LIVER INTERNATIONAL 2018;38(3):503-514
(IF: 4.5, Journal Ranking: 16, Number of Journals of this Field: 80, Ranking: 20.00%)

239

The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C
Batbold Batsaikhan, ¶ÀÂ@¶h, ¸­©ú­Û, ¶À³©®p, «J¤D¤¯, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, §E©ú¶©, ²ø¸UÀs, §õ´º´Ü, À¹¹Å¨¥* - - 1 - Oncotarget - Oncotarget 2018 9¨÷(30´Á):21313-21321­¶
(IF: 5.168, »â°ì±Æ¦W: 44, »â°ì´Á¥Z¼Æ: 217, »â°ì±Æ¦W: 20.28%)

The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C
Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Nei-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang, Jin-Ching Lee, Chia-Yen Dai - - 1 - Oncotarget - Oncotarget 2018;9(30):21313-21321
(IF: 5.168, Journal Ranking: 44, Number of Journals of this Field: 217, Ranking: 20.28%)

240

Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.
Mücke MM, Backus LI, Mücke VT, Coppola N, Preda CM, ¸­©ú­Û, Tang LSY, Belperio PS, Wilson EM, §E©ú¶©, Zeuzem S, Herrmann E, Vermehren J* - - 1 - The Lancet Gastroenterology & Hepatology - LANCET GASTROENTEROLOGY & HEPATOLOGY 2018 3¨÷(3´Á):172-180­¶
(IF: 45.042, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 2.15%)

Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.
Mücke MM, Backus LI, Mücke VT, Coppola N, Preda CM, Yeh ML, Tang LSY, Belperio PS, Wilson EM, Yu ML, Zeuzem S, Herrmann E, Vermehren J* - - 1 - The Lancet Gastroenterology & Hepatology - LANCET GASTROENTEROLOGY & HEPATOLOGY 2018;3(3):172-180
(IF: 45.042, Journal Ranking: 2, Number of Journals of this Field: 93, Ranking: 2.15%)

241

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
Jun TW, ¸­©ú­Û, Yang JD, Chen VL, Nguyen P, Giama NH, ¶À³©®p, Hsing AW, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, Roberts LR, §E©ú¶©, Nguyen MH* - - 1 - Liver International. - LIVER INTERNATIONAL 2018 38¨÷(5´Á):895-902­¶
(IF: 4.5, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 80, »â°ì±Æ¦W: 20.00%)

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
Jun TW, Yeh ML, Yang JD, Chen VL, Nguyen P, Giama NH, Huang CF, Hsing AW, Dai CY, Huang JF, Chuang WL, Roberts LR, Yu ML, Nguyen MH* - - 1 - Liver International. - LIVER INTERNATIONAL 2018;38(5):895-902
(IF: 4.5, Journal Ranking: 16, Number of Journals of this Field: 80, Ranking: 20.00%)

242

Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapy.
¶À³©®p, ¸­©ú­Û, ¶ÀÂ@¶h, ªL¤l³ó, ³¯«H¦¨, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, §E©ú¶©* - - 1 - Journal of Gastroenterology and Hepatology - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2018 33¨÷(5´Á):1108-1114­¶
(IF: 3.483, »â°ì±Æ¦W: 27, »â°ì´Á¥Z¼Æ: 80, »â°ì±Æ¦W: 33.75%)

Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapy.
Huang CF, Yeh ML, Huang CI, Lin ZY, Chen SC, Dai CY, Huang JF, Chuang WL, Yu ML* - - 1 - Journal of Gastroenterology and Hepatology - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2018;33(5):1108-1114
(IF: 3.483, Journal Ranking: 27, Number of Journals of this Field: 80, Ranking: 33.75%)

243

Author response to "Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients".
Jun TW, Nguyen MH*, §E©ú¶© - - 1 - Liver International - LIVER INTERNATIONAL 2018 38¨÷(6´Á):1141­¶
(IF: 4.5, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 80, »â°ì±Æ¦W: 20.00%)

Author response to "Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients".
Jun TW, Nguyen MH*, Yu ML - - 1 - Liver International - LIVER INTERNATIONAL 2018;38(6):1141
(IF: 4.5, Journal Ranking: 16, Number of Journals of this Field: 80, Ranking: 20.00%)

244

Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin for treatment of recurrent chronic hepatitis C genotype 1 infection after liver transplantation: Real-world experience.
§E©ú¶©, ³¯³ó«W, ¶À³©®p, ªL°êµØ, ¸­©ú­Û, ¶ÀÂ@¶h, Á©s°a, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs* - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018 117¨÷(6´Á):518-526­¶
(IF: 2.452, »â°ì±Æ¦W: 42, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 27.10%)

Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin for treatment of recurrent chronic hepatitis C genotype 1 infection after liver transplantation: Real-world experience.
Yu ML, Chen YL, Huang CF, Lin KH, Yeh ML, Huang CI, Hsieh MH, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL* - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018;117(6):518-526
(IF: 2.452, Journal Ranking: 42, Number of Journals of this Field: 155, Ranking: 27.10%)

245

Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan.
Á©s°a, ¸­©ú­Û, ĬªF¥°, ¼B¤jºû, ¶À³©®p, ¶ÀÂ@¶h, ¤ý­zºö, ¶À§Ó´I, À¹¹Å¨¥, °ª¹Å§», ²ø¸UÀs, ³¯°ö­õ, ¼B«T¤H*, §E©ú¶©* - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018 117¨÷(6´Á):497-504­¶
(IF: 2.452, »â°ì±Æ¦W: 42, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 27.10%)

Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan.
Hsieh MH, Yeh ML, Su TH, Liu TW, Huang CF, Huang CI, Wang SC, Huang JF, Dai CY, Kao JH, Chuang WL, Chen PJ, Liu CJ, Yu ML* - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018;117(6):497-504
(IF: 2.452, Journal Ranking: 42, Number of Journals of this Field: 155, Ranking: 27.10%)

246

Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience.
Chen VL, ¸­©ú­Û, Le AK, Jun M, Saeed WK, Yang JD, ¶À³©®p, Lee HY, ½²¨Ø­Å, §õ¬üæ¢, Giama N, Kim NG, Nguyen PP, Dang H, Ali HA, Zhang N, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, Roberts LR, Jun DW, Lim YS, §E©ú¶©*, Nguyen MH* - - 1 - Alimentary Pharmacology & Therapeutics - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2018 8¨÷(1´Á):44-54­¶
(IF: 7.357, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 261, »â°ì±Æ¦W: 3.83%)

Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience.
Chen VL, Yeh ML, Le AK, Jun M, Saeed WK, Yang JD, Huang CF, Lee HY, Tsai PC, Lee MH, Giama N, Kim NG, Nguyen PP, Dang H, Ali HA, Zhang N, Huang JF, Dai CY, Chuang WL, Roberts LR, Jun DW, Lim YS, Yu ML*, Nguyen MH* - - 1 - Alimentary Pharmacology & Therapeutics - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2018;8(1):44-54
(IF: 7.357, Journal Ranking: 10, Number of Journals of this Field: 261, Ranking: 3.83%)

247

A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-responders.
½²¨Ø­Å, ¼B¤jºû, ¶À³©®p, ¸­©ú­Û, À¹¹Å¨¥, ²ø¸UÀs, ¶À§Ó´I, §E©ú¶©* - - 1 - Journal of the Chinese Medical Association - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2018 81¨÷(8´Á):670-675­¶
(IF: 1.66, »â°ì±Æ¦W: 72, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 46.45%)

A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-responders.
Tsai PC, Liu TW, Huang CF, Yeh ML, Dai CY, Chuang WL, Huang JF, Yu ML* - - 1 - Journal of the Chinese Medical Association - JOURNAL OF THE CHINESE MEDICAL ASSOCIATION 2018;81(8):670-675
(IF: 1.66, Journal Ranking: 72, Number of Journals of this Field: 155, Ranking: 46.45%)

248

Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection.
ªL§Ó¤å, ³¯Ä£´Ë, ªL§Ó­õ, §õ§B¬Ó, ùÀAªe, ³\®a¹ü, Á¨K¥Á, Koh KW, Chou TC, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs,³¯³ó§Q*, §E©ú¶©.* - - 1 - Clinical and Translational Gastroenterology - CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 2018 9¨÷(6´Á):166­¶
(IF: 4.621, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 80, »â°ì±Æ¦W: 18.75%)

Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection.
Lin CW, Chen YS, Lin CC, Lee PH, Lo GH, Hsu CC, Hsieh PM, Koh KW, Chou TC, Dai CY, Huang JF, Chuang WL, Chen YL, Yu ML.* - - 1 - Clinical and Translational Gastroenterology - CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 2018;9(6):166
(IF: 4.621, Journal Ranking: 15, Number of Journals of this Field: 80, Ranking: 18.75%)

249

Twelve-week Ravidasvir plus ritonavir-boosted Danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study.
°ª¹Å§»*, §E©ú¶©, ³¯±Ò¯q, ´^¦¨¤¸, ³¯©ú³ó, Tang H, Chen Q, Wu JJ - - 1 - Journal of Gastroenterology and Hepatology - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2018 33¨÷(8´Á):1507-1510­¶
(IF: 3.483, »â°ì±Æ¦W: 27, »â°ì´Á¥Z¼Æ: 80, »â°ì±Æ¦W: 33.75%)

Twelve-week Ravidasvir plus ritonavir-boosted Danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study.
Kao JH*, Yu ML, Chen CY, Peng CY, Chen MY, Tang H, Chen Q, Wu JJ - - 1 - Journal of Gastroenterology and Hepatology - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2018;33(8):1507-1510
(IF: 3.483, Journal Ranking: 27, Number of Journals of this Field: 80, Ranking: 33.75%)

250

Reply to "Rescue for interferon failures in HCV genotype 1/HBV dually infection"
Á©s°a, §E©ú¶©* - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018 117¨÷(9´Á):861-862­¶
(IF: 2.452, »â°ì±Æ¦W: 42, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 27.10%)

Reply to "Rescue for interferon failures in HCV genotype 1/HBV dually infection"
Hsieh MH, Yu ML* - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018;117(9):861-862
(IF: 2.452, Journal Ranking: 42, Number of Journals of this Field: 155, Ranking: 27.10%)

251

Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection.
ªL§Ó¤å*, ³¯Ä£´Ë, ªL·q´¼, §õ§B¬Ó, ùÀAªe, ³\®a¹ü, Á¨K¥Á, Koh KW, ¥Õ©ú©¾, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, ³¯³ó«W, §E©ú¶© - - 1 - PLoS One - PLOS ONE 2018 13¨÷(9´Á):e0202650­¶
(IF: 2.766, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 23.44%)

Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection.
Lin CW*, Chen YS, Lin CC, Lee PH, Lo GH, Hsu CC, Hsieh PM, Koh KW, Bair MJ, Dai CY, Huang JF, Chuang WL, Chen YL, Yu ML - - 1 - PLoS One - PLOS ONE 2018;13(9):e0202650
(IF: 2.766, Journal Ranking: 15, Number of Journals of this Field: 64, Ranking: 23.44%)

252

Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals.
¶À³©®p, ¸­©ú­Û, ¶ÀÂ@¶h, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, ³¯§Ó¦{*, §E©ú¶©* - - 1 - Scientific Reports - SCIENTIFIC REPORTS 2018 8¨÷(1´Á):15058­¶
(IF: 4.122, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 18.75%)

Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals.
Huang CF, Yeh ML, Huang CI, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Chen JJ*, Yu ML* - - 1 - Scientific Reports - SCIENTIFIC REPORTS 2018;8(1):15058
(IF: 4.122, Journal Ranking: 12, Number of Journals of this Field: 64, Ranking: 18.75%)

253

Association between cryoglobulinemia and liver fibrosis in chronic hepatitis C patients
Batsaikhan B, ¶ÀÂ@¶h, ¸­©ú­Û, ¶À³©®p, ±ç³Õµ{, Á©ú«Û, ¶À§Ó´I, §E©ú¶©, ²ø¸UÀs, §õ´º´Ü, §õ¨Ø­Û*, À¹¹Å¨¥* - - 1 - Journal of Gastroenterology and Hepatology - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2018 33¨÷(11´Á):1897-1903­¶
(IF: 3.483, »â°ì±Æ¦W: 27, »â°ì´Á¥Z¼Æ: 80, »â°ì±Æ¦W: 33.75%)

Association between cryoglobulinemia and liver fibrosis in chronic hepatitis C patients
Batsaikhan B, Huang CI, Yeh ML, Huang CF, Liang PC, Hsieh MY, Huang JF, Yu ML, Chuang WL, Lee JC, Lee PL*, Dai CY* - - 1 - Journal of Gastroenterology and Hepatology - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2018;33(11):1897-1903
(IF: 3.483, Journal Ranking: 27, Number of Journals of this Field: 80, Ranking: 33.75%)

254

Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection.
¶À³©®p, ¤ý­zºö, ±i¤åÀé, ¸­©ú­Û, ¶ÀÂ@¶h, ªL¤l³ó, ³¯«H¦¨, ²ø¸UÀs, ¶À§Ó´I, À¹¹Å¨¥, ³¯³ó«W, §E©ú¶©* - - 1 - Scientific Reports - SCIENTIFIC REPORTS 2018 8¨÷(1´Á):15821­¶
(IF: 4.122, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 18.75%)

Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection.
Huang CF, Wang SC, Chang WT, Yeh ML, Huang CI, Lin ZY, Chen SC, Chuang WL, Huang JF, Dai CY, Chen YL, Yu ML* - - 1 - Scientific Reports - SCIENTIFIC REPORTS 2018;8(1):15821
(IF: 4.122, Journal Ranking: 12, Number of Journals of this Field: 64, Ranking: 18.75%)

255

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B.
Hsu YC, Jun T, Huang YT, ¸­©ú­Û, Lee CL, Ogawa S, Cho SH, Lin JT, §E©ú¶©, Nguyen MH*, Tanaka Y* - - 1 - Alimentary Pharmacology & Therapeutics - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2018 48¨÷(10´Á):1128-1137­¶
(IF: 7.357, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 261, »â°ì±Æ¦W: 3.83%)

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B.
Hsu YC, Jun T, Huang YT, Yeh ML, Lee CL, Ogawa S, Cho SH, Lin JT, Yu ML, Nguyen MH*, Tanaka Y* - - 1 - Alimentary Pharmacology & Therapeutics - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2018;48(10):1128-1137
(IF: 7.357, Journal Ranking: 10, Number of Journals of this Field: 261, Ranking: 3.83%)

256

Reply to "The choice of antiviral therapy for hepatitis C recurrence after liver transplantation in the real world".
§E©ú¶© - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018 117¨÷(11´Á):1038-1039­¶
(IF: 2.452, »â°ì±Æ¦W: 42, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 27.10%)

Reply to "The choice of antiviral therapy for hepatitis C recurrence after liver transplantation in the real world".
Yu ML* - - 1 - Journal of the Formosan Medical Association - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 2018;117(11):1038-1039
(IF: 2.452, Journal Ranking: 42, Number of Journals of this Field: 155, Ranking: 27.10%)

257

Association of hyperuricemia with disease severity in chronic hepatitis C patients.
±i®x»·, ¸­©ú­Û, ¶ÀÂ@¶h, ªL¤l³ó, ³¯«H¦¨, Á©s°a, À¹¹Å¨¥, ¶À§Ó´I, ¶À³©®p*, ²ø¸UÀs, §E©ú¶© - - 1 - PLoS One - PLOS ONE 2018 13¨÷(11´Á):e0207043­¶
(IF: 2.766, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 23.44%)

Association of hyperuricemia with disease severity in chronic hepatitis C patients.
Jang TY, Yeh ML, Huang CI, Lin ZY, Chen SC, Hsieh MH, Dai CY, Huang JF, Huang CF*, Chuang WL, Yu ML - - 1 - PLoS One - PLOS ONE 2018;13(11):e0207043
(IF: 2.766, Journal Ranking: 15, Number of Journals of this Field: 64, Ranking: 23.44%)

258

Updates in the management and treatment of HCV genotype 3, what are the remaining challenges?
¶À§Ó´I, ¶À³©®p, ¸­©ú­Û, À¹¹Å¨¥, §E©ú¶©, ²ø¸UÀs* - - 1 - Expert Review of Anti-infective Therapy - EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2018 16¨÷(12´Á):907-912­¶
(IF: 3.141, »â°ì±Æ¦W: 84, »â°ì´Á¥Z¼Æ: 261, »â°ì±Æ¦W: 32.18%)

Updates in the management and treatment of HCV genotype 3, what are the remaining challenges?
Huang JF, Huang CF, Yeh ML, Dai CY, Yu ML, Chuang WL* - - 1 - Expert Review of Anti-infective Therapy - EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2018;16(12):907-912
(IF: 3.141, Journal Ranking: 84, Number of Journals of this Field: 261, Ranking: 32.18%)

259

Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals.
¶À³©®p, ¸­©ú­Û, ¶ÀÂ@¶h, ±ç³Õµ{, ªL©yÐA, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©* - - 1 - Hepatology International - HEPATOLOGY INTERNATIONAL 2018 12¨÷(6´Á):544-551­¶
(IF: 4.117, »â°ì±Æ¦W: 22, »â°ì´Á¥Z¼Æ: 80, »â°ì±Æ¦W: 27.50%)

Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals.
Huang CF, Yeh ML, Huang CI, Liang PC, Lin YH, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Yu ML* - - 1 - Hepatology International - HEPATOLOGY INTERNATIONAL 2018;12(6):544-551
(IF: 4.117, Journal Ranking: 22, Number of Journals of this Field: 80, Ranking: 27.50%)

260

Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan.
¼B®¶÷~, §E©ú¶©, ´^¦¨¤¸, Á°]·½, ¶À©Éµ¾, Ĭºû¤å, ¾GÙy¨k, ªL§Ó³®, ù²M¦À, ³¯±Ò¯q, ³¯§Ó¬w, Ma Q, Brooks-Rooney C, °ª¹Å§»* - - 1 - Alimentary Pharmacology & Therapeutics - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2018 48¨÷(11-12´Á):1290-1300­¶
(IF: 7.357, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 261, »â°ì±Æ¦W: 3.83%)

Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan.
Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH* - - 1 - Alimentary Pharmacology & Therapeutics - ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2018;48(11-12):1290-1300
(IF: 7.357, Journal Ranking: 10, Number of Journals of this Field: 261, Ranking: 3.83%)

261

The Paradoxical Effects of Different Hepatitis C Viral Loads on Host DNA Damage and Repair Abilities.
¤ý­zºö, ¿à«a¦p, §õ¨Î¶§, ¦¿±Ò¾±, §E«a»ö, Sakamoto N, Ò\¤å·ì, Á©s°a, ¶À§Ó´I, ²ø¸UÀs, À¹¹Å¨¥*, §E©ú¶©* - - 1 - PLoS One - PLoS One 2017 12¨÷(1´Á):e0164281­¶
(IF: 3.057, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 23.44%)

The Paradoxical Effects of Different Hepatitis C Viral Loads on Host DNA Damage and Repair Abilities.
Wang SC, Lai KR, Li CY, Chiang CS, Yu GY, Sakamoto N, Tu WY, Hsieh MH, Huang JF, Chuang WL, Dai CY*, Yu ML*. - - 1 - PLoS One - PLoS One 2017;12(1):e0164281
(IF: 3.057, Journal Ranking: 15, Number of Journals of this Field: 64, Ranking: 23.44%)

262

Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and antiviral therapy.
½²¨Ø­Å, ¶À³©®p, §E©ú¶©* - - 1 - Journal of Hepatology - J Hepatol 2017 66¨÷(2´Á):464­¶
(IF: 12.486, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 6.33%)

Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and antiviral therapy.
Tsai PC, Huang CF, Yu ML* - - 1 - Journal of Hepatology - J Hepatol 2017;66(2):464
(IF: 12.486, Journal Ranking: 5, Number of Journals of this Field: 79, Ranking: 6.33%)

263

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan.
½²¨Ø­Å, ¼B¤jºû, Á©s°a, ¸­©ú­Û, ±ç³Õµ{, ªL©yÐA, ¶ÀÂ@¶h, ¶À³©®p, Á©ú«Û, «J¤D¤¯, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©*. - - 1 - The Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017 33¨÷(1´Á):44-49­¶
(IF: 1.15, »â°ì±Æ¦W: 103, »â°ì´Á¥Z¼Æ: 128, »â°ì±Æ¦W: 80.47%)

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan.
Tsai PC, Liu TW, Hsieh MH, Yeh ML, Liang PC, Lin YH, Huang CI, Huang CF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Yu ML*. - - 1 - The Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017;33(1):44-49
(IF: 1.15, Journal Ranking: 103, Number of Journals of this Field: 128, Ranking: 80.47%)

264

Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.
¶À³©®p, ¶ÀÂ@¶h, ¸­©ú­Û, ¤ý­zºö, ³¯«a¦t, ¬_¦ö¥Á, ªL·q´¼, ½²©ö¬À, ½²¨Ø­Å, ªL¤l³ó, ³¯«H¦¨, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, §E©ú¶©* - - 1 - EBioMedicine - EBioMedicine 2017 15¨÷(1´Á):81-89­¶
(IF: 6.183, »â°ì±Æ¦W: 13, »â°ì´Á¥Z¼Æ: 133, »â°ì±Æ¦W: 9.77%)

Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.
Huang CF, Huang CY, Yeh ML, Wang SC, Chen KY, Ko YM, Lin CC, Tsai YS, Tsai PC, Lin ZY, Chen SC, Dai CY, Huang JF, Chuang WL, Yu ML* - - 1 - EBioMedicine - EBioMedicine 2017;15(1):81-89
(IF: 6.183, Journal Ranking: 13, Number of Journals of this Field: 133, Ranking: 9.77%)

265

The impact of hepatitis C virus outside the liver: Evidence from Asia.
Younossi ZM*, Tanaka A, Eguchi Y, Lim YS, §E©ú¶©, Kawada N, Dan YY, Brooks-Rooney C, Negro F, Mondelli MU. - - 1 - Liver International - Liver Int 2017 37¨÷(2´Á):159-172­¶
(IF: 4.116, »â°ì±Æ¦W: 18, »â°ì´Á¥Z¼Æ: 73, »â°ì±Æ¦W: 24.66%)

The impact of hepatitis C virus outside the liver: Evidence from Asia.
Younossi ZM*, Tanaka A, Eguchi Y, Lim YS, Yu ML, Kawada N, Dan YY, Brooks-Rooney C, Negro F, Mondelli MU. - - 1 - Liver International - Liver Int 2017;37(2):159-172
(IF: 4.116, Journal Ranking: 18, Number of Journals of this Field: 73, Ranking: 24.66%)

266

Time-degenerative factors and the risk of hepatocellular carcinoma after antiviral therapy among hepatic C virus patients: a model for prioritization of treatment.
§E©ú¶©, ¶À³©®p, ¸­©ú­Û, ½²¨Ø­Å, ¶ÀÂ@¶h, Á©s°a, Á©ú«Û, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, À¹¹Å¨¥*, ²ø¸UÀs* - - 1 - CLINICAL CANCER RESEARCH - CLIN CANCER RES 2017 23¨÷(7´Á):1690-1697­¶
(IF: 9.619, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 217, »â°ì±Æ¦W: 5.53%)

Time-degenerative factors and the risk of hepatocellular carcinoma after antiviral therapy among hepatic C virus patients: a model for prioritization of treatment.
Yu ML, Huang CF, Yeh ML, Tsai PC, Huang CI, Hsieh MH, Hsieh MY, Lin ZY, Chen SC, Huang JF, Dai CY*, Chuang WL* - - 1 - CLINICAL CANCER RESEARCH - CLIN CANCER RES 2017;23(7):1690-1697
(IF: 9.619, Journal Ranking: 12, Number of Journals of this Field: 217, Ranking: 5.53%)

267

Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance.
¶À³©®p, ¸­©ú­Û, ¶ÀÂ@¶h, Lin YJ, ½²¨Ø­Å, ªL¤l³ó, Chan SY, ³¯«H¦¨, ·¨Ãh³ü, ¶À§Ó´I, ¿c³Ó¨k, À¹¹Å¨¥, Jen CL, Yuan Y, L'Italien G, Wang LY, §õ¬üæ¢*, §E©ú¶©*, ²ø¸UÀs, ³¯«Ø¤¯ - - 1 - Oncotarget - ONCOTARGET 2017 8¨÷(27´Á):43925-43933­¶
(IF: 5.168, »â°ì±Æ¦W: 44, »â°ì´Á¥Z¼Æ: 217, »â°ì±Æ¦W: 20.28%)

Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance.
Huang CF, Yeh ML, Huang CI, Lin YJ, Tsai PC, Lin ZY, Chan SY, Chen SC, Yang HI, Huang JF, Lu SN, Dai CY, Jen CL, Yuan Y, L'Italien G, Wang LY, Lee MH*, Yu ML*, Chuang WL, Chen CJ - - 1 - Oncotarget - ONCOTARGET 2017;8(27):43925-43933
(IF: 5.168, Journal Ranking: 44, Number of Journals of this Field: 217, Ranking: 20.28%)

268

Disease severity and erythropoiesis in chronic hepatitis C
¶À³©®p, ¶ÀÂ@¶h, ¸­©ú­Û, «J¥à, «J¤D¤¯, Á©ú«Û, ¶À§Ó´I, ³¯«H¦¨, ªL¤l³ó, À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©* - - 1 - Journal of Gastroenterology and Hepatology - J Gastroenterol Hepatol 2017 32¨÷(4´Á):864-869­¶
(IF: 3.452, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 32.91%)

Disease severity and erythropoiesis in chronic hepatitis C
Huang CF, Huang CI, Yeh ML, Hou C, Hou NJ, Hsieh MY, Huang JF, Chen SC, Lin ZY, Dai CY, Chuang WL, Yu ML* - - 1 - Journal of Gastroenterology and Hepatology - J Gastroenterol Hepatol 2017;32(4):864-869
(IF: 3.452, Journal Ranking: 26, Number of Journals of this Field: 79, Ranking: 32.91%)

269

Short duration of direct-acting antivirals for acute HCV infection.
§E©ú¶©* - - 1 - The Lancet Infectious Diseases - Lancet Infect Dis 2017 17¨÷(5´Á):481-482­¶
(IF: 19.864, »â°ì±Æ¦W: 1, »â°ì´Á¥Z¼Æ: 84, »â°ì±Æ¦W: 1.19%)

Short duration of direct-acting antivirals for acute HCV infection.
Yu ML - - 1 - The Lancet Infectious Diseases - Lancet Infect Dis 2017;17(5):481-482
(IF: 19.864, Journal Ranking: 1, Number of Journals of this Field: 84, Ranking: 1.19%)

270

Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C.
¶À³©®p, ¶ÀÂ@¶h, ¸­©ú­Û, ¤ý­zºö, ³¯«a¦t, ¬_¦ö¥Á, ªL·q´¼, ½²©ö¬À, ½²¨Ø­Å, ªL¤l³ó, ³¯«H¦¨, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, §E©ú¶©* - - 1 - Oncotarget - Oncotarget 2017 8¨÷(20´Á):32618-32625­¶
(IF: 5.168, »â°ì±Æ¦W: 44, »â°ì´Á¥Z¼Æ: 217, »â°ì±Æ¦W: 20.28%)

Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C.
Huang CF, Huang CI, Yeh ML, Wang SC, Chen KY, Ko YM, Lin CC, Tsai YS, Tsai PC, Lin ZY, Chen SC, Dai CY, Huang JF, Chuang WL, Yu ML* - - 1 - Oncotarget - Oncotarget 2017;8(20):32618-32625
(IF: 5.168, Journal Ranking: 44, Number of Journals of this Field: 217, Ranking: 20.28%)

271

Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.
Jacinta A. Holmes, §E©ú¶©and Raymond T. Chung* - - 1 - Expert Opinion On Drug Safety - Expert Opin. Drug Saf. 2017 19¨÷(0´Á):1-21­¶
(IF: 3.439, »â°ì±Æ¦W: 63, »â°ì´Á¥Z¼Æ: 256, »â°ì±Æ¦W: 24.61%)

Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.
Jacinta A. Holmes, Ming-Lung Yu and Raymond T. Chung* - - 1 - Expert Opinion On Drug Safety - Expert Opin. Drug Saf. 2017;19(0):1-21
(IF: 3.439, Journal Ranking: 63, Number of Journals of this Field: 256, Ranking: 24.61%)

272

Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity.
À¹±Ò©ú, §E©ú¶©, §ùÂE»«, ¶À­PÀC, ¶À¬L¸s, ²ø¸UÀs* - - 1 - Surgery for Obesity and Related Diseases - SURG OBES RELAT DIS 2017 13¨÷(4´Á):686-692­¶
(IF: 4.496, »â°ì±Æ¦W: 11, »â°ì´Á¥Z¼Æ: 196, »â°ì±Æ¦W: 5.61%)

Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity.
Tai CM, Yu ML, Tu HP, Huang CK, Hwang JC, Chuang WL* - - 1 - Surgery for Obesity and Related Diseases - SURG OBES RELAT DIS 2017;13(4):686-692
(IF: 4.496, Journal Ranking: 11, Number of Journals of this Field: 196, Ranking: 5.61%)

273

Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients.
¶À§Ó´I*, ¸­©ú­Û, ¶À³©®p, ¶ÀÂ@¶h, ½²¨Ø­Å, À¹±Ò©ú,·¨µØÄÖ, À¹¹Å¨¥, Á©s°a, ³¯«H¦¨, §E©ú¶©, ²ø¸UÀs* - - 1 - PLoS One - PLOS ONE 2017 12¨÷(5´Á):e0174394­¶
(IF: 2.806, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 23.44%)

Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients.
Huang JF*, Yeh ML, Huang CF, Huang CI, Tsai PC, Tai CM, Yang HL, Dai CY, Hsieh MH, Chen SC, Yu ML, Chuang WL* - - 1 - PLoS One - PLOS ONE 2017;12(5):e0174394
(IF: 2.806, Journal Ranking: 15, Number of Journals of this Field: 64, Ranking: 23.44%)

274

Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients.
±i®x»·(R), ªL¨Ø½@, ¶ÀÂ@¶h,¹ùÀu¬ü, ¸­©ú­Û, ´¿¨|ª@, ±ç³Õµ{, ³\Ú{©y, ½²¬IÅÜ, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, À¹¹Å¨¥, ¶À³©®p*, ªô¥@ªY*, ²ø¸UÀs, §E©ú¶© - - 1 - PLoS One - PLOS ONE 2017 12¨÷(6´Á):e0178883­¶
(IF: 2.806, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 23.44%)

Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients.
Jang TY, Lin PC, Huang CI, Liao YM, Yeh ML, Zeng YS, Liang PC, Hsu WY, Tsai SP, Lin ZY, Chen SC, Huang JF, Dai CY, Huang CF*, Chiou SS*, Chuang WL, Yu ML - - 1 - PLoS One - PLOS ONE 2017;12(6):e0178883
(IF: 2.806, Journal Ranking: 15, Number of Journals of this Field: 64, Ranking: 23.44%)

275

Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection.
ªL¤j¶®(R), ¸­©ú­Û, ¶ÀÂ@¶h, ³¯³ó«W, À¹¹Å¨¥, ¶À§Ó´I, ªL¤l³ó, ³¯«H¦¨, ¶À³©®p*, §E©ú¶©, ²ø¸UÀs - - 1 - The Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017 33¨÷(6´Á):284-289­¶
(IF: 1.15, »â°ì±Æ¦W: 103, »â°ì´Á¥Z¼Æ: 128, »â°ì±Æ¦W: 80.47%)

Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection.
Lin TY, Yeh ML, Huang CI, Chen YL, Dai CY, Huang JF, Lin ZY, Chen SC, Huang CF*, Yu ML, Chuang WL - - 1 - The Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017;33(6):284-289
(IF: 1.15, Journal Ranking: 103, Number of Journals of this Field: 128, Ranking: 80.47%)

276

Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database.
½²¨Ø­Å, ¼B¤jºû, ½²©ö¬À, ¬_¦ö¥Á, ³¯«a¦t, ªL·q´¼, ¶ÀÂ@¶h, ±ç³Õµ{, ªL©yÐA, Á©ú«Û, «J¤D¤¯, ¶À³©®p, ¸­©ú­Û, ªL¤l³ó, ³¯«H¦¨, À¹¹Å¨¥, ²ø¸UÀs, ¶À§Ó´I, §E©ú¶©* - - 1 - MEDICINE - MEDICINE 2017 96¨÷(22´Á):e6984­¶
(IF: 1.803, »â°ì±Æ¦W: 58, »â°ì´Á¥Z¼Æ: 154, »â°ì±Æ¦W: 37.66%)

Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database.
Tsai PC, Liu TW, Tsai YS, Ko YM, Chen KY, Lin CC, Huang CI, Liang PC, Lin YH, Hsieh MY, Hou NJ, Huang CF, Yeh ML, Lin ZY, Chen SC, Dai CY, Chuang WL, Huang JF, Yu ML*. - - 1 - MEDICINE - MEDICINE 2017;96(22):e6984
(IF: 1.803, Journal Ranking: 58, Number of Journals of this Field: 154, Ranking: 37.66%)

277

Interactive effects between Lymphotoxin £\ +252 polymorphism and habits of substance use on risk of hepatocellular carcinoma.
½²ºaµo*, ³¯«H¦¨, ªL¤l³ó, À¹¹Å¨¥, ¶À§Ó´I, §E©ú¶©, ²ø¸UÀs - - 1 - The Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017 33¨÷(7´Á):334-338.­¶
(IF: 1.15, »â°ì±Æ¦W: 103, »â°ì´Á¥Z¼Æ: 128, »â°ì±Æ¦W: 80.47%)

Interactive effects between Lymphotoxin £\ +252 polymorphism and habits of substance use on risk of hepatocellular carcinoma.
Tsai JF*, Chen SC, Lin ZY, Dai CY, Huang JF, Yu ML, Chuang WL - - 1 - The Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017;33(7):334-338.
(IF: 1.15, Journal Ranking: 103, Number of Journals of this Field: 128, Ranking: 80.47%)

278

Hepatitis C treatment from "response-guided" to "resource-guided" therapy in the transition era from interferon-containing to interferon-free regimens.
§E©ú¶©* - - 1 - Journal of Gastroenterology and Hepatology - J Gastroenterol Hepatol 2017 32¨÷(8´Á):1436-1442­¶
(IF: 3.452, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 32.91%)

Hepatitis C treatment from "response-guided" to "resource-guided" therapy in the transition era from interferon-containing to interferon-free regimens.
Yu ML* - - 1 - Journal of Gastroenterology and Hepatology - J Gastroenterol Hepatol 2017;32(8):1436-1442
(IF: 3.452, Journal Ranking: 26, Number of Journals of this Field: 79, Ranking: 32.91%)

279

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.
§õ¬üæ¢*, ¶À³©®p, ¿à¾Ç¬w, ªL«T«Û, À¹¹Å¨¥, ¼B«T¤H, ¤ý´º¥°, ¶À§Ó´I, Ĭ¤å¨¹, ·¨§»§Ó, ¬ö¼s©ú, ¸­©ú­Û, ²ø§BùÚ, ®}¤h­õ, ¶ÀÂ@¶h, °ªºa¹F, ³¯¤¶³¹, ³¯ª@¥°, ¾G¤åºÍ, ·¨Ãh³ü, Yuan Y, ¿c³Ó¨k, ¨H¤@¼_, ¼B®¶÷~, ´^¦¨¤¸, °ª¹Å§», §E©ú¶©, ²ø¸UÀs, ³¯«Ø¤¯ - - 1 - Scientific Reports - Sci Rep 2017 7¨÷(1´Á):3718­¶
(IF: 4.259, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 15.63%)

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.
Lee MH*, Huang CF, Lai HC, Lin CY, Dai CY, Liu CJ, Wang JH, Huang JF, Su WP, Yang HC, Kee KM, Yeh ML, Chuang PH, Hsu SJ, Huang CI, Kao JT, Chen CC, Chen SH, Jeng WJ, Yang HI, Yuan Y, Lu SN, Sheen IS, Liu CH, Peng CY, Kao JH, Yu ML, Chuang WL, Chen CJ - - 1 - Scientific Reports - Sci Rep 2017;7(1):3718
(IF: 4.259, Journal Ranking: 10, Number of Journals of this Field: 64, Ranking: 15.63%)

280

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients.
¶ÀÂ@¶h, ¶À³©®p, ¸­©ú­Û, ªL©yÐA, ±ç³Õµ{, Á©s°a, À¹¹Å¨¥, Á©ú«Û, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I*, §E©ú¶©, ²ø¸UÀs - - 1 - Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017 33¨÷(8´Á):394-399.­¶
(IF: 1.15, »â°ì±Æ¦W: 103, »â°ì´Á¥Z¼Æ: 128, »â°ì±Æ¦W: 80.47%)

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients.
Huang CI, Huang CF, Yeh ML, Lin YH, Liang PC, Hsieh MH, Dai CY, Hsieh MY, Lin ZY, Chen SC, Huang JF*, Yu ML, Chuang WL. - - 1 - Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017;33(8):394-399.
(IF: 1.15, Journal Ranking: 103, Number of Journals of this Field: 128, Ranking: 80.47%)

281

Independent and additive interaction between polymorphisms of tumor necrosis factor £\-308 and lymphotoxin £\+252 on risk of hepatocellular carcinoma related to hepatitis B.
½²ºaµo*, ³¯«H¦¨, ªL¤l³ó, À¹¹Å¨¥, ¶À§Ó´I, §E©ú¶©, ²ø¸UÀs - - 1 - Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017 33¨÷(9´Á):453-457­¶
(IF: 1.15, »â°ì±Æ¦W: 103, »â°ì´Á¥Z¼Æ: 128, »â°ì±Æ¦W: 80.47%)

Independent and additive interaction between polymorphisms of tumor necrosis factor alpha-308 and lymphotoxin alpha+252 on risk of hepatocellular carcinoma related to hepatitis B
Tsai JF*, Chen SC, Lin ZY, Dai CY, Huang JF, Yu ML, Chuang WL - - 1 - Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017;33(9):453-457
(IF: 1.15, Journal Ranking: 103, Number of Journals of this Field: 128, Ranking: 80.47%)

282

Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis C.
§E©ú¶©* - - 1 - Gastroenterology - Gastroenterology 2017 153¨÷(3´Á):867­¶
(IF: 18.392, »â°ì±Æ¦W: 1, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 1.27%)

Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis C.
Yu ML* - - 1 - Gastroenterology - Gastroenterology 2017;153(3):867
(IF: 18.392, Journal Ranking: 1, Number of Journals of this Field: 79, Ranking: 1.27%)

283

Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis.
Vutien P, Jin M, Le MH, Nguyen P, Trinh S, ¶À§Ó´I, §E©ú¶©, ²ø¸UÀs, Nguyen MH* - - 1 - PLoS One - PLoS One 2017 12¨÷(9´Á):e0183851­¶
(IF: 2.806, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 23.44%)

Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis.
Vutien P, Jin M, Le MH, Nguyen P, Trinh S, Huang JF, Yu ML, Chuang WL, Nguyen MH* - - 1 - PLoS One - PLoS One 2017;12(9):e0183851
(IF: 2.806, Journal Ranking: 15, Number of Journals of this Field: 64, Ranking: 23.44%)

284

The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinoma
ªL§Ó¤å, ªL§Ó­õ, §õ§B¬Ó, ùÀAªe, Á¨K¥Á, Koh KW, §õ§Ó¤¸, ³¯³ó«W, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, ³¯Ä£´Ë, §E©ú¶©* - - 1 - Oncotarget - Oncotarget 2017 8¨÷(54´Á):91902-91913­¶
(IF: 5.168, »â°ì±Æ¦W: 44, »â°ì´Á¥Z¼Æ: 217, »â°ì±Æ¦W: 20.28%)

The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinoma
Lin CW, Lin CC, Lee PH, Lo GH, Hsieh PM, Koh KW, Lee CY, Chen YL, Dai CY, Huang JF, Chuang WL, Chen YS, Yu ML* - - 1 - Oncotarget - Oncotarget 2017;8(54):91902-91913
(IF: 5.168, Journal Ranking: 44, Number of Journals of this Field: 217, Ranking: 20.28%)

285

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma.
¸­©ú­Û, ¶ÀÂ@¶h, ¶À³©®p, Á©ú«Û, ªL¤l³ó, ¶À§Ó´I, À¹¹Å¨¥, §E©ú¶©, ³¯«H¦¨*, ²ø¸UÀs - - 1 - PLoS One - PLoS One 2017 12¨÷(9´Á):e0184878­¶
(IF: 2.806, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 23.44%)

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma.
Yeh ML, Huang CI, Huang CF, Hsieh MY, Lin ZY, Huang JF, Dai CY, Yu ML, Chen SC*, Chuang WL - - 1 - PLoS One - PLoS One 2017;12(9):e0184878
(IF: 2.806, Journal Ranking: 15, Number of Journals of this Field: 64, Ranking: 23.44%)

286

Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals
¸­©ú­Û,¶À³©®p,Á©s°a,¬_¦ö¥Á,³¯«a¦t,¼B¤jºû,ªL©yÐA,±ç³Õµ{,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,¶ÀÂ@¶h,¶À§Ó´I,³¢¬fÅï,À¹¹Å¨¥*,§E©ú¶©*,²ø¸UÀs. - - 1 - Journal of Gastroenterology and Hepatology - J Gastroenterol Hepatol 2017 32¨÷(10´Á):1754-1762­¶
(IF: 3.452, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 32.91%)

Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals
Yeh ML, Huang CF, Hsieh MH, Ko YM, Chen KY, Liu TW, Lin YH, Liang PC, Hsieh MY, Lin ZY, Chen SC, Huang CI, Huang JF, Kuo PL, Dai CY*, Yu ML*, Chuang WL - - 1 - Journal of Gastroenterology and Hepatology - J Gastroenterol Hepatol 2017;32(10):1754-1762
(IF: 3.452, Journal Ranking: 26, Number of Journals of this Field: 79, Ranking: 32.91%)

287

Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus.
Choijilsuren G, Jhou RS, Chou SF, Chang CJ, ·¨Ãh³ü, ³¯¬v·½, ²ø¸UÀs, §E©ú¶©, ¬I¹Å©M* - - 1 - Scientific Reports - Sci Rep 2017 7¨÷(1´Á):14461­¶
(IF: 4.259, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 15.63%)

Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus.
Choijilsuren G, Jhou RS, Chou SF, Chang CJ, Yang HI, Chen YY, Chuang WL, Yu ML, Shih C* - - 1 - Scientific Reports - Sci Rep 2017;7(1):14461
(IF: 4.259, Journal Ranking: 10, Number of Journals of this Field: 64, Ranking: 15.63%)

288

The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents.
¶À§Ó´I, ¶À³©®p, ¸­©ú­Û, À¹¹Å¨¥, Á©s°a, ·¨¥¿ºÖ, ¶ÀÂ@¶h, ªL©yÐA, ±ç³Õµ{, ªL¤l³ó, ³¯«H¦¨, §E©ú¶©, ²ø¸UÀs* - - 1 - Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017 33¨÷(11´Á):567-571­¶
(IF: 1.15, »â°ì±Æ¦W: 103, »â°ì´Á¥Z¼Æ: 128, »â°ì±Æ¦W: 80.47%)

The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents.
Huang JF, Huang CF, Yeh ML, Dai CY, Hsieh MH, Yang JF, Huang CI, Lin YH, Liang PC, Lin ZY, Chen SC, Yu ML, Chuang WL* - - 1 - Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017;33(11):567-571
(IF: 1.15, Journal Ranking: 103, Number of Journals of this Field: 128, Ranking: 80.47%)

289

Association Between Screen-detected Gallstone Disease and Cancer in a Cohort Study
§E©ú¶©* - - 1 - Gastroenterology - Gastroenterology 2017 153¨÷(5´Á):1453­¶
(IF: 18.392, »â°ì±Æ¦W: 1, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 1.27%)

Association Between Screen-detected Gallstone Disease and Cancer in a Cohort Study
Yu ML* - - 1 - Gastroenterology - Gastroenterology 2017;153(5):1453
(IF: 18.392, Journal Ranking: 1, Number of Journals of this Field: 79, Ranking: 1.27%)

290

Reply to "cost effectiveness of hepatitis C treatments: Need for a comprehensive evaluation".
½²¨Ø­Å, ¼B¤jºû, §E©ú¶©* - - 1 - Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017 33¨÷(11´Á):586­¶
(IF: 1.15, »â°ì±Æ¦W: 103, »â°ì´Á¥Z¼Æ: 128, »â°ì±Æ¦W: 80.47%)

Reply to "cost effectiveness of hepatitis C treatments: Need for a comprehensive evaluation".
Tsai PC, Liu TW, Yu ML* - - 1 - Kaohsiung Journal of Medical Sciences - Kaohsiung J Med Sci 2017;33(11):586
(IF: 1.15, Journal Ranking: 103, Number of Journals of this Field: 128, Ranking: 80.47%)

291

Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1.
°ª¹Å§», §E©ú¶©, ´^¦¨¤¸, Heo J, ¦¶±Ò¤¯, ±i©w©v, Lee YJ, ­JÚz½÷, Yoon KT, Paik SW, Lim YS, Ahn SH, Isakov V, McPhee F, Hu W, Scott Swenson E, Yin PD, Treitel M* - - 1 - Journal of Gastroenterology and Hepatology - J Gastroenterol Hepatol 2017 32¨÷(12´Á):1998-2005­¶
(IF: 3.452, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 32.91%)

Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1.
Kao JH, Yu ML, Peng CY, Heo J, Chu CJ0, Chang TT, Lee YJ, Hu TH, Yoon KT, Paik SW, Lim YS, Ahn SH, Isakov V, McPhee F, Hu W, Scott Swenson E, Yin PD, Treitel M* - - 1 - Journal of Gastroenterology and Hepatology - J Gastroenterol Hepatol 2017;32(12):1998-2005
(IF: 3.452, Journal Ranking: 26, Number of Journals of this Field: 79, Ranking: 32.91%)

292

Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments.
¶À³©®p, §E©ú¶©* - - 1 - Expert Opinion on Pharmacotherapy - Expert Opin Pharmacother. 2017 18¨÷(17´Á):1867-1874­¶
(IF: 3.894, »â°ì±Æ¦W: 48, »â°ì´Á¥Z¼Æ: 256, »â°ì±Æ¦W: 18.75%)

Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments.
Huang CF, Yu ML* - - 1 - Expert Opinion on Pharmacotherapy - Expert Opin Pharmacother. 2017;18(17):1867-1874
(IF: 3.894, Journal Ranking: 48, Number of Journals of this Field: 256, Ranking: 18.75%)

293

25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacy.
¶À§Ó´I, ¬_¦ö¥Á, ¶À³©®p, ¸­©ú­Û, À¹¹Å¨¥, Á©s°a, ¶ÀÂ@¶h, ·¨µØÄÖ, ¤ý­zºö, ªL¤l³ó, ³¯«H¦¨, §E©ú¶©, ²ø¸UÀs* - - 1 - Hepatology Research - Hepatol Res 2017 47¨÷(13´Á):1383-1389­¶
(IF: 2.602, »â°ì±Æ¦W: 47, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 59.49%)

25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacy.
Huang JF, Ko YM, Huang CF, Yeh ML, Dai CY, Hsieh MH, Huang CI, Yang HL, Wang SC, Lin ZY, Chen SC, Yu ML, Chuang WL* - - 1 - Hepatology Research - Hepatol Res 2017;47(13):1383-1389
(IF: 2.602, Journal Ranking: 47, Number of Journals of this Field: 79, Ranking: 59.49%)

294

Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase.
½²ºû­Û, ±iÁo½å*, ®]Þm´¼, ³¯®ü¶¯, Wu CC, ³\ªÃ¼Ý, ¾GÀAµ¾*, §E©ú¶©* - - 1 - Oncotarget - Oncotarget 2017 8¨÷(54´Á):91928-91937­¶
(IF: 5.168, »â°ì±Æ¦W: 44, »â°ì´Á¥Z¼Æ: 217, »â°ì±Æ¦W: 20.28%)

Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase.
Tsai WL, Chang TH*, Sun WC, Chan HH, Wu CC, Hsu PI, Cheng JS*, Yu ML* - - 1 - Oncotarget - Oncotarget 2017;8(54):91928-91937
(IF: 5.168, Journal Ranking: 44, Number of Journals of this Field: 217, Ranking: 20.28%)

295

Fasting sugar, blood pressure, and uric acid are factors related to positive proteinuria and an impaired eGFR.
Á©s°a, ·¨¥¿ºÖ, ªL¤å¤@, ¼çàH²[, ³¢¬ü®S, ±i¹ç®a, ¤ý»FÄÖ, ²ø¸UÀs, §E©ú¶©, À¹¹Å¨¥* - - 1 - Journal of the Chinese Medical Association - J Chin Med Assoc 2017 80¨÷(12´Á):782-789­¶
(IF: 1.252, »â°ì±Æ¦W: 82, »â°ì´Á¥Z¼Æ: 154, »â°ì±Æ¦W: 53.25%)

Fasting sugar, blood pressure, and uric acid are factors related to positive proteinuria and an impaired eGFR.
Hsieh MH, Yang JF, Lin WY, Chien HH, Kuo MC, Chang NC, Wang CL, Chuang WL, Yu ML, Dai CY* - - 1 - Journal of the Chinese Medical Association - J Chin Med Assoc 2017;80(12):782-789
(IF: 1.252, Journal Ranking: 82, Number of Journals of this Field: 154, Ranking: 53.25%)

296

A Functional Polymorphism at the FGF10 Gene Is Associated With Extreme Myopia (vol 54, pg 3265, 2013)
Hsi, E; Chen, KC; Chang, WS,§E©ú¶©,Liang, CL; Hank, SH - - 1 - INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE - - 2017 54¨÷(5´Á):3265-71­¶
(IF: 3.303, »â°ì±Æ¦W: 11, »â°ì´Á¥Z¼Æ: 59, »â°ì±Æ¦W: 18.64%)

A Functional Polymorphism at the FGF10 Gene Is Associated With Extreme Myopia (vol 54, pg 3265, 2013)
Hsi, E; Chen, KC; Chang, WS; Yu, ML; Liang, CL; Hank, SH - - 1 - INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE - - 2017;54(5):3265-71
(IF: 3.303, Journal Ranking: 11, Number of Journals of this Field: 59, Ranking: 18.64%)

297

Corrigendum to "Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment" [EBioMedicine 15 (2017) 81-89].
¶À³©®p#, ¶ÀÂ@¶h, ¸­©ú­Û, Shu-Chi Wang, Kuan-Yu Chen, Yu-Min Ko, Ching-Chih Lin, Yi-Shan Tsai, ½²¨Ø­Å, Zu-Yau Lin, Shinn-Cherng Chen, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, §E©ú¶©* - - 0 - EBIOMEDICINE - EBIOMEDICINE 2017 17¨÷(0´Á):237­¶
(IF: 11.1, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 7.35%)

Corrigendum to "Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment" [EBioMedicine 15 (2017) 81-89].
Chung-Feng Huang, Ching-I Huang, Ming-Lun Yeh, Shu-Chi Wang, Kuan-Yu Chen, Yu-Min Ko, Ching-Chih Lin, Yi-Shan Tsai, Pei-Chien Tsai, Zu-Yau Lin, Shinn-Cherng Chen, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu - - 0 - EBIOMEDICINE - EBIOMEDICINE 2017;17(0):237
(IF: 11.1, Journal Ranking: 10, Number of Journals of this Field: 136, Ranking: 7.35%)

298

Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir.
Younossi ZM*, Stepanova M, Chan HL, §õ¬üæ¢, §E©ú¶©, Dan YY, Choi MS, Henry L - - 1 - MEDICINE - MEDICINE 2016 95¨÷(9´Á):e2702­¶
(IF: 2.133, »â°ì±Æ¦W: 40, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 25.81%)

Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir.
Younossi ZM, Stepanova M, Chan HL, Lee MH, Yu ML, Dan YY, Choi MS, Henry L - - 1 - MEDICINE - MEDICINE 2016;95(9):e2702
(IF: 2.133, Journal Ranking: 40, Number of Journals of this Field: 155, Ranking: 25.81%)

299

Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C
§f©ú¿o, ¶ÀÂ@¶h, À¹¹Å¨¥, ¤ý­zºö, Á©ú«Û, Á©s°a, ±ç³Õµ{, ªL©yÐA, «J¤D¤¯, ¸­©ú­Û, ¶À³©®p, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, ²ø¸UÀs*, §E©ú¶©* - - 1 - Scientific Reports - SCI REP-UK 2016 6¨÷(-´Á):22995­¶
(IF: 5.228, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 63, »â°ì±Æ¦W: 11.11%)

Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C
Lu MY, Huang CI, Dai CY, Wang SC, Hsieh MY, Hsieh MH, Liang PC, Lin YH, Hou NJ, Yeh ML, Huang CF, Lin ZY, Chen SC, Huang JF, Chuang WL*, Yu ML*. - - 1 - Scientific Reports - SCI REP-UK 2016;6(-):22995
(IF: 5.228, Journal Ranking: 7, Number of Journals of this Field: 63, Ranking: 11.11%)

300

·L¤pRNA let-7g »P¤zÂZ¯À¹p¤Ú«ÂªL¨ó¦P§í¨îC«¬¨xª¢¯f¬r½Æ»s
©Pª³ª³, ¶À³©®p, ¸­©ú­Û, ½²©ö©k, Á©ú«Û, ¶ÀÂ@¶h,¶À§Ó´I, ½²¨Ø­Å, ¸F­P»·, ¨ô¦g¯è, ½²ºû­Û, ²ø¸UÀs, §E©ú¶©, À¹¹Å¨¥* - - 1 - JOURNAL OF MOLECULAR MEDICINE-JMM - J MOL MED 2016 94¨÷(3´Á):311-320­¶
(IF: 4.855, »â°ì±Æ¦W: 19, »â°ì´Á¥Z¼Æ: 124, »â°ì±Æ¦W: 15.32%)

MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replication
Chou WW, Huang CF, Yeh ML, Tsai YS, Hsieh MY, Huang CI, Huang JF, Tsai PC, Hsi E, Juo SH, Tsai WL, Chuang WL, Yu ML, Dai CY* - - 1 - JOURNAL OF MOLECULAR MEDICINE-JMM - J MOL MED 2016;94(3):311-320
(IF: 4.855, Journal Ranking: 19, Number of Journals of this Field: 124, Ranking: 15.32%)

301

Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection.
§E©ú¶©* - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2016 64¨÷(4´Á):981-982­¶
(IF: 10.59, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 6.33%)

Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection.
Yu ML* - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2016;64(4):981-982
(IF: 10.59, Journal Ranking: 5, Number of Journals of this Field: 79, Ranking: 6.33%)

302

Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
À¹±Ò©ú, 黄­PÀC, §ùÂE»«, ¶À¬L¸s, ¸­©ú­Û, ¶À³©®p, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©* - - 1 - MEDICINE - MEDICINE 2016 95¨÷(12´Á):e3120­¶
(IF: 2.133, »â°ì±Æ¦W: 40, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 25.81%)

Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM, Huang CK, Tu HP, Hwang JC, Yeh ML, Huang CF, Huang JF, Dai CY, Chuang WL, Yu ML* - - 1 - MEDICINE - MEDICINE 2016;95(12):e3120
(IF: 2.133, Journal Ranking: 40, Number of Journals of this Field: 155, Ranking: 25.81%)

303

¿}§¿¯f¯f¤H¨Ï¥ÎDDP-4 inhibitor ³y¦¨«æ©Ê¯ØŦª¢±´°Q
·¨µµÅï, ¨Hª´¬î, §E©ú¶©, ¶ÀÄ£Ùy, ³¯±Rà±* - - 1 - JOURNAL OF FOOD AND DRUG ANALYSIS - J FOOD DRUG ANAL 2016 24¨÷(2´Á):450-454­¶
(IF: 1.98, »â°ì±Æ¦W: 39, »â°ì´Á¥Z¼Æ: 125, »â°ì±Æ¦W: 31.20%)

Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors
Tzu-Lin Yang, Mei-Chiou Shen, Ming-Lung Yu, Yaw-Bin Huang, Chung-Yu Chen - - 1 - JOURNAL OF FOOD AND DRUG ANALYSIS - J FOOD DRUG ANAL 2016;24(2):450-454
(IF: 1.98, Journal Ranking: 39, Number of Journals of this Field: 125, Ranking: 31.20%)

304

Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol
§d«a¹F,³¢¬fÅï,Ĭ¥@Ùy,³¯ÃÀ¯§,¸­©ú­Û,¶ÀÂ@¶h,·¨¥¿ºÖ,ªL¹Å¯q,Á©s°a,Á©ú«Û,¶À³©®p,ªL¤å¤@,§E©ú¶©,À¹¹Å¨¥*,¤ý¾Ë«³* - - 1 - Journal of Clinical Lipidology - J CLIN LIPIDOL 2016 10¨÷(2´Á):420-425­¶
(IF: 4.906, »â°ì±Æ¦W: 23, »â°ì´Á¥Z¼Æ: 255, »â°ì±Æ¦W: 9.02%)

Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol
Kuan-Ta Wu, Po-Lin Kuo, Shih-Bin Su, Yi-Yu Chen, Ming-Lum Yeh, Ching-I Huang, Jeng-Fu Yang, Chia-I Lin, Meng-Hsuan Hsieh, Ming-Yen Hsieh, Chung-Feng Huang, Wen-Yi Lin, Ming-Lung Yu, Chia-Yen Dai, Hsien-Yi Wang - - 1 - Journal of Clinical Lipidology - J CLIN LIPIDOL 2016;10(2):420-425
(IF: 4.906, Journal Ranking: 23, Number of Journals of this Field: 255, Ranking: 9.02%)

305

Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection.
¸­©ú­Û, Á©ú«Û, ¶ÀÂ@¶h, ¶À³©®p, Á©s°a, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©* - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - J GASTROEN HEPATOL 2016 31¨÷(4´Á):835-841­¶
(IF: 3.322, »â°ì±Æ¦W: 25, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 31.65%)

Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection.
Yeh ML, Hsieh MY, Huang CI, Huang CF, Hsieh MH, Huang JF, Dai CY, Chuang WL, Yu ML* - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - J GASTROEN HEPATOL 2016;31(4):835-841
(IF: 3.322, Journal Ranking: 25, Number of Journals of this Field: 79, Ranking: 31.65%)

306

¿}§¿¯f¦]¯À¤zÂZrGT¹ï¦å¤pªO¤ñ¨Ò©óºC©ÊC«¬¨xª¢¨xŦÅÖºû¤Æ§PŪ
¶À³©®p,²ø¸UÀs,§E©ú¶©* - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2016 32¨÷(6´Á):334-335­¶
(IF: 1, »â°ì±Æ¦W: 104, »â°ì´Á¥Z¼Æ: 124, »â°ì±Æ¦W: 83.87%)

Interference of diabetes on the association of gamma-glutamyl transpeptidase to platelet ratio (GPR) with liver fibrosis in chronic hepatitis C
Chung-Feng Huang,Wan-Long Chuang,Ming-Lung Yu* - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2016;32(6):334-335
(IF: 1, Journal Ranking: 104, Number of Journals of this Field: 124, Ranking: 83.87%)

307

ªvÀø«e¦å¿}ª¬ºA¨M©wC«¬¨xª¢»´¯f±wªÌ¯f¬r¦¨¥\²M°£«á²£¥Í¨xÀù­·ÀI
¶À³©®p,¸­©ú­Û,¶ÀÂ@¶h,½²¨Ø­Å,¬_¦ö¥Á,³¯«a¦t,ªL¤l³ó,³¯«H¦¨,À¹¹Å¨¥,²ø¸UÀs,¶À§Ó´I*,§E©ú¶©* - - 1 - MEDICINE - MEDICINE 2016 95¨÷(27´Á):e4157­¶
(IF: 2.133, »â°ì±Æ¦W: 40, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 25.81%)

Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative anti-viral therapy
Chung-Feng Huang,Ming-Lun Yeh,Cing-Yi Huang,Pei-Chien Tsai,Yu-Min Ko,Kuan-Yu Chen,Zu-Yau Lin,Shinn-Cherng Chen,Chia-Yen Dai,Wan-Long Chuang,Jee-Fu Huang*,Ming-Lung Yu* - - 1 - MEDICINE - MEDICINE 2016;95(27):e4157
(IF: 2.133, Journal Ranking: 40, Number of Journals of this Field: 155, Ranking: 25.81%)

308

¶W­µªiÁn¿ç®g¤O¯ßªi¼v¹³¨t²Î¦bºC©Ê¨x¯f¤W¨xŦÅÖºû¤Æµû¦ôªºÀ³¥Î
ªL©yÐA, ¸­©ú­Û, ¶ÀÂ@¶h, ·¨¥¿ºÖ, ±ç³Õµ{, ¶À³©®p, À¹¹Å¨¥, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I*, §E©ú¶©, ²ø¸UÀs - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2016 32¨÷(7´Á):362-366­¶
(IF: 1, »â°ì±Æ¦W: 104, »â°ì´Á¥Z¼Æ: 124, »â°ì±Æ¦W: 83.87%)

The performance of acoustic radiation force impulse imaging in predicting liver fibrosis in chronic liver diseases.
Lin YH, Yeh ML, Huang CI, Yang JF, Liang PC, Huang CF, Dai CY, Lin ZY, Chen SC, Huang JF*, Yu ML, Chuang WL. - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2016;32(7):362-366
(IF: 1, Journal Ranking: 104, Number of Journals of this Field: 124, Ranking: 83.87%)

309

Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy
§f©ú¿o, ¶ÀÂ@¶h, Á©ú«Û, Á»A®S, ¸F­P»·, ½²¨Ø­Å, ½²©ö¬À, ªL·q´¼, Á©s°a, ±ç³Õµ{, ªL©yÐA, «J¤D¤¯, ¸­©ú­Û, ¶À³©®p, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, ²ø¸UÀs, À¹¹Å¨¥*, §E©ú¶©* - - 1 - Oncotarget - ONCOTARGET 2016 10¨÷(18632´Á):oncotarget.11348­¶
(IF: 5.008, »â°ì±Æ¦W: 36, »â°ì´Á¥Z¼Æ: 213, »â°ì±Æ¦W: 16.90%)

Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy
Lu MY, Huang CI, Hsieh MY, Hsieh TJ, Hsi Edward, Tsai PC, Tsai YS, Lin CC, Hsieh MH, Liang PC, Lin YH, Hou NJ, Yeh ML, Huang CF, Lin ZY, Chen SC, Huang JF, Chuang WL, Dai CY*, Yu ML* - - 1 - Oncotarget - ONCOTARGET 2016;10(18632):oncotarget.11348
(IF: 5.008, Journal Ranking: 36, Number of Journals of this Field: 213, Ranking: 16.90%)

310

Distinct subpopulations of hepatitis C virus infectious cells with different levels of intracellular hepatitis C virus core protein
¤ý­zºö,·¨¥¿ºÖ,¤ý»FÄÖ,¶À³©®p,ªL·ì¯ô,³¯ÃÀ¯§,ù±R®x,§õ¬f©µ,§d«a¹F,ªL¹Å¯q,Á©s°a,²ø¥°¼Ý,¦ó±Ò¥\,§E©ú¶©,À¹¹Å¨¥* - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2016 32¨÷(10´Á):487¡V493­¶
(IF: 1, »â°ì±Æ¦W: 104, »â°ì´Á¥Z¼Æ: 124, »â°ì±Æ¦W: 83.87%)

Distinct subpopulations of hepatitis C virus infectious cells with different levels of intracellular hepatitis C virus core protein
Shu-Chi Wang, Jeng-Fu Yang, Chao-Ling Wang, Chung-Feng Huang, Yu-Yin Lin, Yi-You Chen, Chung-Ting Lo, Po-Yen Lee, Kuan-Ta Wu, Chia-I. Lin, Meng-Hsuan Hsieh, Hung-Yi Chuang, Chi-Kung Ho, Ming-Lung Yu, Chia-Yen Dai* - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2016;32(10):487¡V493
(IF: 1, Journal Ranking: 104, Number of Journals of this Field: 124, Ranking: 83.87%)

311

Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan
Á©s°a,¤ý­zºö,Á©ú«Û,¶À³©®p,¸­©ú­Û,·¨¥¿ºÖ,±i¬ì,ªL½«¦p,ªL«T¯§,³¯±¬ªN,¶À§Ó´I,À¹¹Å¨¥,½²©u§g*,²ø¸UÀs,§E©ú¶© - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2016 32¨÷(10´Á):526¡V530­¶
(IF: 1, »â°ì±Æ¦W: 104, »â°ì´Á¥Z¼Æ: 124, »â°ì±Æ¦W: 83.87%)

Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan
Meng-Hsuan Hsieh, Shu-Chi Wang, Ming-Yen Hsieh, Chung-Feng Huang, Ming-Lun Yeh, Jeng-Fu Yang, Ko Chang, Wei-Ru Lin, Chun-Yu Lin, Tun-Chieh Chen, Jee-Fu Huang, Chia-Yen Dai, Jih-Jin Tsai*, Wan-Long Chuang, Ming-Lung Yu - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2016;32(10):526¡V530
(IF: 1, Journal Ranking: 104, Number of Journals of this Field: 124, Ranking: 83.87%)

312

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.
Omata M, Kanda T, Wei L, §E©ú¶©, ²ø¸UÀs, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Al-Mahtab M, McCaughan GW, Wasim J, Crawford DH, °ª¹Å§», Yokosuka O, Lau GK, Sarin SK. - - 1 - Hepatology International - HEPATOL INT 2016 10¨÷(5´Á):681-701­¶
(IF: 1.125, »â°ì±Æ¦W: 70, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 88.61%)

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.
Omata M*, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Al-Mahtab M, McCaughan GW, Wasim J, Crawford DH, Kao JH, Yokosuka O, Lau GK, Sarin SK. - - 1 - Hepatology International - HEPATOL INT 2016;10(5):681-701
(IF: 1.125, Journal Ranking: 70, Number of Journals of this Field: 79, Ranking: 88.61%)

313

APASL consensus statements and recommendation on treatment of hepatitis C.
Omata M*, Kanda T, Wei L, §E©ú¶©, ²ø¸UÀs, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DH, °ª¹Å§», Yokosuka O, Lau GK, Sarin SK. - - 1 - Hepatology International - HEPATOL INT 2016 10¨÷(5´Á):702-726­¶
(IF: 1.125, »â°ì±Æ¦W: 70, »â°ì´Á¥Z¼Æ: 79, »â°ì±Æ¦W: 88.61%)

APASL consensus statements and recommendation on treatment of hepatitis C.
Omata M*, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DH, Kao JH, Yokosuka O, Lau GK, Sarin SK. - - 1 - Hepatology International - HEPATOL INT 2016;10(5):702-726
(IF: 1.125, Journal Ranking: 70, Number of Journals of this Field: 79, Ranking: 88.61%)

314

Four weeks of paritaprevir/ritonavir/ombitasvir plus dasabuvir encountering dengue fever resulted in sustained virological response in an HCV patient: A case report.
¶À³©®p, ±i®x»·, ¿c¬f¼Ù, §E©ú¶©* - - 1 - MEDICINE - MEDICINE 2016 95¨÷(47´Á):e5304­¶
(IF: 2.133, »â°ì±Æ¦W: 40, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 25.81%)

Four weeks of paritaprevir/ritonavir/ombitasvir plus dasabuvir encountering dengue fever resulted in sustained virological response in an HCV patient: A case report.
Huang CF, Jang TY, Lu PL, Yu ML* - - 1 - MEDICINE - MEDICINE 2016;95(47):e5304
(IF: 2.133, Journal Ranking: 40, Number of Journals of this Field: 155, Ranking: 25.81%)

315

Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study.
¸­©ú­Û, ¶ÀÂ@¶h, Á©ú«Û, ¶À³©®p, Á©s°a, ¶À§Ó´I*, À¹¹Å¨¥, ªL¤l³ó, ³¯«H¦¨, §E©ú¶©, ²ø¸UÀs - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2016 32¨÷(11´Á):559-566­¶
(IF: 1, »â°ì±Æ¦W: 104, »â°ì´Á¥Z¼Æ: 124, »â°ì±Æ¦W: 83.87%)

Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study.
Yeh ML, Huang CI, Hsieh MY, Huang CF, Hsieh MH, Huang JF*, Dai CY, Lin ZY, Chen SC, Yu ML, Chuang WL - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2016;32(11):559-566
(IF: 1, Journal Ranking: 104, Number of Journals of this Field: 124, Ranking: 83.87%)

316

Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.
Nakagawa S, Wei L, Song WM, Higashi T, Ghoshal S, Kim RS, Bian CB, Yamada S, Sun X, Venkatesh A, Goossens N, Bain G, Lauwers GY, Koh AP, El-Abtah M, Ahmad NB, Hoshida H, Erstad DJ, Gunasekaran G, Lee Y, §E©ú¶©, ²ø¸UÀs, À¹¹Å¨¥, Kobayashi M, Kumada H, Beppu T, Baba H - - 1 - CANCER CELL - CANCER CELL 2016 30¨÷(6´Á):879-890­¶
(IF: 31.743, »â°ì±Æ¦W: 9, »â°ì´Á¥Z¼Æ: 242, »â°ì±Æ¦W: 3.72%)

Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.
Nakagawa S, Wei L, Song WM, Higashi T, Ghoshal S, Kim RS, Bian CB, Yamada S, Sun X, Venkatesh A, Goossens N, Bain G, Lauwers GY, Koh AP, El-Abtah M, Ahmad NB, Hoshida H, Erstad DJ, Gunasekaran G, Lee Y, Yu ML, Chuang WL, Dai CY, Kobayashi M, Kumada H, Beppu T, Baba H - - 1 - CANCER CELL - CANCER CELL 2016;30(6):879-890
(IF: 31.743, Journal Ranking: 9, Number of Journals of this Field: 242, Ranking: 3.72%)

317

The unexpected high risk of occurrence or recurrence of hepatocellular carcinoma after successful antiviral therapy with interferon-free direct-acting antivirals
§E©ú¶©*, ¶À³©®p - - 1 - Translational Cancer Research - TRANSL CANCER RES 2016 5¨÷(Suppl 6´Á):S1111-S1115­¶
(IF: 1.757, »â°ì±Æ¦W: 166, »â°ì´Á¥Z¼Æ: 213, »â°ì±Æ¦W: 77.93%)

The unexpected high risk of occurrence or recurrence of hepatocellular carcinoma after successful antiviral therapy with interferon-free direct-acting antivirals
Yu ML*, Huang CF - - 1 - Translational Cancer Research - TRANSL CANCER RES 2016;5(Suppl 6):S1111-S1115
(IF: 1.757, Journal Ranking: 166, Number of Journals of this Field: 213, Ranking: 77.93%)

318

Association between response to pegylated interferon/ribavirin therapy and ribavirin levels
À¹¹Å¨¥, §E©ú¶©, ²ø¸UÀs* - - 1 - HEPATOLOGY - HEPATOLOGY 2015 61¨÷(1´Á):408-409­¶
(IF: 11.055, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 76, »â°ì±Æ¦W: 6.58%)

Association between response to pegylated interferon/ribavirin therapy and ribavirin levels
Chia-Yen Dai, Ming-Lung Yu, Wan-Lung Chuang - - 1 - HEPATOLOGY - HEPATOLOGY 2015;61(1):408-409
(IF: 11.055, Journal Ranking: 5, Number of Journals of this Field: 76, Ranking: 6.58%)

319

ªø®Ä«¬¤zÂZ¯À¦³µL¦X¨Ö¨Ï¥Î¹p¤Ú«ÂÆF¹ïC«¬¨xª¢¯f¬r°ò¦]«¬²Ä¤G«¬¦å²G³zªR±wªÌªvÀøÀø®Ä:¤@ÀH¾÷¤À°t¸ÕÅç
¼B®¶÷~,¼B«T¤H,¶À³©®p,ªL¬Lºû,À¹¹Å¨¥,±çµ{¶W, ¶À§Ó´I,¬x°ö»¨, ½²§»Ùy, ½²©s©ø,§õ­P»·, Chen SI, Yang SS, Su TH, Yang HC, ³¯°ö­õ, ³¯©w«H, ²ø¸UÀs, §E©ú¶©, °ª¹Å§»* - - 1 - GUT - GUT 2015 64¨÷(2´Á):303-311­¶
(IF: 14.66, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 76, »â°ì±Æ¦W: 2.63%)

Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.
Liu CH, Liu CJ, Huang CF, Lin JW, Dai CY, Liang CC, Huang JF, Hung PH, Tsai HB, Tsai MK, Lee CY, Chen SI, Yang SS, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Yu ML, Kao JH* - - 1 - GUT - GUT 2015;64(2):303-311
(IF: 14.66, Journal Ranking: 2, Number of Journals of this Field: 76, Ranking: 2.63%)

320

Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution.
¼B¤jºû,¸­©ú­Û,¶À³©®p, ªL©É§D, ¶À§Ó´I, À¹¹Å¨¥, ³¯³ó«W*, ²ø¸UÀs, §E©ú¶© - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2015 31¨÷(1´Á):26-33­¶
(IF: 0.803, »â°ì±Æ¦W: 107, »â°ì´Á¥Z¼Æ: 123, »â°ì±Æ¦W: 86.99%)

Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution.
Liu TW, Yeh ML, Huang CF, Lin IL, Huang JF, Dai CY, Chen YL*, Chuang WL, Yu ML - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2015;31(1):26-33
(IF: 0.803, Journal Ranking: 107, Number of Journals of this Field: 123, Ranking: 86.99%)

321

¿}§¿¯f»PPNPLA3°ò¦]Åܲ§¤§¬ÛÃö¹ïºC©ÊC«¬¨xª¢ÄY­««×¼vÅT
¶À³©®p,À¹¹Å¨¥,¸­©ú­Û,¶ÀÂ@¶h,À¹±Ò©ú,Á©s°a,±ç³Õµ{,ªL©y§»,Á©ú«Û,·¨µØÄÖ,¶À§Ó´I,ªL¤l³ó,³¯«H¦¨,§E©ú¶©*,²ø¸UÀs* - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2015 62¨÷(3´Á):512-518­¶
(IF: 11.336, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 76, »â°ì±Æ¦W: 5.26%)

Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection
Chung-Feng Huang,Chia-Yen Dai,Ming-Lun Yeh, Ching-I Huang,Chi-Ming Tai,Meng-Hsuan Hsieh,Po-Cheng Liang,Yi-Hung Lin,Ming-Yen Hsieh,Hua-Ling Yang,Jee-Fu Huang,Zu-Yau Lin,Shinn-Cherng Chen,Ming-Lung Yu*,Wan-Long Chuang* - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2015;62(3):512-518
(IF: 11.336, Journal Ranking: 4, Number of Journals of this Field: 76, Ranking: 5.26%)

322

Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma.
¸­©ú­Û, ¶ÀÂ@¶h, ¶À³©®p, Á©ú«Û, ¶À§Ó´I, À¹¹Å¨¥, ªL¤l³ó, ³¯«H¦¨*, §E©ú¶©, ²ø¸UÀs - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2015 31¨÷(2´Á):77-82­¶
(IF: 0.803, »â°ì±Æ¦W: 107, »â°ì´Á¥Z¼Æ: 123, »â°ì±Æ¦W: 86.99%)

Neoadjuvant transcatheter arterial chemoembolization does not provide survival benefit compared to curative therapy alone in single hepatocellular carcinoma.
Yeh ML, Huang CI, Huang CF, Hsieh MY, Huang JF, Dai CY, Lin ZY, Chen SC*, Yu ML, Chuang WL - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2015;31(2):77-82
(IF: 0.803, Journal Ranking: 107, Number of Journals of this Field: 123, Ranking: 86.99%)

323

³zªR»PÀù¯g¤§­·ÀI
ªL©ú«Û, ³¢¬ü®S, ¬x±Ò´¼, §d¤å¥¿, ³¯¥ß©v, §E©ú¶©, ³\§Ó¦¨, §õ«Ø§», ³¯ÂE¶v, ¶À©|§Ó* - - 1 - PLOS One - PLOS ONE 2015 10¨÷(4´Á):e0122856­¶
(IF: 3.234, »â°ì±Æ¦W: 9, »â°ì´Á¥Z¼Æ: 57, »â°ì±Æ¦W: 15.79%)

Association of Dialysis with the Risks of Cancers.
Lin MY, Kuo MC, Hung CC, Wu WJ, Chen LT, Yu ML, Hsu CC, Lee CH, Chen HC, Hwang SJ*. - - 1 - PLOS One - PLOS ONE 2015;10(4):e0122856
(IF: 3.234, Journal Ranking: 9, Number of Journals of this Field: 57, Ranking: 15.79%)

324

C«¬¨xª¢²V¦X¯f¬r°ò¦]«¬²Ä¤@«¬¤Î²Ä¤G«¬¤§¯f¬r¤Î±J¥D¯S¼x
¶À³©®p,¶ÀÂ@¶h,¸­©ú­Û,¶À§Ó´I,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,§E©ú¶©,À¹¹Å¨¥*,²ø¸UÀs - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2015 31¨÷(5´Á):271-277­¶
(IF: 0.803, »â°ì±Æ¦W: 107, »â°ì´Á¥Z¼Æ: 123, »â°ì±Æ¦W: 86.99%)

Host and virological characteristics of the patients with hepatitis C virus mixed genotype 1 and 2 infection
Chung-Feng Huang,Ching-I Huang,Ming-Lun Yeh,Jee-Fu Huang,Ming-Yen Hsieh,Zu-Yau Lin,Shinn-Cherng Chen,Ming-Lung Yu,Chia-Yen Dai*,Wan-Long Chuang - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2015;31(5):271-277
(IF: 0.803, Journal Ranking: 107, Number of Journals of this Field: 123, Ranking: 86.99%)

325

¥H¦å²M¾Ç½Õ¬d¤è¦¡¿ëÃѤô¨a«á·P¬V¯gªº¦MÀI¦]¤l: ¦b²ö©Ô§J»ä­·­·¨a«á¨ü¨a¤H­û¤¤ªºÁa¦V½Õ¬d
ªL«T¯§,³¯±¬ªN,À¹¹Å¨¥,§E©ú¶©,¿c¬f¼Ù,ÃC¥¿½å,³¯«Û¦°* - - 1 - BMJ Open - BMJ OPEN 2015 5¨÷(5´Á):e007008(1-8)­¶
(IF: 2.271, »â°ì±Æ¦W: 40, »â°ì´Á¥Z¼Æ: 154, »â°ì±Æ¦W: 25.97%)

Serological investigation to identify risk factors for post-flood infectious diseases: a longitudinal survey among people displaced by Typhoon Morakot in Taiwan.
Chun-Yu Lin, Tun-Chieh Chen, Chia-Yen Dai, Ming-Lung Yu, Po-Liang Lu, Jeng-Hsien Yen, Yen-Hsu Chen* - - 1 - BMJ Open - BMJ OPEN 2015;5(5):e007008(1-8)
(IF: 2.271, Journal Ranking: 40, Number of Journals of this Field: 154, Ranking: 25.97%)

326

Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in taiwan.
§E©ú¶©,¸­©ú­Û, ½²¨Ø­Å, ¶ÀÂ@¶h, ¶À§Ó´I,¶À³©®p, Á©s°a, ±ç³Õµ{, ªL©yÐA, Á©ú«Û, ªL¤å¤@, «J¤D¤¯, ªL¤l³ó, ³¯«H¦¨, À¹¹Å¨¥, ²ø¸UÀs*, ±i¤å¦t* - - 1 - MEDICINE - MEDICINE 2015 94¨÷(13´Á):e690(1-8)­¶
(IF: 5.723, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 154, »â°ì±Æ¦W: 9.74%)

Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in taiwan.
Yu ML, Yeh ML, Tsai PC, Huang CI, Huang JF, Huang CF, Hsieh MH, Liang PC, Lin YH, Hsieh MY, Lin WY, Hou NJ, Lin ZY, Chen SC, Dai CY, Chuang WL*, Chang WY. - - 1 - MEDICINE - MEDICINE 2015;94(13):e690(1-8)
(IF: 5.723, Journal Ranking: 15, Number of Journals of this Field: 154, Ranking: 9.74%)

327

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients.
¸­©ú­Û, ´^¦¨¤¸(¦@¦P²Ä¤@), À¹¹Å¨¥, ¿à¾Ç¬w, ¶À³©®p, Á©ú«Û, ¶À§Ó´I, ³¯«H¦¨, ªL¤l³ó, §E©ú¶©*, ²ø¸UÀs* - - 1 - PLoS One - PLoS One 2015 10¨÷(4´Á):e0122259(1-11)­¶
(IF: 3.234, »â°ì±Æ¦W: 9, »â°ì´Á¥Z¼Æ: 57, »â°ì±Æ¦W: 15.79%)

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients.
Yeh ML, Peng CY, Dai CY, Lai HC, Huang CF, Hsieh MY, Huang JF, Chen SC, Lin ZY, Yu ML*, Chuang WL* - - 1 - PLoS One - PLoS One 2015;10(4):e0122259(1-11)
(IF: 3.234, Journal Ranking: 9, Number of Journals of this Field: 57, Ranking: 15.79%)

328

PNPLA3°ò¦]¦h«¬©ÊÅܤƨM©wC«¬¨xª¢¯×ªÕ©ÊÅܤƶȭ­©óªÎªÎ­D±wªÌ
¶À³©®p,³¯§Ó¦{,¸­©ú­Û,¶ÀÂ@¶h,Á©ú«Û,·¨µØÄÖ,À¹¹Å¨¥,¶À§Ó´I,ªL¤l³ó,³¯«H¦¨,²ø¸UÀs,³¯³ó§Q,§E©ú¶©* - - 1 - Scientific Reports - SCI REP-UK 2015 5¨÷(-´Á):11901­¶
(IF: 5.578, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 57, »â°ì±Æ¦W: 8.77%)

PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients
Chung-Feng Huang,Jyh-Jou Chen, Ming-Lun Yeh, Ching-I Huang, Ming-Yen Hsieh, Hua-Ling Yang, Chia-Yen Dai, Jee-Fu Huang, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang,Yao-Li Chen,Ming-Lung Yu* - - 1 - Scientific Reports - SCI REP-UK 2015;5(-):11901
(IF: 5.578, Journal Ranking: 5, Number of Journals of this Field: 57, Ranking: 8.77%)

329

Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial.
¼B®¶÷~, ¶À³©®p, ¼B«T¤H, À¹¹Å¨¥, ¶À§Ó´I, ªL¬Lºû, ±çµ{¶W, ·¨³ÓµÏ, ªL§Ó³®, ĬªF¥°, ·¨§»§Ó, ³¯°ö­õ, ³¯©w«H, ²ø¸UÀs, °ª¹Å§»*, §E©ú¶©* - - 1 - SCIENTIFIC REPORTS - SCI REP-UK 2015 5¨÷(-´Á):11710­¶
(IF: 5.578, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 57, »â°ì±Æ¦W: 8.77%)

Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial.
Liu CH, Huang CF, Liu CJ, Dai CY, Huang JF, Lin JW, Liang CC, Yang SS, Lin CL, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Kao JH*, Yu ML*. - - 1 - SCIENTIFIC REPORTS - SCI REP-UK 2015;5(-):11710
(IF: 5.578, Journal Ranking: 5, Number of Journals of this Field: 57, Ranking: 8.77%)

330

High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms.
McPhee F*, Suzuki Y, Toyota J, Karino Y, Chayama K, Kawakami Y, §E©ú¶©, Ahn SH, Ishikawa H, Bhore R, Zhou N, Hernandez D, Mendez P, Kumada H. - - 1 - ADVANCES IN THERAPY - ADV THER 2015 32¨÷(7´Á):637-649­¶
(IF: 2.272, »â°ì±Æ¦W: 132, »â°ì´Á¥Z¼Æ: 255, »â°ì±Æ¦W: 51.76%)

High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms.
McPhee F*, Suzuki Y, Toyota J, Karino Y, Chayama K, Kawakami Y, Yu ML, Ahn SH, Ishikawa H, Bhore R, Zhou N, Hernandez D, Mendez P, Kumada H. - - 1 - ADVANCES IN THERAPY - ADV THER 2015;32(7):637-649
(IF: 2.272, Journal Ranking: 132, Number of Journals of this Field: 255, Ranking: 51.76%)

331

PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
À¹±Ò©ú, ¶À­PÀC, §ùÂE»«, ¶À¬L¸s, ±i¦N¥õ, §E©ú¶©* - - 1 - Surgery for Obesity and Related Diseases - SURG OBES RELAT DIS 2015 11¨÷(4´Á):888-894­¶
(IF: 4.066, »â°ì±Æ¦W: 13, »â°ì´Á¥Z¼Æ: 198, »â°ì±Æ¦W: 6.57%)

PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
Tai CM, Huang CK, Tu HP, Hwang JC, Chang CY, Yu ML* - - 1 - Surgery for Obesity and Related Diseases - SURG OBES RELAT DIS 2015;11(4):888-894
(IF: 4.066, Journal Ranking: 13, Number of Journals of this Field: 198, Ranking: 6.57%)

332

Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.
ªL¿ü¾±, §õªY»T, §E©ú¶©, ±i©w©v, Ĭ«Øºû, ­J§B½å, ³¯Ä£´Ë, ¶À«T³Í, ¿à­«¦°, ªL«T¹A, §d»F­ë* - - 1 - HEPATOLOGY - HEPATOLOGY 2015 61¨÷(6´Á):1870-1879­¶
(IF: 11.055, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 76, »â°ì±Æ¦W: 6.58%)

Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.
Lin HH, Lee SS, Yu ML, Chang TT, Su CW, Hu BS, Chen YS, Huang CK, Lai CH, Lin JN, Wu JC* - - 1 - HEPATOLOGY - HEPATOLOGY 2015;61(6):1870-1879
(IF: 11.055, Journal Ranking: 5, Number of Journals of this Field: 76, Ranking: 6.58%)

333

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
·¨´¼³Ç, ½²ºû­Û, Ĭºû¤å, ¶À³©®p, ¾GÙy¨k, ù²M¦À, ´¿°êªK, ¦ÈÁp·ç, ¤ý«T¶¯, ®}¤h­õ, ¿à¾Ç¬w, Ĭ«Øºû, ¼B«T¤H, ´^¦¨¤¸, §E©ú¶©* - - 1 - PLoS One - PLOS ONE 2015 10¨÷(9´Á):e0137852(1-13)­¶
(IF: 3.234, »â°ì±Æ¦W: 9, »â°ì´Á¥Z¼Æ: 57, »â°ì±Æ¦W: 15.79%)

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
Yang CC, Tsai WL, Su WW, Huang CF, Cheng PN, Lo CC, Tseng KC, Mo LR, Wang CH, Hsu SJ, Lai HC, Su CW, Liu CJ, Peng CY, Yu ML* - - 1 - PLoS One - PLOS ONE 2015;10(9):e0137852(1-13)
(IF: 3.234, Journal Ranking: 9, Number of Journals of this Field: 57, Ranking: 15.79%)

334

New treatments for HCV: Perspective from Asia
§E©ú¶©*, ²ø¸UÀs - - 1 - Clinical Liver Disease - CLIN LIVER DIS 2015 5¨÷(1´Á):17-21­¶
(IF: 3.66, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 76, »â°ì±Æ¦W: 31.58%)

New treatments for HCV: Perspective from Asia
Yu ML*, Chuang WL - - 1 - Clinical Liver Disease - CLIN LIVER DIS 2015;5(1):17-21
(IF: 3.66, Journal Ranking: 24, Number of Journals of this Field: 76, Ranking: 31.58%)

335

Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients.
¶À§Ó´I, ¸­©ú­Û, §E©ú¶©, ¶À³©®p, À¹¹Å¨¥, Á©ú«Û, Á©s°a, ¶ÀÂ@¶h, ªL¤l³ó, ³¯«H¦¨, ¿½Âz®e, ¨¯¿ü¼ý, ²ø¸UÀs* - - 1 - PLoS One - PLOS ONE 2015 10¨÷(10´Á):e0139796(1-13)­¶
(IF: 3.234, »â°ì±Æ¦W: 9, »â°ì´Á¥Z¼Æ: 57, »â°ì±Æ¦W: 15.79%)

Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients.
Huang JF, Yeh ML, Yu ML, Huang CF, Dai CY, Hsieh MY, Hsieh MH, Huang CI, Lin ZY, Chen SC, Hsiao PJ, Shin SJ, Chuang WL* - - 1 - PLoS One - PLOS ONE 2015;10(10):e0139796(1-13)
(IF: 3.234, Journal Ranking: 9, Number of Journals of this Field: 57, Ranking: 15.79%)

336

Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial.
¼B®¶÷~, ¶À³©®p, ¼B«T¤H, À¹¹Å¨¥, ¶À§Ó´I, ªL¬Lºû, ±çµ{¶W, ·¨³Ó¾±, ªL§Ó³®, ĬªF¥°, ·¨§»§Ó, ³¯°ö­õ, ³¯©w«H, ²ø¸UÀs, °ª¹Å§»*,§E©ú¶©* - - 1 - Scientific Reports - SCI REPSCI REP-UK 2015 5¨÷(-´Á):15255­¶
(IF: 5.578, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 57, »â°ì±Æ¦W: 8.77%)

Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial.
Liu CH, Huang CF, Liu CJ, Dai CY, Huang JF, Lin JW, Liang CC, Yang SS, Lin CL, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Kao JH*, Yu ML*. - - 1 - Scientific Reports - SCI REPSCI REP-UK 2015;5(-):15255
(IF: 5.578, Journal Ranking: 5, Number of Journals of this Field: 57, Ranking: 8.77%)

337

Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study.
¸­©ú­Û, Á©ú«Û, ¶ÀÂ@¶h, ¶À³©®p, Á©s°a, ±ç³Õµ{, ªL©yÐA, «J¤D¤¯, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs*, §E©ú¶©* - - 1 - MEDICINE - MEDICINE 2015 94¨÷(42´Á):e1837­¶
(IF: 5.723, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 154, »â°ì±Æ¦W: 9.74%)

Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study.
Yeh ML, Hsieh MY, Huang CI, Huang CF, Hsieh MH, Liang PC, Lin YH, Hou NJ, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL*, Yu ML* - - 1 - MEDICINE - MEDICINE 2015;94(42):e1837
(IF: 5.723, Journal Ranking: 15, Number of Journals of this Field: 154, Ranking: 9.74%)

338

Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy.
ªL§Ó¤å, ³¯Ä£´Ë, ªL§Ó­õ, ³¯Ãý¦p, ùÀAªe, §õ§B¬Ó, ³¢¬fÅï, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs, §E©ú¶©* - - 1 - Scientific Reports - SCI REP-UK 2015 5¨÷(-´Á):15807­¶
(IF: 5.578, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 57, »â°ì±Æ¦W: 8.77%)

Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy.
Lin CW, Chen YS, Lin CC, Chen YJ, Lo GH, Lee PH, Kuo PL, Dai CY, Huang JF, Chung WL, Yu ML* - - 1 - Scientific Reports - SCI REP-UK 2015;5(-):15807
(IF: 5.578, Journal Ranking: 5, Number of Journals of this Field: 57, Ranking: 8.77%)

339

The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients.
¶À§Ó´I, ¸­©ú­Û, §E©ú¶©, À¹¹Å¨¥, ¶À³©®p, ¶ÀÂ@¶h, ½²¨Ø­Å,ªL¨Øã¸, ³¯³ó«W, ±i¤åÀé, «J¤D¤¯, ªL¤l³ó, ³¯«H¦¨, ²ø¸UÀs* - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - J GASTROEN HEPATOL 2015 30¨÷(12´Á):1768-1774­¶
(IF: 3.504, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 76, »â°ì±Æ¦W: 34.21%)

The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients.
Huang JF, Yeh ML, Yu ML, Dai CY, Huang CF, Huang CI, Tsai PC, Lin PC, Chen YL, Chang WT, Hou NJ, Lin ZY, Chen SC, Chuang WL* - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - J GASTROEN HEPATOL 2015;30(12):1768-1774
(IF: 3.504, Journal Ranking: 26, Number of Journals of this Field: 76, Ranking: 34.21%)

340

High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients
§E©ú¶©, À¹¹Å¨¥, ¶À³©®p, §õ¨Î»T, ¸­©ú­Û, ¸­®É©s, ³¢¦æ¹D, ¶À§Ó´I, ±i­õ»Ê, ³¯ÂE¶v, ¨ô¦g¯è, ¶À©|§Ó*, ²ø¸UÀs* - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2014 60¨÷(2´Á):253-259­¶
(IF: 10.401, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 75, »â°ì±Æ¦W: 6.67%)

High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients
Yu ML, Dai CY, Huang CF, Lee JJ, Yeh ML, Yeh SM, Kuo HT, Huang JF, Chang JM, Chen HC, Juo SH, Hwang SJ*, Chuang WL*; FORMOSA-LIKE group. - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2014;60(2):253-259
(IF: 10.401, Journal Ranking: 5, Number of Journals of this Field: 75, Ranking: 6.67%)

341

Discrepancy between Serological and Virological Analysis of Viral Hepatitis in Hemodialysis Patients
±i­õ»Ê,¶À³©®p,³¯«ä¹Å,À¹¹Å¨¥,¸­©ú­Û,¶À§Ó´I,³¢¦æ¹D*,²ø¸UÀs,§E©ú¶©,¶À©|§Ó,³¯ÂE¶v* - - 1 - International Journal of Medical Sciences - INT J MED SCI 2014 11¨÷(5´Á):436-441­¶
(IF: 1.552, »â°ì±Æ¦W: 65, »â°ì´Á¥Z¼Æ: 156, »â°ì±Æ¦W: 41.67%)

Discrepancy between Serological and Virological Analysis of Viral Hepatitis in Hemodialysis Patients
Jer-Ming Chang, Chung-Feng Huang, Szu-Chia Chen, Chia-Yen Dai, Ming-Lun Yeh, Jee-Fu,Huang, Hsing-Tao Kuo, Wan-Long Chuang, Ming-Lung Yu, Shang-Jyh Hwang, Hung-Chun Chen - - 1 - International Journal of Medical Sciences - INT J MED SCI 2014;11(5):436-441
(IF: 1.552, Journal Ranking: 65, Number of Journals of this Field: 156, Ranking: 41.67%)

342

Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing.
¾G­s­^,½²©s®p,½²¿·¦p,²øÄR¤ë,ªL¤l³ó,Á©ú¸Î,³¯«H¦¨,²ø¸UÀs,¤ý¨}«Û,§E©ú¶©,À¹¹Å¨¥,½²ºaµo*. - - 1 - Asian Pacific Journal of Cancer Prevention - ASIAN PAC J CANCER P 2014 15¨÷(2´Á):637-642­¶
(IF: 1.5, »â°ì±Æ¦W: 163, »â°ì´Á¥Z¼Æ: 203, »â°ì±Æ¦W: 80.30%)

Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing.
Jeng JE, Tsai MF, Tsai HR, Chuang LY, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Tsai JF*. - - 1 - Asian Pacific Journal of Cancer Prevention - ASIAN PAC J CANCER P 2014;15(2):637-642
(IF: 1.5, Journal Ranking: 163, Number of Journals of this Field: 203, Ranking: 80.30%)

343

Complete Activation of Autophagic Process Attenuates Liver Injury and Improves Survival in Septic Mice
ªL§Ó¤å, Lo S, ´^¹D¶¯, §dªÃ®a, Lee PH,Chang YF, ³¢¬fÅï, §E©ú¶©*, °K¦æ­×*,Á¶®´¹*. - - 1 - Shock - Shock 2014 41¨÷(3´Á):241-249­¶
(IF: 2.732, »â°ì±Æ¦W: 39, »â°ì´Á¥Z¼Æ: 204, »â°ì±Æ¦W: 19.12%)

Complete Activation of Autophagic Process Attenuates Liver Injury and Improves Survival in Septic Mice
Lin CW, Lo S, Perng DS, Wu DB, Lee PH, Chang YF, Kuo PL, Yu ML*, Yuan SS*, Hsieh YC. - - 1 - Shock - Shock 2014;41(3):241-249
(IF: 2.732, Journal Ranking: 39, Number of Journals of this Field: 204, Ranking: 19.12%)

344

Peripheral Blood Mononuclear Cells MicroRNA Predicts Treatment Outcome of Hepatitis C Virus genotype 1 infection.
¸F­P»·,¶À³©®p,À¹¹Å¨¥,¨ô¦g¯è,©Pª³ª³,¶À§Ó´I,¸­©ú­Û,ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,²ø¸UÀs*,§E©ú¶©* - - 1 - ANTIVIRAL RESEARCH - Antivir Res 2014 15¨÷(-´Á):135-142­¶
(IF: 3.434, »â°ì±Æ¦W: 58, »â°ì´Á¥Z¼Æ: 256, »â°ì±Æ¦W: 22.66%)

Peripheral Blood Mononuclear Cells MicroRNA Predicts Treatment Outcome of Hepatitis C Virus genotype 1 infection.
Hsi E, Huang CF, Dai CY, Juo SH, Chou WW, Huang JF, Yeh ML, Lin ZY, Chen SC, Wang LY, Chuang WL*, Yu ML* - - 1 - ANTIVIRAL RESEARCH - Antivir Res 2014;15(-):135-142
(IF: 3.434, Journal Ranking: 58, Number of Journals of this Field: 256, Ranking: 22.66%)

345

µL
Á©s°a,½²©u§g,Á©ú«Û,¶À³©®p,¸­©ú­Û,·¨¥¿ºÖ,±i¬ì,ªL½«¦p,ªL«T¯§,³¯±¬ªN,¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©*,²ø¸UÀs - - 1 - PLOS ONE - PLOS ONE 2014 9¨÷(4´Á):e94791(1-7)­¶
(IF: 3.534, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 14.55%)

Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection
Meng-Hsuan Hsieh, Jih-Jin Tsai, Ming-Yen Hsieh, Chung-Feng Huang , Ming-Lun Yeh , Jeng- - - 1 - PLOS ONE - PLOS ONE 2014;9(4):e94791(1-7)
(IF: 3.534, Journal Ranking: 8, Number of Journals of this Field: 55, Ranking: 14.55%)

346

C«¬¨xª¢¯f¬r¤zÂZ¬~µÇ±wªÌB«¬¨xª¢¯f¬r¶q¤Îªí­±§Ü­ì¶q¬ÛÃö©Ê
¶À³©®p,¸­©ú­Û,§õ¨Î»T,³¯¬ü¬z,À¹¹Å¨¥,¶À§Ó´I,±i­õ»Ê,³¯ÂE¶v,¶À©|§Ó,²ø¸UÀs,§E©ú¶©* - - 1 - Hepatology International - HEPATOL INT 2014 8¨÷(2´Á):224-232­¶
(IF: 2.468, »â°ì±Æ¦W: 35, »â°ì´Á¥Z¼Æ: 75, »â°ì±Æ¦W: 46.67%)

Hepatitis C viremia interferes with serum hepatitis B virus surface antigen and DNA levels in hepatitis B uremics
Chung-Feng Huang, Ming-Lun Yeh, Jia-Jung Lee, Mei-Chin Chen, Chia-Yen Dai, Jee-Fu Huang, Jer-Ming Chang, Hung-Chun Chen, Shang-Jyh Hwang, Wan-Long Chuang, Ming-Lung Yu * - - 1 - Hepatology International - HEPATOL INT 2014;8(2):224-232
(IF: 2.468, Journal Ranking: 35, Number of Journals of this Field: 75, Ranking: 46.67%)

347

ªø®Ä«¬¤zÂZ¯À¦X¨Ö¹p¤Ú«ÂÆF¦b°ò¦]«¬²Ä¤@«¬¤Î²Ä¤G«¬²V¦X·P¬V¤§ºC©ÊC«¬¨xª¢±wªÌªºªvÀø®ÄªG¬ã¨s
¶ÀÂ@¶h,¶À³©®p(¦@¦P²Ä¤@),¶À§Ó´I,À¹¹Å¨¥,¸­©ú­Û,Á©ú«Û,ªL¤l³ó,³¯«H¸Û,¤ý¨}«Û,§E©ú¶©,²ø¸UÀs* - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - J GASTROEN HEPATOL 2014 29¨÷(5´Á):1012-1018­¶
(IF: 3.627, »â°ì±Æ¦W: 19, »â°ì´Á¥Z¼Æ: 75, »â°ì±Æ¦W: 25.33%)

The treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection
Ching-I Huang,Chung-Feng Huang,Jee-Fu Huang,Chia-Yen Dai,Ming-Lun Yeh,Ming-Yen Hsieh,Zu-Yau Lin,Shinn-Cherng Chen,Liang-Yen Wang,Ming-Lung Yu,Wan-Long Chuang* - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - J GASTROEN HEPATOL 2014;29(5):1012-1018
(IF: 3.627, Journal Ranking: 19, Number of Journals of this Field: 75, Ranking: 25.33%)

348

ªvÀø«e¦å¤¤¤þ¾¢ÓiñQÂಾ酶¿@«×¬°«D¨xµw¤ÆC«¬¨xª¢±wªÌ¸g¦¨¥\¯f¬r²M°£«á²£¥Í¨xÀùªº­«­n¹w´ú¦]¤l
¶À³©®p,¸­©ú­Û,½²¨Ø­Å,Á©s°a,·¨µØÄÖ,Á©ú«Û,·¨¥¿ºÖ,ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,À¹¹Å¨¥*,¶À§Ó´I,²ø¸UÀs,§E©ú¶©* - - 1 - Journal of Hepatology - J HEPATOL 2014 61¨÷(1´Á):67-74­¶
(IF: 10.401, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 75, »â°ì±Æ¦W: 6.67%)

Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication
Chung-Feng Huang,Ming-Lun Yeh,Pei-Chien Tsai,Meng-Hsuan Hsieh,Hua-Ling Yang,Ming-Yen Hsieh,Jeng-Fu Yang,Zu-Yau Lin,Shinn-Cherng Chen,Liang-Yen Wang,Chia-Yen Dai*,Jee-Fu Huang,Wan-Long Chuang,Ming-Lung Yu* - - 1 - Journal of Hepatology - J HEPATOL 2014;61(1):67-74
(IF: 10.401, Journal Ranking: 5, Number of Journals of this Field: 75, Ranking: 6.67%)

349

Urinary transforming growth factor £\ and serum £\-fetoprotein as tumor markers of hepatocellular carcinoma.
¾G­s­^, ½²©s®p(¦@¦P²Ä¤@), ½²¿·¦p(¦@¦P²Ä¤@), ²øÄR¤ë*, ªL¤l³ó, Á©ú¸Î, ³¯«H¦¨, ²ø¸UÀs, ¤ý¨}«Û, §E©ú¶©, À¹¹Å¨¥, ½²ºaµo* - - 1 - TUMOR BIOLOGY - TUMOR BIOL 2014 35¨÷(4´Á):3689-3698­¶
(IF: 2.84, »â°ì±Æ¦W: 93, »â°ì´Á¥Z¼Æ: 203, »â°ì±Æ¦W: 45.81%)

Urinary transforming growth factor £\ and serum £\-fetoprotein as tumor markers of hepatocellular carcinoma.
Jeng JE, Tsai MF, Tsia HR, Chuang LY*, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Tsai JF* - - 1 - TUMOR BIOLOGY - TUMOR BIOL 2014;35(4):3689-3698
(IF: 2.84, Journal Ranking: 93, Number of Journals of this Field: 203, Ranking: 45.81%)

350

C«¬¨xª¢·P¬V¼W¥[µo®i¥½´ÁµÇŦ¯fªº­·ÀI-¨Ï¥ÎÄvª§­·ÀI¤ÀªR
§õ¨Î»T,ªL©ú«Û, ±iºaúâ,¬x±Ò´¼, ±i­õ»Ê, ³¯ÂE¶v, §E©ú¶©, ¶À©|§Ó* - - 1 - PLoS One - PLOS ONE 2014 9¨÷(6´Á):e100790(1-7)­¶
(IF: 3.534, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 14.55%)

Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis
Lee JJ, Lin MY, Chang JS, Hung CC, Chang JM, Chen HC, Yu ML, Hwang SJ* - - 1 - PLoS One - PLOS ONE 2014;9(6):e100790(1-7)
(IF: 3.534, Journal Ranking: 8, Number of Journals of this Field: 55, Ranking: 14.55%)

351

¨xµw¤Æ»PªÍµ²®Öµo¥Í²v¤§¬ÛÃö©Ê
ªL¾Ð´@,§dªÃ¾±,ªL«T¦ö,ªL©ú«Û,²ø¥°¼Ý,¶À§Ó´I*,§E©ú¶©,²ø¸UÀs - - 1 - American journal of epidemiology - AM J EPIDEMIOL 2014 180¨÷(1´Á):103-110­¶
(IF: 4.975, »â°ì±Æ¦W: 11, »â°ì´Á¥Z¼Æ: 162, »â°ì±Æ¦W: 6.79%)

Cirrhosis as a Risk Factor for Tuberculosis Infection¡XA Nationwide Longitudinal
Yi-Ting Lin,Ping-Hsun Wu,Chun-Yu Lin,Ming-Yen Lin,Hung-Yi Chuang,Jee-Fu Huang*,Wan-Long Chuang - - 1 - American journal of epidemiology - AM J EPIDEMIOL 2014;180(1):103-110
(IF: 4.975, Journal Ranking: 11, Number of Journals of this Field: 162, Ranking: 6.79%)

352

T-cell autophagy deficiency increases mortality and suppresses immune responses after sepsis.
ªL§Ó¤å, ùÀAªe,³\¶Ô, Hsieh CH, Chang YF, Hou BS, °ª­^½å, Lin CC, §E©ú¶©, °K¦æ­×*, Á¶®´¹. - - 1 - PLOS ONE - PLOS ONE 2014 9¨÷(7´Á):e102066(1-13)­¶
(IF: 3.534, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 14.55%)

T-cell autophagy deficiency increases mortality and suppresses immune responses after sepsis.
Lin CW, Lo S, Hsu C, Hsieh CH, Chang YF, Hou BS, Kao YH, Lin CC, Yu ML, Yuan SS*, Hsieh YC. - - 1 - PLOS ONE - PLOS ONE 2014;9(7):e102066(1-13)
(IF: 3.534, Journal Ranking: 8, Number of Journals of this Field: 55, Ranking: 14.55%)

353

Novel quasi-subgenotype D2 of hepatitis B virus identified in Taiwanese aborigines
Tran H, §E©ú¶©, À¹¹Å¨¥, ªL©É§D, ¸­©ú­Û, ²ø¸UÀs, Abe K* - - 1 - Virus Genes - Virus Genes 2014 49¨÷(1´Á):30-37­¶
(IF: 1.837, »â°ì±Æ¦W: 121, »â°ì´Á¥Z¼Æ: 165, »â°ì±Æ¦W: 73.33%)

Novel quasi-subgenotype D2 of hepatitis B virus identified in Taiwanese aborigines
Tran H, Yu ML, Dai CY, Lin IL, Yeh ML, Chuang WL, Abe K* - - 1 - Virus Genes - Virus Genes 2014;49(1):30-37
(IF: 1.837, Journal Ranking: 121, Number of Journals of this Field: 165, Ranking: 73.33%)

354

Comparison of the Abbott RealTime HBV assay with the Roche Cobas AmpliPrep/Cobas TaqMan HBV assay for HBV DNA detection and quantification
¸­©ú­Û, ¶À³©®p, Á©ú«Û, ¶À§Ó´I, À¹¹Å¨¥, §E©ú¶©*, ²ø¸UÀs - - 1 - Journal of Clinical Virology - J Clin Virol 2014 60¨÷(3´Á):206-214­¶
(IF: 3.466, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 33, »â°ì±Æ¦W: 30.30%)

Comparison of the Abbott RealTime HBV assay with the Roche Cobas AmpliPrep/Cobas TaqMan HBV assay for HBV DNA detection and quantification
Yeh ML, Huang CF, Hsieh MY, Huang JF, Dai CY, Yu ML*, Chuang WL - - 1 - Journal of Clinical Virology - J Clin Virol 2014;60(3):206-214
(IF: 3.466, Journal Ranking: 10, Number of Journals of this Field: 33, Ranking: 30.30%)

355

Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy.
¸­©ú­Û, ¶À³©®p, ¶ÀÂ@¶h, ¼B²Qªâ, ·¨µØÄÖ, Á©ú«Û, ¶À§Ó´I, À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©* - - 1 - PLOS ONE - PLOS ONE 2014 9¨÷(7´Á):e101790(1-7)­¶
(IF: 3.534, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 14.55%)

Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy.
Yeh ML, Huang CF, Huang CI, Liu SF, Yang HL, Hsieh MY, Huang JF, Dai CY, Chuang WL, Yu ML* - - 1 - PLOS ONE - PLOS ONE 2014;9(7):e101790(1-7)
(IF: 3.534, Journal Ranking: 8, Number of Journals of this Field: 55, Ranking: 14.55%)

356

inosine triphosphate pyrophosphatase °ò¦]Åܲ§»PºC©ÊC«¬¨xª¢2/3°ò¦]«¬ªvÀø´_µo¦MÀI
À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©* - - 1 - Hepatology - Hepatology 2014 60¨÷(6´Á):2129-2130­¶
(IF: 11.19, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 75, »â°ì±Æ¦W: 4.00%)

Variants of the inosine triphosphate pyrophosphatase gene and relapse risk following treatment for HCV genotype 2/3
Dai CY, Chuang WL, Yu ML* - - 1 - Hepatology - Hepatology 2014;60(6):2129-2130
(IF: 11.19, Journal Ranking: 3, Number of Journals of this Field: 75, Ranking: 4.00%)

357

A 24-Week Pegylated Interferon Alpha-2b Versus a 12-Week Pegylated Interferon Alpha-2b Alone or With Ribavirin for Patients With Acute Hepatitis C
À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶©* - - 1 - Hepatology - Hepatology 2014 60¨÷(6´Á):2128-9­¶
(IF: 11.19, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 75, »â°ì±Æ¦W: 4.00%)

A 24-Week Pegylated Interferon Alpha-2b Versus a 12-Week Pegylated Interferon Alpha-2b Alone or With Ribavirin for Patients With Acute Hepatitis C
Dai CY, Chuang WL, Yu ML* - - 1 - Hepatology - Hepatology 2014;60(6):2128-9
(IF: 11.19, Journal Ranking: 3, Number of Journals of this Field: 75, Ranking: 4.00%)

358

¦b³y¦å·F²Ó­M²¾´Ó¤¤C«¬¨xª¢¥Ñ±a­ìªÌ¶Ç¬V¤§­Ó®×
¿½´f¾ì*,¼B¯q©÷,¤ý¼z´¹,§d©Ó¿«,¨ô¤h®p,³\·ç®p,½²¼z¬Ã, S.Y. Hsiao,±i»FªQ,ªL³ÓÂ×,¼B¤j´¼,²ø¸UÀs,§E©ú¶© - - 1 - Transplant Infectious Disease - TRANSPL INFECT DIS 2014 16¨÷(6´Á):1003-1006­¶
(IF: 2.25, »â°ì±Æ¦W: 13, »â°ì´Á¥Z¼Æ: 26, »â°ì±Æ¦W: 50.00%)

Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.
H.-H. Hsiao*, Y.-C. Liu, H.-C. Wang, C.-H. Wu, S.-F. Cho, J.-F. Hsu, H.-J. Tsai1, S.Y. Hsiao, C.-S. Chang, S.-F. Lin, T.-C. Liu, W.-L. Chuang andM.-L. Yu - - 1 - Transplant Infectious Disease - TRANSPL INFECT DIS 2014;16(6):1003-1006
(IF: 2.25, Journal Ranking: 13, Number of Journals of this Field: 26, Ranking: 50.00%)

359

Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10-month withdrawal of pioglitazone in patients with Type 2 diabetes
ªL©ø¼w, §õ¬ü¤ë, ¶¾¤[­õ, Chen Brian-Ken, §E©ú¶©, ¨¯¿ü¼ý* - - 1 - DIABETIC MEDICINE - DIABETIC MED 2014 31¨÷(11´Á):1341-1349­¶
(IF: 3.064, »â°ì±Æ¦W: 55, »â°ì´Á¥Z¼Æ: 124, »â°ì±Æ¦W: 44.35%)

Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10-month withdrawal of pioglitazone in patients with Type 2 diabetes
Lin KD, Lee MY, Feng CC, Chen BK, Yu ML, Shin SJ* - - 1 - DIABETIC MEDICINE - DIABETIC MED 2014;31(11):1341-1349
(IF: 3.064, Journal Ranking: 55, Number of Journals of this Field: 124, Ranking: 44.35%)

360

Independent and additive interaction between tumor necrosis factor £] +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
¾G­s­^,§d¼zªÚ,½²©s®p,½²¿·¦p,²øÄR¤ë,ªL¤l³ó,Á©ú¸Î,³¯«H¦¨,²ø¸UÀs,¤ý¨}«Û,§E©ú¶©,À¹¹Å¨¥,½²ºaµo* - - 1 - Asian Pacific Journal of Cancer Prevention - ASIAN PAC J CANCER P 2014 15¨÷(23´Á):10209-15­¶
(IF: 1.5, »â°ì±Æ¦W: 163, »â°ì´Á¥Z¼Æ: 203, »â°ì±Æ¦W: 80.30%)

Independent and additive interaction between tumor necrosis factor £] +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE, Wu HF, Tsai MF, Tsai HR, Chuang LY, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY,Yu ML, Dai CY, Tsai JF* - - 1 - Asian Pacific Journal of Cancer Prevention - ASIAN PAC J CANCER P 2014;15(23):10209-15
(IF: 1.5, Journal Ranking: 163, Number of Journals of this Field: 203, Ranking: 80.30%)

361

Host factors determining the efficacy of hepatitis C treatment.
²ø¸UÀs*, §E©ú¶© - - 1 - JOURNAL OF GASTROENTEROLOGY - J GASTROENTEROL 2013 48¨÷(1´Á):22-30­¶
(IF: 3.788, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 22.97%)

Host factors determining the efficacy of hepatitis C treatment.
Chuang WL*, Yu ML. - - 1 - JOURNAL OF GASTROENTEROLOGY - J GASTROENTEROL 2013;48(1):22-30
(IF: 3.788, Journal Ranking: 17, Number of Journals of this Field: 74, Ranking: 22.97%)

362

«D¨xÀùÀù¯gC«¬¨xª¢±wªÌ±µ¨üªø®Ä«¬¤zÂZ¯À¦X¨Ö¹p¤Ú«ÂÆFªvÀø¤§Àø®Ä»P¦w¥þ©Ê¦h¤¤¤ß¬ã¨s
¶À³©®p,¶À§Ó´I,³¯ªZ¬F,¸­©ú­Û,¶ÀÂ@¶h,·¨¥¿ºÖ,²ø¸UÀs,À¹¹Å¨¥,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,§E©ú¶©* - - 1 - Hepatology International - HEPATOL INT 2013 7¨÷(1´Á):180-187­¶
(IF: 2.642, »â°ì±Æ¦W: 33, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 44.59%)

The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter study
Chung-Feng Huang,Jee-Fu Huang,Wu-Cheng Chen,Ming-Lun Yeh,Ching-I Huang,Jeng-Fu Yang,Wan-Long Chuang,Chia-Yen Dai,Ming-Yen Hsieh,Zu-Yau Lin,Shinn-Cherng Chen,Ming-Lung Yu* - - 1 - Hepatology International - HEPATOL INT 2013;7(1):180-187
(IF: 2.642, Journal Ranking: 33, Number of Journals of this Field: 74, Ranking: 44.59%)

363

C«¬¨xª¢±wªÌ±a¦³¤¶¥Õ¯À28B¦MÀI°ò¦]«¬±wªÌ¶·¦bªvÀø²Ä4¶g®É¨ã¦³¸û¦nªº¤zÂZ¯À¤ÏÀ³¥H¹FªvÀøÀø®Ä
¶À³©®p,§E©ú¶©,°ª¹Å§»,´¿©§©v,¸­©ú­Û,¶À§Ó´I,À¹¹Å¨¥,ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,¨ô¦g¯è,²ø¸UÀs,¼B®¶÷~* - - 1 - JOURNAL OF CLINICAL VIROLOGY - J CLIN VIROL 2013 56¨÷(4´Á):293-298­¶
(IF: 3.287, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 34, »â°ì±Æ¦W: 29.41%)

Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
Chung-Feng Huang,Ming-Lung Yu,Jia-Horng Kao,Tai-Chung Tseng,Ming-Lun Yeh,Jee-Fu Huang,Chia-Yen Dai,Zu-Yau Lin,Shinn-Cherng Chen,Liang-Yen Wang,Suh-Hang Hank Juo,Wan-Long Chuang,Chen-Hua Liu* - - 1 - JOURNAL OF CLINICAL VIROLOGY - J CLIN VIROL 2013;56(4):293-298
(IF: 3.287, Journal Ranking: 10, Number of Journals of this Field: 34, Ranking: 29.41%)

364

C«¬¨xª¢°ò¦]«¬²Ä¤G«¬±wªÌ±µ¨ü¦A¦¸ªvÀø¦¨¥\ªº¯f¬r¹w´ú¦]¤l
¶À³©®p,À¹¹Å¨¥*,¸­©ú­Û,¶À§Ó´I,¶ÀÂ@¶h,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,¨ô¦g¯è,²ø¸UÀs,ªL©yÀR,§E©ú¶© - - 1 - PLoS One - PLOS ONE 2013 8¨÷(3´Á):e58882­¶
(IF: 3.73, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 56, »â°ì±Æ¦W: 12.50%)

Virological predictors of response to retreatment in hepatitis C genotype 2 infected patients
Huang CF,Dai CY*,Yeh ML,Huang JF,Huang CI,Hsieh MY,Lin ZY,Chen SC,Wang LY,Juo SH,Chuang WL,Lin YC,Yu ML - - 1 - PLoS One - PLOS ONE 2013;8(3):e58882
(IF: 3.73, Journal Ranking: 7, Number of Journals of this Field: 56, Ranking: 12.50%)

365

Glucose abnormalities in hepatitis C virus infection.
¶À§Ó´I,§E©ú¶©,À¹¹Å¨¥,²ø¸UÀs* - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2013 29¨÷(2´Á):61-68­¶
(IF: 0.502, »â°ì±Æ¦W: 104, »â°ì´Á¥Z¼Æ: 121, »â°ì±Æ¦W: 85.95%)

Glucose abnormalities in hepatitis C virus infection.
Huang JF, Yu ML, Dai CY, Chuang WL*. - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2013;29(2):61-68
(IF: 0.502, Journal Ranking: 104, Number of Journals of this Field: 121, Ranking: 85.95%)

366

Ånµ²¥Û©MºC©ÊC«¬¨xª¢ªº¬ÛÃö©Ê: ¦b»OÆWC «¬¨xª¢©M B«¬¨xª¢²±¦æ¶mÂí¶W­µªi¬ã¨s
À¹¹Å¨¥,ªL¹Å¯q,¸­©ú­Û,Á©s°a,¶À³©®p,«J¤D¤¯,Á©ú«Û,¶À§Ó´I, ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,±i¤å¦t,³¯ºa²»*,§E©ú¶©, ²ø¸UÀs - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2013 29¨÷(8´Á):430-435­¶
(IF: 0.502, »â°ì±Æ¦W: 104, »â°ì´Á¥Z¼Æ: 121, »â°ì±Æ¦W: 85.95%)

Association between gallbladder stones and chronic hepatitis C: Ultrasonographic survey in a hepatitis C and B hyperendemic township in Taiwan
Chia-Yen Dai, Chia-I Lin, Ming-Lun Yeh, Meng-Hsuan Hsie, Chung-Feng Huang, Nai-Jen Hou, Ming-Yen Hsieh, Jee-Fu Huang, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Wen-Yu Chang, Jong-Shyong Cheng*, Ming-Lung Yu, Wan-Long Chuang - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2013;29(8):430-435
(IF: 0.502, Journal Ranking: 104, Number of Journals of this Field: 121, Ranking: 85.95%)

367

±J¥D¤¶¥Õ¯À28B°ò¦]Åܲ§©ó¨È¬wC«¬¨xª¢±wªÌªvÀø¥¢±Ñ«á¦A¦¸ªvÀøÁ{§É®Ä¯q
¶À³©®p,¸­©ú­Û,Á©s°a,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,¶À§Ó´I,¨ô¦g¯è,ªL©yÀR,À¹¹Å¨¥*,²ø¸UÀs,§E©ú¶© - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - J GASTROEN HEPATOL 2013 28¨÷(9´Á):1515-1520­¶
(IF: 3.325, »â°ì±Æ¦W: 22, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 29.73%)

Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin
Chung-Feng Huang,Ming-Lun Yeh,Meng-Hsuan Hsieh,Ming-Yen Hsieh,Zu-Yau Lin,Shinn-Cherng Chen,Liang-Yen Wang,Jee-Fu Huang,Suh-Hang Hank Juo,Yi-Ching Lin,Chia-Yen Dai*,Wan-Long Chuang,Ming-Lung Yu - - 1 - JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY - J GASTROEN HEPATOL 2013;28(9):1515-1520
(IF: 3.325, Journal Ranking: 22, Number of Journals of this Field: 74, Ranking: 29.73%)

368

¨È¬wºC©ÊB«¬¨xª¢e§Ü­ì¶§©Ê¯f±w±µ¨ü¤z¦w¯àªvÀø¤§¾d©TÀøªk:¤@¦h¤¤¤ß¬ã¨s
À¹¹Å¨¥,´¿©§©v,Grace Wong,¶À§Ó´I,Vicent Wong, ¼B«T¤H, §E©ú¶©, ²ø¸UÀs,°ª¹Å§»,³¯¤O¤¸*,³¯©w«H - - 1 - JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY - J ANTIMICROB CHEMOTH 2013 68¨÷(10´Á):2332-2338­¶
(IF: 5.338, »â°ì±Æ¦W: 18, »â°ì´Á¥Z¼Æ: 261, »â°ì±Æ¦W: 6.90%)

Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study
Chia-Yen Dai, Tai-Chung Tseng, Grace Wong,Jee-Fu Huang, Vicent Wong, Chun-Jen Liu, Ming-Lung Yu, Wan-Long Chuang, Jia-Horng Kao, Henry Chan*, Ding-Sjinn Chen - - 1 - JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY - J ANTIMICROB CHEMOTH 2013;68(10):2332-2338
(IF: 5.338, Journal Ranking: 18, Number of Journals of this Field: 261, Ranking: 6.90%)

369

Sustained hcv clearance and increased HBsAg seroclearance in patients with dual chronic hepatitis C and B during post-treatment follow-up.
§E©ú¶©, §õ¸à¿Ñ(¦@¦P²Ä¤@), Chen CL, ²ø¸UÀs, ¿c³Ó¨k, ¼B®¶¾ì, Wu SS, ¹ùÄR·ë, ³¢¦æ¹D, »¯¦³¸Û, ¸³¤ô¸q, ·¨½åÄÉ, °ª¹Å§», Su WW, Lin CL, Yang HC, ³¯°ö­õ, ³¯©w«H, ¼B«T¤H*; Taiwan Liver-Net Consortium. - - 1 - HEPATOLOGY - HEPATOLOGY 2013 57¨÷(6´Á):2135-2142­¶
(IF: 12.003, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 2.70%)

Sustained hcv clearance and increased HBsAg seroclearance in patients with dual chronic hepatitis C and B during post-treatment follow-up.
Yu ML, Lee CM, Chen CL, Chuang WL, Lu SN, Liu CH, Wu SS, Liao LY, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Su WW, Lin CL, Yang HC, Chen PJ, Chen DS, Liu CJ; Taiwan Liver-Net Consortium. - - 1 - HEPATOLOGY - HEPATOLOGY 2013;57(6):2135-2142
(IF: 12.003, Journal Ranking: 2, Number of Journals of this Field: 74, Ranking: 2.70%)

370

Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.
·¨§»§Ó, ³¯¬è¬Â, Shen YC, Peng CY, ¼B«T¤H, Tseng TC, ĬªF¥°, ²ø¸UÀs, §E©ú¶©, À¹¹Å¨¥, ¼B®¶¾ì, ³¯°ö­õ, ³¯©w«H, °ª¹Å§»*. - - 1 - HEPATOLOGY - HEPATOLOGY 2013 57¨÷(3´Á):934-943­¶
(IF: 12.003, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 2.70%)

Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.
Yang HC, Chen CL, Shen YC, Peng CY, Liu CJ, Tseng TC, Su TH, Chuang WL, Yu ML, Dai CY, Liu CH, Chen PJ, Chen DS, Kao JH*. - - 1 - HEPATOLOGY - HEPATOLOGY 2013;57(3):934-943
(IF: 12.003, Journal Ranking: 2, Number of Journals of this Field: 74, Ranking: 2.70%)

371

Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapy
³¯§g»¨(CR), ¶À§Ó´I, ¶À³©®p, ¸­©ú­Û, ·¨¥¿ºÖ, Á©ú«Û, «J¤D¤¯, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ²ø¸UÀs, À¹¹Å¨¥, §E©ú¶©* - - 1 - Hepatology international - HEPATOL INT 2013 7¨÷(1´Á):162-170­¶
(IF: 2.642, »â°ì±Æ¦W: 33, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 44.59%)

Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapy
Chen CH, Huang JF, Huang CF, Yeh ML, Yang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chuang WL, Dai CY, Yu ML - - 1 - Hepatology international - HEPATOL INT 2013;7(1):162-170
(IF: 2.642, Journal Ranking: 33, Number of Journals of this Field: 74, Ranking: 44.59%)

372

Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.
ªL§Ó¤å, Lin CC, ¦ÈÁp·ç, ±i¦N¥õ, ´^¹D¶¯, ³\®a¹ü, ùÀAªe, ³¯Ä£´Ë, ÃC¥ÃªN, Hu JT, §E©ú¶©, §õ§B¬Ó, ªL»F°ó, ·¨½åÄÉ*. - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2013 58¨÷(4´Á):730-735­¶
(IF: 9.858, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 6.76%)

Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.
Lin CW, Lin CC, Mo LR, Chang CY, Perng DS, Hsu CC, Lo GH, Chen YS, Yen YC, Hu JT, Yu ML, Lee PH, Lin JT, Yang SS. - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2013;58(4):730-735
(IF: 9.858, Journal Ranking: 5, Number of Journals of this Field: 74, Ranking: 6.76%)

373

µL
Öª­P»·, ³¯ÅU¤¤,±iÚ{²Q,§E©ú¶©,±ç¤¤¬Â*,¨ô¦g¯è* - - 1 - INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE - INVEST OPHTH VIS SCI 2013 54¨÷(5´Á):3265-3271­¶
(IF: 3.441, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 59, »â°ì±Æ¦W: 8.47%)

A functional polymorphism at the FGF10 gene is associated with extreme myopia.
Edward Hsi, Ku-Chung Chen, Wan-Shu Chang, Ming-Lung Yu, Chung-Ling Liang*,Suh-Hang Hank Juo* - - 1 - INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE - INVEST OPHTH VIS SCI 2013;54(5):3265-3271
(IF: 3.441, Journal Ranking: 5, Number of Journals of this Field: 59, Ranking: 8.47%)

374

Pegylated interferon and ribavirin: A therapeutic option in patients who fail to respond to telaprevir-based triple therapy?
À¹¹Å¨¥, ²ø¸UÀs, §E©ú¶© - - 1 - Hepatology - Hepatology 2013 58¨÷(4´Á):1519-1520­¶
(IF: 12.003, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 2.70%)

Pegylated interferon and ribavirin: A therapeutic option in patients who fail to respond to telaprevir-based triple therapy?
Dai CY, Chuang WL, Yu ML. - - 1 - Hepatology - Hepatology 2013;58(4):1519-1520
(IF: 12.003, Journal Ranking: 2, Number of Journals of this Field: 74, Ranking: 2.70%)

375

The Evolution of HCV treatment in Taiwan
¶À³©®p,²ø¸UÀs,§E©ú¶©* - - 0 - Current Hepatitis Reports - Curr Hepatitis Rep 2013 12¨÷(1´Á):143¡V148­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

The Evolution of HCV treatment in Taiwan
Huang CF, Chaung WL, Yu ML* - - 0 - Current Hepatitis Reports - Curr Hepatitis Rep 2013;12(1):143¡V148
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

376

Pegylated Interferon-£\2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis: A Randomized Trial.
¼B®¶¾ì, ¶À³©®p, ¼B«T¤H, À¹¹Å¨¥, ±çµ{¶W, ¶À§Ó´I, Hung PH, ½²§»Ùy, ½²©s©ø, Chen SI, ªL¬Lºû, ·¨³ÓµÏ, ĬªF¥°, ·¨§»§Ó, ³¯°ö­õ, ³¯©w«H, ²ø¸UÀs, §E©ú¶©, °ª¹Å§»* - - 1 - ANNALS OF INTERNAL MEDICINE - ANN INTERN MED 2013 159¨÷(11´Á):729-738­¶
(IF: 13.976, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 3.87%)

Pegylated Interferon-£\2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis: A Randomized Trial.
Liu CH, Huang CF, Liu CJ, Dai CY, Liang CC, Huang JF, Hung PH, Tsai HB, Tsai MK, Chen SI, Lin JW, Yang SS, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Yu ML, Kao JH* - - 1 - ANNALS OF INTERNAL MEDICINE - ANN INTERN MED 2013;159(11):729-738
(IF: 13.976, Journal Ranking: 6, Number of Journals of this Field: 155, Ranking: 3.87%)

377

Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma.
¶À°·©ú, ¸­©ú­Û, ²ø¥@©÷, ¤ý¨}«Û, ªL¤l³ó, ³¯«H¦¨, ½²ºaµo, ¤ý´Ë¸Z, ³¢¥\·¢, À¹¹Å¨¥*, §E©ú¶©, §õª÷¼w, ²ø¸UÀs - - 0 - Indian Journal of Gastroenterology - Indian J Gastroenterol 2013 32¨÷(4´Á):253-257­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma
Wong KM, Yeh ML, Chuang SC, Wang LY, Lin ZY, Chen SC, Tsai JF, Wang SN, Kuo KK, Dai CY*, Yu ML, Lee KT, Chuang WL - - 0 - Indian Journal of Gastroenterology - Indian J Gastroenterol 2013;32(4):253-257
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

378

¤¶¥Õ¯À28B°ò¦]¦h«¬©Ê¦bºC©ÊC«¬¨xª¢²Ä¤@«¬±wªÌ±µ¨ü24¶gªø®Ä«¬¤zÂZ¯À¦X¨Ö¹p¤Ú«ÂÆFªvÀøÀøµ{¤§¨¤¦â
¶À³©®p,¶À§Ó´I,·¨¥¿ºÖ,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,¨ô¦g¯è,²ø¸UÀs,À¹¹Å¨¥*,§E©ú¶©* - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2012 27¨÷(1´Á):1-8­¶
(IF: 9.264, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 5.41%)

Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
Chung-Feng Huang,Jee-Fu Huang,Jeng-Fu Yang,Ming-Yen Hsieh,Zu-Yau Lin,Shinn-Cherng Chen,Liang-Yen Wang,Suh-Hang Hank Juo,Ku-Chung Chen,Wan-Long Chuang,Hsing-Tao Kuo,Chia-Yen Dai,Ming-Lung Yu* - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2012;27(1):1-8
(IF: 9.264, Journal Ranking: 4, Number of Journals of this Field: 74, Ranking: 5.41%)

379

±J¥D¤¶¥Õ¯À28B°ò¦]«¬Åܲ§¤Î¯f¬r°Ê¤O¾Ç©ó¨È¬w¤H·P¬VC«¬¨xª¢¯f¬r°ò¦]«¬²Ä¤@«¬±µ¨ü¼Ð·ÇÀøµ{ªº¨¤¦â
¶À³©®p,¸­©ú­Û,¶À§Ó´I,·¨¥¿ºÖ,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,¨ô¦g¯è,À¹¹Å¨¥*,²ø¸UÀs,§E©ú¶© - - 1 - ANTIVIRAL RESEARCH - ANTIVIR RES 2012 93¨÷(2´Á):239-244­¶
(IF: 4.301, »â°ì±Æ¦W: 36, »â°ì´Á¥Z¼Æ: 261, »â°ì±Æ¦W: 13.79%)

Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard¡Vof-care for Asians with hepatitis C genotype 1
Chung-Feng Huang,Ming-Lun Yeh,Jee-Fu Huang,Jeng-Fu Yang,Ming-Yen Hsieh, Zu-Yau Lin,Shinn-Cherng Chen,Liang-Yen Wang,Edward His, Suh-Hang Hank Juo,Chia-Yen Dai*,Wan-Long Chuang, Ming-Lung Yu - - 1 - ANTIVIRAL RESEARCH - ANTIVIR RES 2012;93(2):239-244
(IF: 4.301, Journal Ranking: 36, Number of Journals of this Field: 261, Ranking: 13.79%)

380

µL
¶À§Ó´I,§E©ú¶©,¶À³©®p,¨ô¦g¯è,À¹¹Å¨¥,Á©ú«Û,«J¤D¤¯,¸­©ú­Û,Á©s°a,·¨¥¿ºÖ,ªL¤l³ó,³¯«H¸Û,¨¯Áí³¹,²ø¸UÀs* - - 1 - LIVER INTERNATIONAL - LIVER INT 2012 32¨÷(6´Á):962-969­¶
(IF: 3.824, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 21.62%)

The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy
Huang JF,Yu ML,Huang CF,Juo SH, Dai CY, Hsieh MY, Hou NJ,Yeh ML,Hsieh MH,Yang JF,Lin ZY, Chen SC,Shin SJ,Chuang WL*. - - 1 - LIVER INTERNATIONAL - LIVER INT 2012;32(6):962-969
(IF: 3.824, Journal Ranking: 16, Number of Journals of this Field: 74, Ranking: 21.62%)

381

Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients.
À¹±Ò©ú, Huang CK, Hwang JC, Chiang H, Chang CY, Lee CT, §E©ú¶©*,ªL»F°ó* - - 1 - OBESITY SURGERY - OBES SURG 2012 22¨÷(7´Á):1016-1021­¶
(IF: 3.286, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 199, »â°ì±Æ¦W: 8.54%)

Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients.
À¹±Ò©ú, Huang CK, Hwang JC, Chiang H, Chang CY, Lee CT, §E©ú¶©*,Lin JT * - - 1 - OBESITY SURGERY - OBES SURG 2012;22(7):1016-1021
(IF: 3.286, Journal Ranking: 17, Number of Journals of this Field: 199, Ranking: 8.54%)

382

Mitochondrial polymorphism 12361A>G is associated with nonalcoholic fatty liver disease.
MING-YING LU, ¶À§Ó´I, ¹ùÖöµ®, REN-KUI BAI, ROBERT B. TRIEU, ²ø¸UÀs, §E©ú¶©*, ¨ô¦g¯è, ¤ý±i¾¤§g - - 1 - Transl Res. - TRANSL RES 2012 159¨÷(1´Á):58-59­¶
(IF: 2.903, »â°ì±Æ¦W: 35, »â°ì´Á¥Z¼Æ: 106, »â°ì±Æ¦W: 33.02%)

Mitochondrial polymorphism 12361A>G is associated with nonalcoholic fatty liver disease.
Lu MY, Huang JF, Liao YC, Bai RK, ROBERT B. TRIEU, Chuang WL, Yu ML*, Juo SH, Wong LJ - - 1 - Transl Res. - TRANSL RES 2012;159(1):58-59
(IF: 2.903, Journal Ranking: 35, Number of Journals of this Field: 106, Ranking: 33.02%)

383

Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1.
¶À³©®p,¸­©ú­Û,¶À§Ó´I,·¨¥¿ºÖ,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,Öª§Ó»·,¨ô¦g¯è,À¹¹Å¨¥*,²ø¸UÀs,§E©ú¶© - - 1 - ANTIVIRAL RESEARCH - ANTIVIR RES 2012 93¨÷(2´Á):239-244­¶
(IF: 4.301, »â°ì±Æ¦W: 36, »â°ì´Á¥Z¼Æ: 261, »â°ì±Æ¦W: 13.79%)

Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1.
Huang CF, Yeh ML, Huang JF, Yang JF, Hsieh MY, Lin ZY, Chen SC, Wang LY, Hsi E, Juo SH, Dai CY, Chuang WL, Yu ML. - - 1 - ANTIVIRAL RESEARCH - ANTIVIR RES 2012;93(2):239-244
(IF: 4.301, Journal Ranking: 36, Number of Journals of this Field: 261, Ranking: 13.79%)

384

Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients.
Á©ú«Û,À¹¹Å¨¥,§õ¥ß¬f,¶À§Ó´I,²ø¸UÀs,«J¤D¤¯,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,±i¤å¦t,§E©ú¶©* - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2012 28¨÷(2´Á):86-93­¶
(IF: 0.477, »â°ì±Æ¦W: 98, »â°ì´Á¥Z¼Æ: 112, »â°ì±Æ¦W: 87.50%)

Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients.
Hsieh MY, Dai CY, Lee LP, Huang JF, Chuang WL, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Yu ML. - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2012;28(2):86-93
(IF: 0.477, Journal Ranking: 98, Number of Journals of this Field: 112, Ranking: 87.50%)

385

Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.
Á©s°a,ªL¤å¤@,¼çàH²[,²ÄR¦X,¶À¥ü¼e,·¨¥¿ºÖ,±i¹ç®a,¶À³©®p,¤ý肈ÄÖ,²ø¸UÀs,§E©ú¶©,À¹¹Å¨¥*,¦ó±Ò¥\ - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2012 28¨÷(9´Á):470-476­¶
(IF: 0.477, »â°ì±Æ¦W: 98, »â°ì´Á¥Z¼Æ: 112, »â°ì±Æ¦W: 87.50%)

Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.
Hsieh MH, Lin WY, Chien HH, Chien LH, Huang CK, Yang JF, Chang NC, Huang CF, Wang CL, Chuang WL, Yu ML, Dai CY*, Ho CK. - - 1 - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG J MED SCI 2012;28(9):470-476
(IF: 0.477, Journal Ranking: 98, Number of Journals of this Field: 112, Ranking: 87.50%)

386

Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C
¶À§Ó´I,¶À¥ü¼e,§E©ú¶©,À¹¹Å¨¥,¶À³©®p,¬xÁ¨¶²,¸­©ú­Û,Á©s°a,·¨¥¿ºÖ,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,§d¶¶¥Í*,²ø¸UÀs - - 1 - Hepatology International - HEPATOL INT 2012 6¨÷(3´Á):613-619­¶
(IF: 2.645, »â°ì±Æ¦W: 28, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 37.84%)

Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C
Jee-Fu Huang ,Chao-Kuan Huang ,Ming-Lung Yu,Chia-Yen Dai,Chung-Feng Huang,Wei-Wen Hung, Ming-Lun Yeh,Meng-Hsuan Hsieh ,Jeng-Fu Yang, Ming-Yen Hsieh,Zu-Yau Lin,Shinn-Chern Chen,Shun-Sheng Wu,Wan-Long Chuang - - 1 - Hepatology International - HEPATOL INT 2012;6(3):613-619
(IF: 2.645, Journal Ranking: 28, Number of Journals of this Field: 74, Ranking: 37.84%)

387

Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.
§E©ú¶©, ¼B®¶¾ì, ¶À³©®p, Tseng TC, ¶À§Ó´I, À¹¹Å¨¥, ªL¤l³ó, ³¯«H¦¨, ¤ý¨}«Û, ¨ô¦g¯è, ²ø¸UÀs, °ª¹Å§»*. - - 1 - PLoS One - PLOS ONE 2012 7¨÷(12´Á):e52048­¶
(IF: 4.092, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 85, »â°ì±Æ¦W: 14.12%)

Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.
Yu ML, Liu CH, Huang CF, Tseng TC, Huang JF, Dai CY, Lin ZY, Chen SC, Wang LY, Juo SH, Chuang WL, Kao JH* - - 1 - PLoS One - PLOS ONE 2012;7(12):e52048
(IF: 4.092, Journal Ranking: 12, Number of Journals of this Field: 85, Ranking: 14.12%)

388

Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinomap
Wong KM, ¸­©ú­Û, ²ø¥@©÷, ¤ý¨}«Û, ªL¤l³ó, ³¯«H¦¨, ½²ºaµo, ¤ý´Ë¸Z, ³¢¥\·¢, À¹¹Å¨¥, §E©ú¶©, §õª÷¼w, ²ø¸UÀs - - 0 - 2012¦~08¤ë - 2012 32¨÷(4´Á):253-257­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma
Wong, K.M., Yeh, M.L., Chuang, S.C., Wang L.Y., Lin, Z.Y., Chen, S.C., Tsai, J.F., Wang, S.N., Kuo, K.K., Dai, C.Y., Yu, M.L., Lee, K.T., Chuang W.L.* - - 0 - 2012¦~08¤ë - 2012;32(4):253-257
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

389

APASL consensus statements and management algorithms for hepatitis C virus infection.
Omata M*, Kanda T, §E©ú¶©, Yokosuka O, Lim S-G, Jafri W, Tateishi R, Hamid S, ²ø¸UÀs, Chutaputti A, Wei L, Sollano J, Sarin S, °ª¹Å§», McCaughan G. - - 1 - Hepatology International - HEPATOL INT 2012 6¨÷(2´Á):409-435­¶
(IF: 2.645, »â°ì±Æ¦W: 28, »â°ì´Á¥Z¼Æ: 74, »â°ì±Æ¦W: 37.84%)

APASL consensus statements and management algorithms for hepatitis C virus infection.
Omata M*, Kanda T, Yu ML, Yokosuka O, Lim S-G, Jafri W, Tateishi R, Hamid S, Chuang WL, Chutaputti A, Wei L, Sollano J, Sarin S, Kao JH, McCaughan G - - 1 - Hepatology International - HEPATOL INT 2012;6(2):409-435
(IF: 2.645, Journal Ranking: 28, Number of Journals of this Field: 74, Ranking: 37.84%)

390

ºC©ÊC«¬¨xª¢¯f¬r°ò¦]«¬»P¨È¬w¤H¤¶¥Õ¯À28B°ò¦]¦h­«©ÊªºÃöÁp
¶À³©®p,À¹¹Å¨¥,¶À§Ó´I,²ø¸UÀs,§E©ú¶©* - - 1 - Hepatology - HEPATOLOGY 2011 53¨÷(1´Á):367-368­¶
(IF: 10.84, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 3.08%)

Linkage of the Hepatitis C Virus Genotype and Interleukin-28B Genetic Polymorphisms in Asian Patients
Chung-Feng Huang,Chia-Yen Dai,Jee-Fu Huang,Wan-Long Chuang,Ming-Lung Yu* - - 1 - Hepatology - HEPATOLOGY 2011;53(1):367-368
(IF: 10.84, Journal Ranking: 2, Number of Journals of this Field: 65, Ranking: 3.08%)

391

The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - A multicenter prospective trial.
¶À§Ó´I,§E©ú¶©,¶À³©®p,¥Cªø´I,À¹¹Å¨¥,¶ÀÂ@¶h,¸­©ú­Û,·¨¥¿ºÖ,Á©ú«Û,«J¤D¤¯,ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,²ø¸UÀs* - - 1 - Journal of Hepatology - J HEPATOL 2011 54¨÷(2´Á):219-226­¶
(IF: 7.818, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 6.15%)

The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - A multicenter prospective trial.
Huang JF, Yu ML, Huang CF, Chiu CF, Dai CY, Huang CI, Yeh ML, Yang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Wang LY, Chuang WL. - - 1 - Journal of Hepatology - J HEPATOL 2011;54(2):219-226
(IF: 7.818, Journal Ranking: 4, Number of Journals of this Field: 65, Ranking: 6.15%)

392

¥xÆW±Ú¸s¼ö¥ð§J³J¥Õ70°ò¦]¦h«¬©Ê»P¾¸­µ©ÊÅ¥·l©ö·P©Ê¤§Ãö«Y
±i¹ç®a,¦ó±Ò¥\,ªL©¯©y,§E©ú¶©,²ºÕ¦ö,¦ó©[º½* - - 1 - Audiology and Neurotology - AUDIOL NEURO-OTOL 2011 16¨÷(3´Á):168-174­¶
(IF: 2.228, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 41, »â°ì±Æ¦W: 9.76%)

Association of Polymorphisms of Heat Shock Protein 70 with Susceptibility to Noise-Induced Hearing Loss in the Taiwanese Population
Chang NC, Ho CK, Lin HY, Yu ML, Chien CY, Ho KY* - - 1 - Audiology and Neurotology - AUDIOL NEURO-OTOL 2011;16(3):168-174
(IF: 2.228, Journal Ranking: 4, Number of Journals of this Field: 41, Ranking: 9.76%)

393

¦b¤¤°ê¤H¨k©Ê³\¦hÂH²G°ò¦]¦h«¬©Ê©MÁxµ²¥Û¦³Ãö
²ø¥@©÷, ¨ô¦g¯è, Öª­P»·, ¤ý´Ë¸Z, ½²¨Ø­Å, §E©ú¶©, §õª÷¼w*. - - 1 - Clinica Chimica Acta - CLIN CHIM ACTA 2011 412¨÷(7-8´Á):599-603­¶
(IF: 2.535, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 28, »â°ì±Æ¦W: 17.86%)

Multiple mucin genes polymorphisms are associated with gallstone disease in Chinese men.
Chuang SC, Juo SH, Hsi E, Wang SN, Tsai PC, Yu ML, Lee KT*. - - 1 - Clinica Chimica Acta - CLIN CHIM ACTA 2011;412(7-8):599-603
(IF: 2.535, Journal Ranking: 5, Number of Journals of this Field: 28, Ranking: 17.86%)

394

¥xÆWSUMO4°ò¦]¦h«¬©Ê»P²Ä¤G«¬¿}§¿¯f¦å¿}±±¨î¤§¬ÛÃö©Ê
ªL©¯©y,§õ¤ôÀs,§E©ú¶©,¿½¾À®e,Á©ú®a,¤ý¥©§D,¤ý«º¤D,¨¯¿ü¼ý* - - 1 - J Endocrinol Invest - J ENDOCRINOL INVEST 2011 33¨÷(6´Á):401-405­¶
(IF: 1.347, »â°ì±Æ¦W: 87, »â°ì´Á¥Z¼Æ: 105, »â°ì±Æ¦W: 82.86%)

Small ubiquitin-like modifier-4 Met55Val polymorphism is associated glycemic control of Type 2 diabetes mellitus in Taiwan.
Lin HY, Li SL, Yu ML, Hsiao PJ, Hsieh MC, Wang CL, Wang TN, Shin SJ* - - 1 - J Endocrinol Invest - J ENDOCRINOL INVEST 2011;33(6):401-405
(IF: 1.347, Journal Ranking: 87, Number of Journals of this Field: 105, Ranking: 82.86%)

395

«OÀI»PC«¬¨xª¢¯f±wªvÀø»P§_¡G¥xÆW¯f±w¸û¬°©¯¹B
À¹¹Å¨¥,¸­©ú­Û,¶À§Ó´I,²ø¸UÀs,§E©ú¶©* - - 1 - Hepatology - HEPATOLOGY 2011 53¨÷(4´Á):1399­¶
(IF: 10.84, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 3.08%)

Insurance status and treatment candidacy of patients with hepatitis C: Taiwanese patients are luckier.
Chia-Yen Dai,MMing-Lun Yeh,Jee-Fu Huang,Wan-Long Chuang,Ming-Lung Yu* - - 1 - Hepatology - HEPATOLOGY 2011;53(4):1399
(IF: 10.84, Journal Ranking: 2, Number of Journals of this Field: 65, Ranking: 3.08%)

396

Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.
¶À§Ó´I,¶À³©®p,§E©ú¶©,À¹¹Å¨¥,¶ÀÂ@¶h,¸­©ú­Û,Á©ú¸Î,·¨¥¿ºÖ,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,²ø¸UÀs* - - 1 - J Gastroenterol Hepatol - J GASTROEN HEPATOL 2011 26¨÷(3´Á):530-5­¶
(IF: 2.317, »â°ì±Æ¦W: 28, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 43.08%)

Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.
Huang JF, Huang CF, Yu ML, Dai CY, Huang CI, Yeh ML, Hsieh MH, Yang JF, Hsieh MY, Lin ZY, Chen SC, Chuang WL* - - 1 - J Gastroenterol Hepatol - J GASTROEN HEPATOL 2011;26(3):530-5
(IF: 2.317, Journal Ranking: 28, Number of Journals of this Field: 65, Ranking: 43.08%)

397

Association Between Virological Response and Decline in Hemoglobin Concentration During Pegylated Interferon and Ribavirin Therapy in HCV Genotype 1: Another Story
À¹¹Å¨¥,¶À³©®p,¶À§Ó´I,²ø¸UÀs,§E©ú¶©* - - 1 - Hepatology - HEPATOLOGY 2011 53¨÷(5´Á):1774-1775­¶
(IF: 10.84, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 3.08%)

Association Between Virological Response and Decline in Hemoglobin Concentration During Pegylated Interferon and Ribavirin Therapy in HCV Genotype 1: Another Story
Dai CY, Huang CF, Huang JF, Chuang WL,Yu ML * - - 1 - Hepatology - HEPATOLOGY 2011;53(5):1774-1775
(IF: 10.84, Journal Ranking: 2, Number of Journals of this Field: 65, Ranking: 3.08%)

398

Apelin gene polymorphism influences apelin expression and obesity phenotypes in Chinese women1¡V3
¹ùÖöµ®, ©Pª³ª³, §õ¨Ì¹ç, Shih-Chang Chuang, ªL¤å­µ, Bhaskar VKS Lakkakula, §E©ú¶©,¨ô¦g¯è - - 1 - Am J Clin Nutr - AM J CLIN NUTR 2011 94¨÷(3´Á):921-8­¶
(IF: 6.606, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 70, »â°ì±Æ¦W: 4.29%)

Apelin gene polymorphism influences apelin expression and obesity phenotypes in Chinese women1¡V3
Yi-Chu Liao, Wen-Wen Chou, Yi-Ning Li, Shih-Chang Chuang, Wen-Yi Lin, Bhaskar VKS Lakkakula, Ming-Lung Yu,and Suh-Hang Hank Juo - - 1 - Am J Clin Nutr - AM J CLIN NUTR 2011;94(3):921-8
(IF: 6.606, Journal Ranking: 3, Number of Journals of this Field: 70, Ranking: 4.29%)

399

The importance of the definition of early virological response for predicting treatment efficacy for chronic hepatitis C.
§E©ú¶© - - 1 - Hepatology - HEPATOLOGY 2011 53¨÷(4´Á):1403­¶
(IF: 10.885, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 2.82%)

The importance of the definition of early virological response for predicting treatment efficacy for chronic hepatitis C.
Yu ML - - 1 - Hepatology - HEPATOLOGY 2011;53(4):1403
(IF: 10.885, Journal Ranking: 2, Number of Journals of this Field: 71, Ranking: 2.82%)

400

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients.
§E©ú¶©, ¶À³©®p, ¶À§Ó´I, ±i¹ç®a, ·¨¥¿ºÖ, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t, Li YN, Wu MS, À¹¹Å¨¥, ¨ô¦g¯è, ²ø¸UÀs* - - 1 - Hepatology - HEPATOLOGY 2011 53¨÷(1´Á):7-13­¶
(IF: 10.885, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 2.82%)

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients.
Yu ML, Huang CF, Huang JF, Chang NC, Yang JF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Li YN, Wu MS, Dai CY, Juo SH, Chuang WL - - 1 - Hepatology - HEPATOLOGY 2011;53(1):7-13
(IF: 10.885, Journal Ranking: 2, Number of Journals of this Field: 71, Ranking: 2.82%)

401

ºC©ÊB«¬¨xª¢¯f±w¦Ûµo©Ê«æ©Êµo§@¥H§Ü¯f¬rÃĪvÀø¤§µ²ªG
À¹¹Å¨¥,¸­©ú­Û,¶À³©®p,¶À§Ó´I,§E©ú¶©,²ø¸UÀs* - - 1 - Hepatology - HEPATOLOGY 2011 54¨÷(3´Á):1108-1109­¶
(IF: 10.885, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 2.82%)

Outcome of patients suffering from a spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure and treated with antivirals.
Chia-Yen Dai, Ming-Lun Yeh,Chuang-Feng Huang, Jee-Fu Huang,Ming-Lung Yu, Wan-Long Chuang* - - 1 - Hepatology - HEPATOLOGY 2011;54(3):1108-1109
(IF: 10.885, Journal Ranking: 2, Number of Journals of this Field: 71, Ranking: 2.82%)

402

BRAP activates the inflammatory cascades and increases the risk for carotid atherosclerosis.
¹ùÖöµ®, ¤ý¥ÃªQ,³¢¨|§e, Kouichi Ozaki,Toshihiro Tanaka,ªL¨qªâ, ±i»ï§», ³¯ÅU¤¤,§E©ú¶©,¨ô¦g¯è* - - 1 - Molecular Medicine - MOL MED 2011 17¨÷(9-10´Á):1065-1074­¶
(IF: 5.908, »â°ì±Æ¦W: 11, »â°ì´Á¥Z¼Æ: 106, »â°ì±Æ¦W: 10.38%)

BRAP activates the inflammatory cascades and increases the risk for carotid atherosclerosis.
Liao YC, Wang YS, Guo YC, Ozaki K, Tanaka T, Lin HF, Chang MH, Chen KC, Yu ML, Sheu SH, Juo SH* - - 1 - Molecular Medicine - MOL MED 2011;17(9-10):1065-1074
(IF: 5.908, Journal Ranking: 11, Number of Journals of this Field: 106, Ranking: 10.38%)

403

Polymorphism at the mucin-like protocadherin gene influences susceptibility to gallstone disease.
²ø¥@©÷, Öª­P»·, ¤ý´Ë¸Z, §E©ú¶©, §õª÷¼w*, ¨ô¦g¯è* - - 1 - CLINICA CHIMICA ACTA - CLIN CHIM ACTA 2011 412¨÷(20´Á):2089¡V2093­¶
(IF: 2.388, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 30, »â°ì±Æ¦W: 20.00%)

Polymorphism at the mucin-like protocadherin gene influences susceptibility to gallstone disease.
Chuang SC, Hsi E, Wang SN, Yu ML, Lee KT*, Juo SH**. - - 1 - CLINICA CHIMICA ACTA - CLIN CHIM ACTA 2011;412(20):2089¡V2093
(IF: 2.388, Journal Ranking: 6, Number of Journals of this Field: 30, Ranking: 20.00%)

404

Intestinal Parasitic Infections in Foreigners Detected by Stool Examination in Taiwan
Á©s°a, ªL¶®¶³, ³\à±®Û, ·¨¥¿ºÖ, ³\à±²E, ³¯ªZ­ë, À¹¹Å¨¥, §E©ú¶©, ¦ó±Ò¥\* - - 9 - The Open Infectious Diseases Journal - 2011 5¨÷(-´Á):135-141­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Intestinal Parasitic Infections in Foreigners Detected by Stool Examination in Taiwan
Meng-Hsuan Hsieh, Ya-Yun Lin, Yu-Kuei Hsu, Jeng-Fu Yang, Yu-Chun Hsu, Wu-Cheng Chen, Chia-Yen Dai, Ming-Lung Yu, Chi-Kung Ho* - - 9 - The Open Infectious Diseases Journal - 2011;5(-):135-141
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

405

µL
¶À§Ó´I,¶À¥ü¼e,§E©ú¶©,À¹¹Å¨¥,¶À³©®p,¬xÁ¨¶²,¸­©ú­Û,Á©s°a,·¨¥¿ºÖ,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,§Å¸t½å*,²ø¸UÀs - - 1 - Hepatol Int - HEPATOL INT 2011 8¨÷(8´Á):88-99­¶
(IF: 2.963, »â°ì±Æ¦W: 23, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 32.39%)

Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C
Jee-Fu Huang,Chao-Kuan Huang,Ming-Lung Yu,Chia-Yen Dai,Chung-Feng Huang,Wei-Wen Hung,Ming-Lun Yeh,Meng-Hsuan Hsieh,Jeng-Fu Yang,Ming-Yen Hsieh,Zu-Yau Lin,Shinn-Chern Chen,Shun-Sheng Wu*,Wan-Long Chuang - - 1 - Hepatol Int - HEPATOL INT 2011;8(8):88-99
(IF: 2.963, Journal Ranking: 23, Number of Journals of this Field: 71, Ranking: 32.39%)

406

Lack of association between the IL-10 gene polymorphisms and features of the metabolic syndrome.
§E©ú¶©, Lakkakula Bhaskar VKS, ¹ùÖöµ®, ½²¨Ø­Å, Yang YH, ¨ô¦g¯è* - - 1 - J Invest Med - J INVEST MED 2011 59¨÷(2´Á):267-71­¶
(IF: 1.536, »â°ì±Æ¦W: 55, »â°ì´Á¥Z¼Æ: 153, »â°ì±Æ¦W: 35.95%)

Lack of association between the IL-10 gene polymorphisms and features of the metabolic syndrome.
Lu MY, Lakkakula Bhaskar VKS, Liao YC, Tsai PC, Yang YH, Juo SH* - - 1 - J Invest Med - J INVEST MED 2011;59(2):267-71
(IF: 1.536, Journal Ranking: 55, Number of Journals of this Field: 153, Ranking: 35.95%)

407

The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
¤ý§Ó¤å,ªL©¯©y(¦@¦P²Ä¤@),¨¯¿ü¼ý,§E©ú¶©,ªL¤l³ó,À¹¹Å¨¥,¶À§Ó´I,³¯«H¦¨, §õ¤ôÀs,²ø¸UÀs* - - 1 - Liver Int. - LIVER INT 2011 3¨÷(19´Á):1326-31­¶
(IF: 3.84, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 22.54%)

The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
Wang CW, Lin HY, Shin SJ, Yu ML, Lin ZY, Dai CY, Huang JF, Chen SC, Li SS, Chuang WL*. - - 1 - Liver Int. - LIVER INT 2011;3(19):1326-31
(IF: 3.84, Journal Ranking: 16, Number of Journals of this Field: 71, Ranking: 22.54%)

408

Pegylated interferon plus ribavirin therapy improves pancreatic £]-cell function in chronic hepatitis C patients.
¶À§Ó´I, À¹¹Å¨¥, §E©ú¶©, ¶À³©®p, ¶ÀÂ@¶h, ¸­©ú­Û, ·¨¥¿ºÖ, «J¤D¤¯, ¿½Âz®e, ªL¤l³ó, ³¯«H¦¨, ¨¯¿ü¼ý, ²ø¸UÀs* - - 1 - Liver Int. - LIVER INT 2011 31¨÷(8´Á):1155-62.­¶
(IF: 3.84, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 22.54%)

Pegylated interferon plus ribavirin therapy improves pancreatic £]-cell function in chronic hepatitis C patients.
Huang JF, Dai CY, Yu ML, Huang CF, Huang CI, Yeh ML, Yang JF, Hou NJ, Hsiao PJ, Lin ZY, Chen SC, Shin SJ, Chuang WL*. - - 1 - Liver Int. - LIVER INT 2011;31(8):1155-62.
(IF: 3.84, Journal Ranking: 16, Number of Journals of this Field: 71, Ranking: 22.54%)

409

Hepatic Akt expression correlates with advanced fibrosis in patients with chronic hepatitis C infection.
¶À§Ó´I, ²øÆA°Ä, À¹¹Å¨¥, §E©ú¶©, ¶À³©®p, ¿½Âz®e, Á©ú«Û, ¶ÀÂ@¶h, ¸­©ú­Û, ·¨¥¿ºÖ, ªL¤l³ó, ³¯«H¦¨, ²ø¸UÀs* - - 1 - Hepatol Res. - HEPATOL RES 2011 41¨÷(5´Á):430-436.­¶
(IF: 1.857, »â°ì±Æ¦W: 47, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 66.20%)

Hepatic Akt expression correlates with advanced fibrosis in patients with chronic hepatitis C infection.
Huang JF, Chuang YH, Dai CY, Yu ML, Huang CF, Hsiao PJ, Hsieh MY, Huang CI, Yeh ML, Yang JF, Lin ZY, Chen SC, Chuang WL*. - - 1 - Hepatol Res. - HEPATOL RES 2011;41(5):430-436.
(IF: 1.857, Journal Ranking: 47, Number of Journals of this Field: 71, Ranking: 66.20%)

410

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.
¸­©ú­Û, Hung CH, ¶À§Ó´I, ¼B«T¤H*, §õ¸à¿Ñ*, À¹¹Å¨¥, ¤ý´º¥°, ªL¤l³ó, ¿c³Ó¨k, ­J±R½÷, §E©ú¶©, °ª¹Å§», ²ø¸UÀs, ³¯°ö­õ, ³¯©w«H - - 1 - PLoS One. - PLOS ONE 2011 6¨÷(6´Á):e20752.­¶
(IF: 4.411, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 85, »â°ì±Æ¦W: 14.12%)

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.
Yeh ML, Hung CH, Huang JF, Liu CJ*, Lee CM*, Dai CY, Wang JH, Lin ZY, Lu SN, Hu TH, Yu ML, Kao JH, Chuang WL, Chen PJ, Chen DS. - - 1 - PLoS One. - PLOS ONE 2011;6(6):e20752.
(IF: 4.411, Journal Ranking: 12, Number of Journals of this Field: 85, Ranking: 14.12%)

411

¦Ñ¦~¤HC«¬¨xª¢
¶À³©¾W, ²ø¸UÀs, §E©ú¶©* - - 1 - Kaohsiung J Med Sci. - KAOHSIUNG J MED SCI 2011 27¨÷(12´Á):533-7­¶
(IF: 0.474, »â°ì±Æ¦W: 92, »â°ì´Á¥Z¼Æ: 106, »â°ì±Æ¦W: 86.79%)

Chronic hepatitis C infection in the elderly
Huang CF, Chuang WL, Yu ML*. - - 1 - Kaohsiung J Med Sci. - KAOHSIUNG J MED SCI 2011;27(12):533-7
(IF: 0.474, Journal Ranking: 92, Number of Journals of this Field: 106, Ranking: 86.79%)

412

Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
·¨¥¿ºÖ,ªL¶®¶³,Á©s°a,½²¬îÂE,¼B²Qªâ,§E©ú¶©,À¹¹Å¨¥,¶À§Ó´I*,ªL¤å¤@,ªL¤l³ó,³¯«H¦¨,²ø¸UÀs - - 1 - Kaohsiung J Med Sci. - KAOHSIUNG J MED SCI 2011 27¨÷(7´Á):258-63.­¶
(IF: 0.474, »â°ì±Æ¦W: 92, »â°ì´Á¥Z¼Æ: 106, »â°ì±Æ¦W: 86.79%)

Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
Yang JF, Lin YY, Hsieh MH, Tsai CH, Liu SF, Yu ML, Dai CY, Huang JF*, Lin WY, Lin ZY, Chen SC, Chuang WL. - - 1 - Kaohsiung J Med Sci. - KAOHSIUNG J MED SCI 2011;27(7):258-63.
(IF: 0.474, Journal Ranking: 92, Number of Journals of this Field: 106, Ranking: 86.79%)

413

Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving
´¿©§©v, §E©ú¶©, ¼B«T¤H, ªL§Ó³®, Huang YW, ³\´º²±, ¼B®¶¾ì, Kuo SF, Pan CJ, ·¨½åÄÉ, Ĭ«Øºû, ³¯°ö­õ, ³¯©w«H, °ª¹Å§». - - 1 - Antivir Ther - ANTIVIR THER 2011 16¨÷(5´Á):629-637­¶
(IF: 3.774, »â°ì±Æ¦W: 50, »â°ì´Á¥Z¼Æ: 249, »â°ì±Æ¦W: 20.08%)

Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving
Tseng TC, Yu ML, Liu CJ, Lin CL, Huang YW, Hsu CS, Liu CH, Kuo SF, Pan CJ, Yang SS, Su CW, Chen PJ, Chen DS, Kao JH. - - 1 - Antivir Ther - ANTIVIR THER 2011;16(5):629-637
(IF: 3.774, Journal Ranking: 50, Number of Journals of this Field: 249, Ranking: 20.08%)

414

Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C.
Vermehren J, §E©ú¶©, Monto A, Yao JD, Anderson C, Bertuzis R, Schneider G, Sarrazin C. - - 1 - J Clin Virol. - J CLIN VIROL 2011 52¨÷(2´Á):133-137­¶
(IF: 4.023, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 32, »â°ì±Æ¦W: 21.88%)

Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C.
Vermehren J, Yu ML, Monto A, Yao JD, Anderson C, Bertuzis R, Schneider G, Sarrazin C. - - 1 - J Clin Virol. - J CLIN VIROL 2011;52(2):133-137
(IF: 4.023, Journal Ranking: 7, Number of Journals of this Field: 32, Ranking: 21.88%)

415

µL
¶À§Ó´I,¶À³©®p,§E©ú¶©,À¹¹Å¨¥,¶ÀÂ@¶h,¸­©ú­Û,Á©s°a,·¨¥¿ºÖ,Á©ú«Û,ªL¤l³ó,³¯«H¸Û,²ø¸UÀs* - - 1 - J Gastroenterol Hepatol. - J GASTROEN HEPATOL 2011 26¨÷(3´Á):530-535­¶
(IF: 2.41, »â°ì±Æ¦W: 33, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 46.48%)

Serum visfatin is correlated with disease severity and
Jee-Fu Huang, Chung-Feng Huang, Ming-Lung Yu,Chia-Yen Dai, Ching-I Huang, - - 1 - J Gastroenterol Hepatol. - J GASTROEN HEPATOL 2011;26(3):530-535
(IF: 2.41, Journal Ranking: 33, Number of Journals of this Field: 71, Ranking: 46.48%)

416

ºC©ÊC«¬¨xª¢¯f±w¥Hªø®Ä«¬¤zÂZ¯À¦X¨Ö¹p©Þ°£ªvÀø¯à§ïµ½¯ØŦbeta²Ó­M¥\¯à
¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©,¶À³©®p,¶ÀÂ@¶h,¸­©ú­Û,·¨¥¿ºÖ,«J¤D¤¯,¿½Âz®e,ªL¤l³ó,³¯«H¦¨,¨¯¿ü¼ý,²ø¸UÀs* - - 1 - Liver International - LIVER INT 2011 31¨÷(8´Á):1155-62­¶
(IF: 3.84, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 22.54%)

Pegylated interferon plus ribavirin therapy improves pancreatic £]-cell function in chronic hepatitis C patients.
Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu,Chung-Feng Huang,Ching-I Huang, Ming-Lun Yeh,Jeng-Fu Yang6, Nei-Jen Hou1, Pi-Jung Hsiao, Zu-Yau Lin, Shinn-Chern Chen, Shyi-Jang Shin,Wan-Long Chuang* - - 1 - Liver International - LIVER INT 2011;31(8):1155-62
(IF: 3.84, Journal Ranking: 16, Number of Journals of this Field: 71, Ranking: 22.54%)

417

Small ubiquitin-like modifier-4 Met55Vel polymorphism is associated with glycemic control of type 2 diabetes mellitus in Taiwan
ªL©¯©y,Li SS,§E©ú¶©,¿½Âz®e,Á©ú®a,ªL©ø¼w,¤ý¥©§D,¨¯¿ü¼ý* - - 1 - J ENDOCRINOL INVEST - J ENDOCRINOL INVEST 2010 33¨÷(6´Á):401-5­¶
(IF: 1.888, »â°ì±Æ¦W: 73, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 78.49%)

Small ubiquitin-like modifier-4 Met55Vel polymorphism is associated with glycemic control of type 2 diabetes mellitus in Taiwan
Lin HY, Li SS, Yu ML, Hsiao PJ, Hsieh MC, Lin KD, Wang CL, Shin SJ* - - 1 - J ENDOCRINOL INVEST - J ENDOCRINOL INVEST 2010;33(6):401-5
(IF: 1.888, Journal Ranking: 73, Number of Journals of this Field: 93, Ranking: 78.49%)

418

ªø®Ä«¬¤zÂZ¯À¦X¨Ö¹p¤Ú«ÂÆF¦bºC©ÊC«¬¨xª¢¦Ñ¤H±wªÌ¤§Àø®Ä»P¦w¥þ©Ê¬ã¨s
¶À³©®p,·¨¥¿ºÖ,À¹¹Å¨¥,¶À§Ó´I,«J¤D¤¯,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,±i¤å¦t,§E©ú¶©* - - 1 - Journal of Infectious Disease - J INFECT DIS 2010 201¨÷(-´Á):1­¶
(IF: 5.682, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 51, »â°ì±Æ¦W: 7.84%)

Efficacy and safety of peginterferon combined with ribavirin in treating older patients with chronic hepatitis C
Chung-Feng Huang,Jeng-Fu Yang,Chia-Yen Dai,Jee-Fu Huang,Nai-Jen Hou,Ming-Yen Hsieh,Zu-Yau Lin,Shinn-Cherng Chen,Ming-Yuh Hsieh,Liang-Yen Wang,Wen-Yu Chang,Wan-Long Chuang,Ming-Lung Yu* - - 1 - Journal of Infectious Disease - J INFECT DIS 2010;201(-):1
(IF: 5.682, Journal Ranking: 4, Number of Journals of this Field: 51, Ranking: 7.84%)

419

¤HÃþ¥Õ¦å²y§Ü­ì»PºC©ÊC«¬¨xª¢¯f¬r¥Hªø®Ä¤zÂZ¯À¦X¨ÖribavirinªvÀø¤ÏÀ³
À¹¹Å¨¥,²ø¸UÀs,Á©ú«Û,¶À§Ó´I,ªL¶®¶³,»u¨Ø·ì,«J¤D¤¯,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,§E©ú¶©* - - 1 - Antiviral Res - ANTIVIR RES 2010 85¨÷(2´Á):396-402­¶
(IF: 3.613, »â°ì±Æ¦W: 47, »â°ì´Á¥Z¼Æ: 216, »â°ì±Æ¦W: 21.76%)

Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients.
Dai CY, Chuang WL, Hsieh MY, Huang JF, Lin YY, Chu PY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML* - - 1 - Antiviral Res - ANTIVIR RES 2010;85(2):396-402
(IF: 3.613, Journal Ranking: 47, Number of Journals of this Field: 216, Ranking: 21.76%)

420

C«¬¨xª¢¯f¬r¦å¯g«¬»P§C¦å¤pªO¼Æ:¤@¥xÆWB«¬»PC«¬¨xª¢°ª²±¦æ¦a°Ï¤§¬ã¨s
À¹¹Å¨¥,¦ó±Ò¥\,¶À§Ó´I,Á©ú«Û,«J¤D¤¯,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,±i¤å¦t,§E©ú¶©*,²ø¸UÀs* - - 1 - J Hepatol - J HEPATOL 2010 52¨÷(2´Á):160-166­¶
(IF: 7.056, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 9.09%)

Hepatitis C virus viremia and low platelet count: A study in a hepatitis B & C endemic area in Taiwan.
Dai CY, Ho CK, Huang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Yu ML*, Chuang WL* - - 1 - J Hepatol - J HEPATOL 2010;52(2):160-166
(IF: 7.056, Journal Ranking: 5, Number of Journals of this Field: 55, Ranking: 9.09%)

421

°ª¶¯¦a°Ï¥~Äy³Ò¤uÁT«K¤§¸z¹D±H¥ÍÂÎÀËÅç
Á©s°a,ªL¤å¤@,À¹¹Å¨¥,¶À§Ó´I,¶À¥ü¼e,¼çàH²[,¤ý»FÄÖ,²ø¸UÀs,§d«T¤¯,³¯¼üÀM,¦ó±Ò¥\*,§E©ú¶© - - 1 - Kaohsiung J Med Sci - KAOHSIUNG J MED SCI 2010 26¨÷(3´Á):136¡V43­¶
(IF: 0.607, »â°ì±Æ¦W: 83, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 90.22%)

INTESTINAL PARASITIC INFECTION DETECTED BY STOOL EXAMINATION IN FOREIGN LABORERS IN KAOHSIUNG
Meng-Hsuan Hsieh,Wen-Yi Lin,Chia-Yen Dai,Jee-Fu Huang,Chao-Kuan Huang,Hsu-Han Chien,Chao-Ling Wang,Wan-Long Chung,Jiunn-Ren Wu,Eng-Rin Chen,Chi-Kung Ho*,Ming-Lung Yu - - 1 - Kaohsiung J Med Sci - KAOHSIUNG J MED SCI 2010;26(3):136¡V43
(IF: 0.607, Journal Ranking: 83, Number of Journals of this Field: 92, Ranking: 90.22%)

422

©óºC©ÊC«¬¨xª¢¥¼¹F§Ö³t¯f¬r¤ÏÀ³±wªÌ¤¤¦­´Á¹w´ú¨ä¹F¨ì«ùÄò¯f¬r¤ÏÀ³¤§¬ã¨s
¶À³©®p,·¨¥¿ºÖ,¶À§Ó´I,À¹¹Å¨¥,«J¤D¤¯,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,±i¤å¦t,²ø¸UÀs,§E©ú¶©* - - 1 - Journal of Gastroenterology and Hepatology - J GASTROEN HEPATOL 2010 -¨÷(25´Á):758-765­¶
(IF: 2.275, »â°ì±Æ¦W: 29, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 52.73%)

Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response
Chung-Feng Huang,Jeng-Fu Yang,Jee-Fu Huang,Chia-Yen Dai, Chang-Fu Chiu,Nai-Jen Hou, Ming-Yen Hsieh,Zu-Yau Lin,Shinn-Cherng Chen,Ming-Yuh Hsieh,Liang-Yen Wang,Wen-Yu Chang,Wan-Long Chuang,Ming-Lung Yu* - - 1 - Journal of Gastroenterology and Hepatology - J GASTROEN HEPATOL 2010;-(25):758-765
(IF: 2.275, Journal Ranking: 29, Number of Journals of this Field: 55, Ranking: 52.73%)

423

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: Some issues.
§d«a¹F,·¨¥¿ºÖ,²ø¸UÀs,§E©ú¶©* - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2010 52¨÷(2´Á):305­¶
(IF: 7.056, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 9.09%)

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: Some issues.
Wu KT, Yang JF, Chuang WL, Yu ML* - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2010;52(2):305
(IF: 7.056, Journal Ranking: 5, Number of Journals of this Field: 55, Ranking: 9.09%)

424

ºC©ÊC«¬¨xª¢±wªÌ±µ¨üªø®Ä«¬¤zÂZ¯À¦X¨ÖªvÀø¤Þ°_¤§¤¤©Ê¥Õ¦å²y§C¤U»P²Óµß·P¬V¤§Ãö«Y
·¨¥¿ºÖ,Á©ú«Û,«J¤D¤¯,À¹¹Å¨¥*,¶À§Ó´I,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,²ø¸UÀs,§E©ú¶© - - 1 - Aliment Pharmacol Ther. - ALIMENT PHARM THER 2010 29¨÷(9´Á):1000¡V1010­¶
(IF: 1.215, »â°ì±Æ¦W: 46, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 83.64%)

Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice.
Yang JF, Hsieh MY, Hou NJ, Dai CY, Huang JF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chuang WL, Yu ML - - 1 - Aliment Pharmacol Ther. - ALIMENT PHARM THER 2010;29(9):1000¡V1010
(IF: 1.215, Journal Ranking: 46, Number of Journals of this Field: 55, Ranking: 83.64%)

425

C«¬¨xª¢¯f¬r°ò¦]«¬²Ä2/3«¬¯f¬r¯f±w¥Hªø®Ä¤zÂZ¯À/¹p¤Ú«ÂªLÁYµuÀøµ{¦X¨ÖªvÀø:¹p¤Ú«ÂªL°_©l¾¯¶q¤§­«­n¨¤¦â
À¹¹Å¨¥,¶À³©®p,¶À§Ó´I,²ø¸UÀs,§E©ú¶©* - - 1 - Hepatology - HEPATOLOGY 2010 51¨÷(5´Á):1861-2­¶
(IF: 11.355, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 3.64%)

Hepatitis C Virus Genotype 2/3 Patients Who Can Receive an Abbreviated Course of Peginterferon/Ribavirin: The Important Role of Initial Ribavirin Doses
Dai CY, Huang CF, Huang JF, Chuang WL, Yu ML* - - 1 - Hepatology - HEPATOLOGY 2010;51(5):1861-2
(IF: 11.355, Journal Ranking: 2, Number of Journals of this Field: 55, Ranking: 3.64%)

426

Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis.
¹ùÖöµ®, ªL¨qªâ, ³¢¨|§e, §E©ú¶©, ¼B´º寛, ¨ô¦g¯è*. - - 1 - GENETICS & HEREDITY - BMC MED GENET 2010 11¨÷(93´Á):0­¶
(IF: 2.84, »â°ì±Æ¦W: 69, »â°ì´Á¥Z¼Æ: 144, »â°ì±Æ¦W: 47.92%)

Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis.
Liao YC, Lin HF, Guo YC, Yu ML, Liu CK, Juo SH*. - - 1 - GENETICS & HEREDITY - BMC MED GENET 2010;11(93):0
(IF: 2.84, Journal Ranking: 69, Number of Journals of this Field: 144, Ranking: 47.92%)

427

¥xÆWB«¬¨xª¢¤§°ò¦]«¬¥H»Ã¯À³sµ²§K¬Ì§lªþ¤ÀªRªk¤ÀÃþ
¼B²Qªâ,Á©s°a,«J¤D¤¯,Á©ú«Û,¶À§Ó´I,À¹¹Å¨¥*,§E©ú¶©,²ø¸UÀs - - 1 - HEPATOL INT - HEPATOL INT 2010 4¨÷(3´Á):601-607­¶
(IF: 1.725, »â°ì±Æ¦W: 41, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 63.08%)

Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan
Shu-Fen Liu,Meng-Hsuan Hsieh,Nai-Jen Hou,Ming-Yen Hsieh,Jee-Fu Huang,Chia-Yen Dai*,Ming-Lung Yu,Wan-Long Chuang - - 1 - HEPATOL INT - HEPATOL INT 2010;4(3):601-607
(IF: 1.725, Journal Ranking: 41, Number of Journals of this Field: 65, Ranking: 63.08%)

428

¦å²M°ª±Ó·P©Ê¢Ñ¤ÏÀ³³J¥Õ»PºC©Ê¢Ñ«¬¨xª¢±wªÌ±µ¨üªø®Ä«¬¤zÂZ¯À¦X¨ÖRibavirin¬ÛÃö©Ê¬ã¨s
¶À³©®p,Á©ú«Û,·¨¥¿ºÖ,³¯ªZ¬F,¸­©ú­Û,¶ÀÂ@¶h,À¹¹Å¨¥,§E©ú¶©,ªL¤l³ó,³¯«H¦¨,²ø¸UÀs,¶À§Ó´I* - - 1 - Hepatology International - HEPATOL INT 2010 4¨÷(0´Á):621-627­¶
(IF: 1.725, »â°ì±Æ¦W: 41, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 63.08%)

Serum hs-CRP was correlated with treatment response¡@to pegylated interferon and ribavirin combination therapy¡@in chronic hepatitis C patients
Chung-Feng Huang,Ming-Yen Hsieh,Jeng-Fu Yang,Wu-Cheng Chen,Ming-Lun Yeh,Ching-I Huang,Chia-Yen Dai,Ming-Lung Yu,Zu-Yau Lin,Shinn-Chern Chen,Wan-Long Chuang,Jee-Fu Huang* - - 1 - Hepatology International - HEPATOL INT 2010;4(0):621-627
(IF: 1.725, Journal Ranking: 41, Number of Journals of this Field: 65, Ranking: 63.08%)

429

Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection.
À¹¹Å¨¥,¶À§Ó´I,Á©ú«Û, ²ø¸UÀs,§E©ú¶©* - - 1 - Gut (2010) - GUT 2010 59¨÷(3´Á):418­¶
(IF: 9.357, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 4.62%)

Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection.
Dai CY, Huang JF, Hsieh MY, Chuang WL, Yu ML* - - 1 - Gut (2010) - GUT 2010;59(3):418
(IF: 9.357, Journal Ranking: 3, Number of Journals of this Field: 65, Ranking: 4.62%)

430

The 8-oxoguanine glycosylase I (hOGG1) Ser326Cys variant affects the susceptibility to multi-vessel disease in Taiwan coronary artery disease patients
¤ý¥©§D¡AªL©v¾Ë¡AªL©¯©y¡A³\³Ó¶¯¡A§E©ú¶©¡A¿½Âz®e¡AªL©ø¼w¡A³\¶Ô¡A·¨«³ÄÉ¡A¨¯¿ü¼ý* - - 1 - THROMB RES - THROMB RES 2010 126¨÷(4´Á):319-23­¶
(IF: 2.406, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 60, »â°ì±Æ¦W: 43.33%)

The 8-oxoguanine glycosylase I (hOGG1) Ser326Cys variant affects the susceptibility to multi-vessel disease in Taiwan coronary artery disease patients
Wang CL, Lin TH, Lin HY, Sheu SH, Yu ML, Hsiao PJ, Lin KD, Hsu C, Yang YH, Shin SJ* - - 1 - THROMB RES - THROMB RES 2010;126(4):319-23
(IF: 2.406, Journal Ranking: 26, Number of Journals of this Field: 60, Ranking: 43.33%)

431

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
§E©ú¶©, §õ¸à¿Ñ, ²ø¸UÀs, ¿c³Ó¨k, À¹¹Å¨¥, ¶À§Ó´I, ªL¤l³ó, ­JÚz½÷, ³¯«Ø§», ¬x»F§», ¤ý´º¥°, Chi-Ling Chen, °ª¹Å§», ¿à©ú¶§, ¼B®¶÷~, ĬªF¥°, Wu SS, ¹ùÄR·ë, ³¢¦æ¹D, »¯¦³¸Û, ¸³¤ô¸q, ·¨½åÄÉ, ³¯°ö­õ, ¼B«T¤H*, ³¯©w«H - - 1 - J Infect Dis - J INFECT DIS 2010 202¨÷(1´Á):86-92­¶
(IF: 5.865, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 57, »â°ì±Æ¦W: 7.02%)

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
Yu ML, Lee CM, Chuang WL, Lu SN, Dai CY, Huang JF, Lin ZY, Hu TH, Chen CH, Hung CH, Wang JH, Chen CL, Kao JH, Lai MY, Liu CH, Su TH, Wu SS, Liao LY, Kuo HT, Chao YC, Tung SY, Yang SS, Chen PJ, Liu CJ*, Chen DS. - - 1 - J Infect Dis - J INFECT DIS 2010;202(1):86-92
(IF: 5.865, Journal Ranking: 4, Number of Journals of this Field: 57, Ranking: 7.02%)

432

Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic
·¨¥¿ºÖ, °ª¥ì¼z, À¹¹Å¨¥, ¶À§Ó´I, Á©ú«Û, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ²ø¸UÀs, §E©ú¶©* - - 1 - Hepatol Int. - HEPATOL INT 2010 4¨÷(4´Á):732-40.­¶
(IF: 2.963, »â°ì±Æ¦W: 23, »â°ì´Á¥Z¼Æ: 71, »â°ì±Æ¦W: 32.39%)

Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic
Yang JF, Kao YH, Dai CY, Huang JF, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chuang WL, Yu ML* - - 1 - Hepatol Int. - HEPATOL INT 2010;4(4):732-40.
(IF: 2.963, Journal Ranking: 23, Number of Journals of this Field: 71, Ranking: 32.39%)

433

C«¬¨xª¢¯f¬r¦å¯g«¬»P¦å¯×­È:¬y¦æ¯f¾Ç¬ã¨s½u¯Á
À¹¹Å¨¥,²ø¸UÀs,¦ó±Ò¥\,§E©ú¶©* - - 1 - J Hepatol - J HEPATOL 2009 50¨÷(2´Á):422-423­¶
(IF: 7.818, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 6.15%)

Hepatitis C viremia and serum lipid levels: A clue from an epidemiology study
Dai CY, Chuang WL, Ho CK, Yu ML* - - 1 - J Hepatol - J HEPATOL 2009;50(2):422-423
(IF: 7.818, Journal Ranking: 4, Number of Journals of this Field: 65, Ranking: 6.15%)

434

B«¬¨xª¢e §Ü­ì³±©Ê¯f±w¨ã«ùÄò¥¿±`¨x«ü¼Æ»P¯f¬r¶q¦å¯g°ª©ó 2000 IU/mL
À¹¹Å¨¥,²ø¸UÀs,¶À§Ó´I,§E©ú¶©* - - 1 - Hepatology - HEPATOLOGY 2009 49¨÷(2´Á):704-705­¶
(IF: 10.84, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 3.08%)

Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL
Dai CY, Chuang WL, Huang JF, Yu ML* - - 1 - Hepatology - HEPATOLOGY 2009;49(2):704-705
(IF: 10.84, Journal Ranking: 2, Number of Journals of this Field: 65, Ranking: 3.08%)

435

What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? Beyond the applause for higher sensitivity
¶ÀÂ@¶h, À¹¹Å¨¥, ¶À§Ó´I, §E©ú¶©* - - 1 - Hepatology - J HEPATOL 2009 50¨÷(1´Á):212­¶
(IF: 7.818, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 6.15%)

What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? Beyond the applause for higher sensitivity
Ching-I Huang, Chia-Yen Dai, Jee-Fu Huang, Ming-Lung Yu* - - 1 - Hepatology - J HEPATOL 2009;50(1):212
(IF: 7.818, Journal Ranking: 4, Number of Journals of this Field: 65, Ranking: 6.15%)

436

Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C
¶À§Ó´I,À¹¹Å¨¥,§E©ú¶©,¨¯¿ü¼ý,Á©ú«Û,¶À³©®p,§õ¥ß§B,ªL©ø¼w,ªL¤l³ó,³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t, ²ø¸UÀs* - - 0 - Journal of HepatologyJournal of Hepatology - J HEPATOL 2009 0¨÷(50´Á):471-478­¶
(IF: 7.818, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 6.15%)

Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C
Jee-Fu Huang, Chia-Yen Da, Ming-Lung Yu, Shyi-Jang Shin,Ming-Yen Hsieh, Chung-Feng Huang, Li-Po Lee, Kun-Der Lin, Zu-Yau Lin, Shinn-Chern Chen, Ming-Yuh Hsieh, Liang-Yen Wang,Wen-Yu Chang, Wan-Long Chuang* - - 0 - Journal of HepatologyJournal of Hepatology - J HEPATOL 2009;0(50):471-478
(IF: 7.818, Journal Ranking: 4, Number of Journals of this Field: 65, Ranking: 6.15%)

437

¯Ø®q¯Àªý§Ü¥i¹w´úºC©ÊC«¬¨xª¢¯f¬r¥Hªø®Ä¤zÂZ¯À¦X¨Öribavirin¦X¨ÖªvÀø¤§¤ÏÀ³
À¹¹Å¨¥,¶À§Ó´I,Á©ú«Û,«J¤D¤¯,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,±i¤å¦t,²ø¸UÀs*,§E©ú¶©* - - 1 - J Hepatol - J HEPATOL 2009 50¨÷(4´Á):712¡V718­¶
(IF: 7.818, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 6.15%)

Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
Dai CY, Huang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL*, Yu ML - - 1 - J Hepatol - J HEPATOL 2009;50(4):712¡V718
(IF: 7.818, Journal Ranking: 4, Number of Journals of this Field: 65, Ranking: 6.15%)

438

ºC©ÊC«¬¨xª¢°ò¦]«¬²Ä¤G©Î²Ä¤T«¬ªvÀøªº¤Q¦r¸ô¤f:¼W¥[¾¯¶qÁYµuÀøµ{©Î¥¿±`¾¯¶q©µªøÀøµ{
¶À³©®p,À¹¹Å¨¥,¶À§Ó´I,²ø¸UÀs,§E©ú¶©* - - 1 - Hepatology - HEPATOLOGY 2009 49¨÷(4´Á):1395-1396­¶
(IF: 10.84, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 3.08%)

A crossing in therapy for hepatitis C virus genotype 2 or 3: increasing ribavirin dose with shortened duration or reducing ribavirin dose with standard duration
4. Chung-Feng Huang, Chia-Yen Dai, Jee-Fu Huang , Wan-Long Chuang, Ming-Lung Yu - - 1 - Hepatology - HEPATOLOGY 2009;49(4):1395-1396
(IF: 10.84, Journal Ranking: 2, Number of Journals of this Field: 65, Ranking: 3.08%)

439

C«¬¨xª¢¯f¬rªø®Ä¤zÂZ¯À¦X¨ÖribavirinªvÀø¯f¬r¤ÏÀ³¤§¯f¬r»P±J¥D¦]¤l
À¹¹Å¨¥,²ø¸UÀs,¶À§Ó´I,Á©ú«Û,§E©ú¶©* - - 1 - Hepatology - HEPATOLOGY 2009 49¨÷(6´Á):2125­¶
(IF: 10.84, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 3.08%)

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: Some concerns
Dai CY, Chuang WL, Huang JF, Hsieh MY, Yu ML* - - 1 - Hepatology - HEPATOLOGY 2009;49(6):2125
(IF: 10.84, Journal Ranking: 2, Number of Journals of this Field: 65, Ranking: 3.08%)

440

B«¬¨xª¢©ó­ì¦í¥Á¤p«Ä¸g¬Ì­]¬I¥´20¦~¤§«áªºµo®i:¤@ªÀ°Ï¬ã¨s
¶À³©®p,À¹¹Å¨¥,²ø¸UÀs,¦ó±Ò¥\,¶À§Ó´I,§d¤j¤¤,§õ¥ß¬f,«J¤D¤¯,Á©ú«Û,ªL¤l³ó,Á©ú¸Î,¤ý¨}«Û,³¯«H¦¨,½²ºaµo,±i¤å¦t,§E©ú¶©* - - 1 - PREVENTIVE MEDICINE - PREV MED 2009 48¨÷(4´Á):397-400­¶
(IF: 3.172, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 122, »â°ì±Æ¦W: 17.21%)

HBV infection in indigenous children, 20 years after immunization in Taiwan: A community-based study
Chung-Feng Huang,Chia-Yen Dai,Wan-Long Chuang,Chi-Kung Ho,Ta-Chung Wu,Nai-Jen Hou,Li-Po Lee,Ming-Yen Hsieh,Jee-Fu Huang,Zu-Yau Lin,Shinn-Cherng Chen,Ming-Yuh Hsieh,Liang-Yen Wang,Jun-Fa Tsai,Wen-Yu Chang,Ming-Lung Yu* - - 1 - PREVENTIVE MEDICINE - PREV MED 2009;48(4):397-400
(IF: 3.172, Journal Ranking: 21, Number of Journals of this Field: 122, Ranking: 17.21%)

441

Unveiling Glucose Abnormalities in Patients With Chronic Hepatitis C Infection
¸­©ú­Û, ¶À§Ó´I, §E©ú¶©, À¹¹Å¨¥, ²ø¸UÀs* - - 1 - Am J Gastroenterology - AM J GASTROENTEROL 2009 104¨÷(4´Á):1051­¶
(IF: 6.012, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 9.23%)

Unveiling Glucose Abnormalities in Patients With Chronic Hepatitis C Infection
Ming-Lun Yeh, Jee-Fu Huang, Ming-Lung Yu, Chia-Yen Dai, Wan-Long Chuang* - - 1 - Am J Gastroenterology - AM J GASTROENTEROL 2009;104(4):1051
(IF: 6.012, Journal Ranking: 6, Number of Journals of this Field: 65, Ranking: 9.23%)

442

C«¬¨xª¢·P¬V»P¥NÁ¯g­Ô¸s¡Ð¤@­Ó¥xÆWC«¬¨xª¢°ª²±¦æ¦a°Ï¤§ªÀ°Ï¬ã¨s
¶À§Ó´I,²ø¸UÀs,§E©ú¶©,§EªQ¾ì,¶À³©®p,¶ÀÂ@¶h,¸­©ú­Û,Á©s°a,·¨¥¿ºÖ,ªL¤l³ó,³¯«H¦¨,À¹¹Å¨¥*,±i¤å¦t - - 1 - The Kaohsiung Journal of Medical Sciences - KAOHSIUNG J MED SCI 2009 25¨÷(6´Á):299-305­¶
(IF: 0.607, »â°ì±Æ¦W: 83, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 90.22%)

Hepatitis C Virus Infection and Metabolic Syndrome-A Community-Based Study in an Endemic Area of Taiwan
(Jee-Fu Huang,Wan-Long Chuang,Ming-Lung Yu,Sung-Hua Yu,Chung-Feng Huang,Ching-I Huang,Ming-Lun Yeh,Meng-Hsuan Hsieh,Jeng-Fu Yang,Zu-Yau Lin,Shinn-Chern Chen,Chia-Yen Dai*Wen-Yu Chang - - 1 - The Kaohsiung Journal of Medical Sciences - KAOHSIUNG J MED SCI 2009;25(6):299-305
(IF: 0.607, Journal Ranking: 83, Number of Journals of this Field: 92, Ranking: 90.22%)

443

C«¬¨xª¢·P¬V»P¥NÁ¯g­Ô¸s- ¤@­Ó¥xÆWC«¬¨xª¢°ª²±¦æ¦a°Ï¤§ªÀ°Ï¬ã¨s
¶À§Ó´I,²ø¸UÀs,§E©ú¶©,§EªQ¾ì,¶À³©®p,¶ÀÂ@¶h,¸­©ú­Û,Á©s°a,·¨¥¿ºÖ,ªL¤l³ó,³¯«H¦¨,À¹¹Å¨¥*,±i¤å¦t - - 9 - Kaohsiung J Med Sci. - KAOHSIUNG J MED SCI 2009 25¨÷(6´Á):299-305­¶
(IF: 0.607, »â°ì±Æ¦W: 83, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 90.22%)

Hepatitis C Virus Infection and Metabolic Syndrome---A Community-based Study in an Endemic Area of Taiwan.
Huang JF, Chuang WL, Yu ML, Yu SH, Huang CF, Huang CI, Yeh ML, Hsieh MH, Yang JF, Lin ZY, Chen SC, Dai CY*, Chang WY. - - 9 - Kaohsiung J Med Sci. - KAOHSIUNG J MED SCI 2009;25(6):299-305
(IF: 0.607, Journal Ranking: 83, Number of Journals of this Field: 92, Ranking: 90.22%)

444

ribavirin¦­´Á¾¯¶q»PC«¬¨xª¢¯f¬r°ò¦]«¬²Ä¤@«¬¯f¬r¦X¨ÖªvÀø¤ÏÀ³¤§¨¤¦â
À¹¹Å¨¥,¶À³©®p,²ø¸UÀs,¶À§Ó´I,§E©ú¶©* - - 1 - Hepatology - AM J GASTROENTEROL 2009 104¨÷(9´Á):2358-2359­¶
(IF: 6.012, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 9.23%)

Pretreatment Prediction of Virological Response to Peginterferon Plus Ribavirin Therapy in Patients
Dai CY, Huang CF, Chuang WL, Huang JF, Yu ML* - - 1 - Hepatology - AM J GASTROENTEROL 2009;104(9):2358-2359
(IF: 6.012, Journal Ranking: 6, Number of Journals of this Field: 65, Ranking: 9.23%)

445

¥xÆW¤H¿ø-¹L®ñ¤Æ¥hÅÜ©Ê×Q¦h«¬©Ê°ò¦] IVS3-23T/G ¹ï¾¸­µ©ÊÅ¥·l©ö·P©Ê¤§¼vÅT
±i¹ç®a,¦ó±Ò¥\,§d©ú»a,§E©ú¶©,¦ó©[º½* - - 1 - American Journal of Otolaryngology--Head and Neck Medicine and Surgery - AM J OTOLARYNG 2009 30¨÷(6´Á):396-400­¶
(IF: 1.016, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 36, »â°ì±Æ¦W: 58.33%)

Effect of manganese-superoxide dismutase genetic polymorphisms IVS3-23T/G on noise susceptibility in Taiwan
Chang NC, Ho CK, Wu MT, Yu ML, Ho KY* - - 1 - American Journal of Otolaryngology--Head and Neck Medicine and Surgery - AM J OTOLARYNG 2009;30(6):396-400
(IF: 1.016, Journal Ranking: 21, Number of Journals of this Field: 36, Ranking: 58.33%)

446

(¦b¥xÆWµLºC©ÊBC«¬¨xª¢ªÌ¨ä¨x¥\¯à²§±`»P¥NÁ¯g­Ô¸s¤Î¨­Åé½è¶q«ü¼Æ¬ÛÃö)
Á©s°a,¦ó±Ò¥\,«J¤D¤¯, Á©ú«Û,ªL¤å¤@,·¨¥¿ºÖ,ªô¬L´º,¶À§Ó´I,±i¹ç®a,¤ý»FÄÖ, À¹¹Å¨¥*,²ø¸UÀs, §E©ú¶© - - 1 - International Journal of Obesity - INT J OBESITY 2009 33¨÷(11´Á):1309-1317­¶
(IF: 4.343, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 66, »â°ì±Æ¦W: 6.06%)

Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.
M-H Hsieh, C-K Ho, N-J Hou, M-Y Hsieh, W-Y Lin, J-F Yang, C-C Chiu, J-F Huang, N-C Chang, C-L Wang, C-Y Dai*, W-L Chuang M-L Yu - - 1 - International Journal of Obesity - INT J OBESITY 2009;33(11):1309-1317
(IF: 4.343, Journal Ranking: 4, Number of Journals of this Field: 66, Ranking: 6.06%)

447

¹p¤Ú«ÂªL°_©l¾¯¶q»PC«¬¨xª¢¯f¬r°ò¦]«¬²Ä1b¨È«¬¯f¬r¥Hªø®Ä¤zÂZ¯À/¹p¤Ú«ÂªL¦X¨ÖªvÀø¤ÏÀ³¤§­«­n¨¤¦â
À¹¹Å¨¥,¶À³©®p,²ø¸UÀs,¶À§Ó´I,§E©ú¶©* - - 1 - American Journal of Gastroenterology - AM J GASTROENTEROL 2009 104¨÷(9´Á):2358-2359­¶
(IF: 6.012, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 9.23%)

The substantial role of initial ribavirin dose on the response to peginterferon £\/ribavirin therapy in patients with genotype 1b chronic hepatitis C
Dai CY, Huang CF, Chuang WL, Huang JF, Yu ML* - - 1 - American Journal of Gastroenterology - AM J GASTROENTEROL 2009;104(9):2358-2359
(IF: 6.012, Journal Ranking: 6, Number of Journals of this Field: 65, Ranking: 9.23%)

448

Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand.
Chainuvati S, Cheng J, Hou JL, Hsu CW, Jia JD, Komolmit P, Kwon SY, Lee CH, Li H, Li Y, Liu CJ, Neo BL, Peng CY, Tanwandee T, Wongcharatrawee S, Wu JC, §E©ú¶©, Zhang XX*. - - 1 - Hepatol Int - HEPATOL INT 2009 2009¨÷(3´Á):453¡V460­¶
(IF: 1.725, »â°ì±Æ¦W: 41, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 63.08%)

Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand.
Chainuvati S, Cheng J, Hou JL, Hsu CW, Jia JD, Komolmit P, Kwon SY, Lee CH, Li H, Li Y, Liu CJ, Neo BL, Peng CY, Tanwandee T, Wongcharatrawee S, Wu JC, Yu ML, Zhang XX*. - - 1 - Hepatol Int - HEPATOL INT 2009;2009(3):453¡V460
(IF: 1.725, Journal Ranking: 41, Number of Journals of this Field: 65, Ranking: 63.08%)

449

Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.
¾G­s­^, ½²¿·¦p, ²øÄR¤ë, ½²ºaµo*, ªL¤l³ó, Á©ú¸Î, ³¯«H¦¨, ²ø¸UÀs, ¤ý¨}«Û, §E©ú¶©, À¹¹Å¨¥, ±i«Ø°ê - - 1 - Medicine (Baltimore) - MEDICINE 2009 88¨÷(6´Á):349-57­¶
(IF: 5.054, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 132, »â°ì±Æ¦W: 9.09%)

Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.
Jeng JE*, Tsai HR, Chuang LY, Tsai JF, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Chang JG*. - - 1 - Medicine (Baltimore) - MEDICINE 2009;88(6):349-57
(IF: 5.054, Journal Ranking: 12, Number of Journals of this Field: 132, Ranking: 9.09%)

450

Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice.
·¨¥¿ºÖ,Á©ú«Û,«J¤D¤¯,À¹¹Å¨¥,¶À§Ó´I,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,²ø¸UÀs,§E©ú¶©* - - 1 - Aliment Pharmacol Ther. - ALIMENT PHARM THER 2009 29¨÷(9´Á):1000-10­¶
(IF: 4.357, »â°ì±Æ¦W: 31, »â°ì´Á¥Z¼Æ: 236, »â°ì±Æ¦W: 13.14%)

Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice.
Yang JF, Hsieh MY, Hou NJ, Dai CY, Huang JF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chuang WL, Yu ML*. - - 1 - Aliment Pharmacol Ther. - ALIMENT PHARM THER 2009;29(9):1000-10
(IF: 4.357, Journal Ranking: 31, Number of Journals of this Field: 236, Ranking: 13.14%)

451

Treatment of chronic hepatitis C in Asia: when East meets West.
§E©ú¶©,²ø¸UÀs* - - 1 - J Gastroenterol Hepatol - J GASTROEN HEPATOL 2009 24¨÷(3´Á):336-45­¶
(IF: 2.317, »â°ì±Æ¦W: 28, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 43.08%)

Treatment of chronic hepatitis C in Asia: when East meets West.
Yu ML, Chuang WL* - - 1 - J Gastroenterol Hepatol - J GASTROEN HEPATOL 2009;24(3):336-45
(IF: 2.317, Journal Ranking: 28, Number of Journals of this Field: 65, Ranking: 43.08%)

452

Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNA.
ªL¶®¶³, ¶À§Ó´I, ¼B²Qªâ, §E©ú¶©, ½²¬îÂE, ·¨¥¿ºÖ, ªL©É§D, À¹¹Å¨¥, ªL¤l³ó, ³¯«H¦¨, ±i¤å¦t, ²ø¸UÀs* - - 1 - Scand J Infect Dis - SCAND J INFECT DIS 2009 41¨÷(8´Á):614-8­¶
(IF: 1.7, »â°ì±Æ¦W: 44, »â°ì´Á¥Z¼Æ: 57, »â°ì±Æ¦W: 77.19%)

Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNA.
Lin YY, Huang JF, Liu SF, Yu ML, Tsai CH, Yang JF, Lin IL, Dai CY, Lin ZY, Chen SC, Chang WY, Chuang WL* - - 1 - Scand J Infect Dis - SCAND J INFECT DIS 2009;41(8):614-8
(IF: 1.7, Journal Ranking: 44, Number of Journals of this Field: 57, Ranking: 77.19%)

453

Comparison of Clinical Application of the Abbott HBV PCR Kit and the VERSANT HBV DNA 3.0 Test to Measure Serum Hepatitis B Virus DNA in Taiwanese Patients.
·¨¥¿ºÖ,ªL¶®¶³,¶À§Ó´I,¼B²Qªâ, Chu PY, Á©ú«Û,ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,À¹¹Å¨¥,²ø¸UÀs,§E©ú¶©* - - 0 - Kaohsiung J Med Sci. - KAOHSIUNG J MED SCI 2009 25¨÷(8´Á):413-22­¶
(IF: 0.607, »â°ì±Æ¦W: 83, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 90.22%)

Comparison of Clinical Application of the Abbott HBV PCR Kit and the VERSANT HBV DNA 3.0 Test to Measure Serum Hepatitis B Virus DNA in Taiwanese Patients.
Yang JF, Lin YY, Huang JF, Liu SF, Chu PY, Hsieh MY, Lin ZY, Chen SC, Wang LY, Dai CY, Chuang WL, Yu ML*. - - 0 - Kaohsiung J Med Sci. - KAOHSIUNG J MED SCI 2009;25(8):413-22
(IF: 0.607, Journal Ranking: 83, Number of Journals of this Field: 92, Ranking: 90.22%)

454

Effect of manganese-superoxide dismutase genetic polymorphisms IVS3-23T/G on noise susceptibility in Taiwan.
±i¹ç®a, ¦ó±Ò¥\, §d©ú»a, §E©ú¶©, ¦ó©[º½*. - - 1 - Am J Otolaryngol - AM J OTOLARYNG 2009 30¨÷(6´Á):396-400­¶
(IF: 1.016, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 36, »â°ì±Æ¦W: 58.33%)

Effect of manganese-superoxide dismutase genetic polymorphisms IVS3-23T/G on noise susceptibility in Taiwan.
Chang NC, Ho CK, Wu MT, Yu ML, Ho KY*. - - 1 - Am J Otolaryngol - AM J OTOLARYNG 2009;30(6):396-400
(IF: 1.016, Journal Ranking: 21, Number of Journals of this Field: 36, Ranking: 58.33%)

455

Small ubiquitin-like modifier-4 Met55Val polymorphism is associated with glycemic control of type 2 diabetes mellitus in Taiwan.
ªL©¯©y, Li SS, §E©ú¶©, ¿½Âz®e, Á©ú®a, ªL©ø¼w, ¤ý»FÄÖ, ¤ý«º¤D, ¨¯¿ü¼ý*. - - 1 - J Endocrinol Invest - J ENDOCRINOL INVEST 2009 2009¨÷(11´Á):12­¶
(IF: 1.347, »â°ì±Æ¦W: 87, »â°ì´Á¥Z¼Æ: 105, »â°ì±Æ¦W: 82.86%)

Small ubiquitin-like modifier-4 Met55Val polymorphism is associated with glycemic control of type 2 diabetes mellitus in Taiwan.
Lin HY, Li SS, Yu ML, Hsiao PJ, Hsieh MC, Lin KD, Wang CL, Wang TN, Shin SJ*. - - 1 - J Endocrinol Invest - J ENDOCRINOL INVEST 2009;2009(11):12
(IF: 1.347, Journal Ranking: 87, Number of Journals of this Field: 105, Ranking: 82.86%)

456

What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? Beyond the applause for higher sensitivity.
¶ÀÂ@¶h,À¹¹Å¨¥,¶À§Ó´I,§E©ú¶©* - - 1 - J Hepatol - J HEPATOL 2009 50¨÷(1´Á):211-4­¶
(IF: 7.818, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 6.15%)

What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? Beyond the applause for higher sensitivity.
Huang CI, Dai CY, Huang JF, Yu ML* - - 1 - J Hepatol - J HEPATOL 2009;50(1):211-4
(IF: 7.818, Journal Ranking: 4, Number of Journals of this Field: 65, Ranking: 6.15%)

457

Insight into Alcohol Consumption-Related Problems and Its Correlates Among Taiwanese Alcoholic Hepatogastroenterological Clinic Patients.
ÃC¥¿ªÚ, À¹¹Å¨¥, «J¤D¤¯, Ray C. Hsiao‌, §E©ú¶©* - - 1 - Subst Use Misuse - SUBST USE MISUSE 2009 44¨÷(4´Á):593-4­¶
(IF: 0.725, »â°ì±Æ¦W: 96, »â°ì´Á¥Z¼Æ: 117, »â°ì±Æ¦W: 82.05%)

Insight into Alcohol Consumption-Related Problems and Its Correlates Among Taiwanese Alcoholic Hepatogastroenterological Clinic Patients.
Yen CF, Dai CY, Hou NJ, Hsiao RC, Yu ML* - - 1 - Subst Use Misuse - SUBST USE MISUSE 2009;44(4):593-4
(IF: 0.725, Journal Ranking: 96, Number of Journals of this Field: 117, Ranking: 82.05%)

458

Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
¼B«T¤H, ²ø¸UÀs, §õ¥þÂÓ, §E©ú¶©, ¿c³Ó¨k, §d¶¶¥Í, ¹ùÄR·ë, ³¯¬è¬Â, ³¢¦æ¹D, »¯¦³¸Û, ¸³¤ô¸q, ·¨½åÄÉ, °ª¹Å§», Liu CH, Ĭºû¤å, Lin CL, ¾G¥Ã»Ê, ³¯°ö­õ, ³¯©w«H* - - 1 - Gastroenterology - GASTROENTEROLOGY 2009 136¨÷(2´Á):496-504­¶
(IF: 12.899, »â°ì±Æ¦W: 1, »â°ì´Á¥Z¼Æ: 65, »â°ì±Æ¦W: 1.54%)

Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, Liao LY, Chen CL, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Liu CH, Su WW, Lin CL, Jeng YM, Chen PJ, Chen DS* - - 1 - Gastroenterology - GASTROENTEROLOGY 2009;136(2):496-504
(IF: 12.899, Journal Ranking: 1, Number of Journals of this Field: 65, Ranking: 1.54%)

459

¬Y¨Ç²Ó­M¿E¯À°ò¦]¦h«¬©Ê»Pµo¥ÍºC©Êªý¶ë©ÊªÍ¯f¤§¦MÀI©Ê¯Ê¥F¬ÛÃö©Ê
Á©s°a, Á鶼¤å, ¶À¦N§Ó, §õ«Ø§», ¦ó±Ò¥\, §E©ú¶©, ¶À¬¢鑚, §õ¯Â¼ü, §d©ú»a*, David C. Christiani - - 1 - The Kaohsiung Journal of Medicien Science - 2008 24¨÷(3´Á):126-137­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

LACK OF ASSOCIATIONS BETWEEN SEVERAL POLYMORPHISMS IN CYTOKINE GENES ANDTHE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASES IN TAIWAN
Meng-Hsuan Hsieh, Inn-Wen Chong, Jhi-Jhu Hwang, Chien-Hung Lee, Chi-Kung Ho, Ming-Lung Yu, Chia-Tsuan Huang, Chung-Ying Lee, Ming-Tsang Wu*, David C. Christiani - - 1 - The Kaohsiung Journal of Medicien Science - 2008;24(3):126-137
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

460

°ò¦]«¬²Ä¤G«¬ºC©ÊC«¬¨xª¢¯f¬r«Øij¥H¸ûµuÀøµ{¦X¨ÖªvÀø§Ö³t¯f¬r¤ÏÀ³¤§¥i¯à¨M©w¦]¯À
À¹¹Å¨¥, ²ø¸UÀs, ¶À§Ó´I, Á©ú«Û, §E©ú¶©* - - 1 - HEPATOLOGY - HEPATOLOGY 2008 48¨÷(1´Á):342­¶
(IF: 11.355, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 3.64%)

Possible Determinants of Rapid Virological Response Suggesting Shorter Courses of Combination Therapy for Hepatitis C Virus Genotype 2
Dai CY, Chuang WL, Huang JF, Hsieh MY, Yu ML* - - 1 - HEPATOLOGY - HEPATOLOGY 2008;48(1):342
(IF: 11.355, Journal Ranking: 2, Number of Journals of this Field: 55, Ranking: 3.64%)

461

¤@ºØ¹ê®É¶¡¤ÏÂà¿ý¦h»E酶Ãì¤ÏÀ³¸Õ¾¯À³¥Î©ó°ò¦]«¬²Ä¤@»P²Ä¤G«¬C«¬¨xª¢¯f¬r©w¶q´ú©w¤§ªí²{¯S¼x
¶À§Ó´I,À¹¹Å¨¥,ªL¶®¶³,§E©ú¶©, ¼B²Qªâ,ªL©É§D,Á©ú«Û, §õ¥ß¬f, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ±i¤å¦t, ²ø¸UÀs* - - 1 - Clin Chem Lab Med - CLIN CHEM LAB MED 2008 46¨÷(4´Á):475-480­¶
(IF: 1.888, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 26, »â°ì±Æ¦W: 46.15%)

Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infections.
Huang JF, Dai CY, Lin YY, Yu ML, Liu SF, Lin IL, Hsieh MY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Chang WY, Chuang WL* - - 1 - Clin Chem Lab Med - CLIN CHEM LAB MED 2008;46(4):475-480
(IF: 1.888, Journal Ranking: 12, Number of Journals of this Field: 26, Ranking: 46.15%)

462

ºC©ÊC«¬¨xª¢¯f±w¸²µå¿}²§±`¯S¼x¤§¦Aµû¦ô
¶À§Ó´I,§E©ú¶©,À¹¹Å¨¥,Á©ú«Û,¶À©|§Ó,¿½¾À®e,§õ¥ß¬f,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,¨¯¿ü¼ý,±i¤å¦t,²ø¸UÀs* - - 1 - Am J Gastroenterol - AM J GASTROENTEROL 2008 103¨÷(0´Á):1-8­¶
(IF: 6.444, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 10.91%)

Reappraisal of the Characteristics of Glucose Abnormalities in Patients With Chronic Hepatitis C Infection.
Huang JF, Yu ML, Dai CY, Hsieh MY, Hwang SJ, Hsiao PJ, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Shin SJ, Chang WY, Chuang WL* - - 1 - Am J Gastroenterol - AM J GASTROENTEROL 2008;103(0):1-8
(IF: 6.444, Journal Ranking: 6, Number of Journals of this Field: 55, Ranking: 10.91%)

463

C«¬¨xª¢¯f¬r¦å¯g»P¸û§C¤§¦å²M¤T»Ä¥Ìªo¯×¤ÎÁx©T¾J­È¬ÛÃö:¤@ªÀ°Ï¬ã¨s
À¹¹Å¨¥,²ø¸UÀs,¦ó±Ò¥\,Á©ú«Û,¶À§Ó´I,§õ¥ß¬f,«J¤D¤¯,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,½²ºaµo,±i¤å¦t,§E©ú¶©* - - 1 - J Hepatol - J HEPATOL 2008 49¨÷(1´Á):9-16­¶
(IF: 7.056, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 9.09%)

Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: A community-based study
Dai CY, Chuang WL, Ho CK, Hsieh MY, Huang JF, Lee LP, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML* - - 1 - J Hepatol - J HEPATOL 2008;49(1):9-16
(IF: 7.056, Journal Ranking: 5, Number of Journals of this Field: 55, Ranking: 9.09%)

464

C«¬¨xª¢¯f¬r°ò¦]«¬²Ä¤@«¬§Ö³t¯f¬r¤ÏÀ³»Pribavirin¦­´Á¼ÉÅS¾¯¶q
À¹¹Å¨¥,²ø¸UÀs,¶À§Ó´I,Á©ú«Û,§E©ú¶©* - - 1 - Hepatology - HEPATOLOGY 2008 48¨÷(2´Á):692-693­¶
(IF: 11.355, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 3.64%)

Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure
Dai CY,Chuang WL,Huang JF,Hsieh MY,Yu ML* - - 1 - Hepatology - HEPATOLOGY 2008;48(2):692-693
(IF: 11.355, Journal Ranking: 2, Number of Journals of this Field: 55, Ranking: 3.64%)

465

Significant association of ABCG8:D19H gene polymorphism with hypercholesterolemia and insulin resistance
³¯§Ó¦¨,¨¯¿ü¼ý,³¢¥\·¢,ªL©ø¼w,§E©ú¶©,¿½Âz®e* - - 1 - J HUM GENET - J HUM GENET 2008 53¨÷(8´Á):757-63­¶
(IF: 2.431, »â°ì±Æ¦W: 74, »â°ì´Á¥Z¼Æ: 138, »â°ì±Æ¦W: 53.62%)

Significant association of ABCG8:D19H gene polymorphism with hypercholesterolemia and insulin resistance
Chen ZC, Shin SJ, Kuo KK, Lin KD, Yu ML, Hsiao PJ - - 1 - J HUM GENET - J HUM GENET 2008;53(8):757-63
(IF: 2.431, Journal Ranking: 74, Number of Journals of this Field: 138, Ranking: 53.62%)

466

Revisit of oral glucose tolerance test: a must for diagnosis of type 2 diabetes in patients with chronic hepatitis C.
Á©ú«Û, À¹¹Å¨¥, ¶À§Ó´I, §õ¥ß¬f, «J¤D¤¯, ²ø¸UÀs, §E©ú¶© - - 1 - Am J Gastroenterol. - AM J GASTROENTEROL 2008 103¨÷(2´Á):487-488­¶
(IF: 6.444, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 10.91%)

Revisit of oral glucose tolerance test: a must for diagnosis of type 2 diabetes in patients with chronic hepatitis C.
Heish MY, Dai CY, Huang JF, Lee LP, Hou NJ, Chuang WL, Yu ML* - - 1 - Am J Gastroenterol. - AM J GASTROENTEROL 2008;103(2):487-488
(IF: 6.444, Journal Ranking: 6, Number of Journals of this Field: 55, Ranking: 10.91%)

467

Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Á©ú«Û, À¹¹Å¨¥, §õ¥ß¬f, ¶À§Ó´I, ½²¤å®i, «J¤D¤¯, ªL¤l³ó, ³¯«H¦¨, ¤ý¨}«Û, ±i¤å¦t, ²ø¸UÀs, §E©ú¶© - - 1 - J Clin Pathol. - J CLIN PATHOL 2008 61¨÷(3´Á):333-7­¶
(IF: 2.342, »â°ì±Æ¦W: 26, »â°ì´Á¥Z¼Æ: 68, »â°ì±Æ¦W: 38.24%)

Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY, Dai CY, Lee LP, Huang JF, Tsai WC, Hou NJ, Lin ZY, Chen SC, Wang LY, Chang WY, Chuang WL, Yu ML. - - 1 - J Clin Pathol. - J CLIN PATHOL 2008;61(3):333-7
(IF: 2.342, Journal Ranking: 26, Number of Journals of this Field: 68, Ranking: 38.24%)

468

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues.
§E©ú¶©, À¹¹Å¨¥, ¶À§Ó´I, Á©ú«Û, ²ø¸UÀs * - - 1 - Hepatology - HEPATOLOGY 2008 47¨÷(5´Á):1792-3­¶
(IF: 11.355, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 3.64%)

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues.
Yu ML, Dai CY, Huang JF, Hsieh MY, Chuang WL. - - 1 - Hepatology - HEPATOLOGY 2008;47(5):1792-3
(IF: 11.355, Journal Ranking: 2, Number of Journals of this Field: 55, Ranking: 3.64%)

469

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial.
§E©ú¶©, À¹¹Å¨¥, ¶À§Ó´I, ¥Cªø´I, ·¨«³ÄÉ, «J¤D¤¯, §õ¥ß¬f, Á©ú«Û, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t, ²ø¸UÀs* - - 1 - Hepatology - HEPATOLOGY 2008 47¨÷(6´Á):1884-93­¶
(IF: 11.355, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 55, »â°ì±Æ¦W: 3.64%)

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial.
Yu ML, Dai CY, Huang JF, Chiu CF, Yang YH, Hou NJ, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL. - - 1 - Hepatology - HEPATOLOGY 2008;47(6):1884-93
(IF: 11.355, Journal Ranking: 2, Number of Journals of this Field: 55, Ranking: 3.64%)

470

Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in Taiwan.
¶À³©®p, ¶À§Ó´I, À¹¹Å¨¥, §E©ú¶©, ¿c³Ó¨k, Á©ú«Û, §õ¥ß¬f, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t, ²ø¸UÀs* - - 1 - Trans R Soc Trop Med Hyg - T ROY SOC TROP MED H 2008 102¨÷(9´Á):929-934­¶
(IF: 2.062, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 15, »â°ì±Æ¦W: 33.33%)

Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in Taiwan.
Huang CF, Huang JF, Dai CY, Yu ML, Lu SN, Hsieh MY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL* - - 1 - Trans R Soc Trop Med Hyg - T ROY SOC TROP MED H 2008;102(9):929-934
(IF: 2.062, Journal Ranking: 5, Number of Journals of this Field: 15, Ranking: 33.33%)

471

Hepatitis C virus infection among children in aboriginal areas in Taiwan.
§d¤j¤¤, ²ø¸UÀs, À¹¹Å¨¥, ¶À§Ó´I, Á©ú«Û, «J¤D¤¯, §õ¥ß¬f, ªL¤l³ó, ·¨¥¿ºÖ, ªô¬L´º, ³¯«H¦¨, Á©ú¸Î, ±i¤å¦t, §E©ú¶©* - - 1 - Trans R Soc Trop Med Hyg. - T ROY SOC TROP MED H 2008 102¨÷(9´Á):935-8­¶
(IF: 2.062, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 15, »â°ì±Æ¦W: 33.33%)

Hepatitis C virus infection among children in aboriginal areas in Taiwan.
Wu TC, Chuang WL, Dai CY, Huang JF, Hsieh MY, Hou NJ, Lee LP, Lin WY, Yang JF, Chiu CC, Chen SC, Hsieh MY, Chang WY, Yu ML* - - 1 - Trans R Soc Trop Med Hyg. - T ROY SOC TROP MED H 2008;102(9):935-8
(IF: 2.062, Journal Ranking: 5, Number of Journals of this Field: 15, Ranking: 33.33%)

472

°ª¦å²M§¿»Ä¬°²Ä¤G«¬¿}§¿¯f¤§¿W¯S¦MÀI¦]¤l
À¹¹Å¨¥,²ø¸UÀs,¦ó±Ò¥\,¼ÚÀéÄË,¶À§Ó´I,Á©ú«Û,§E©ú¶©* - - 1 - Diabetes Care - DIABETES CARE 2008 31¨÷(9´Á):67­¶
(IF: 7.349, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 5.38%)

High serum uric acid as a novel risk factor for type 2 diabetes: rsponse to Dehghan et al.
Dai CY, Chuang WL, Ho CK, Ou TT, Huang JF, Hsieh MY, Yu ML* - - 1 - Diabetes Care - DIABETES CARE 2008;31(9):67
(IF: 7.349, Journal Ranking: 5, Number of Journals of this Field: 93, Ranking: 5.38%)

473

Transforming growth factor-beta 1°ò¦]¦h«¬©Ê»PºC©ÊC«¬¨xª¢¯f¬r¯S¼x¤§ÃöÁp
À¹¹Å¨¥,²ø¸UÀs,§õ¥ß¬f,¼ï¤å¥¿,¶À§Ó´I,Á©ú«Û,«J¤D¤¯ ,ªL¤l³ó, ³¯«H¦¨,Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t,§E©ú¶©* - - 1 - Transl Res (J LAB CLIN MED) - J LAB CLIN MED 2008 152¨÷(4´Á):151-156­¶
(IF: 2.795, »â°ì±Æ¦W: 6, »â°ì´Á¥Z¼Æ: 26, »â°ì±Æ¦W: 23.08%)

Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C
Dai CY, Chuang WL, Li-Po Lee, Pan WC, Huang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Yu ML* - - 1 - Transl Res (J LAB CLIN MED) - J LAB CLIN MED 2008;152(4):151-156
(IF: 2.795, Journal Ranking: 6, Number of Journals of this Field: 26, Ranking: 23.08%)

474

Rapid virological response to peginterferon and ribavirin for hepatitis C genotype 1: the role of weight-based ribavirin exposure.
§E©ú¶©, À¹¹Å¨¥, ¶À§Ó´I, ²ø¸UÀs* - - 1 - Hepatology - HEPATOLOGY 2008 48¨÷(3´Á):1019-1020­¶
(IF: 10.734, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 4.00%)

Rapid virological response to peginterferon and ribavirin for hepatitis C genotype 1: the role of weight-based ribavirin exposure.
Ming-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang* - - 1 - Hepatology - HEPATOLOGY 2008;48(3):1019-1020
(IF: 10.734, Journal Ranking: 2, Number of Journals of this Field: 50, Ranking: 4.00%)

475

Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet
¿½Âz®e,Á»A®S,³¢¥\·¢,¬xÁ¨¶²,½²©[Ä_,·¨²MÖq,§E©ú¶©,¨¯¿ü¼ý* - - 1 - BMC Mol Biol - BMC MOL BIOL 2008 26¨÷(9´Á):82-91­¶
(IF: 3.371, »â°ì±Æ¦W: 93, »â°ì´Á¥Z¼Æ: 263, »â°ì±Æ¦W: 35.36%)

Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet
Hsiao PJ, Hsieh TJ, Kuo KK, Hung WW, Tsai KB, Yang CH, Yu ML, Shin SJ* - - 1 - BMC Mol Biol - BMC MOL BIOL 2008;26(9):82-91
(IF: 3.371, Journal Ranking: 93, Number of Journals of this Field: 263, Ranking: 35.36%)

476

Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection.
¶À§Ó´I,§E©ú¶©,À¹¹Å¨¥,Á©ú«Û,¶À©|§Ó,¿½Âz®e,§õ¥ß¬f,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,¨¯¿ü¼ý,±i¤å¦t,²ø¸UÀs* - - 1 - AM J GASTROENTEROL - AM J GASTROENTEROL 2008 103¨÷(8´Á):1933-40­¶
(IF: 6.101, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 10.00%)

Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection.
Huang JF, Yu ML, Dai CY, Hsieh MY, Hwang SJ, Hsiao PJ, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Shin SJ, Chang WY, Chuang WL* - - 1 - AM J GASTROENTEROL - AM J GASTROENTEROL 2008;103(8):1933-40
(IF: 6.101, Journal Ranking: 5, Number of Journals of this Field: 50, Ranking: 10.00%)

477

A randomised study of peginterferon and ribavirin for 16 vs 24 weeks in patients with genotype 2 chronic hepatitis C.
§E©ú¶©, À¹¹Å¨¥, ¶À§Ó´I, «J¤D¤¯, §õ¥ß¬f, Á©ú«Û, ¥Cªø´I, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t, ²ø¸UÀs* - - 1 - GUT - GUT 2007 56¨÷(4´Á):553-559­¶
(IF: 10.015, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 6.00%)

A randomised study of peginterferon and ribavirin for 16 vs 24 weeks in patients with genotype 2 chronic hepatitis C.
Yu ML, Dai CY, Huang JF, Hou NJ, Lee LP, Hsieh MY, Chiu CF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL* - - 1 - GUT - GUT 2007;56(4):553-559
(IF: 10.015, Journal Ranking: 3, Number of Journals of this Field: 50, Ranking: 6.00%)

478

¤z¾A¯àªvÀø¤z¦w¯à§ÜÃĩʬðÅÜ®èB«¬¨xª¢¯f¬r
À¹¹Å¨¥,²ø¸UÀs,Á©ú«Û,§õ¥ß¬f, ¶À§Ó´I, «J¤D¤¯, ªL¤l³ó, ³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,½²ºaµo,±i¤å¦t, §E©ú¶©* - - 1 - ANTIVIRAL RESEARCH - ANTIVIR RES 2007 75¨÷(2´Á):146-151­¶
(IF: 3.406, »â°ì±Æ¦W: 43, »â°ì´Á¥Z¼Æ: 193, »â°ì±Æ¦W: 22.28%)

Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B
Dai CY, Chuang WL, Hsieh MY, Lee LP, Huang JF, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML* - - 1 - ANTIVIRAL RESEARCH - ANTIVIR RES 2007;75(2):146-151
(IF: 3.406, Journal Ranking: 43, Number of Journals of this Field: 193, Ranking: 22.28%)

479

ºC©ÊC«¬¨xª¢¤zÂZ¯ÀªvÀø¤§«ùÄò¯f¬r¾Ç¤ÏÀ³¯à´î§C¨xµw¤Æªºµo¥Í¡G¥xÆW1386¯f¨Ò¤§¬ã¨s
¶À§Ó´I, §E©ú¶©, §õ¥þÂÓ, À¹¹Å¨¥, «J¤D¤¯, Á©ú«Û, ¤ý´º¥°, ¿c³Ó¨k, ¨H¤@¼_, ªL¿ü»Ê*, ²ø¸UÀs, ¹ù¹B½d - - 1 - ALIMENTARY PHARMACOLOGY & THERAPEUTICS - ALIMENT PHARM THERAP 2007 25¨÷(9´Á):1029-1037­¶
(IF: 3.434, »â°ì±Æ¦W: 40, »â°ì´Á¥Z¼Æ: 193, »â°ì±Æ¦W: 20.73%)

Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386-patient study from Taiwan
Huang JF, Yu ML, Lee CM, Dai CY, Hou NJ, Hsieh MY, Wang JH, Lu SN, Sheen IS, Lin SM, Chuang WL, Liaw YF. - - 1 - ALIMENTARY PHARMACOLOGY & THERAPEUTICS - ALIMENT PHARM THERAP 2007;25(9):1029-1037
(IF: 3.434, Journal Ranking: 40, Number of Journals of this Field: 193, Ranking: 20.73%)

480

«D¨xµw¤Æ¯f±w±µ¨ü¨x¤Á¤ù¤§­·ÀI¤Îµo¥Í²v¡G3806¯f¨Ò¤§µû¦ô
¶À§Ó´I, Á©ú«Û, À¹¹Å¨¥, «J¤D¤¯, §õ¥ß¬f, ªL¤l³ó, ³¯«H¦¨, ¤ý¨}«Û, Á©ú¸Î, ±i¤å¦t, §E©ú¶©*, ²ø¸UÀs - - 1 - GUT - GUT 2007 56¨÷(5´Á):736-737­¶
(IF: 9.002, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 48, »â°ì±Æ¦W: 6.25%)

The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies
Huang JF, Hsieh MY, Dai CY, Hou NJ, Lee LP, Lin ZY, Chen SC, Wang LY, Hsieh MY, Chang WY, Yu ML*, Chuang WL - - 1 - GUT - GUT 2007;56(5):736-737
(IF: 9.002, Journal Ranking: 3, Number of Journals of this Field: 48, Ranking: 6.25%)

481

The role of gender on clearance of hepatitis C virus: a different story in an area endemic for hepatitis B and C
À¹¹Å¨¥, ¶À§Ó´I, Á©ú«Û, §õ¥ß¬f,¦ó±Ò¥\,²ø¸UÀs,§E©ú¶©* - - 1 - GUT - GUT 2007 56¨÷(5´Á):737-738­¶
(IF: 9.002, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 48, »â°ì±Æ¦W: 6.25%)

The role of gender on clearance of hepatitis C virus: a different story in an area endemic for hepatitis B and C
Dai CY, Huang JF, Hsieh MY, Lee LP, Ho CK, Chuang WL, Yu ML* - - 1 - GUT - GUT 2007;56(5):737-738
(IF: 9.002, Journal Ranking: 3, Number of Journals of this Field: 48, Ranking: 6.25%)

482

¦b¤@B«¬»PC«¬¨xª¢°ª²±¦æ°ÏC«¬¨xª¢¯f¬r¦å¯g¼W¥[²Ä¤G«¬¿}§¿¯fªº¬ÛÃö©Ê
¶À§Ó´I, À¹¹Å¨¥, ¶À©|§Ó, ¦ó±Ò¥\, ¿½Âz®e, Á©ú«Û, §õ¥ß¬f, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ¨¯¿ü¼ý, ±i¤å¦t, ²ø¸UÀs*, §E©ú¶©* - - 1 - AMERICAN JOURNAL OF GASTROENTEROLOGY - AM J GASTROENTEROL 2007 102¨÷(6´Á):1237-1243­¶
(IF: 5.608, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 48, »â°ì±Æ¦W: 10.42%)

Hepatitis C Viremia Increases the Association With Type 2 Diabetes Mellitus in a Hepatitis B and C Endemic Area: An Epidemiological Link With Virological Implication
Huang JF, Dai CY, Hwang SJ, Ho CK, Hsiao PJ, Hsieh MY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Shin SJ, Chang WY, Chuang WL*, Yu ML - - 1 - AMERICAN JOURNAL OF GASTROENTEROLOGY - AM J GASTROENTEROL 2007;102(6):1237-1243
(IF: 5.608, Journal Ranking: 5, Number of Journals of this Field: 48, Ranking: 10.42%)

483

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
Lin SM, §E©ú¶©, Lee CM, Chien RN, Sheen IS, Chu CM, Liaw YF* - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2007 46¨÷(1´Á):45-52­¶
(IF: 6.642, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 8.00%)

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
Lin SM, Yu ML, Lee CM, Chien RN, Sheen IS, Chu CM, Liaw YF* - - 1 - JOURNAL OF HEPATOLOGY - J HEPATOL 2007;46(1):45-52
(IF: 6.642, Journal Ranking: 4, Number of Journals of this Field: 50, Ranking: 8.00%)

484

APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers - Reply
§E©ú¶©*, À¹¹Å¨¥, ²ø¸UÀs - - 1 - HEPATOLOGY - HEPATOLOGY 2007 45¨÷(6´Á):1587-1588­¶
(IF: 10.734, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 4.00%)

APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers - Reply
Yu ML*, Dai CY, Chuang WL - - 1 - HEPATOLOGY - HEPATOLOGY 2007;45(6):1587-1588
(IF: 10.734, Journal Ranking: 2, Number of Journals of this Field: 50, Ranking: 4.00%)

485

Links between triglyceride levels, hepatitis C virus infection and diabetes.
À¹¹Å¨¥,¶À§Ó´I,Á©ú«Û,§õ¥ß¬f,«J¤D¤¯,§E©ú¶©,²ø¸UÀs* - - 1 - GUT - GUT 2007 56¨÷(8´Á):1167-8­¶
(IF: 10.015, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 6.00%)

Links between triglyceride levels, hepatitis C virus infection and diabetes.
Dai CY, Huang JF, Hsieh MY, Lee LP, Hou NJ, Yu ML, Chuang WL - - 1 - GUT - GUT 2007;56(8):1167-8
(IF: 10.015, Journal Ranking: 3, Number of Journals of this Field: 50, Ranking: 6.00%)

486

The antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in chronic hepatitis C patients
Á©ú«Û,À¹¹Å¨¥,§õ¥ß¬f,¶À§Ó´I,½²¤å¦¨,«J¤D¤¯,ªL¤l³ó,³¯«H¦¨,¤ý¨}«Û,±i¤å¦t ,²ø¸UÀs,§E©ú¶©* - - 1 - J Clin Pathol. - J CLIN PATHOL 2007 ---¨÷(----´Á):Jun 1.­¶
(IF: 2.426, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 66, »â°ì±Æ¦W: 31.82%)

The antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in chronic hepatitis C patients
Hsieh MY, Dai CY, Lee LP, Huang JF, Tsai WC, Hou NJ, Lin ZY, Chen SC, Wang LY, Chang WY, Chuang WL, Yu ML - - 1 - J Clin Pathol. - J CLIN PATHOL 2007;---(----):Jun 1.
(IF: 2.426, Journal Ranking: 21, Number of Journals of this Field: 66, Ranking: 31.82%)

487

Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patients
§õ¥ß¬f,À¹¹Å¨¥,²ø¸UÀs,±i¤å¦t,«J¤D¤¯,Á©ú«Û,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,³¯ªFºa,§E©ú¶©* - - 1 - J Gastroenterol Hepatol. - J GASTROEN HEPATOL 2007 22¨÷(4´Á):515-7­¶
(IF: 1.673, »â°ì±Æ¦W: 38, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 76.00%)

Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patients
Lee LP, Dai CY, Chuang WL, Chang WY, Hou NJ, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chen TJ, Yu ML - - 1 - J Gastroenterol Hepatol. - J GASTROEN HEPATOL 2007;22(4):515-7
(IF: 1.673, Journal Ranking: 38, Number of Journals of this Field: 50, Ranking: 76.00%)

488

°ª¦å¯×¯g¦b¾¸­µ©ÊÅ¥»Ù¤¤ªº¨¤¦â
±i¹ç®a,§E©ú¶©,¦ó©[º½,¦ó±Ò¥\* - - 1 - Otolaryngology-Head and Neck Surgery - OTOLARYNG HEAD NECK 2007 137¨÷(4´Á):603-606­¶
(IF: 1.339, »â°ì±Æ¦W: 10, »â°ì´Á¥Z¼Æ: 29, »â°ì±Æ¦W: 34.48%)

Hyperlipidemia in noise-induced hearing loss
Chang NC, Yu ML, Ho KY, Ho CK* - - 1 - Otolaryngology-Head and Neck Surgery - OTOLARYNG HEAD NECK 2007;137(4):603-606
(IF: 1.339, Journal Ranking: 10, Number of Journals of this Field: 29, Ranking: 34.48%)

489

Prevention of donor to recipient transmission of HCV in stem cell transplantation: some issues.
À¹¹Å¨¥,²ø¸UÀs,¶À§Ó´I,Á©ú«Û,§E©ú¶©* - - 1 - American Journal of Gastroenterology - AM J GASTROENTEROL 2007 102¨÷(10´Á):2350-2351­¶
(IF: 6.101, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 10.00%)

Prevention of donor to recipient transmission of HCV in stem cell transplantation: some issues.
Dai CY, Chuang WL, Huang JF, Hsieh MY, Yu ML* - - 1 - American Journal of Gastroenterology - AM J GASTROENTEROL 2007;102(10):2350-2351
(IF: 6.101, Journal Ranking: 5, Number of Journals of this Field: 50, Ranking: 10.00%)

490

SEN and Hepatitis Virus Infections in Nontransfused Children and Pediatric Thalassemia Patients with Multiple Transfusions in Taiwan
ªô¥@ªY,¶À§Ó´I,±i®õÚz ,Á©ú«Û,À¹¹Å¨¥*,§E©ú¶©,±i¤å¦t,²ø¸UÀs - - 1 - Digestion - DIGESTION 2007 74¨÷(3-4´Á):208-214­¶
(IF: 2.097, »â°ì±Æ¦W: 27, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 54.00%)

SEN and Hepatitis Virus Infections in Nontransfused Children and Pediatric Thalassemia Patients with Multiple Transfusions in Taiwan
Chiou SS, Huang JF, Chang TT, Hsieh MY, Dai CY*, Yu ML, Chang WY, Chuang WL - - 1 - Digestion - DIGESTION 2007;74(3-4):208-214
(IF: 2.097, Journal Ranking: 27, Number of Journals of this Field: 50, Ranking: 54.00%)

491

Reply(A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy)
§E©ú¶©*,À¹¹Å¨¥,²ø¸UÀs - - 1 - Hepatology - HEPATOLOGY 2007 45¨÷(6´Á):1587-1588­¶
(IF: 10.734, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 4.00%)

Reply(A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy)
Yu ML,Dai CY,Chuang WL - - 1 - Hepatology - HEPATOLOGY 2007;45(6):1587-1588
(IF: 10.734, Journal Ranking: 2, Number of Journals of this Field: 50, Ranking: 4.00%)

492

(¦b¥xÆWºC©ÊC«¬¨xª¢¤§¨xŦ¯×ªÕÅܩʤΨxŦÅÖºû¤Æ)
Á©s°a,§õ¥ß¬f,Á©ú«Û,½²©[Ä_,¶À§Ó´I,«J¤D¤¯,³¯«H¦¨,ªL¤l³ó,Á©ú¸Î,¤ý¨}«Û,À¹¹Å¨¥*,²ø¸UÀs,§E©ú¶© - - 1 - Japanese Journal of Infectious Disease - JPN J INFECT DIS 2007 60¨÷(6´Á):377-381­¶
(IF: 0.91, »â°ì±Æ¦W: 43, »â°ì´Á¥Z¼Æ: 47, »â°ì±Æ¦W: 91.49%)

Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
Hsieh MH, Lee LP, Hsieh MY, Tsai KB, Huang JF, Hou NJ, Chen SC, Lin ZY, Hsieh MY, Wang LY, Dai CY*, Chuang WL, Yu ML - - 1 - Japanese Journal of Infectious Disease - JPN J INFECT DIS 2007;60(6):377-381
(IF: 0.91, Journal Ranking: 43, Number of Journals of this Field: 47, Ranking: 91.49%)

493

Á{§É«D¨xµw¤Æ¥¢¥NÀv©ÊºC©ÊB«¬¨xª¢¯f±w¥H¤z¦w¯àªvÀø¤§¦­´Á¤ÏÀ³
À¹¹Å¨¥,§E©ú¶©,Á©ú«Û,§õ¥ß¬f, «J¤D¤¯,¶À§Ó´I, ³¯«H¦¨, ªL¤l³ó, Á©ú¸Î,¤ý¨}«Û,½²ºaµo,±i¤å¦t,²ø¸UÀs * - - 0 - LIVER INTERNATIONAL - LIVER INT 2007 27¨÷(10´Á):1364-1370­¶
(IF: 2.344, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 48, »â°ì±Æ¦W: 43.75%)

Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
Dai CY, Yu ML, Hsieh MY, Lee LP, Hou NJ, Huang JF, Chen SC, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Chang WY, Chuang WL, - - 0 - LIVER INTERNATIONAL - LIVER INT 2007;27(10):1364-1370
(IF: 2.344, Journal Ranking: 21, Number of Journals of this Field: 48, Ranking: 43.75%)

494

Significant correlations between severe fatty liver and risk factors for metabolic syndrome
¿½Âz®e, ³¢¥\·¢, ¨¯¿ü¼ý, Yang YH, Lin WY, Yang JF, Chiu CC, Chuang WL, Tsai TR, §E©ú¶©* - - 1 - J GASTROEN HEPATOL - J GASTROEN HEPATOL 2007 22¨÷(12´Á):2118-2123­¶
(IF: 1.673, »â°ì±Æ¦W: 38, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 76.00%)

Significant correlations between severe fatty liver and risk factors for metabolic syndrome
Hsiao PJ, Kuo KK, Shin SJ, Yang YH, Lin WY, Yang JF, Chiu CC, Chuang WL, Tsai TR, Yu ML. - - 1 - J GASTROEN HEPATOL - J GASTROEN HEPATOL 2007;22(12):2118-2123
(IF: 1.673, Journal Ranking: 38, Number of Journals of this Field: 50, Ranking: 76.00%)

495

¥Ò«¬¸~½FÃa¦º¦]¤l308.2ªº«¬©Ê¦ñÀHÄY­«©Ê¨xÅÖºû¤Æ¤Î¸û°ª¦MÀI©Ê¨x²Ó­MÀùµo¥Í
¾G­s­^,½²ºaµo*,²øÄR¤ë,¦ó¬ü¶m,ªL¤l³ó,Á©ú¸Î,³¯«H¦¨,²ø¸UÀs,¤ý¨}«Û,§E©ú¶©,À¹¹Å¨¥,±i«Ø°ê - - 1 - Neoplasia - NEOPLASIA 2007 9¨÷(11´Á):987-992­¶
(IF: 5.674, »â°ì±Æ¦W: 17, »â°ì´Á¥Z¼Æ: 132, »â°ì±Æ¦W: 12.88%)

Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma
Jeng JE, Tsai JF*, Chuang LY, Ho MS, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Chang JG - - 1 - Neoplasia - NEOPLASIA 2007;9(11):987-992
(IF: 5.674, Journal Ranking: 17, Number of Journals of this Field: 132, Ranking: 12.88%)

496

Qualitative application of cobas amplicor HCV test version 2.0 assays in patients with chronic hepatitis C virus infection and comparison of clinical performance with version 1.0
Á©ú«Û,§õ¥ß¬f,«J¤D¤¯,·¨¥¿ºÖ,¶À§Ó´I*,À¹¹Å¨¥,²ø¸UÀs,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,±i¤å¦t,§E©ú¶© - - 9 - Kaohsiung J Med Sci - 2007 23¨÷(7´Á):332-338­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Qualitative application of cobas amplicor HCV test version 2.0 assays in patients with chronic hepatitis C virus infection and comparison of clinical performance with version 1.0
Hsieh MY, Lee LP, Hou NJ, Yang JF, Huang JF*, Dai CY, Chuang WL, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Yu ML - - 9 - Kaohsiung J Med Sci - 2007;23(7):332-338
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

497

Long-term effects of interferon-based therapy for chronic hepatitis C.
§E©ú¶©,¶À³©®p,À¹¹Å¨¥,¶À§Ó´I,²ø¸UÀs* - - 1 - Oncology - ONCOLOGY-BASEL 2007 72¨÷(1´Á):16-23­¶
(IF: 2.444, »â°ì±Æ¦W: 71, »â°ì´Á¥Z¼Æ: 132, »â°ì±Æ¦W: 53.79%)

Long-term effects of interferon-based therapy for chronic hepatitis C.
Yu ML, Huang CF, Dai CY, Huang JF, Chuang WL* - - 1 - Oncology - ONCOLOGY-BASEL 2007;72(1):16-23
(IF: 2.444, Journal Ranking: 71, Number of Journals of this Field: 132, Ranking: 53.79%)

498

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.
ªL¿ü»Ê, §E©ú¶©, §õ¸à¿Ñ, ²ºa«n, ¨H¤@¼_, ¦¶¹Å©ú, ¹ù¹B½d* - - 1 - J Hepatology - J HEPATOL 2007 46¨÷(1´Á):45-52­¶
(IF: 6.642, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 8.00%)

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.
Lin SM, Yu ML, Lee CM, Chien RN, Sheen IS, Chu CM, Liaw YF*. - - 1 - J Hepatology - J HEPATOL 2007;46(1):45-52
(IF: 6.642, Journal Ranking: 4, Number of Journals of this Field: 50, Ranking: 8.00%)

499

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues.
§E©ú¶©, À¹¹Å¨¥, ¶À§Ó´I, Á©ú«Û, ²ø¸UÀs* - - 1 - Hepatology - HEPATOLOGY 2007 47¨÷(5´Á):1792-1793­¶
(IF: 10.734, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 50, »â°ì±Æ¦W: 4.00%)

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues.
Yu ML, Dai CY, Huang JF, hsieh MY, Chuang WL* - - 1 - Hepatology - HEPATOLOGY 2007;47(5):1792-1793
(IF: 10.734, Journal Ranking: 2, Number of Journals of this Field: 50, Ranking: 4.00%)

500

Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease
¤ý´Ë¸Z, ¸­Ä£©v ,§E©ú¶©, À¹¹Å¨¥, ¾¬¤åµX, ²ø¸UÀs, §õª÷¼w* - - 1 - EUROPEAN JOURNAL OF CLINICAL INVESTIGATION - EUR J CLIN INVEST 2006 36¨÷(3´Á):176-180­¶
(IF: 2.847, »â°ì±Æ¦W: 19, »â°ì´Á¥Z¼Æ: 103, »â°ì±Æ¦W: 18.45%)

Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease
Wang SN, Yeh YT, Yu ML, Dai CY, Chi WC, Chung WL, Lee KT* - - 1 - EUROPEAN JOURNAL OF CLINICAL INVESTIGATION - EUR J CLIN INVEST 2006;36(3):176-180
(IF: 2.847, Journal Ranking: 19, Number of Journals of this Field: 103, Ranking: 18.45%)

501

¦å²M¤¤adiponectin¿@«×¦bÁxÅn¤§Áx©T¾Jµ²¥Û©M¦â¯À¥Û¶¡¤§ÅܤÆ
¤ý´Ë¸Z, ¸­Ä£©v, §E©ú¶©, ¤ý»FÄÖ, §õª÷¼w* - - 1 - BRITISH JOURNAL OF SURGERY - BRIT J SURG 2006 93¨÷(8´Á):981-986­¶
(IF: 4.092, »â°ì±Æ¦W: 5, »â°ì´Á¥Z¼Æ: 138, »â°ì±Æ¦W: 3.62%)

Serum adiponectin levels in cholesterol and pigment cholelithiasis
Wang SN, Yeh YT, Yu ML, Wang CL , Lee KT* - - 1 - BRITISH JOURNAL OF SURGERY - BRIT J SURG 2006;93(8):981-986
(IF: 4.092, Journal Ranking: 5, Number of Journals of this Field: 138, Ranking: 3.62%)

502

Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.
À¹¹Å¨¥, ²ø¸UÀs, ±i¤å¦t, ³¯«H¦¨, §õ¥ß¬f, Á©ú«Û, «J¤D¤¯, ªL¤l³ó, ¶À§Ó´I, Á©ú¸Î, ¤ý¨}«Û, §E©ú¶©* - - 1 - JOURNAL OF INFECTIOUS DISEASES - J INFECT DIS 2006 193¨÷(1´Á):98-101­¶
(IF: 5.363, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 47, »â°ì±Æ¦W: 8.51%)

Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.
Dai CY, Chuang WL, Chang WY, Chen SC, Lee LP, Hsieh MY, Hou NJ, Lin ZY, Huang JF, Hsieh MY, Wang LY, Yu ML* - - 1 - JOURNAL OF INFECTIOUS DISEASES - J INFECT DIS 2006;193(1):98-101
(IF: 5.363, Journal Ranking: 4, Number of Journals of this Field: 47, Ranking: 8.51%)

503

A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan.
§E©ú¶©, À¹¹Å¨¥, ªL¤l³ó, §õ¥ß¬f, «J¤D¤¯, Á©ú«Û, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t, ²ø¸UÀs* - - 1 - Liver Int. - LIVER INT 2006 26¨÷(1´Á):73-81­¶
(IF: 1.766, »â°ì±Æ¦W: 25, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 54.35%)

A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan.
Ming-Lung Yu, Chia-Yen Dai, Zu-Yau Lin, Li-Po Lee, Nei-Jen Hou, Ming-Yen Hsieh, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Wan-Long Chuang* - - 1 - Liver Int. - LIVER INT 2006;26(1):73-81
(IF: 1.766, Journal Ranking: 25, Number of Journals of this Field: 46, Ranking: 54.35%)

504

Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C
·¨¥¿ºÖ, À¹¹Å¨¥, ²ø¸UÀs, ªL¤å¤@, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ½²ºaµo, ±i¤å¦t, §E©ú¶©* - - 1 - JAPANESE JOURNAL OF INFECTIOUS DISEASES - JPN J INFECT DIS 2006 59¨÷(1´Á):25-30­¶
(IF: 0.91, »â°ì±Æ¦W: 43, »â°ì´Á¥Z¼Æ: 47, »â°ì±Æ¦W: 91.49%)

Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C
Yang JF, Dai CY, Chuang WL, Lin WY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML* - - 1 - JAPANESE JOURNAL OF INFECTIOUS DISEASES - JPN J INFECT DIS 2006;59(1):25-30
(IF: 0.91, Journal Ranking: 43, Number of Journals of this Field: 47, Ranking: 91.49%)

505

Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
ªL¤l³ó*, ²ø¸UÀs, ²øÆv°Ä, §E©ú¶©, Á©ú¸Î, ¤ý¨}«Û, ½²ºaµo - - 1 - J Gastroenterol Hepatol. - J GASTROEN HEPATOL 2006 21¨÷(2´Á):398-405­¶
(IF: 1.718, »â°ì±Æ¦W: 28, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 60.87%)

Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
Zu-Yau Lin*, Wan-Long Chuang, Yen-Huang Chuang, Ming-Lung Yu, Ming-Yuh Hsieh, Liang-Yen Wang, Jung-Fa Tsai - - 1 - J Gastroenterol Hepatol. - J GASTROEN HEPATOL 2006;21(2):398-405
(IF: 1.718, Journal Ranking: 28, Number of Journals of this Field: 46, Ranking: 60.87%)

506

The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
¶À§Ó´I, ²ø¸UÀs, À¹¹Å¨¥, ³¯«H¦¨, ªL¤l³ó, §õ¥ß¬f, ¤ý¨}«Û, Á©ú¸Î, ±i¤å¦t, §E©ú¶© * - - 1 - J Viral Hepat. - J VIRAL HEPATITIS 2006 13¨÷(6´Á):396-401­¶
(IF: 2.55, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 32.61%)

The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
Jee-Fu Huang, Wan-Long Chuang, Chia-Yen Dai, Shinn-Cherng Chen, Zu-Yau Lin, Li-Po Lee, Liang-Yen Wang, Ming-Yuh Hsieh, Wen-Yu Chang, Ming-Lung Yu* - - 1 - J Viral Hepat. - J VIRAL HEPATITIS 2006;13(6):396-401
(IF: 2.55, Journal Ranking: 15, Number of Journals of this Field: 46, Ranking: 32.61%)

507

Etiology, severity and recurrence of acute pancreatitis in southern taiwan.
³¯§g»¨,À¹¹Å¨¥, «J¤D¤¯, ³¯«H¦¨, ²ø¸UÀs, §E©ú¶©* - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - J FORMOS MED ASSOC 2006 105¨÷(7´Á):550-555­¶
(IF: 0.533, »â°ì±Æ¦W: 77, »â°ì´Á¥Z¼Æ: 103, »â°ì±Æ¦W: 74.76%)

Etiology, severity and recurrence of acute pancreatitis in southern taiwan.
Chen CH, Dai CY, Hou NJ, Chen SC, Chuang WL, Yu ML* - - 1 - JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION - J FORMOS MED ASSOC 2006;105(7):550-555
(IF: 0.533, Journal Ranking: 77, Number of Journals of this Field: 103, Ranking: 74.76%)

508

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
¶À´ü´Ñ, ³¯«³¶¯, ÅU¤§ªN, ²ø¸UÀs, §E©ú¶©, ¿à©ú¶§, »¯¦³¸Û, §õ¥þÂÓ, ¤ý´º¥°, À¹¹Å¨¥, ¨©¥ýªÛ, ¹ù¶®°ó, ³¯°ö­õ*, ³¯©w«H - - 1 - Pharmacogenomics - PHARMACOGENOMICS 2006 7¨÷(5´Á):697-709­¶
(IF: 3.623, »â°ì±Æ¦W: 37, »â°ì´Á¥Z¼Æ: 193, »â°ì±Æ¦W: 19.17%)

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
Hwang Y, Chen EY, Gu ZJ, Wan-Long Chuang , Ming-Lung Yu , Lai MY, Chao YC, Lee CM, Wang JH, Chia-Yen Dai , Shian-Jy Bey M, Liao YT, Chen PJ*, Chen DS. - - 1 - Pharmacogenomics - PHARMACOGENOMICS 2006;7(5):697-709
(IF: 3.623, Journal Ranking: 37, Number of Journals of this Field: 193, Ranking: 19.17%)

509

Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?
¶À§Ó´I, ²ø¸UÀs, À¹¹Å¨¥, ¦ó±Ò¥\, ¶À©|§Ó, ³¯«H¦¨, ªL¤l³ó, ¤ý¨}«Û, ±i¤å¦t, §E©ú¶©* - - 1 - JOURNAL OF INTERNAL MEDICINE - J INTERN MED 2006 260¨÷(3´Á):255-262­¶
(IF: 4.73, »â°ì±Æ¦W: 11, »â°ì´Á¥Z¼Æ: 103, »â°ì±Æ¦W: 10.68%)

Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?
Huang JF, Chuang WL, Dai CY, Ho CK, Hwang SJ, Chen SC, Lin ZY, Wang LY, Chang WY, Yu ML* - - 1 - JOURNAL OF INTERNAL MEDICINE - J INTERN MED 2006;260(3):255-262
(IF: 4.73, Journal Ranking: 11, Number of Journals of this Field: 103, Ranking: 10.68%)

510

Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
§E©ú¶©, ²ø¸UÀs, À¹¹Å¨¥, §õ¥ß¬f, Á©ú«Û, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t, ½²¶¶¶©, ³¢¦æ¹D* - - 1 - Translational Research¡]J LAB CLIN MED¡^ - J LAB CLIN MED 2006 148¨÷(3´Á):120-7.­¶
(IF: 2.023, »â°ì±Æ¦W: 27, »â°ì´Á¥Z¼Æ: 105, »â°ì±Æ¦W: 25.71%)

Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML, Chuang WL, Dai CY, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Tsai SL, Kuo HT* - - 1 - Translational Research¡]J LAB CLIN MED¡^ - J LAB CLIN MED 2006;148(3):120-7.
(IF: 2.023, Journal Ranking: 27, Number of Journals of this Field: 105, Ranking: 25.71%)

511

Polymorphism of interferon-gamma gene at position+874 and clinical characteristics of chronic hepatitis C
À¹¹Å¨¥, ²ø¸UÀs, Á©ú«Û, §õ¥ß¬f, «J¤D¤¯, ³¯«H¦¨, ªL¤l³ó, Á©ú¸Î, ¤ý¨}«Û, ½²ºaµo, ±i¤å¦t, §E©ú¶©* - - 1 - TRANSLATIONAL RESEARCH - TRANSL RES 2006 148¨÷(3´Á):128-133­¶
(IF: 0, »â°ì±Æ¦W: 25, »â°ì´Á¥Z¼Æ: 25, »â°ì±Æ¦W: 100.00%)

Polymorphism of interferon-gamma gene at position+874 and clinical characteristics of chronic hepatitis C
Dai CY, Chuang WL, Hsieh MY, Lee LP, Hou NJ, Chen SC, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML* - - 1 - TRANSLATIONAL RESEARCH - TRANSL RES 2006;148(3):128-133
(IF: 0, Journal Ranking: 25, Number of Journals of this Field: 25, Ranking: 100.00%)

512

Diagnosis of icteric-type hepatocellular carcinoma by fine needle aspiration: a case report.
¶À§Ó´I, ³¯«H¦¨, ¤ý¨}«Û, §E©ú¶©, À¹¹Å¨¥, ²ø¸UÀs, ±i¤å¦t. - - 1 - Acta Cytol. - ACTA CYTOL 2006 50¨÷(5´Á):531-3.­¶
(IF: 1.022, »â°ì±Æ¦W: 48, »â°ì´Á¥Z¼Æ: 66, »â°ì±Æ¦W: 72.73%)

Diagnosis of icteric-type hepatocellular carcinoma by fine needle aspiration: a case report.
Jee-Fu Huang , Shinn-Cherng Chen , Liang-Yen Wang , Ming-Lung Yu , Chia-Yen Dai , Wan-Long Chuang , Wen-Yu Chang . - - 1 - Acta Cytol. - ACTA CYTOL 2006;50(5):531-3.
(IF: 1.022, Journal Ranking: 48, Number of Journals of this Field: 66, Ranking: 72.73%)

513

Associations of tumour necrosis factor alpha promoter polymorphisms at position-308 and -238 with clinical characteristics of chronic hepatitis C
À¹¹Å¨¥, ²ø¸UÀs, §õ¥ß¬f, ³¯«H¦¨, «J¤D¤¯, ªL¤l³ó, Á©ú«Û, Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t, §E©ú¶©* - - 1 - JOURNAL OF VIRAL HEPATITIS - J VIRAL HEPATITIS 2006 13¨÷(11´Á):770-774­¶
(IF: 3.29, »â°ì±Æ¦W: 13, »â°ì´Á¥Z¼Æ: 48, »â°ì±Æ¦W: 27.08%)

Associations of tumour necrosis factor alpha promoter polymorphisms at position-308 and -238 with clinical characteristics of chronic hepatitis C
Dai CY (Dai, C-Y.), Chuang WL (Chuang, W-L.), Lee LP (Lee, L-P.), Chen SC (Chen, S-C.), Hou NJ (Hou, N-J.), Lin ZY (Lin, Z-Y.), Hsieh MY (Hsieh, M-Y.), Hsieh MY (Hsieh, M-Y.), Wang LY (Wang, L-Y.), Chang WY (Chang, W-Y.), Yu ML* (Yu, M-L.) - - 1 - JOURNAL OF VIRAL HEPATITIS - J VIRAL HEPATITIS 2006;13(11):770-774
(IF: 3.29, Journal Ranking: 13, Number of Journals of this Field: 48, Ranking: 27.08%)

514

A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
§E©ú¶©, ªL¿ü»Ê, §õ¥þÂÓ, À¹¹Å¨¥, ±i¤å¦t, ³¯«H¦¨, §õ¥ß¬f, ªL¤l³ó, Á©ú¸Î, ¤ý¨}«Û, ²ø¸UÀs*, ¹ù¹B½d - - 1 - Hepatology. - HEPATOLOGY 2006 44¨÷(5´Á):1086-97.­¶
(IF: 10.446, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 48, »â°ì±Æ¦W: 4.17%)

A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
Yu ML, Lin SM, Lee CM, Dai CY, Chang WY, Chen SC, Lee LP, Lin ZY, Hsieh MY, Wang LY, Chuang WL*, Liaw YF - - 1 - Hepatology. - HEPATOLOGY 2006;44(5):1086-97.
(IF: 10.446, Journal Ranking: 2, Number of Journals of this Field: 48, Ranking: 4.17%)

515

A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
§E©ú¶©, À¹¹Å¨¥, §õ¥ß¬f, «J¤D¤¯, Á©ú«Û, ¶À§Ó´I, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t, ²ø¸UÀs* - - 1 - Liver Int. - LIVER INT 2006 26¨÷(10´Á):1187-1195.­¶
(IF: 1.766, »â°ì±Æ¦W: 25, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 54.35%)

A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
Yu ML, Dai CY, Lee LP, Hou NJ, Hsieh MY, Huang JF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL* - - 1 - Liver Int. - LIVER INT 2006;26(10):1187-1195.
(IF: 1.766, Journal Ranking: 25, Number of Journals of this Field: 46, Ranking: 54.35%)

516

¤z¦w¯àªvÀøB«¬¨xª¢¤Þ°_¥¢Àv¯f±w¦­´Á¦º¤`²v-¥HMELD¤ÎINDEX«ü¼Ð¹w«áµû¦ô
À¹¹Å¨¥,²ø¸UÀs,«J¤D¤¯,§õ¥ß¬f,Á©ú«Û, ªL¤l³ó, ³¯«H¦¨, ¶À§Ó´I,Á©ú¸Î,¤ý¨}«Û,½²ºaµo,±i¤å¦t, §E©ú¶©* - - 1 - CLINICAL THERAPEUTICS - CLIN THER 2006 28¨÷(12´Á):2081-2092­¶
(IF: 2.893, »â°ì±Æ¦W: 55, »â°ì´Á¥Z¼Æ: 199, »â°ì±Æ¦W: 27.64%)

Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors
Dai CY, Chuang WL, Hou NJ, Lee LP, Hsieh MY, Lin ZY, Chen SC, Huang JF, Hsieh MY, Wang LY, Tsai JF, Wen-Yu, Yu ML* - - 1 - CLINICAL THERAPEUTICS - CLIN THER 2006;28(12):2081-2092
(IF: 2.893, Journal Ranking: 55, Number of Journals of this Field: 199, Ranking: 27.64%)

517

A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
§E©ú¶©, ªL¿ü©ú, ²ø¸UÀs, À¹¹Å¨¥, ¤ý´º¥°, ¿c³Ó¨k, ¨H¤@¼_, ±i¤å¦t, §õ¥þ¿Ñ*, ¹ù¹B½d - - 1 - ANTIVIRAL THERAPY - ANTIVIR THER 2006 11¨÷(8´Á):985-994­¶
(IF: 4.982, »â°ì±Æ¦W: 22, »â°ì´Á¥Z¼Æ: 199, »â°ì±Æ¦W: 11.06%)

A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
Yu ML, Lin SM, Chuang WL, Dai CY, Wang JH, Lu SN, Sheen IS, Chang WY, Lee CM*, Liaw YF - - 1 - ANTIVIRAL THERAPY - ANTIVIR THER 2006;11(8):985-994
(IF: 4.982, Journal Ranking: 22, Number of Journals of this Field: 199, Ranking: 11.06%)

518

Treatment of chronic hepatitis C in southern Taiwan.
²ø¸UÀs, §E©ú¶©, À¹¹Å¨¥, ±i¤å¦t* - - 1 - INTERVIROLOGY - INTERVIROLOGY 2006 49¨÷(1-2´Á):99-106­¶
(IF: 1.448, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 23, »â°ì±Æ¦W: 91.30%)

Treatment of chronic hepatitis C in southern Taiwan.
Chuang WL, Yu ML, Dai CY, Chang WY* - - 1 - INTERVIROLOGY - INTERVIROLOGY 2006;49(1-2):99-106
(IF: 1.448, Journal Ranking: 21, Number of Journals of this Field: 23, Ranking: 91.30%)

519

Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.
§E©ú¶©, À¹¹Å¨¥, §õ¥ß¬f, Á©ú«Û, «J¤D¤¯, ¶À§Ó´I, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t, ²ø¸UÀs* - - 1 - ANTIVIRAL THERAPY - ANTIVIR THER 2006 11¨÷(8´Á):1015-1019­¶
(IF: 4.982, »â°ì±Æ¦W: 22, »â°ì´Á¥Z¼Æ: 199, »â°ì±Æ¦W: 11.06%)

Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.
Yu ML, Dai CY, Lee LP, Hsieh MY, Hou NJ, Huang JF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL* - - 1 - ANTIVIRAL THERAPY - ANTIVIR THER 2006;11(8):1015-1019
(IF: 4.982, Journal Ranking: 22, Number of Journals of this Field: 199, Ranking: 11.06%)

520

Safety of fine-needle aspiration in patients with small hepatocellular carcinoma.
¤ý§Ó¤å, ªL¤l³ó*, ²ø¸UÀs, ¤ý¨}«Û, §E©ú¶©, ³¯«H¦¨, Á©ú¸Î, ½²ºaµo, ±i¤å¦t - - 1 - HEPATOLOGY RESEARCH - HEPATOL RES 2005 31¨÷(1´Á):31-35­¶
(IF: 1.474, »â°ì±Æ¦W: 32, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 69.57%)

Safety of fine-needle aspiration in patients with small hepatocellular carcinoma.
Wang CW, Lin ZY*, Chuang WL, Wang LY, Yu ML, Chen SC, Hsieh MY, Tsai JF, Chang WY. - - 1 - HEPATOLOGY RESEARCH - HEPATOL RES 2005;31(1):31-35
(IF: 1.474, Journal Ranking: 32, Number of Journals of this Field: 46, Ranking: 69.57%)

521

High versus standard doses interferon-alpha in the treatment of naive chronic hepatitis C patients in Taiwan: a 10-year cohort study
§E©ú¶©, À¹¹Å¨¥, ³¯«H¦¨, §õ¥ß¬f, Á©ú«Û, ªL¤l³ó, Á©ú¸Î, ¤ý¨}«Û, ½²ºaµo, ±i¤å¦t, ²ø¸UÀs* - - 1 - BMC INFECTIOUS DISEASES - BMC INFECT DIS 2005 5¨÷(1´Á):27­¶
(IF: 2.066, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 41, »â°ì±Æ¦W: 51.22%)

High versus standard doses interferon-alpha in the treatment of naive chronic hepatitis C patients in Taiwan: a 10-year cohort study
Yu ML, Dai CY, Chen SC, Lee LP, Hsieh MY, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Chang WY, Chuang WL* - - 1 - BMC INFECTIOUS DISEASES - BMC INFECT DIS 2005;5(1):27
(IF: 2.066, Journal Ranking: 21, Number of Journals of this Field: 41, Ranking: 51.22%)

522

Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
²ø¸UÀs, À¹¹Å¨¥, ±i¤å¦t, §õ¥ß¬f, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, §E©ú¶©* - - 1 - ANTIVIRAL THERAPY - ANTIVIR THER 2005 10¨÷(1´Á):125-33­¶
(IF: 6.036, »â°ì±Æ¦W: 1, »â°ì´Á¥Z¼Æ: 22, »â°ì±Æ¦W: 4.55%)

Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML* - - 1 - ANTIVIRAL THERAPY - ANTIVIR THER 2005;10(1):125-33
(IF: 6.036, Journal Ranking: 1, Number of Journals of this Field: 22, Ranking: 4.55%)

523

Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.
§õ¹ØªF, §E©ú¶©, Cheng PN, ¿à©ú¶§, »¯¦³¸Û, Hwang SJ, ±i¤å¦t, ±i©w©v, Hsieh TY, Liu CJ, ³¯©w«H* - - 1 - JOURNAL OF VIRAL HEPATITIS - J VIRAL HEPATITIS 2005 12¨÷(3´Á):283-291­¶
(IF: 2.55, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 32.61%)

Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.
Lee SD, Yu ML, Cheng PN, Lai MY, Chao YC, Hwang SJ, Chang WY, Chang TT, Hsieh TY, Liu CJ, Chen DS* - - 1 - JOURNAL OF VIRAL HEPATITIS - J VIRAL HEPATITIS 2005;12(3):283-291
(IF: 2.55, Journal Ranking: 15, Number of Journals of this Field: 46, Ranking: 32.61%)

524

µL
²ø¸UÀs*, §E©ú¶©, À¹¹Å¨¥, ±i¤å¦t - - 1 - INTERVIROLOGY - INTERVIROLOGY 2005 49¨÷(1-2´Á):99-106­¶
(IF: 1.776, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 23, »â°ì±Æ¦W: 91.30%)

Treatment of chronic hepatitis C in southern Taiwan
Chuang WL*, Yu ML, Dai CY, Chang WY - - 1 - INTERVIROLOGY - INTERVIROLOGY 2005;49(1-2):99-106
(IF: 1.776, Journal Ranking: 21, Number of Journals of this Field: 23, Ranking: 91.30%)

525

µL
À¹¹Å¨¥, ²ø¸UÀs, ±i¤å¦t, ³¯«H¦¨, §õ¥ß¬f, Á©ú«Û, «J¤D¤¯, ªL¤l³ó, Á©ú¸Î, ¤ý¨}«Û, §E©ú¶©* - - 1 - ANTIVIRAL RESEARCH - ANTIVIR RES 2005 67¨÷(2´Á):93-97­¶
(IF: 3.406, »â°ì±Æ¦W: 43, »â°ì´Á¥Z¼Æ: 193, »â°ì±Æ¦W: 22.28%)

Polymorphisms in the interferon-gamma gene at position+874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin
Dai CY, Chuang WL, Chang WY, Chen SC, Lee LP, Hsieh MY, Hou NJ, Lin ZY, Hsieh MY, Wang LY, Yu ML* - - 1 - ANTIVIRAL RESEARCH - ANTIVIR RES 2005;67(2):93-97
(IF: 3.406, Journal Ranking: 43, Number of Journals of this Field: 193, Ranking: 22.28%)

526

µL
§E©ú¶©, «J¤D¤¯, À¹¹Å¨¥, ±i¤å¦t, ²ø¸UÀs* - - 1 - ANTIMICROBIAL AGENTS AND CHEMOTHERAPY - ANTIMICROB AGENTS CH 2005 49¨÷(9´Á):3986-3987­¶
(IF: 4.379, »â°ì±Æ¦W: 25, »â°ì´Á¥Z¼Æ: 193, »â°ì±Æ¦W: 12.95%)

Successful treatment of fulminant Hepatitis C by therapy with Alpha Interferon and Ribavirin
Yu ML, Hou NJ, Dai CY, Chang WY, Chuang WL* - - 1 - ANTIMICROBIAL AGENTS AND CHEMOTHERAPY - ANTIMICROB AGENTS CH 2005;49(9):3986-3987
(IF: 4.379, Journal Ranking: 25, Number of Journals of this Field: 193, Ranking: 12.95%)

527

µL
À¹¹Å¨¥, ²ø¸UÀs, ±i¤å¦t, ³¯«H¦¨, §º»Ê¿³, Á©ú«Û, ªL¤l³ó, Á©ú¸Î, ¤ý¨}«Û, ½²ºaµo, §E©ú¶©* - - 1 - JOURNAL OF INFECTION - J INFECTION 2005 51¨÷(2´Á):110-115­¶
(IF: 1.882, »â°ì±Æ¦W: 31, »â°ì´Á¥Z¼Æ: 43, »â°ì±Æ¦W: 72.09%)

SEN virus infection among patients on maintenance hemodialysis in southern Taiwan
Dai CY, Chuang WL, Chang WY, Chen SC, Sung MH, Hsieh MY, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Yu ML* - - 1 - JOURNAL OF INFECTION - J INFECTION 2005;51(2):110-115
(IF: 1.882, Journal Ranking: 31, Number of Journals of this Field: 43, Ranking: 72.09%)

528

µL
½²ºaµo*, ¾G­s­^, ²øÄR¤ë, ¤×¼z¬Â, ¤ý¨}«Û, Á©ú¸Î, ³¯«H¦¨ , ²ø¸UÀs , ªL¤l³ó , §E©ú¶© , À¹¹Å¨¥ - - 1 - SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY - SCAND J GASTROENTERO 2005 40¨÷(1´Á):68-75­¶
(IF: 1.824, »â°ì±Æ¦W: 22, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 47.83%)

Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma
Tsai JF*, Jeng JE, Chuang LY, You HL, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Yu ML, Dai CY - - 1 - SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY - SCAND J GASTROENTERO 2005;40(1):68-75
(IF: 1.824, Journal Ranking: 22, Number of Journals of this Field: 46, Ranking: 47.83%)

529

Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin.
À¹¹Å¨¥,²ø¸UÀs,±i¤å¦t,³¯«H¦¨,§õ¥ß¬f,Á©ú«Û,«J¤D¤¯,ªL¤l³ó,Á©ú¸Î,¤ý¨}«Û,§E©ú¶© - - 0 - World J Gastroenterol. - 2005 11¨÷(27´Á):4241-4245­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin.
Dai CY, Chuang WL, Chang WY, Chen SC, Lee LP, Hsieh MY, Hou NJ, Lin ZY, Hsieh MY, Wang LY, Yu ML. - - 0 - World J Gastroenterol. - 2005;11(27):4241-4245
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

530

µL
À¹¹Å¨¥, §E©ú¶©, ²ø¸UÀs, §õ¥ß¬f, Á©ú¸Î, «J¤D¤¯, ±i¤å¦t - - 1 - HEPATOLOGY - HEPATOLOGY 2005 42¨÷(4´Á):655A-655A Suppl. 1­¶
(IF: 10.416, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 4.35%)

Tumor necrosis factor alpha promoter polymorphism at position-308 predicts hepatitis C virus response to combination therapy with high dose interferon and ribavirin
Dai CY, Yu ML, Chuang WL, Lee LP, Hsieh MY, Hou NJ, Chang WY - - 1 - HEPATOLOGY - HEPATOLOGY 2005;42(4):655A-655A Suppl. 1
(IF: 10.416, Journal Ranking: 2, Number of Journals of this Field: 46, Ranking: 4.35%)

531

A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factors
§E©ú¶©,À¹¹Å¨¥,³¯«H¦¨,§õ¥ß¬f,¶À§Ó´I,ªL¤l³ó,Á©ú¸Î,¤ý¨}«Û,²ø¸UÀs,±i¤å¦t - - 1 - Antiviral Res - ANTIVIR RES 2004 63¨÷(1´Á):25-32­¶
(IF: 3.32, »â°ì±Æ¦W: 40, »â°ì´Á¥Z¼Æ: 186, »â°ì±Æ¦W: 21.51%)

A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factors
Ming-Lung Yu , Chia-Yen Dai , Shinn-Cherng Chen , Li-Po Lee , Jee-Fu Huang, Zu-Yau Lin , Ming-Yuh Hsieh , Liang-Yen Wang , Wan-Long Chuang , Wen-Yu Chang - - 1 - Antiviral Res - ANTIVIR RES 2004;63(1):25-32
(IF: 3.32, Journal Ranking: 40, Number of Journals of this Field: 186, Ranking: 21.51%)

532

Âb·}¬O¨xµw¤Æ¯f¤H¨Öµo¨xÀùªº¦MÀI¦]¤l
½²ºaµo, ¾G­s­^, ²øÄR¤ë, ªL¤l³ó, Á©ú¸Î, ³¯«H¦¨, ²ø¸UÀs, ¤ý¨}«Û, §E©ú¶©, À¹¹Å¨¥ - - 1 - Medicine - MEDICINE 2004 83¨÷(3´Á):176-187­¶
(IF: 3.727, »â°ì±Æ¦W: 11, »â°ì´Á¥Z¼Æ: 103, »â°ì±Æ¦W: 10.68%)

Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis
Tsai JF, Jeng JE, Chuang LY, Ho MS, Ko YC, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY - - 1 - Medicine - MEDICINE 2004;83(3):176-187
(IF: 3.727, Journal Ranking: 11, Number of Journals of this Field: 103, Ranking: 10.68%)

533

Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primers.
À¹¹Å¨¥ , §E©ú¶© , ªL¤l³ó , ³¯«H¦¨ , Á©ú«Û, §õ¥ß¬f , «J¤D¤¯, Á©ú¸Î ,¤ý¨}«Û , ½²ºaµo , ²ø¸UÀs , ±i¤å¦t - - 1 - Hepatol Res. - HEPATOL RES 2004 27¨÷(2´Á):95-100­¶
(IF: 0.991, »â°ì±Æ¦W: 38, »â°ì´Á¥Z¼Æ: 47, »â°ì±Æ¦W: 80.85%)

Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primers.
Chia-Yen Dai , Ming-Lung Yu , Zu-Yau Lin , Shinn-Cherng Chen , Ming-Yen Hsieh , Li-Po Lee , Nai-Jen Hou , Ming-Yuh Hsieh , Liang-Yen Wang , Jung-Fa Tsai , Wan-Long Chuang , Wen-Yu Chang - - 1 - Hepatol Res. - HEPATOL RES 2004;27(2):95-100
(IF: 0.991, Journal Ranking: 38, Number of Journals of this Field: 47, Ranking: 80.85%)

534

Prevalence and clinical significance of SEN virus infection among volunteer blood donors in southern Taiwan.
À¹¹Å¨¥ , §E©ú¶© , ªL¤l³ó , ³¯«H¦¨ , Á©ú¸Î , ¤ý¨}«Û , ½²ºaµo , ²ø¸UÀs , ±i¤å¦t . - - 1 - Dig Dis Sci. - DIGEST DIS SCI 2004 49¨÷(7´Á):1181-5­¶
(IF: 1.427, »â°ì±Æ¦W: 30, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 65.22%)

Prevalence and clinical significance of SEN virus infection among volunteer blood donors in southern Taiwan.
Chia-Yen Dai , Ming-Lung Yu , Zu-Yau Lin , Shinn-Cherng Chen , Ming-Yuh Hsieh , Liang-Yen Wang , Jung-Fa Tsai , Wan-Long Chuang , ChanWY . - - 1 - Dig Dis Sci. - DIGEST DIS SCI 2004;49(7):1181-5
(IF: 1.427, Journal Ranking: 30, Number of Journals of this Field: 46, Ranking: 65.22%)

535

The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin.
À¹¹Å¨¥ , ²ø¸UÀs , ±i¤å¦t , ³¯«H¦¨ , §õ¥ß¬f , ªL¤l³ó , «J¤D¤¯ , Á©ú¸Î , ¤ý¨}«Û , §E©ú¶© - - 1 - Antiviral Res. - ANTIVIR RES 2004 64¨÷(1´Á):47-53­¶
(IF: 3.32, »â°ì±Æ¦W: 40, »â°ì´Á¥Z¼Æ: 186, »â°ì±Æ¦W: 21.51%)

The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin.
Chia-Yen Dai , Wan-Long Chuang , Wen-Yu Chang , Shinn-Cherng Chen , Li-Po Lee , Zu-Yau Lin , Nai-Jen Hou , Ming-Yuh Hsieh , Liang-Yen Wang , Ming-Lung Yu . - - 1 - Antiviral Res. - ANTIVIR RES 2004;64(1):47-53
(IF: 3.32, Journal Ranking: 40, Number of Journals of this Field: 186, Ranking: 21.51%)

536

Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in Taiwan.
²ø¸UÀs , À¹¹Å¨¥ , ³¯«H¦¨ , §õ¥ß¬f , ªL¤l³ó , Á©ú¸Î , ¤ý¨}«Û , §E©ú¶© , ±i¤å¦t - - 1 - Liver Int. - LIVER 2004 24¨÷(6´Á):595-602­¶
(IF: 2.379, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 32.61%)

Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in Taiwan.
Wan-Long Chuang , Chia-Yen Dai , Shinn-Cherng Chen , Li-Po Lee , Zu-Yau Lin , Ming-Yuh Hsieh , Liang-Yen Wang , Ming-Lung Yu , Wen-Yu Chang . - - 1 - Liver Int. - LIVER 2004;24(6):595-602
(IF: 2.379, Journal Ranking: 15, Number of Journals of this Field: 46, Ranking: 32.61%)

537

Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in Taiwan.
À¹¹Å¨¥ , §E©ú¶© , ³¯«H¦¨ , ªL¤l³ó , Á©ú¸Î , ¤ý¨}«Û , ½²ºaµo , ²ø¸UÀs , ±i¤å¦t - - 1 - J Clin Pathol. - J CLIN PATHOL 2004 57¨÷(2´Á):141-5­¶
(IF: 2.966, »â°ì±Æ¦W: 12, »â°ì´Á¥Z¼Æ: 64, »â°ì±Æ¦W: 18.75%)

Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in Taiwan.
Chia-Yen Dai , Ming-Lung Yu , Shinn-Cherng Chen , Zu-Yau Lin , Ming-Yuh Hsieh , Liang-Yen Wang , Jung-Fa Tsai , Wan-Long Chuang , Wen-Yu Chang . - - 1 - J Clin Pathol. - J CLIN PATHOL 2004;57(2):141-5
(IF: 2.966, Journal Ranking: 12, Number of Journals of this Field: 64, Ranking: 18.75%)

538

Âb·}¬O¨xµw¤Æªº¦MÀI¦]¤l: ¯f¨Ò¹ï·Ó¬ã¨s
½²ºaµo, ²øÄR¤ë, ªL¤l³ó, Á©ú¸Î, ³¯«H¦¨, ²ø¸UÀs, §E©ú¶©, À¹¹Å¨¥, - - 1 - Medicine - 2003 82¨÷(5´Á):365-372­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Habitual betel quid chewing as a risk factor for cirrhosis: a case-control study
Tsai JF, Chuang LY, Ko YC, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY - - 1 - Medicine - 2003;82(5):365-372
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

539

£¸¦~»´¨k©Ê¦X¨Ö§½³¡µ²¸`©Ê¼W¥Í¤Î°°¸~½F¤§¯f¨Ò³ø§i(2003)
§d¤å»x, ³¯«H¦¨, À¹¹Å¨¥, §E©ú¶©, Á©ú¸Î, ªL¤l³ó, ¤ý¨}«Û, ½²ºaµo, ±i¤å¦t, ²ø¸UÀs - - 1 - JGastroenterology & Hepatology - 2003 18¨÷(0´Á):1320-1322­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Coexistence of Focal Nodular Hyperplasia and Pseudotumor cased by Focal Spared lesion in the liver in a Young Man
Wen-Chih Wu, Shinn-Cherng Chen, Chia-Yen Dia, Ming-Lung Yu, Ming-Yuh Hsieh, Zu-Yau Lin, Liang-Yen Wang, Jung-Fa Tsia, Wen-Yu Chang, Wan-Long Chuang - - 1 - JGastroenterology & Hepatology - 2003;18(0):1320-1322
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

540

¦å²M²Ä¤G«¬Ãþ¯Ø®q¯À¥Íªø¦]¤l¤Î¥Ò«¬­L¨à³J¥Õ°µ¬°¨x²Ó­MÀù¸~½F¼Ð°O
½²ºaµo , ¾G­s­^, ²øÄR¤ë, ¤×¼z¬Â, ¦ó¬ü¶m, ¿à¬K¥Í, ¤ý¨}«Û , Á©ú¸Î , ³¯«H¦¨ , ²ø¸UÀs , ªL¤l³ó , §E©ú¶© , À¹¹Å¨¥ - - 1 - Tumour Biol - 2003 24¨÷(6´Á):291-298­¶
(IF: , »â°ì±Æ¦W: , »â°ì´Á¥Z¼Æ: , »â°ì±Æ¦W: %)

Serum Insulin-Like Growth Factor-II and alpha-Fetoprotein as Tumor Markers of Hepatocellular Carcinoma
Tsai JF, Jeng JE, Chuang LY, You HL, Ho MS, Lai CS, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Yu ML, Dai CY - - 1 - Tumour Biol - 2003;24(6):291-298
(IF: , Journal Ranking: , Number of Journals of this Field: , Ranking: %)

541

¥Ò«¬¸~½FÃa¦º¦]¤l«P¶i°Ï308®Ö苷»Ä¦h«¬©Ê»P¥xÆW¦a°ÏºC©ÊC«¬¨xÀù±wªÌ±µ¨ü¤zÂZ¯ÀªvÀø¤ÏÀ³¤§ÃöÁp(2003)
§E©ú¶©,À¹¹Å¨¥,ªô¬L´º,§õ¥ß¬f,ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î,¤ý¨}«Û,Chen CJ,²ø¸UÀs,±i¤å¦t - - 1 - Antiviral Res - 2003 59¨÷(1´Á):35-40­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Tumor necrosis factor alpha promoter polymorphisms at position -308 in Taiwanese chronic hepatitis C patients treated with interferon-alpha.
Yu ML, Dai CY, Chiu CC, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chen CJ, Chuang WL, Chang WY - - 1 - Antiviral Res - 2003;59(1):35-40
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

542

¤HÃþ¥Õ¦å²y§Ü­ìI¤ÎII«¬¹ï°¸°ò¦]«¬ºA¹ï¥xÆW¦a°ÏºC©ÊC«¬¨xª¢¯f±w¤zÂZ¯ÀªvÀø¤ÏÀ³¤§¼vÅT(2003)
§E©ú¶©, À¹¹Å¨¥,³¯«H¦¨, ªô¬L´º,§õ¥ß¬f,ªL¤l³ó,Á©ú¸Î,¤ý¨}«Û,²ø¸UÀs,±i¤å¦t - - 1 - J Infect Dis (JID) - 2003 188¨÷(1´Á):62-65­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Human Leukocyte Antigen Class I and II Alleles and Response to Interferon-alpha Treatment, in Taiwanese Patients with Chronic Hepatitis C Virus Infection.
Yu ML, Dai CY, Chen SC, Chiu CC, Lee LP, Lin ZY, Hsieh MY, Wang LY, Chuang WL, Chang WY. - - 1 - J Infect Dis (JID) - 2003;188(1):62-65
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

543

«æ©Ê¯ØŦª¢¦X¨ÖAlstrom¯g­Ô¸s¡X¯f¨Ò³ø§i(2003)
§d¤å»x,³¯«H¦¨,À¹¹Å¨¥,§E©ú¶©,Á©ú¸Î,ªL¤l³ó ,¤ý¨}«Û,½²ºaµo,±i¤å¦t,²ø¸UÀs - - 0 - Kaohsiung J Med Sci. - 2003 19¨÷(7´Á):358-361­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Alstrom syndrome with acute pancreatitis: a case report.
Wu WC, Chen SC, Dia CY, Yu ML, Hsieh MY, Lin ZY, Wang LY, Tsai JF, Chang WY, Chuang WL. - - 0 - Kaohsiung J Med Sci. - 2003;19(7):358-361
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

544

¦~Äֹ勵±`¤HµÇ¤ºªýÄÇ«ü¼Ð´ú¶q¤§¼vÅT(2003)
ªL¤l³ó,¤ý¨}«Û,§E©ú¶©,À¹¹Å¨¥,³¯«H¦¨,²ø¸UÀs,Á©ú¸Î,½²ºaµo,±i¤å¦t - - 1 - Abdom Imaging - 2003 28¨÷(2´Á):230-232­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Influence of age on intrarenal resistive index measurement in normal subjects.
Lin ZY, Wang LY, Yu ML, Dai CY, Chen SC, Chuang WL, Hsieh MY, Tsai JF, Chang WY - - 1 - Abdom Imaging - 2003;28(2):230-232
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

545

ÄZ­¹Âb·}¬O¨xµw¤Æµo¥Í¤§¦MÀI¦]¤l--¯f¨Ò¹ï·Ó¬ã¨s(2003)
½²ºaµo,¾G­s­^,²øÄR¤ë,¦ó¬ü¶m,ªL¤l³ó, Á©ú¸Î,³¯«H¦¨,²ø¸UÀs,¤ý¨}«Û,§E©ú¶©,À¹¹Å¨¥,«J¥à - - 1 - Medicine (Baltimore) - 2003 82¨÷(5´Á):365-372­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Habitual betel quid chewing as a risk factor for cirrhosis: a case-control study
Jung-Fa Tsai, Jen-Eing Jeng, Lee-Yea Chuang, Mei-Shang Ho, Yin-Chin Ko, Zu-Yau Lin, Ming-Yuh Hsieh , Shinn-Cherng Chen, Wan-Long Chuang , Liang-Yen Wang , Ming-Lung Yu , Chia-Yen Dai , Chen Ho - - 1 - Medicine (Baltimore) - 2003;82(5):365-372
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

546

¥H·s«¬¤Þ¤lµû¦ô±µ¨ü°ª¾¯¶q¤zÂZ¯ÀªvÀø¤§ºC©ÊC«¬¨xª¢¯f±wTT¯f¬r¤§Á{§Éªí¼x(2003)
À¹¹Å¨¥,§E©ú¶©,³¯«H¦¨,Á©ú¸Î,§õ¥ß¬f,«J¤D¤¯,Á©ú¸Î,¤ý¨}«Û,½²ºaµo,²ø¸UÀs,±i¤å¦t - - 1 - Hepatol Res - 2003 27¨÷(2´Á):95-100­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primers
Dai CY, Yu ML, Lin ZY, Chen SC, Hsieh MY, Lee LP, Hou NJ, Hsieh MY, Wang LY, Tsai JF, Chuang WL, Chang WY - - 1 - Hepatol Res - 2003;27(2):95-100
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

547

¦å²M²Ä¤G«¬Ãþ¯Ø®q¯À¥Íªø¦]¤l¤Î¥Ò«¬­L¨à³J¥Õ°µ¬°¨x²Ó­MÀù¸~½F¼Ð°O(2003)
½²ºaµo , ¾G­s­^, ²øÄR¤ë, ¤×¼z¬Â, ¦ó¬ü¶m, ¿à¬K¥Í, ¤ý¨}«Û , Á©ú¸Î , ³¯«H¦¨ , ²ø¸UÀs , ªL¤l³ó , §E©ú¶© , À¹¹Å¨¥ - - 1 - Tumour Biol - 2003 24¨÷(6´Á):291-298­¶
(IF: , »â°ì±Æ¦W: , »â°ì´Á¥Z¼Æ: , »â°ì±Æ¦W: %)

Serum Insulin-Like Growth Factor-II and alpha-Fetoprotein as Tumor Markers of Hepatocellular Carcinoma
Tsai JF, Jeng JE, Chuang LY, You HL, Ho MS, Lai CS, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Yu ML, Dai CY - - 1 - Tumour Biol - 2003;24(6):291-298
(IF: , Journal Ranking: , Number of Journals of this Field: , Ranking: %)

548

¦å²M²Ä¤G«¬Ãþ¯Ø®q¯À¥Íªø¦]¤l¤Î¥Ò«¬­L¨à³J¥Õ°µ¬°¨x²Ó­MÀù¸~½F¼Ð°O
½²ºaµo , ¾G­s­^, ²øÄR¤ë, ¤×¼z¬Â, ¦ó¬ü¶m, ¿à¬K¥Í, ¤ý¨}«Û , Á©ú¸Î , ³¯«H¦¨ , ²ø¸UÀs , ªL¤l³ó , §E©ú¶© , À¹¹Å¨¥ - - 1 - Tumour Biol - 2003 24¨÷(6´Á):291-298­¶
(IF: , »â°ì±Æ¦W: , »â°ì´Á¥Z¼Æ: , »â°ì±Æ¦W: %)

Serum Insulin-Like Growth Factor-II and alpha-Fetoprotein as Tumor Markers of Hepatocellular Carcinoma
Tsai JF, Jeng JE, Chuang LY, You HL, Ho MS, Lai CS, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Yu ML, Dai CY - - 1 - Tumour Biol - 2003;24(6):291-298
(IF: , Journal Ranking: , Number of Journals of this Field: , Ranking: %)

549

Dimethylformamide ¤Þ°_¤§«æ©Ê¨xª¢ -- ¤@¯f¨Ò³ø§i(2002)
À¹¹Å¨¥,«J¥à,§E©ú¶©,²ø¸UÀs ,¦ó±Ò? - - 0 - ¤¤µØ¾·~Âå¾ÇÂø»x - 2002 9¨÷(1´Á):55-58­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Dimethylformamide-induced acute hepatitis -- A Case Report
Dai CY, Hou C, Yu ML, Chuang WL and Ho CK - - 0 - ¤¤µØ¾·~Âå¾ÇÂø»x - 2002;9(1):55-58
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

550

C«¬¨xª¢±wªÌ±µ¨ü¤zÂZ¯ÀªvÀø²£¥Í§Ü¤zÂZ¯À¤¤©M©Ê§ÜÅ餧¾÷²v¤Î¬ÛÃö¦]¤l
«J¥à, ²ø¸UÀs, §E©ú¶©, À¹¹Å¨¥, ³¯«H¦¨, ªL¤l³ó, Á©ú¸Î, ¤ý¨}«Û, ½²ºaµo, ±i¤å¦t - - 1 - Scand J Gastroenterol - 2002 35¨÷(12´Á):1288-1293­¶
(IF: , »â°ì±Æ¦W: , »â°ì´Á¥Z¼Æ: , »â°ì±Æ¦W: %)

Incidence and associated factors of neutralizing anti-interferon antibodies among chronic hepatitis c patients treated with interferon in Taiwan
Cheng Hou, Wan-Long Chuang, Ming-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, Zu-Yau Lin, Ming-Yuh Hsieh, Liang-Yen Wang, Jung-Fa Tsai and Wen-Yu Chang - - 1 - Scand J Gastroenterol - 2002;35(12):1288-1293
(IF: , Journal Ranking: , Number of Journals of this Field: , Ranking: %)

551

E¥xÆW¦a°Ï¦å²G³zªR¯f¤H¤§ºC©Ê¨xª¢¬ÛÃö¯f¬r·P¬V¤§¬y¦æ¯f¾Ç¤ÎÁ{§Éªí¼x¤§¬ã¨s(2002)
À¹¹Å¨¥, §E©ú¶©, ²ø¸UÀs, Sung MH, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î , ¤ý¨}«Û , ½²ºaµo, ±i¤å¦t - - 1 - Nephron 90(2):148-53 - 2002 90¨÷(2´Á):148-153­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Epidemiology and clinical significance of chronic hepatitis-related viruses infection in hemodialysis patients from taiwan
Dai CY, Yu ML, Chuang WL, Sung MH, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY - - 1 - Nephron 90(2):148-53 - 2002;90(2):148-153
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

552

µLA©ÎB«¬¨xª¢¯f¬r·P¬V¤§¨x«ü¼Æ²§±`»PTT¯f¬r¦Ó«DG«¬¨xª¢¯f¬r·P¬V¬ÛÃö(2002)
À¹¹Å¨¥, §E©ú¶©, ²ø¸UÀs, ´¿ÀAªá, ªL¤l³ó, ³¯«H¦¨ ,Á©ú¸Î ,¤ý¨}«Û, ½²ºaµo, ±i¤å¦t - - 1 - Epidemiol Infect - 2002 129¨÷(2´Á):307-13­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

The prevalence of TT virus and GB virus C/hepatitis G virus infection in individuals with raised liver enzymes but without HBV or HCV infection in Taiwan
Dai CY, Yu ML, Chang WY, Tseng CH, Hou C, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chuang WL. - - 1 - Epidemiol Infect - 2002;129(2):307-13
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

553

C«¬¨xª¢±wªÌ±µ¨ü¤zÂZ¯ÀªvÀø²£¥Í§Ü¤zÂZ¯À¤¤©M©Ê§ÜÅ餧¾÷²v¤Î¬ÛÃö¦]¤l
«J¥à, ²ø¸UÀs, §E©ú¶©, À¹¹Å¨¥, ³¯«H¦¨, ªL¤l³ó, Á©ú¸Î, ¤ý¨}«Û, ½²ºaµo, ±i¤å¦t - - 1 - Scand J Gastroenterol - 2002 35¨÷(12´Á):1288-1293­¶
(IF: , »â°ì±Æ¦W: , »â°ì´Á¥Z¼Æ: , »â°ì±Æ¦W: %)

Incidence and associated factors of neutralizing anti-interferon antibodies among chronic hepatitis c patients treated with interferon in Taiwan
Cheng Hou, Wan-Long Chuang, Ming-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, Zu-Yau Lin, Ming-Yuh Hsieh, Liang-Yen Wang, Jung-Fa Tsai and Wen-Yu Chang - - 1 - Scand J Gastroenterol - 2002;35(12):1288-1293
(IF: , Journal Ranking: , Number of Journals of this Field: , Ranking: %)

554

ºC©ÊC«¬¨xª¢±wªÌC«¬¨xª¢¯f¬r¤ÎTT¯f¬r¹ï°ª¾¯¶qªø´Á¤§¥Ò«¬¤zÂZ¯ÀªvÀø¤§Àø®Ä(2002)
À¹¹Å¨¥,§E©ú¶©, ²ø¸UÀs,«J¤D¤¯,«J¥à,³¯«H¦¨ &# - - 1 - Antiviral Research - 2002 53¨÷(0´Á):9-18­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naïve chronic hepatitis C patients
Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang, Nei-Jen Hou, Cheng Hou, Shinn-Cherng Chen, Zu-Yau Lin, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang - - 1 - Antiviral Research - 2002;53(0):9-18
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

555

---
¶À§Ó´I , ¿c³Ó¨k , Chue PY, §õ¸àÂÓ, §E©ú¶©, ²ø¸UÀs, ¤ý´º¥° , À¹¹Å¨¥, ³¯¸q¶©, Shih CH, ±i¤å¦t - - 1 - Epidemiol Infect - 2002 127¨÷(3´Á):485-92­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies
Jee-Fu Huang, Sherng-Nan Lu, Chue PY, Lee CM, Ming-Lung Yu, Wan-Long Chuang, Jing-Hong Wang, Chai-Yen Dai, Chen IL, Shih CH, Wen-Yu Chang - - 1 - Epidemiol Infect - 2002;127(3):485-92
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

556

(2002)¶À¯n©Ê¨x²Ó­MÀù¤§µo¥Í²v»PÁ{§Éµ²ªG
¶À§Ó´I, ¤ý¨}«Û, ªL¤l³ó, ³¯«H¦¨ ,Á©ú¸Î, ²ø¸UÀs, §E©ú¶© , ¿c³Ó¨k, ¤ý´º¥° ,Yeung KW, ±i¤å¦t - - 1 - J Gastroenterol Hepatol - 2002 17¨÷(2´Á):190-5­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Incidence and clinical outcome of icteric type hepatocellular carcinoma
Jee-Fu Huang, Liang-Yen Wang, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Wan-Long Chuang, Ming-Lung Yu, Sherng-Nan Lu, Jing-Hong Wang, Teng KW and Wen-Yu Chang - - 1 - J Gastroenterol Hepatol - 2002;17(2):190-5
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

557

«º¶ÕÅܤƹï©óµÇ¤º°Ê¯ßªý¤O«ü¼Æ¤§¼vÅT(2002)
ªL¤l³ó,À¹¹Å¨¥,±i¤å¦t , §E©ú¶©,³¯«H¦¨,²ø¸UÀs,Á©ú¸Î,¤ý¨}«Û,½²ºaµo - - 1 - Abdom Imaging - 2002 27¨÷(6´Á):626-8­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Influence of posture change on intrarenal arterial resistive index measurement.
Lin ZY, Dai CY, Chang WY, Yu ML, Chen SC, Chuang WL, Hsieh MY, Wang LY, Tsai JF. - - 1 - Abdom Imaging - 2002;27(6):626-8
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

558

¥H¦å²MC¤ÏÀ³³J¥Õ½è´ú©w°»´ú¨xµw¤Æ¯f¤H¦³µL²Óµß·P¬V¤§Á{§ÉÀ³¥Î(2002)
ªL¤l³ó, ²ø¸UÀs, À¹¹Å¨¥, §E©ú¶©, ³¯«H¦¨ , Á©ú¸Î, ¤ý¨}«Û, ½²ºaµo, ±i¤å¦t - - 0 - Kaohsiung J Med Sci - 2002 18¨÷(3´Á):121-6­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Clinical application of serum C-reactive protein measurement in the detection of bacterial infection in patients with liver cirrhosis
Zu-Yau Lin, Wan-Loung Chuang, Chai-Yen Dai, Ming-Lung Yu, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Jung-Fa Tsai and Wen-Yu Chang - - 0 - Kaohsiung J Med Sci - 2002;18(3):121-6
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

559

C«¬¤ÎB«¬¨xª¢¯f¬r°ª²±¦æ¦a°Ï·P¬VTT¯f¬r¤§Á{§Éªí¼x¤Î°ò¦]«¬¤À§G(2002)
À¹¹Å¨¥, §E©ú¶©, «J¥à, ¿c³Ó¨k, ¶À§Ó´I, ³¯«H¦¨ , ªL¤l³ó, Á©ú¸Î, ½²ºaµo, ¤ý¨}«Û, ±i¤å¦t - - 1 - J Gastroenterol Hepatol - 2002 17¨÷(11´Á):1192-1197­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Clinical characteristics and distribution of genotypes of TT virus infection in a hepatitis C virus-hyperendemic township of a hepatitis B virus-endemic country (Taiwan).
Dai CY, Yu ML, Hou C, Lu SN, Wang JH, Huang JF, Chen SC, Lin ZY, Hsieh MY, Tsai JF, Wang LY, Chuang WL, Chang WY. - - 1 - J Gastroenterol Hepatol - 2002;17(11):1192-1197
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

560

C«¬¨xª¢¯f¬r°ò¦]«¬²±¦æ²vÅܤơGC«¬¨xª¢°ª²±¦æ°Ï¤ÎÂå¾Ç¤¤¤ß¤§¤À¤l¬y¦æ¯f¾Ç¬ã¨s¤ÎÁ{§É©w¸q(2001)
§E©ú¶©, ²ø¸UÀs, ³¯«H¦¨, À¹¹Å¨¥, «J¥à, ¤ý´º¥°, ¿c³Ó¨k, ¶À§Ó´I, ªL¤l³ó, Á©ú¸Î , ½²ºaµo, ¤ý¨}«Û , ±i¤å¦t - - 1 - J Med Virol - 2001 65¨÷(1´Á):58-65­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan.
Ming-Lung Yu, Wan-Long Chuang, Shinn-Cherng Chen, Chia-Yen Dai, Cheng Hou, Jeng-Hong Wang, Shin-Nan Lu, Jee-Fu Huang, Zu-Yau Lin, Ming-Yuh Hsieh, Jung-Fa Tsai, Liang-Yen Wang and Wen-Yu Chang - - 1 - J Med Virol - 2001;65(1):58-65
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

561

C«¬¨xª¢¯f¬r·P¬V¹ïºC©ÊB«¬¨xª¢±wªÌ¤§¼vÅT(2002)
À¹¹Å¨¥,§E©ú¶©,²ø¸UÀs,ªL¤l³ó,³¯«H¦¨,Á©ú¸Î,¤ý¨}«Û,½²ºaµo,±i¤å¦t - - 1 - J Gastroenterol Hepatol - 2001 16¨÷(6´Á):636-40­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection.
Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Jung-Fa Tsai and Wen-Yu Chang - - 1 - J Gastroenterol Hepatol - 2001;16(6):636-40
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

562

¥xÆW¦a°Ï°·±d®½¦åªÌTT¯f¬r¤§¤À¤l¬y¦æ¯f¾Ç¤ÎÁ{§Éªí¼x¤§¬ã¨s(2001)
À¹¹Å¨¥, §E©ú¶©, ²ø¸UÀs, ¤ýÃè¤s, ªL¤l³ó, ³¯«H¦¨, Á©ú¸Î, ¤ý¨}«Û, ½²ºaµo, ±i¤å¦t - - 1 - Transfus Apheresis Sci - 2001 24¨÷(1´Á):9-15­¶
(IF: , »â°ì±Æ¦W: , »â°ì´Á¥Z¼Æ: , »â°ì±Æ¦W: %)

The molecular epidemiology and clinical significance of TT virus (TTV) infection in healthy blood donors from southern Taiwan
Chia-Yen Dai , Ming-Lung Yu , Wan-Long Chuang, Ching-Shan Wang , Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yu Hsieh, Liang-Yen Wang, Jung-Fa Tsai and Wen-Yu Chang - - 1 - Transfus Apheresis Sci - 2001;24(1):9-15
(IF: , Journal Ranking: , Number of Journals of this Field: , Ranking: %)

563

(2001)G«¬¨xª¢¯f¬r·P¬V¹ïºC©ÊC«¬¨xª¢±wªÌ±µ¨ü¥Ò«¬¤zÂZ¯ÀªvÀø¤§¼vÅT
§E©ú¶©,²ø¸UÀs,À¹¹Å¨¥,³¯«H¦¨,ªL¤l³ó, Á©ú¸Î,½²ºaµo,¤ý¨}«Û,±i¤å¦t - - 1 - Antiviral Res - 2001 52¨÷(3´Á):241-9­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy.
Ming-Lung Yu, Wan-Long Chuang , Chia-Yen Dai, Shinn-Cherng Chen, Zu-Yau Lin, Ming-Yuh Hsieh, Jung-Fa Tsai, Liang-Yen Wang and Wen-Yu Chang - - 1 - Antiviral Res - 2001;52(3):241-9
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

564

¥NÀv¨}¦n¨xµw¤Æ¯f¤H¨t¦CµÇ¤ºResistive Index ÅܤƤ§¬ã¨s(2001)
ªL¤l³ó,¤ý¨}«Û,À¹¹Å¨¥,§E©ú¶©,³¯«H¦¨ ,²ø¸UÀs,Á©ú¸Î,½²ºaµo ,±i¤å¦t - - 0 - Journal of Medical Ultrasound - 2001 9¨÷(4´Á):187-192­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Patterns of Serial Intrarenal Resistive Index Changes in Patients with Compensated Liver Cirrhosis
Zu-Yau Lin, Liang-Yen Wang, Chia-Yen Dai, Ming-Lung Yu, Shinn-Cherng Chen, Wan-Long Chuang, Ming-Yuh Hsieh, Jung-Fa Tsai and Wen-Yu Chang - - 0 - Journal of Medical Ultrasound - 2001;9(4):187-192
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

565

(2001)¤@C«¬¨xª¢¤ÎB«¬¨xª¢²±¦æ°ÏGB¯f¬rC/ ¢Õ«¬¨xª¢¯f¬r·P¬V¤§¦å²M¾Ç¤Î¤À¤l¬y¦æ¯f¾Ç¬ã¨s
§E©ú¶©,²ø¸UÀs,À¹¹Å¨¥,¿c³Ó¨k,¤ý´º¥°,¶À§Ó´I,³¯«H¦¨,ªL¤l³ó,Á©ú¸Î,½²ºaµo¡@¤ý¨}«Û¡@±i¤å¦t - - 1 - J Infection - 2001 42¨÷(0´Á):61-66­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

The Serological and Molecular Epidemiology of GB virus C/Hepatitis G Virus Infection in a Hepatitis C and B Endemic Area
Ming-Lung Yu, Chia-Yen Dai, Wan-Long Chuang, Sheng-Nan Lu, Jing-Houng Wang, Jee-Fu Huang, Shinn-Cherng Chen, Zu-Yau Lin, Ming-Yuh Hsieh, Jung-Fa Tsai, Liang-Yen Wang and Wen-Yu Chang - - 1 - J Infection - 2001;42(0):61-66
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

566

¥xÆW¶mÂí«C¤Ö¦~C«¬¨xª¢·P¬V:¬y¦æ¯f¤ÎÁ{§É°lÂܬã¨s(2001)
¶À§Ó´I,¿c³Ó¨k,»u¨Ø·ì,§õ¸à¼Ò,§E©ú¶©,²ø¸UÀs,¤ý´º¥°,À¹¹Å¨¥,³¯¸q¶©,Shih CH ,±i¤å¦t - - 1 - Epidemiol Infect - 2001 127¨÷(3´Á):485-492­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies.
Jee-Fu Huang, Shin-Nan Lu , Pei-Yu Chu, Lee CM, Ming-Lung Yu, Wan-Long Chuang, Jeng-Hong Wang, Chia-Yen Dai, Chen IL, Shih CH and Wen-Yu Chang - - 1 - Epidemiol Infect - 2001;127(3):485-492
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

567

¥xÆW¦a°Ï°ª¦MÀI¸s¤Î¦ÛÄ@®½¦åªÌ¤§G«¬¨xª¢·P¬Vª¬ªp»P¦ÛµM¯fµ{
§E©ú¶©, ²ø¸UÀs, ¤ý¨}«Û, À¹¹Å¨¥, ªô¥@ªY, §º»Ê¿³, ±i»FªQ, ³¯«H¦¨, ¤ýÃè¥Í, ±i®õÚz, ±i¤å¦t - - 1 - J Gastroenterol Hepatol - 2000 15¨÷(0´Á):1404-1410­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Status and natural course of GB virus C/hepatitis G virus infection among high-risk groups and volunteer blood donors in Taiwan.
Yu ML, Chuang WL, Wang LY, Dai CY, Chiou SS, Sung MH, Chang CS, Chen SC, Wang CS, Chang TT, Chang WY. - - 1 - J Gastroenterol Hepatol - 2000;15(0):1404-1410
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

568

¦bE«¬¨xª¢¯f¤H¤¤¡A¥Ò«¬¤zÂZ¯À¤Þµo¤§¥Òª¬¸¢¥\¯à²§±`©M¯f¬r¦]¯À¬ÛÃö
Á©ú®a,§E©ú¶©,²ø¸UÀs,¨¯¿ü¼ý,À¹¹Å¨¥,³¯«H¦¨,ªL¤l³ó,Á©ú¸Î,¤ý¨}«Û,±i¤å¦t - - 1 - European J of Endocrinology - 2000 142¨÷(0´Á):431-437­¶
(IF: , »â°ì±Æ¦W: , »â°ì´Á¥Z¼Æ: , »â°ì±Æ¦W: %)

Virologic pactors related to interferon-£\-induced thyroid dysfunction in patients with chronic hepatitis C
Ming-Chia Hsieh, Ming-Lung Yu, Wan-Long Chuang, Shyi-Jang Shin, Chia-Yen Dai, Shinn-Cherng Chen, Zu-Yan Lin, Ming-Yu Hsieh, Jennifer F Liu, Liang-Yen Wang and Wen-Yu Chang - - 1 - European J of Endocrinology - 2000;142(0):431-437
(IF: , Journal Ranking: , Number of Journals of this Field: , Ranking: %)

569

(2000)¥xÆW¦a°Ï°ª¦MÀI¸s¤Î¦ÛÄ@®½¦åªÌ¤§G«¬¨xª¢·P¬Vª¬ªp»P¦ÛµM¯fµ{
§E©ú¶©, ²ø¸UÀs,¤ý¨}«Û,À¹¹Å¨¥,ªô¥@ªY,§º»Ê¿³,³¯«H¦¨,¤ýÃè¥Í,±i®õÚz,±i¤å¦t - - 1 - J Gastroenterol Hepatol - 2000 15¨÷(0´Á):1404-1410­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

The status and natural course of GB virus C/ hepatitis G virus infection among high risk groups and volunteer blood donors in Taiwan.
Ming-Lung Yu, Wan-Loung Chuang, Liang-Yen Wang, Chia-Yen Dai, Shyh-Shin Chiou, Ming-Hsing Sung, Chao-Sung Chang, Shinn-Cherng Chen, Jiang-Sheng Wang, Tai-Tsung Chang and Wen-Yu Chang - - 1 - J Gastroenterol Hepatol - 2000;15(0):1404-1410
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

570

(2000)¦bE«¬¨xª¢¯f¤H¤¤¡A¥Ò«¬¤zÂZ¯À¤Þµo¤§¥Òª¬¸¢¥\¯à²§±`©M¯f¬r¦]¯À¬ÛÃö
Á©ú®a,§E©ú¶©,²ø¸UÀs,¨¯¿ü¼ý,À¹¹Å¨¥,³¯«H¦¨,ªL¤l³ó,Á©ú¸Î,¤ý¨}«Û,±i¤å¦t - - 1 - European J of Endocrinology - 2000 142¨÷(0´Á):431-437­¶
(IF: , »â°ì±Æ¦W: , »â°ì´Á¥Z¼Æ: , »â°ì±Æ¦W: %)

Virologic pactors related to interferon-£\-induced thyroid dysfunction in patients with chronic hepatitis C
Ming-Chia Hsieh, Ming-Lung Yu, Wan-Long Chuang, Shyi-Jang Shin, Chia-Yen Dai, Shinn-Cherng Chen, Zu-Yan Lin, Ming-Yu Hsieh, Jennifer F Liu, Liang-Yen Wang and Wen-Yu Chang - - 1 - European J of Endocrinology - 2000;142(0):431-437
(IF: , Journal Ranking: , Number of Journals of this Field: , Ranking: %)

571

(1999)¨âºØÀË´úªk¦b¦å²MC«¬¨xª¢RNA ©w¶q¤W¤§Á{§ÉÀ³¥Î
§E©ú¶©, ²ø¸UÀs, ³¯«H¦¨, ªL¤l³ó , Á©ú¸Î, ¤ý¨}«Û, ±i¤å¦t - - 1 - J Glinical Pathology - 1999 52¨÷(11´Á):807-811­¶
(IF: , »â°ì±Æ¦W: , »â°ì´Á¥Z¼Æ: , »â°ì±Æ¦W: %)

Clinical application fof the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.
Ming-Lung Yu, Wan-Long Chuang, Shinn-Cherng Chen, Zu-Yau Lin, Ming-Yuh Hsieh, Liang-Yen Wang and Wen-Yu Chang - - 1 - J Glinical Pathology - 1999;52(11):807-811
(IF: , Journal Ranking: , Number of Journals of this Field: , Ranking: %)

572

¥xÆW¦a°ÏB«¬¨xª¢¤ÎC«¬¨xª¢°ª²±¦æªÀ°Ï¤§¬ã¨s(1999)
¤ý´º¥°, ¿c³Ó¨k, §dºa¦{, ¶À§Ó´I, §E©ú¶©, ³¯«H¦¨, ²ø¸UÀs - - 1 - T Roy Soc Trop Med H - 1999 93¨÷(0´Á):253-254­¶
(IF: , »â°ì±Æ¦W: , »â°ì´Á¥Z¼Æ: , »â°ì±Æ¦W: %)

A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan
Jing-Houng Wang, Sheng-Nan Lu, Jung-Chou Wu, Jee-Fu Huang, Ming-Lung Yu, Shinn-Cherng Chen and Wan-Long Chuang - - 1 - T Roy Soc Trop Med H - 1999;93(0):253-254
(IF: , Journal Ranking: , Number of Journals of this Field: , Ranking: %)

573

(1996)¥xÆW«n³¡¦a°ÏºC©ÊC«¬¨xª¢¯f±wC«¬¨xª¢¬r°ò¦]«¬
§E©ú¶©,²ø¸UÀs,¿c³Ó¨k,³¯«H¦¨,¤ý´º¥°,ªL¤l³ó,Á©ú¸Î,¤ý¨}«Û,±i¤å¦t - - 0 - Kaohsiung J Med Sci - 1996 12¨÷(11´Á):605-12­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

The genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection in southern Taiwan.
Yu ML, Chuang WL, Lu SN, Chen SC, Wang JH, Lin ZY, Hsieh MY, Wang LY, Chang WY. - - 0 - Kaohsiung J Med Sci - 1996;12(11):605-12
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

574

(1996)¥H¥Ò«¬¤zÂZ¯ÀªvÀøºC©ÊC¦æ¨xª¢¯f±w¡G¤@¥ý´Á³ø§i
§E©ú¶©,²ø¸UÀs,³¯«H¦¨,¿c³Ó¨k,¤ý´º¥°,ªL¤l³ó,Á©ú¸Î,¤ý¨}«Û,±i¤å¦t - - 0 - °ªÂåÂå»x - 1996 10¨÷(0´Á):581-589­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Treatment of chronic hepatitis C with interferon-alpha : a preliminary report
Ming-Lung Yu, Wan-Long Wang, Shinn-Cherng Chen, San-Nan Lu, Jeng-Hong Wang, Zu-Yau Lin, Ming-Yuh Hsieh, Liang-Yen Wang and Wen-Yu Chang - - 0 - °ªÂåÂå»x - 1996;10(0):581-589
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

 Project

NO
YEAR ¡X Source ¡X No ¡X Type
Project Name
Duration
1
112 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST111-2314-B-037-069-MY2 ¡X 1 ­Ó¤H«¬
±´°Q¢Ñ«¬¨xª¢¦¨¥\ªvÀø«á¡Astatin¤Îmetformin ¹ïªø´Á¨xÀù¤Î¨x¬ÛÃö¨Öµo¯g¤§¼vÅT(2/2)( )
2023/08/01 ~ 2024/07/31
2
112 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSTC112-2314-B-037-004 ¡X 2 ¾ã¦X«¬
³z¹L¾ã¦X¥Íª«¸ê°T¡B°ò¦¹êÅç¤ÎÁ{§ÉÂàĶÂå¾Ç¬ã¨s¥H¥þ¤è¦ì±´°Q«D°sºë©Ê¯×ªÕ¨xª¢¤§·s¿oªvÀø¼Ð¹v¤Î­P¯f¾÷¨î-¥H¦¸¥@¥N©w§Ç±´°Q³y¦¨«D°sºë©Ê¯×ªÕ©Ê¨xª¢ªº¤W´å©M¤U´å°ò¦]°ò¦]°}¦C·§ªp©M½Õ±±¾÷¨î(3/3)( )
2023/08/01 ~ 2024/07/31
3
111 ¡X H ½ÃºÖ³¡ ¡X MOHW112-TDU-B-221-124007 ¡X  
¸ó¾÷ºc¦h­±¦V¨xÀù¾ã¦XÂàĶ¬ã¨s¡A¥Hµo®i¹w¨¾¤ÎªvÀøµ¦²¤¨Ã«Ø¥ßÁ{§É«ü¤Þ¡G°ò¦Á{§É«e¬ã¨s¡B4P(­Ó¤H¤Æ¡B¹w´ú¡B¹w¨¾¤Î°Ñ»P)¬ã¨s¡B¬y¦æ¯f¾Ç¬ã¨s¡B¦æ¬°¤¶¤J¬ã¨s¡B²Î¦X¤ÀªR¡A¥H¤Î¸gÀÙµû¦ô( )
2023/01/01 ~ 2023/12/31
4
111 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST111-2314-B-037-069-MY2 ¡X 1 ­Ó¤H«¬
±´°Q¢Ñ«¬¨xª¢¦¨¥\ªvÀø«á¡Astatin¤Îmetformin ¹ïªø´Á¨xÀù¤Î¨x¬ÛÃö¨Öµo¯g¤§¼vÅT(1/2)( )
2022/08/01 ~ 2024/07/31
5
111 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST111-2321-B-001-012 ¡X 2 ¾ã¦X«¬
HLA¶W¯Å®½ÃتÌiPS·F²Ó­M©óºë·Ç¦A¥ÍÂå¾Ç¤§À³¥Î-HLA¶W¯Å®½ÃتÌiPS·F²Ó­M©óºë·Ç¦A¥ÍÂå¾Ç¤§À³¥Î(1/3)-¤¤¥¡¬ã¨s°|Â༷´Ú(¦@¦P¥D«ù¤H:§E©ú¶©)( )
2022/05/01 ~ 2023/04/30
6
111 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSTC111-2314-B-037-017 ¡X 2 ¾ã¦X«¬
³z¹L¾ã¦X¥Íª«¸ê°T¡B°ò¦¹êÅç¤ÎÁ{§ÉÂàĶÂå¾Ç¬ã¨s¥H¥þ¤è¦ì±´°Q«D°sºë©Ê¯×ªÕ¨xª¢¤§·s¿oªvÀø¼Ð¹v¤Î­P¯f¾÷¨î-¥H¦¸¥@¥N©w§Ç±´°Q³y¦¨«D°sºë©Ê¯×ªÕ©Ê¨xª¢ªº¤W´å©M¤U´å°ò¦]°ò¦]°}¦C·§ªp©M½Õ±±¾÷¨î(2/3)( )
2022/08/01 ~ 2023/07/31
7
110 ¡X H ½ÃºÖ³¡ ¡X MOHW111-TDU-B-221-114007 ¡X 2 ¾ã¦X«¬
¯×ªÕ¨xª¢¬ÛÃö°ò¦]Åܲ§¤Î«D«I¤J©ÊcccDNA¬ÛÃö¯f¬r¼Ð°O¤¬°Ê¹ïB«¬¨xª¢¯f¬r¤Þ­P¨xÀùªº©Ò§êºtªº¨¤¦â( )
2022/01/01 ~ 2022/12/31
8
110 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST108-2314-B-037-066-MY3 ¡X 1 ­Ó¤H«¬
¥H¥i»¤¾É°ò¦]Âà´Þ¹«¬ã¨sGPX2§Ü¿}§¿¯fªº¾÷¨î¤Î¨ä¹ï¤p¹«ªø´Á¹w«á¤§¼vÅT(3/3)( )
2021/08/01 ~ 2022/07/31
9
110 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST110-2314-B-037-119 ¡X 2 ¾ã¦X«¬
³z¹L¾ã¦X¥Íª«¸ê°T¡B°ò¦¹êÅç¤ÎÁ{§ÉÂàĶÂå¾Ç¬ã¨s¥H¥þ¤è¦ì±´°Q«D°sºë©Ê¯×ªÕ¨xª¢¤§·s¿oªvÀø¼Ð¹v¤Î­P¯f¾÷¨î-¥H¦¸¥@¥N©w§Ç±´°Q³y¦¨«D°sºë©Ê¯×ªÕ©Ê¨xª¢ªº¤W´å©M¤U´å°ò¦]°ò¦]°}¦C·§ªp©M½Õ±±¾÷¨î(1/3)( )
2021/08/01 ~ 2022/07/31
10
110 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X MOST111-2813-C-037-042-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨s­pµe
111¦~«×¤j±M¾Ç¥Í¬ã¨s­pµe-§õ¥ôµû(Âå¾Ç5)( )
2022/07/01 ~ 2023/02/28
11
109 ¡X KI °ªÂå°ê½Ã°| ¡X KMU-KI110002 ¡X  
Clarification of Carcinogenesis and Mutagenesis in Liver Cancer in Taiwan( )
2020/08/01 ~ 2021/07/31
12
109 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST108-2314-B-037-066-MY3 ¡X 1 ­Ó¤H«¬
¥H¥i»¤¾É°ò¦]Âà´Þ¹«¬ã¨sGPX2§Ü¿}§¿¯fªº¾÷¨î¤Î¨ä¹ï¤p¹«ªø´Á¹w«á¤§¼vÅT(2/3)( )
2020/08/01 ~ 2022/07/31
13
108 ¡X KC °ªÂ嶧©ú¥æ¤j ¡X NCTUKMU108-IF-01 ¡X  
¾ã¦X¥Íª«´¼¯à»Pºë·ÇÂå¾Ç±´¯Á¨x¯e¯f­·ÀI¦]¤l(HCV¡BHBV¡BNASH¡BT2DM)¾É­PHCC¤§­P¯f¾÷Âà»PªvÀøµ¦²¤( )
2019/08/01 ~ 2020/07/31
14
108 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST108-2314-B-037-066-MY3 ¡X 1 ­Ó¤H«¬
¥H¥i»¤¾É°ò¦]Âà´Þ¹«¬ã¨sGPX2§Ü¿}§¿¯fªº¾÷¨î¤Î¨ä¹ï¤p¹«ªø´Á¹w«á¤§¼vÅT(1/3)( )
2019/08/01 ~ 2022/07/31
15
108 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST108-2314-B-037-003 ¡X 2 ¾ã¦X«¬
Âǥѥþ¤è¦ì±´¯Á·s­P¯f¾÷¨îµo²{·sªº²Ä2«¬¿}§¿¯f¤§¨xŦªvÀø¹vÂI¡G°ò©óºC©ÊC«¬¨xª¢¯f¬r·P¬V¼Ò¦¡¨ì¤@¯ë±Ú¸s¡B³sµ²°ò¦¡A ¥Íª««H®§¾Ç©MÁ{§Éªº¨t²Î©Ê±´°Q¤§ÂàĶ¬ã¨s-¬ã¨s¤p¹«¤¤»P¿}§¿¯f¬ÛÃöªº¨x°ò¦]Aªº¾÷¨î(3/3)( )
2019/08/01 ~ 2020/07/31
16
108 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X MOST108-2811-B-037-521 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s­û-³¯«a¦t( )
2019/08/01 ~ 2020/07/31
17
107 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST107-2314-B-037-005 ¡X 2 ¾ã¦X«¬
Âǥѥþ¤è¦ì±´¯Á·s­P¯f¾÷¨îµo²{·sªº²Ä2«¬¿}§¿¯f¤§¨xŦªvÀø¹vÂI¡G °ò©óºC©ÊC«¬¨xª¢¯f¬r·P¬V¼Ò¦¡¨ì¤@¯ë±Ú¸s¡B³sµ²°ò¦¡A ¥Íª««H®§¾Ç©MÁ{§Éªº¨t²Î©Ê±´°Q¤§ÂàĶ¬ã¨s-¬ã¨s¤p¹«¤¤»P¿}§¿¯f¬ÛÃöªº¨x°ò¦]Aªº¾÷¨î(2/3)( )
2018/08/01 ~ 2019/07/31
18
107 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST107-2314-B-037-121 ¡X 1 ­Ó¤H«¬
¥H¥i»¤¾É°ò¦]Âà´Þ¹«¬ã¨sGENE A§Ü¿}§¿¯fªº¾÷¨î¤Î¨ä¹ï¤p¹«ªø´Á¹w«á¤§¼vÅT( )
2018/08/01 ~ 2019/07/31
19
107 ¡X Y °ªÂå-¹ü°ò¦X§@­pµe ¡X 108-CCH-KMU-001 ¡X 1 ­Ó¤H«¬
§Q¥Î­M¥~¾½Å餺Inc-DANCR¶q´úC«¬¨xª¢Àø®Ä©M¨xÀùµo¥Í¤§Ãö«Y( )
2019/01/01 ~ 2019/12/31
20
107 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X MOST107-2811-B-037-513 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s­û--³¯«a¦t( )
2018/08/01 ~ 2019/07/31
21
106 ¡X DK «e¤­«ÂI(­ì®Õ°|) ¡X KMU-DK107004 ¡X  
±´°Q¥H¤zÂZ¯À©Î¥Hª½±µ§Ü¯f¬rÃĪ«ªvÀøC«¬¨xª¢±wªÌ¤Sµo¤§²Ó­M¿E¯À¤Î¥þ°ò¦]ªí²{( )
2017/08/01 ~ 2018/07/31
22
106 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST105-2314-B-037-062-MY2 ¡X 1 ­Ó¤H«¬
«Ø¥ß¥H°ò¦]A¬°¥­¥xªºÃĪ«¿z¿ï¾÷¨î¡B¶i¦Ó¬ã¨s¸²µå¿}¥NÁ¬ÛÃö¨x©Ê°ò¦]¤Î¿}§¿¯fªvÀø¤§¬ã¨s(2/2)( )
2017/08/01 ~ 2018/10/31
23
106 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST106-2314-B-037-074 ¡X 2 ¾ã¦X«¬
Âǥѥþ¤è¦ì±´¯Á·s­P¯f¾÷¨îµo²{·sªº²Ä2«¬¿}§¿¯f¤§¨xŦªvÀø¹vÂI¡G °ò©óºC©ÊC«¬¨xª¢¯f¬r·P¬V¼Ò¦¡¨ì¤@¯ë±Ú¸s¡B³sµ²°ò¦¡A ¥Íª««H®§¾Ç©MÁ{§Éªº¨t²Î©Ê±´°Q¤§ÂàĶ¬ã¨s-¬ã¨s¤p¹«¤¤»P¿}§¿¯f¬ÛÃöªº¨x°ò¦]Aªº¾÷¨î(1/3)( )
2017/08/01 ~ 2018/07/31
24
106 ¡X X °ª©_¦X§@­pµe ¡X 107CM-KMU-06 ¡X  
ºC©ÊB«¬»PC«¬¨xª¢¯f¬r¦X¨Ö·P¬V¯f±w±µ¨üC«¬¨xª¢§Ü¯f¬rªvÀø«á¨xÀù»P¨x¯f¬ÛÃö¨Öµo¯gµo¥Í­·ÀI¤§ªø´Á°lÂܬã¨s( )
2018/05/01 ~ 2019/04/30
25
106 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X MOST106-2811-B-037-017 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s­û--½²¨Ø­Å( )
2017/08/01 ~ 2018/07/31
26
106 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X MOST106-2811-B-037-021 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s­û--³¯«a¦t( )
2017/08/01 ~ 2018/07/31
27
105 ¡X NK °ªÂå-¤¤¤s¦X§@­pµe ¡X   ¡X 1 ­Ó¤H«¬
©Ê§O¹ï©óºC©ÊC«¬¨xª¢¤§¯f²z¾÷Âà»PªvÀøÀø®Ä¤§¼vÅT( )
2016/01/31 ~ 2016/12/31
28
105 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST103-2314-B-037-061-MY3 ¡X 1 ­Ó¤H«¬
¥H®ø¤Æ¨t²Î¯S²§ªí²{¤§§Ü®ñ¤Æ°ò¦]­ç°£¹««Ø¥ß²Ä¤G«¬¿}§¿¯f°Êª«¼Ò¦¡(3/3)( )
2016/08/01 ~ 2018/01/31
29
105 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST105-2314-B-037-062-MY2 ¡X 1 ­Ó¤H«¬
«Ø¥ß¥H°ò¦]A¬°¥­¥xªºÃĪ«¿z¿ï¾÷¨î¡B¶i¦Ó¬ã¨s¸²µå¿}¥NÁ¬ÛÃö¨x©Ê°ò¦]¤Î¿}§¿¯fªvÀø¤§¬ã¨s(1/2)( )
2016/08/01 ~ 2018/10/31
30
105 ¡X TP ³»¦y­pµe(°ªÂå) ¡X KMU-TP105D06 ¡X  
¤l­pµe¤»¡B¯×½è¥NÁ¤§³±¹q©Ê¯×³J¥Õ¦bC«¬¨xª¢»¤µoºC©Ê¥NÁ¯e¯f¤§¬ÛÃö¬ã¨s( )
2016/11/01 ~ 2017/10/31
31
105 ¡X TP ³»¦y­pµe(°ªÂå) ¡X KMU-TP105E10 ¡X  
¤l­pµe¤Q¡B·L¤pRNA¹ï©óC«¬¨xª¢¯f¬r©Ò¾É­P¤§²Ó­M¯fÅÜ»P­×¸Éªº¨¤¦â(2-2)( )
2016/11/01 ~ 2017/10/31
32
105 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X MOST105-2811-B-037-018 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s­û--½²¨Ø­Å( )
2016/08/01 ~ 2017/07/31
33
104 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST103-2314-B-037-061-MY3 ¡X 1 ­Ó¤H«¬
¥H®ø¤Æ¨t²Î¯S²§ªí²{¤§§Ü®ñ¤Æ°ò¦]­ç°£¹««Ø¥ß²Ä¤G«¬¿}§¿¯f°Êª«¼Ò¦¡(2/3)( )
2015/08/01 ~ 2018/01/31
34
104 ¡X TP ³»¦y­pµe(°ªÂå) ¡X KMU-TP104D12 ¡X  
¤l­pµe¤Q¤G¡B¯×½è¥NÁ¤§³±¹q©Ê¯×³J¥Õ¦bC «¬¨xª¢»¤µoºC©Ê¥NÁ¯e¯f»P¦Ñ¤Æ´NÂå«~½è¤§量©Ê¬ã¨s( )
2015/10/01 ~ 2016/09/30
35
104 ¡X TP ³»¦y­pµe(°ªÂå) ¡X KMU-TP104E08 ¡X  
¤l­pµe¤K¡B·L¤pRNA¹ï©óC«¬¨xª¢¯f¬r©Ò¾É­P¤§²Ó­M¯fÅÜ»P­×¸Éªº¨¤¦â( )
2015/10/01 ~ 2016/09/30
36
104 ¡X Y °ªÂå-¹ü°ò¦X§@­pµe ¡X 105-CCH-KMU-001 ¡X 1 ­Ó¤H«¬
§Q¥Î²Ó­M¿Ã¥ú¤À¿ï§Þ³N¨Ó±´°QC«¬¨xª¢¯f¬r·P¬V©Ò³y¦¨ªº²Ó­M¯fÅÜ®ÄÀ³( )
2016/01/01 ~ 2017/03/31
37
104 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X MOST104-2811-B-037-022 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s­û--½²©ö¬À( )
2015/08/01 ~ 2016/07/31
38
103 ¡X NK °ªÂå-¤¤¤s¦X§@­pµe ¡X NSYSUKMU103-I003-1 ¡X 2 ¾ã¦X«¬
§Q¥Îª¿©`¦Ì½u³õ®Ä¹q´¹ÅéÀ³¥Î©óDNA/miRNA ¥Íª«·P´ú¾¹( )
2014/01/01 ~ 2014/12/31
39
103 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC101-2314-B-037-062-MY3 ¡X 1 ­Ó¤H«¬
ºC©ÊC«¬¨xª¢¯f±w¦å¿}²§±`ªº­P¯f¾÷Âà¬ã¨s(3/3)( )
2014/08/01 ~ 2015/10/31
40
103 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST103-2314-B-037-061-MY3 ¡X 1 ­Ó¤H«¬
¥H®ø¤Æ¨t²Î¯S²§ªí²{¤§§Ü®ñ¤Æ°ò¦]­ç°£¹««Ø¥ß²Ä¤G«¬¿}§¿¯f°Êª«¼Ò¦¡(1/3)( )
2014/08/01 ~ 2018/01/31
41
103 ¡X TP ³»¦y­pµe(°ªÂå) ¡X KMU-TP103D12 ¡X  
±´°Q­ç°£¿}§¿¯f¬ÛÃö¤§¨xŦ°ò¦]Aªº¤p¹«©ó°ª¯×¤Î¥¿±`¶¼­¹¤U«Pµo¿}§¿¯fªº®Ä¤O( )
2014/08/01 ~ 2015/07/31
42
103 ¡X TP ³»¦y­pµe(°ªÂå) ¡X KMU-TP103E06 ¡X  
¬ã¨sC«¬¨xª¢¯f¬r¼vÅT²Ó­M°ò¦]·l¶Ë-­×¸É¾÷¨î¨Ó±´°Q²Ó­M©M¯f¬r¤§¶¡ªº­@¨ü©Ê¤Î¨ä­PÀù¾÷Âà( )
2014/08/01 ~ 2015/07/31
43
103 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X MOST103-2811-B-037-004 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s­û--½²¨Ø­Å( )
2014/08/01 ~ 2015/07/31
44
103 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X MOST103-2811-B-037-022 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s--½²©ö¬À( )
2014/11/01 ~ 2015/07/31
45
102 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC101-2314-B-037-062-MY3 ¡X 1 ­Ó¤H«¬
ºC©ÊC«¬¨xª¢¯f±w¦å¿}²§±`ªº­P¯f¾÷Âà¬ã¨s(2/3)( )
2013/08/01 ~ 2015/10/31
46
102 ¡X Y °ªÂå-¹ü°ò¦X§@­pµe ¡X 103-CCH-KMU-006 ¡X 1 ­Ó¤H«¬
¦å²M¤¤´åÂ÷«¬MICA³J¥Õªí²{©MC«¬¨xª¢¯f¬r¤Þ¦Ü¨xÅÖºû¤Æ»P¨xÀùªº¬ÛÃö©Ê( )
2014/06/01 ~ 2015/05/31
47
102 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X NSC102-2811-B-037-009 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s­û-½²¨Ø­Å( )
2013/08/01 ~ 2014/07/31
48
101 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC101-2314-B-037-062-MY3 ¡X 1 ­Ó¤H«¬
ºC©ÊC«¬¨xª¢¯f±w¦å¿}²§±`ªº­P¯f¾÷Âà¬ã¨s(1/3)( )
2012/08/01 ~ 2015/10/31
49
101 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X NSC101-2811-B-037-013 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s--½²¨Ø­Å( )
2012/08/01 ~ 2013/07/31
50
100 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC98-2314-B-037-059-MY3 ¡X 1 ­Ó¤H«¬
ºC©ÊC«¬¨xª¢¯f±w¦å¿}²§±`¤§¥\¯à°ò¦]Åé¾Ç¬ã¨s(3/3)( )
2011/08/01 ~ 2013/01/31
51
100 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X NSC101-2811-B-037-002 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s--½²¨Ø­Å( )
2012/01/01 ~ 2012/07/31
52
099 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC98-2314-B-037-059-MY3 ¡X 1 ­Ó¤H«¬
ºC©ÊC«¬¨xª¢¯f±w¦å¿}²§±`¤§¥\¯à°ò¦]Åé¾Ç¬ã¨s(2/3)( )
2010/08/01 ~ 2013/01/31
53
098 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC98-2314-B-037-059-MY3 ¡X 1 ­Ó¤H«¬
ºC©ÊC«¬¨xª¢¯f±w¦å¿}²§±`¤§¥\¯à°ò¦]Åé¾Ç¬ã¨s(1/3)( )
2009/08/01 ~ 2013/01/31
54
098 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X NSC99-2811-B-037-001 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s--¼ïÃý¦p(µù¾P)( )
2010/01/01 ~ 2010/12/31
55
098 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X NSC99-2811-B-037-005 ¡X 9 ³Õ¤h«á¬ã¨s­û
³Õ¤h«á¬ã¨s--§õ«Ø¿³( )
2010/01/01 ~ 2010/12/31
56
097 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC95-2314-B-037-039-MY3 ¡X 2 ¾ã¦X«¬
·s³¯¥NÁ¯g«J¸s¤§Adipokines¿ò¶Ç¾Ç¬ã¨s-­¸°sºë©Ê¯×ªÕ¨x¤Î«D°sºë©Ê¯×ªÕ©Ê¨xª¢¤§¤HÅé°ò¦]¬ã¨s(3/3)( )
2008/08/01 ~ 2009/07/31
57
096 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC95-2314-B-037-039-MY3 ¡X 2 ¾ã¦X«¬
·s³¯¥NÁ¯g«J¸s¤§Adipokines¿ò¶Ç¾Ç¬ã¨s-«D°sºë©Ê¯×ªÕ¨x¤Î«D°sºë©Ê¯×ªÕ©Ê¨xª¢¤§¤HÅé°ò¦]¬ã¨s(2/3)( )
2007/08/01 ~ 2009/07/31
58
095 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC95-2314-B-037-017- ¡X 1 ­Ó¤H«¬
ºC©ÊC«¬¨xª¢¾AÃÄ©ÊÀË´ú¤§¬ã¨s( )
2006/08/01 ~ 2007/10/31
59
095 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC95-2314-B-037-039-MY3 ¡X 2 ¾ã¦X«¬
·s³¯¥NÁ¯g­Ô¸s¤§ADIPOKINES¿ò¶Ç¾Ç¬ã¨s-«D°sºë©Ê¯×ªÕ¨x¤Î«D°sºë©Ê¯×ªÕ©Ê¨xª¢¤§¤HÅé°ò¦]¬ã¨s(1/3)( )
2006/08/01 ~ 2009/07/31
60
095 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X HS960627004-3 ¡X 8 ¤j±M¾Ç¥Í¬ã¨s­pµe
96¦~«×°]¹Îªk¤H°·±d¬ì¾Ç¤å±Ð°òª÷·|Âå¾Ç¨t¾Ç¥Í´»´Á¬ã¨s­pµe--°ª¥ì¼z(«áÂå3)( )
2007/07/01 ~ 2007/09/30
61
095 ¡X Z ¤j±M¾Ç¥Í¬ã¨s­pµe¤Î³Õ¤h«á ¡X 96-2815-C-037-015-B ¡X 8 ¤j±M¾Ç¥Í¬ã¨s­pµe
96¦~«×¤j±M¥Í°Ñ»P±MÃD¬ã¨s­pµe--°ª¥ì¼z( )
2007/07/01 ~ 2008/02/29
62
094 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC94-2314-B-037-082- ¡X 1 ­Ó¤H«¬
ºC©ÊC«¬¨xª¢±wªÌ¦å²M¨t¦C¥Õ¦å²y¤¶½è10¶q»P¨ä«P°Ê°ò¦]¦h«¬©Ê¤§¬ã¨s¡G¨ä»P¯e¯fÄY­««×¤§¬ÛÃö¤Î¥Hªø®Ä¥Ò«¬¤zÂZ¯À¦X¨ÖribavirinªvÀøÀø®Ä¤§Ãö«Y( )
2005/08/01 ~ 2006/07/31
63
093 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC93-2314-B-037-075- ¡X 1 ­Ó¤H«¬
ºC©ÊC«¬¨xª¢¯f±w¥H¥Ò«¬¤zÂZ¯À¦X¨ÖribavirinªvÀø®É¦å¤¤¬õ¦å²y¥Í¦¨¯À»P¦å¦â¯À¤§ÅܤƤΨä¬ÛÃö¦]¤l¤§±´°Q( )
2004/08/01 ~ 2005/07/31
64
093 ¡X X °ª©_¦X§@­pµe ¡X 94CM-KMU-14 ¡X 1 ­Ó¤H«¬
¥H¤zÂZ¯À¦X¨ÖRIBAVIRINªvÀø¥xÆWºC©ÊC«¬¨xª¢¯f±w®É¯f¬r°ò¦]«¬1B»P«D1B¶¡¯f¬r°Ê¤O¾Ç¤§®t²§¤Î¨ä¹ïªvÀø¤ÏÀ³¤§¹w´ú( )
2005/03/01 ~ 2006/02/28
65
092 ¡X H ½ÃºÖ³¡ ¡X   ¡X 1 ­Ó¤H«¬
§ÜB«¬¤ÎC«¬¨xª¢¯f¬rÀøªk¹ï©µº¢¨xµw¤Æ¤Î¨xÀùªº¥\¯àµû¦ô¡G¦^·¹©Ê¤Îªì¨B«e¤©Ê¬ã¨s¡q²Ä¤G¦~¡r(EFFECT OF ANTIVIRAL TREATMENT ON PROGRESSION OF PATIENTS WITH CHRONIC HEPATITIS B AND C VIRUS INFECTION TO CIRRHOSIS AND HEPATOCELLULAR CARCINOMA,A RETROSPECTIVE AND PROSPECTIVE STUDY, (SECOND YEAR))
2004/01/01 ~ 2004/06/30
66
092 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC92-2314-B-037-044- ¡X 1 ­Ó¤H«¬
¤HÃþ¥Õ¦å²y§Ü­ì²Ä¤G«¬»PºC©ÊC«¬¨xª¢¥H¥Ò«¬¤zÂZ¯À/ribavirin¦X¨ÖªvÀøÀø®Ä¤§Ãö«Y( )
2003/08/01 ~ 2004/07/31
67
091 ¡X H ½ÃºÖ³¡ ¡X   ¡X 1 ­Ó¤H«¬
§ÜB«¬¤ÎC«¬¨xª¢¯f¬rÀøªk¹ï©µº¢¨xµw¤Æ¤Î¨xÀùªº¥\¯àµû¦ô¡G¦^·¹©Ê¤Îªì¨B«e¤©Ê¬ã¨s¡q²Ä¤G¦~¡r(EFFECT OF ANTIVIRAL TREATMENT ON PROGRESSION OF PATIENTS WITH CHRONIC HEPATITIS B AND C VIRUS INFECTION TO CIRRHOSIS AND HEPATOCELLULAR CARCINOMA,A RETROSPECTIVE AND PROSPECTIVE STUDY, (SECOND YEAR))
2003/07/01 ~ 2003/12/31
68
091 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSC91-2314-B-037-330 ¡X 1 ­Ó¤H«¬
¥Õ¦å²y¤¶½è10«P°Ê°ò¦]¦h«¬©Ê»PºC©ÊC«¬¨xª¢¥H¥Ò«¬¤zÂZ¯À³æ¿W©Î¥Ò «¬¤zÂZ¯À/ribavirin¦X¨ÖªvÀøÀø®Ä¤§Ãö«Y( )
2002/08/01 ~ 2003/07/31
69
090 ¡X H ½ÃºÖ³¡ ¡X DOH90-HP-1005 ¡X  
§ÜB«¬¤ÎC«¬¨xª¢¯f¬rÀøªk¹ï©µº¢¨xµw¤Æ¤Î¨xÀùªº¦ô¯àµû¦ô:¦^·¹©Ê¤Î «e¤©Ê¬ã¨s(Effect of antiviral treatment on progression of patients with chronic hepatitis B and c virus infection to cirrhosis and hepatocellular carcinoma:a retrospecti)
2001/08/01 ~ 2002/12/31

 Patent

NO Patent Name Country Certified Date Patent No
1 ¹w´ú¤zÂZ¯ÀÀø®Ä¤§¤èªk¤Î®M²Õ ¤¤µØ¥Á°ê 2014/10/01 I454577
2 §Q¥Îlet-7g¤U½ÕC«¬¨xª¢¯f¬rªºNS5B°ò¦]¡B®Ö¤ß³J¥Õ¤Î¯f¬r­t²ü¶q ¤¤µØ¥Á°ê 2016/06/11 I537392
3 ¤@ºØ·L¤p®ÖÁÞ®Ö»ÄLet-7g¥Î©ó§ÜC«¬¨xª¢¯f¬rªº¥Î³~ ¤¤µØ¥Á°ê 2018/12/01 I642787
4 §Q¥ÎLet-7g¤U½ÕC«¬¨xª¢¯f¬rªºNS5B°ò¦]¡B®Ö¤ß³J¥Õ¤Î¯f¬r­t²ü¶q ¥@¬É±M§Q(¬ü°ê) 2017/08/22 9,738,942
5 ¤@ºØÀË´úÁÞÃþ¥NÁ²§±`ªº¤èªk¤Î¨ä¹w¨¾¤ÎªvÀø ¤¤µØ¥Á°ê 2018/04/11 I620933
6 ¤@ºØ¹w´úªø®Ä«¬¤zÂZ¯À¦X¨Ö¹p¤Ú«ÂªL©óªvÀøC«¬¨xª¢¯f¤HÀø®Äªº¤èªk ¤¤µØ¥Á°ê 2018/05/11 I623620
7 ¤@ºØ¹w´úªø®Ä«¬¤zÂZ¯À¦X¨Ö¹p¤Ú«ÂªL©óªvÀøC«¬¨xª¢¯f¤HÀø®Äªº¤èªk ¬ü°ê 2018/08/21 10,053,743
8 ¥H­M¥~¾½Å餺lnc-DANCR¶q¹w´úC«¬¨xª¢¬ÛÃö¨xÀù³N«á¤§´_µo ¤¤µØ¥Á°ê 2021/12/01 I748146
9 ¤@ºØÀË´úÁÞ¥NÁ²§±`ªº¤èªk¤Î¨ä¹w¨¾¤ÎªvÀø ¥@¬É±M§Q(¬ü°ê) 2022/09/13 11,439,689
10 ¤@ºØÀË´ú¿}¥NÁ²§±`ªº¤èªk¤Î¨ä¹w¨¾¤ÎªvÀø ¥@¬É±M§Q(¤é¥») 2022/05/02 7066209